cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
93507,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with 1,3-benzenedimethanamine, (chloromethyl)oxirane and [(2-methylphenoxy)methyl]oxirane",603-017-7,124933-75-1,Not Classified,Notified C&L,9,Not classified:9
93508,"Methyl 2-[(3,7-dimethyl-2,6-octadienylidene)amino]benzoate",267-168-7,67801-47-2,Not Classified,Notified C&L,113,Not classified:113
93509,Magnesium chloride,232-094-6,7786-30-3,Not Classified,REACH registration C&L,1482,Not classified:854;H318:441;H290:442;H315:599;H302:441;H335:171;H319:184;H317:56;H314:1;H412:1
93511,dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane,407-180-3,770722-36-6,Skin Corr. 1A,Harmonised C&L,0,H314:0
93512,Dichloro(methyl)(phenyl)silane,205-746-2,149-74-6,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,85,H318:10;H314:84;H302:39;H335:1;H412:1;H290:1;H340:1;Not classified:1
93515,5-aminosalicylic acid,201-919-1,89-57-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,229,H335:216;H317:145;H315:217;H319:217;H412:11;Not classified:1;H302:2
93517,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with tall-oil fatty acids, 4,4'-isopropylidenediphenol-1-chloro-2,3-epoxypropane co-oligomer and triethylenetetramine",500-459-1,160901-21-3,Met. Corr. 1;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,7,H318:5;H290:5;H411:6;H315:6;H317:1;H319:1
93522,N4-(p-ethoxyphenyl)-3-nitrosulphanilamide,244-727-3,22025-44-1,Eye Irrit. 2,Notified C&L,38,H319:38
93527,Distigmine bromide,240-013-0,15876-67-2,Acute Tox. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H300:1
93530,"Calcium chloride (CaCl2), hydrate",607-129-7,22691-02-7,Eye Irrit. 2,Notified C&L,65,H319:65
93531,chlormequat chloride (ISO);2-chloroethyltrimethylammonium chloride,213-666-4,999-81-5,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H312:0;H302:0
93534,"Ethyl 3,5-dinitrobenzoate",210-559-4,618-71-3,Acute Tox. 4,Notified C&L,38,H302:38
93535,Potassium p-hydroxyphenyl sulphate,253-332-5,37067-27-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
93536,ammonium (1Z)-N-(2-methyl-1-sulfopropan-2-yl)prop-2-enimidate,611-646-3,58374-69-9,Not Classified,REACH registration C&L,1,Not classified:1
93542,"Fatty acids, C14-18 and C16-26-unsatd., esters with pentaerythritol",292-805-0,91001-36-4,Not Classified,Notified C&L,2,Not classified:2
93543,"Proteinase, aspartic",278-856-1,78169-47-8,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,1,H335:1;H334:1;H315:1;H319:1
93546,"Globulins, γ-",232-706-1,9007-83-4,Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H319:42
93549,Toluene-2-sulphonyl chloride,205-113-0,133-59-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,49,H318:40;H314:49;H335:2;H319:1;H290:1
93551,5-methyluracil,200-616-1,65-71-4,Not Classified,Notified C&L,6,Not classified:4;H319:2
93554,2-phthalimidopropionic acid,243-117-4,19506-87-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H301:38;H319:38
93555,"Succinic acid, compound with 2-amino-2-(hydroxymethyl)propane-1,3-diol (1:2)",285-975-2,85169-32-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
93561,Zinc dilactate,240-178-9,16039-53-5,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,102,H410:64;H302:27;H412:25;H318:26;H400:63;H319:38;H315:38;H335:38;Not classified:37
93564,Bismuth tris(dimethyldithiocarbamate),244-299-8,21260-46-8,Not Classified,Notified C&L,37,Not classified:37
93569,"Chromate(2-), [3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-7-nitro-1-naphthalenesulfonato(3-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-, lithium sodium",288-603-7,85828-76-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H400:33;H410:33;H411:10;Not classified:1
93570,Methylmalonic acid,208-219-5,516-05-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54,H335:50;H315:51;H319:51;Not classified:3
93572,Bromhexine hydrochloride,210-280-8,611-75-6,Not Classified,Notified C&L,67,Not classified:56;H332:4;H302:4;H335:2;H315:2;H319:2;H312:2;H301:1;H410:4;H401:1;H400:3;H362:1;H360:1
93573,"Protein hydrolyzates, blood",293-470-3,91079-80-0,Not Classified,Notified C&L,2,Not classified:2
93575,"Fatty acids, C8-10, compds. with N-butyl-1-butanamine",285-214-4,85049-44-1,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,29,H318:22;H314:22;H302:29;H312:7;H315:7;H319:7
93578,Methyl 2-[(2-methylpentylidene)amino]benzoate,256-650-2,50607-64-2,Not Classified,Notified C&L,1375,Not classified:1375
93579,"Dodecan-1-ol, ethoxylated",500-002-6,9002-92-0,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1738,H410:94;H400:362;H302:1263;H319:284;H318:1223;H315:574;Not classified:146;H335:55;H411:18;H412:16;H317:6;H413:2;H314:1
93581,2-methylbut-1-en-3-yne,201-144-9,78-80-8,Flam. Liq. 1;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H302:44;H319:44;H315:44;H335:44;H332:44;H224:43;H304:42;H242:1
93585,Tributyl(methacryloyloxy)stannane,218-452-4,2155-70-6,Not Classified,Notified C&L,5,Not classified:5
93589,"Methyl (19α)-16,17-didehydro-19-methyloxayohimban-16-carboxylate hydrochloride",224-471-9,4373-34-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H319:1
93590,"Benzene, C12-14-alkyl derivs., distn. residues, sulfonated, sodium salts",295-132-0,91844-65-4,Not Classified,Notified C&L,1,Not classified:1
93591,"1,18-octadecanedioic acid",442-490-2,,Not Classified,REACH registration C&L,3,Not classified:3
93594,Methyl 2-methylfuran-3-carboxylate,228-132-6,6141-58-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
93601,"Dihydrogen oxobis[sulphato(2-)-O,O']zirconate(2-)",243-234-0,19696-82-3,Not Classified,Notified C&L,6,Not classified:4;H412:2;H314:2
93602,S-methylthiouronium iodide,224-391-4,4338-95-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H335:4;H315:4;H302:4;H319:4;H312:2;H332:2
93603,sec-butyltriphenylphosphonium bromide,223-587-7,3968-92-1,,Notified C&L,4,H335:4;H315:4;H319:4
93604,Bendroflumethiazide,200-800-1,73-48-3,Not Classified,Notified C&L,58,Not classified:54;H332:1;H302:2;H360:2;H319:1
93607,"Hydrocarbons, C10-C12, isoalkanes, < 2% aromatics",923-000-0,,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 2,Notified C&L,1,H226:1;H411:1;H304:1
93608,"Dehydrogenase, alcohol",232-870-4,9031-72-5,Skin Sens. 1;Resp. Sens. 1,Notified C&L,84,H317:83;H334:84
93609,"Tar acids, brown-coal, C",302-662-9,94114-29-1,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
93613,Flamenol,218-532-9,2174-64-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H302:38;H319:39
93616,Methyl isocyanoacetate,254-593-8,39687-95-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,44,H312:43;H314:44;H332:39;H302:43;H331:5;H318:1;H301:1;H311:1
93617,"Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-(1-oxoneodecyl)-.omega.-hydroxy-",615-076-6,70161-59-0,Skin Sens. 1,Notified C&L,3,H317:3
93618,1-(4-trans-Pentylcyclohexyl)-4-propylbenzene,617-422-1,82991-48-8,Not Classified,Notified C&L,1,Not classified:1
93621,"(1R)-(+)-1-[3,5-Bis(trifluoromethyl)phenyl]ethan-1-ol",603-245-7,127852-28-2,Acute Tox. 4,Notified C&L,43,H302:41;H335:1;H315:2;H319:2
93623,Tetrapropylammonium bromide,217-727-6,1941-30-6,Not Classified,REACH registration C&L,2092,Not classified:2043;H335:47;H315:49;H319:49;H302:1;H412:1
93624,"Trimethyl[2-(phosphonooxy)ethyl]ammonium chloride, calcium salt (1:1)",225-403-0,4826-71-5,Not Classified,REACH registration C&L,19,Not classified:3;H335:14;H315:15;H319:15;H302:1
93627,Dioctadecylamine,204-020-2,112-99-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,59,H335:38;H315:58;H319:58;H410:21;H400:21
93628,"Urea, octadecyl-, reaction products with formaldehyde and iso-Bu alc.",600-366-7,102922-88-3,Not Classified,Notified C&L,1,Not classified:1
93630,"N-(6-oxo-6H-anthra[9,1-cd][1,2]thiazol-7-yl)benzamide",462-550-1,,Aquatic Chronic 4,Notified C&L,1,H413:1
93633,2-[2-(2-methoxyethoxy)ethoxy]ethyl methacrylate,246-288-3,24493-59-2,,Notified C&L,38,Not classified:38
93634,Trimethoxy(oct-7-en-1-yl)silane,610-800-7,52217-57-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H335:51;H315:52;H319:52
93635,"Flavoring materials, butter",293-152-4,91051-97-7,Skin Sens. 1,Notified C&L,25,H317:25
93637,"1-benzyl-1,2-dihydro-3H-indazol-3-one, sodium salt",236-138-5,13185-09-6,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,2,H412:1;H302:2;H335:1;H315:1;H319:1
93639,Dichloromethylpropylsilane,224-843-0,4518-94-9,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,47,H226:43;H314:43;Not classified:4;H318:3;H335:2;H290:1
93653,"Carbamic acid, N,N'-1,6-hexanediylbis-, C,C'-dibutyl ester",608-510-0,3066-67-9,,Notified C&L,38,Not classified:38
93654,"D-4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzylalanine",200-102-7,51-49-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40,H312:39;H332:39;H302:39;Not classified:1
93658,CLAY,934-756-6,,STOT RE 2,Notified C&L,216,H373:72;H372:72;Not classified:72
93659,2-(3-Chloro-2-pyridinyl)-5-oxo-3-pyrazolidinecarboxylic acid ethyl ester,610-490-3,500011-88-1,Aquatic Chronic 2,REACH registration C&L,2,H411:2
93663,"Benzoic acid, 4-(bromomethyl)-2-ethoxy-, ethyl ester",600-941-2,110017-07-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,1,H312:1;H332:1;H315:1;H319:1
93666,"2-bromo-1,3-diethyl-5-methyl-benzene",608-620-9,314084-61-2,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,158,H317:157;H400:157;H410:157;H302:2;H319:2;H315:2;H335:2;H332:1
93670,Mercury dibromide,232-169-3,7789-47-1,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,51,H330:51;H410:51;H400:48;H373:51;H300:51;H310:51;Not classified:1
93682,"1,2-dibromo-1-fluoroethane",206-621-5,358-97-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
93683,"1,N,N-Trimethyl-2-[1-(4-chlorophenyl)-1-phenylethoxy]ethylamine",611-411-5,5668-06-4,Acute Tox. 4,Notified C&L,38,H302:38
93684,"Bis[9,10-dioxoanthracene-1-diazonium] tetrachlorozincate(2-)",282-400-7,84195-93-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
93688,Ethyl 3-(methylthio)propionate,236-370-7,13327-56-5,Not Classified,Notified C&L,171,Not classified:166;H335:5;H315:5;H319:5
93693,"2-Pentenedioic acid, 3-[(2-chloroethyl)amino]-, 1,5-dimethyl ester",601-477-3,117422-23-8,Acute Tox. 4,Notified C&L,1,H302:1
93700,"(1S-(1α,2β,5beta))-5-methyl-(1-isopropyl)cyclohexan-2-ol",245-554-6,23283-97-8,Not Classified,Notified C&L,2,Not classified:2
93703,3-(triethoxysilyl)propiononitrile,213-050-5,919-31-3,Not Classified,REACH registration C&L,70,Not classified:5;H335:42;H315:64;H319:43;H411:22
93709,(1R)-3-chloro-1-phenylpropan-1-ol,627-168-3,100306-33-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:40;H315:41;H319:41
93712,"1H-Pyrazole-3-carboxylic acid, 4,4'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)imino(6-chloro-1,3,5-triazine-4,2-diyl)imino(6-sulfo-3,1-phenylene)azo]]bis[4,5-dihydro-5-oxo-1-(4-sulfophenyl)-, sodium salt",288-999-1,85959-09-7,Not Classified,Notified C&L,17,Not classified:17
93714,"1,1'-sulphinylbispropane",224-227-1,4253-91-2,Resp. Sens. 1,Notified C&L,38,H334:38
93720,"(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide",421-810-4,194602-27-2,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H317:0;H411:0;H302:0
93721,"(1α,2β,4α)-1,2,4-trimethylcyclopentane",240-918-0,16883-48-0,Flam. Liq. 2,Notified C&L,4,H225:4
93722,"Ferrate(4-), hexakis(cyano-C)-, Et 2-[6-(ethylamino)-3-(ethylimino)-2,7-dimethyl-3H-xanthen-9-yl]benzoate copper(2+) salts",235-469-2,12237-63-7,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,335,H400:330;H410:332;H319:6;H318:235;Not classified:3
93729,6-methoxy-m-cresol,214-791-7,1195-09-1,,Notified C&L,7,H335:6;H315:7;H302:6;H319:7
93738,"N-(dimethylvinylsilyl)-1,1-dimethyl-1-vinylsilylamine",231-701-1,7691-02-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,94,H302:31;H412:26;H226:94;H311:26;H332:12;H314:67;H318:2;H335:1;H315:1
93741,2-(4-(Ethoxycarbonyl)-3-ethoxyphenyl)acetic acid,619-435-8,99469-99-5,Eye Dam. 1,Notified C&L,48,H318:47;H302:1
93742,Bis(sec-butyl) disulphide,227-702-1,5943-30-6,Not Classified,Notified C&L,126,Not classified:88;H335:38;H315:38;H319:38
93743,"Fats and Glyceridic oils, Theobroma grandiflorum",609-676-7,394236-97-6,Not Classified,Notified C&L,1,Not classified:1
93744,2-fluorophenylhydrazine hydrochloride,220-885-9,2924-15-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,48,H312:42;H302:46;H319:48;H315:48;H335:47;H332:42
93746,Mianserin,246-088-6,24219-97-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,156,H312:156;H332:156;H302:156
93747,Reaction mass of (R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol and Methylene Chloride,929-144-0,,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2A;Acute Tox. 4;Carc. 2,REACH registration C&L,1,H302:1;H319:1;H315:1;H317:1;H225:1;H332:1;H351:1
93750,"Fatty acids, C14-18 and C18-unsatd., branched and linear, esters with trimethylolpropane",284-956-6,85005-23-8,Not Classified,Notified C&L,36,Not classified:34;H413:2
93751,"1,2,3,4-tetrahydronaphthalene-1,5-diol",255-070-7,40771-26-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
93753,"Phosphonic acid, [iminobis(methylene)]bis-, N-coco alkyl derivs., ammonium salts",272-025-7,68649-37-6,Not Classified,Notified C&L,19,Not classified:19
93757,2'-deoxyguanosine,213-505-8,961-07-9,Acute Tox. 4,Notified C&L,44,H302:41;Not classified:2;H335:1;H315:1;H319:1;H312:1;H332:1
93759,1-methyl-2-piperidinemethanol,244-078-6,20845-34-5,,Notified C&L,6,H335:6;H315:6;H319:6;H227:1
93760,Benzyl(methyl)(2-methylaminoethyl)amine,203-006-3,102-11-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
93761,Sorbitan stearate,215-664-9,1338-41-6,Not Classified,REACH registration C&L,531,Not classified:519;H319:10;H412:2
93764,"Silica, [(dimethyl[2-methyl-3-(methylamino)propyl]silyl]oxy]- and [(trimethylsilyl)oxy]-modified",617-568-6,844491-94-7,,Notified C&L,1,Not classified:1
93767,2-phenylpyridine,213-763-1,1008-89-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:38;H315:44;H319:44
93769,"(R)-[[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]phenylacetic acid",264-133-8,63422-71-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,42,H335:39;H315:40;H319:40;H302:1;Not classified:1
93770,"1-Propanamine, 3-(C12-14-alkyloxy) derivs.",270-939-0,68511-41-1,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,23,H410:23;H314:23;H302:23
93776,Mecamylamine hydrochloride,212-555-8,826-39-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:40;H315:40;H301:40;H319:40;H312:1;H302:1;H332:1
93778,"m-phenoxybenzyl cis-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate",263-346-3,61949-76-6,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,125,H410:125;H302:125;H400:125;H317:125;H332:125
93779,(3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone,423-290-4,66938-41-8,Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H341:0;H400:0;H410:0
93780,"Copper, [3,7,11,15-tetramethyl-2-hexadecenyl 9-ethenyl-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoato(2-)-N23,N24,N25,N26]-, [SP-4-2-[3S-[3α(2E,7S*,11S*),4β,21β]]]-",239-830-5,15739-09-0,Not Classified,Notified C&L,89,Not classified:89
93781,6-isopropyl-o-toluidine,226-083-5,5266-85-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H335:1;H302:1;H319:1;H315:1;H226:1;H332:1
93783,"Tributyl-2-methoxypropylphosphonium salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[phenol]",468-740-0,,Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,1,H317:1;H411:1
93790,2-(4-methoxyphenyl)-2-pyrrolidin-1-ylacetonitrile,239-243-4,15190-12-2,Acute Tox. 4,Notified C&L,38,H302:38
93792,"1,3-dichloroacetone",208-585-6,534-07-6,Acute Tox. 2;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 1;Muta. 2,REACH registration C&L,75,H341:47;H330:75;H314:74;H300:75;H311:5;H310:70;H410:31;H318:27;H400:30;H319:1;H315:1;H335:1
93793,2-pyridylamine,207-988-4,504-29-0,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,150,H412:4;H318:5;H314:5;H301:148;H311:125;H312:20;H319:120;H411:45;H315:119;H335:103;H330:12;H331:15;Not classified:2;H370:1;H332:1
93795,Caramiphen hydrogen edisilate,204-759-0,125-86-0,Acute Tox. 4,Notified C&L,38,H302:38
93797,2-ethylcyclohexanol,223-174-1,3760-20-1,Eye Dam. 1,Notified C&L,39,H318:39;H227:1
93798,"Methyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate",219-900-1,2566-89-4,Not Classified,Notified C&L,40,Not classified:39;H252:1
93802,"Xanthylium, 9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethyl-, molybdatesilicate",263-793-4,63022-06-0,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,151,H400:143;H410:145;H318:45;H373:6;H411:6
93803,reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol;1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1),407-290-1,,Eye Dam. 1,Harmonised C&L,0,H318:0
93809,Tris[(3-ethyl-3-oxetanyl)methyl] phosphite,254-662-2,39865-35-5,,Notified C&L,33,Not classified:33
93810,4-hydroxy-3-methoxymandelic acid,200-224-0,55-10-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:38;H315:39;H319:39;H302:1
93811,"4-[[2-amino-4-hydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]-3-[(4-nitrophenyl)azo]phenyl]azo]-5-hydroxynaphthalene-2,7-disulphonic acid",274-726-3,70660-46-7,Not Classified,Notified C&L,2,Not classified:1;H315:1
93814,1-methylhexyl acetate,227-647-3,5921-82-4,Aquatic Chronic 2,Notified C&L,1,H411:1
93815,"2,5-difluorotoluene",207-205-6,452-67-5,Flam. Liq. 2,Notified C&L,44,H225:44;H335:4;H315:4;H319:4
93816,6-nitro-2-toluonitrile,217-553-0,1885-76-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H312:39;H302:39;H319:39;H315:39;H335:38;H332:39
93817,"3-Naphth-2-yl-D-alanine, N-BOC protected",616-417-1,76985-10-9,,Notified C&L,2,Not classified:1;H335:1;H315:1;H319:1
93821,Fluoroacetyl chloride,206-623-6,359-06-8,Skin Corr. 1B,Notified C&L,1,H314:1
93822,"29-(nonylphenoxy)-3,6,9,12,15,18,21,24,27-nonaoxanonacosanol",248-294-1,27177-08-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,28,H412:25;H318:27;H315:27;H302:27;H413:1;H319:1;H411:2
93825,"benazolin (ISO);4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid",223-297-0,3813-05-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H315:0;H319:0
93827,"Methyl 2,6,10-trimethylcyclododeca-2,5,9-trien-1-yl ketone",248-995-2,28371-99-5,,Notified C&L,1554,H317:1354;H410:1354;H319:1286;H411:200;H315:200;H400:68
93830,Ethyl 4-chlorobenzoate,230-844-7,7335-27-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
93837,"3,3',3''-propane-1,2,3-triyltrioxytripropiononitrile",219-573-5,2465-93-2,,Notified C&L,6,H312:5;H332:5;H302:5;H315:2;H301:1;H319:2;H335:1
93838,"Sodium 6,7-dihydroxynaphthalene-2-sulphonate",205-198-4,135-53-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:40;H315:40;H319:41
93839,"5,5-dimethylhexanoic acid",246-289-9,24499-80-7,,Notified C&L,3,H312:1;H332:1;H302:2;H319:1;H335:2;H318:2;H315:2
93842,p-phenylenedimethanol,209-641-2,589-29-7,Acute Tox. 4,Notified C&L,3,H302:2;H332:1;Not classified:1
93843,"Natural gas (petroleum), raw liq. mix;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C",265-048-9,64741-48-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
93847,4-(ethoxymethyl)-2-methoxyphenol,236-136-4,13184-86-6,Not Classified,Notified C&L,94,Not classified:93;H315:1;H319:1
93850,"Fatty acids, C6-19-branched, calcium salts",270-064-4,68409-80-3,Not Classified,REACH registration C&L,64,Not classified:3;H315:59;H413:2
93855,Prednisolone 21-pivalate,214-172-1,1107-99-9,,Notified C&L,2,H302:2;H373:1;H332:1
93856,4-hydroxyhexan-3-one,225-637-3,4984-85-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H226:39;H312:38;H332:38;H302:38
93860,(-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine,406-030-4,105812-81-5,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0;H302:0
93863,"4-methyl-1,3-dioxolane",214-008-9,1072-47-5,Flam. Liq. 2,Notified C&L,45,H225:41;H224:3;H315:2;H319:2;Not classified:1
93865,"4,5-dimethyl-2-(trimethylsilyl)-3-thiophenecarboxylic acid",605-753-4,175217-23-9,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
93866,"3 beta,5 beta-Dihydroxy-15 beta,16 beta-methylene-5 beta-androst-6-en-17-one",617-346-9,82543-15-5,Not Classified,REACH registration C&L,3,Not classified:2;H312:1;H302:1;H319:1;H315:1;H335:1;H332:1
93867,Indol-3-yl methyl ketone,211-875-5,703-80-0,Not Classified,Notified C&L,2,Not classified:1;H335:1;H315:1;H319:1
93873,L-lysine L-glutamate,226-474-0,5408-52-6,Not Classified,Notified C&L,2,Not classified:2
93874,Ethylene bis(chloroformate),204-674-9,124-05-0,Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H314:38;H302:38
93877,Methyl 4-(chloromethyl)benzoate,251-806-6,34040-64-7,,Notified C&L,6,H314:6;H318:1
93880,Propylthiouracil,200-103-2,51-52-5,Acute Tox. 4;Carc. 2,Notified C&L,47,H351:44;H302:47;H361:1;H412:1
93883,"Calcium bis[3-[[(dimethylamino)methylene]amino]-3-(2,4,6-triiodophenyl)propionate]",214-565-8,1151-11-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,24,H318:24;H302:24
93885,4-acetylbenzoic acid,209-588-5,586-89-0,,Notified C&L,51,Not classified:44;H335:5;H315:6;H319:6;H302:1
93888,1-(4-fluoro-2-hydroxyphenyl)ethanone,604-626-0,1481-27-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:47;H315:48;H319:48
93890,1-(cyanoacetyl)piperidine,239-111-6,15029-30-8,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H312:38;H302:42;H319:42;H335:42;H332:38;H315:4
93892,"2,2'-[ethylenebis(oxymethylene)]bisoxirane",218-746-2,2224-15-9,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Muta. 2;Repr. 1B;Aquatic Chronic 3,REACH registration C&L,215,H341:110;H302:112;H412:4;H318:4;H317:129;H360:4;H315:172;Not classified:37;H319:45;H312:2;H332:2
93893,2-methoxy-4-nitrobenzenediazonium,248-642-2,27761-26-8,Unst. Expl.,REACH registration C&L,3,H200:2;Not classified:1
93895,"Zinc oxide (ZnO), calcined",297-712-9,93686-58-9,Not Classified,Notified C&L,1,Not classified:1
93897,"Proteinase, pancreatic",232-626-7,9001-72-3,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,1,H335:1;H334:1;H315:1;H319:1
93900,5-Bromo-4-chloro-2-fluorobenzoic acid,608-274-9,289038-22-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
93904,(S)-butan-2-ol,224-168-1,4221-99-2,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3;STOT SE 3,Harmonised C&L,0,H226:0;H336:0;H335:0;H319:0
93914,"Quaternary ammonium compounds, (2,3-dihydroxypropyl)bis(hydroxyethyl)tallow alkyl, chlorides",274-276-8,70025-19-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,18,H318:18;H315:18
93918,Rhenium triiodide,239-698-9,15622-42-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
93919,"9-Octadecenoic acid (Z)-, 1,2,3-propanetriyl ester, sulfated, potassium salts",295-073-0,91782-97-7,Not Classified,Notified C&L,1,Not classified:1
93921,"Trifluoro[1,1'-oxybis[butane]]boron",209-783-5,593-04-4,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,42,H318:3;H314:42;H331:41;H301:41;H311:41;H312:1;H302:1;H332:1
93922,Octahydro-1H-indole,224-472-4,4375-14-8,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H226:1;H318:1;H335:1;H315:1
93930,"Dihydrogen bis[P,P-dioctyl diphosphato(2-)-O'',O''''][hydroxyacetato(2-)-O1,O2]titanate(2-), branched and linear",271-571-3,68585-64-8,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,4,H302:4;H318:2;H315:4;H317:2;H226:4;H335:2;H319:2
93934,"Phenol, 2,6-dichloro-4-fluoro-",609-626-4,392-71-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:38;H315:39;H319:39;H312:5;H314:5;H411:5;H302:5;H332:1
93935,"2-ISOPROPYL-1,3-DIOXANE-5,5-DICARBOXYLIC ACID DIETHYL ESTER",609-063-4,35113-48-5,Skin Sens. 1,REACH registration C&L,2,H317:2
93937,"3,3'-dichlorobenzidine dihydrochloride",210-323-0,612-83-9,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Carc. 1B;Aquatic Chronic 1,REACH registration C&L,165,H312:165;H410:82;H318:37;H317:165;H350:165;H411:83;H400:45
93938,"3-aminopropyldimethylamine;N,N-dimethyl-1,3-diaminopropane",203-680-9,109-55-7,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Harmonised C&L,0,H226:0;H314:0;H302:0;H317:0
93939,Magnesium dioleate,216-303-8,1555-53-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,43,H315:38;H319:38;Not classified:5
93941,Cyclododecanecarboxylic acid,212-937-4,884-36-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
93942,C.I. Reactive Yellow 176,604-206-7,140876-15-9,Not Classified,Notified C&L,9,Not classified:8;H317:1;H334:1
93945,5-BROMOTHIOPHENE-2-CARBOXYLIC ACID,615-911-4,7311-63-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
93949,3-methylpentane,202-481-4,96-14-0,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H336:0;H411:0;H315:0;H225:0;H304:0
93951,"Dihydro-3-(isododecenyl)furan-2,5-dione",257-266-8,51546-74-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
93957,"N-[5-(phenylamino)penta-2,5-dienylidene]aniline monohydrochloride",216-094-3,1497-49-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,47,H312:2;H302:2;H319:47;H315:47;H335:46
93962,"Hexane-2,3-dione",223-350-8,3848-24-6,Flam. Liq. 3;STOT RE 2,Notified C&L,1505,H226:1505;H373:1347;H335:152;H315:152;H319:152;H371:24;Not classified:2
93964,Dipotassium isobutyl phosphate,271-341-2,68541-10-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,23,H318:22;H314:22;H315:1;H319:1
93966,Methyl 1H-indole-2-carboxylate,214-861-7,1202-04-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,6,H335:5;H315:6;H302:4;H319:6;H312:2;H332:2
93968,"Juniper, Juniperus phoenicea, ext.",289-970-6,90046-03-0,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,99,H226:98;H317:98;H411:98;H304:99;H400:1;H410:1
93969,"7-hydroxynaphthalene-1,3-disulphonic acid",204-245-6,118-32-1,Not Classified,Notified C&L,1,Not classified:1
93970,Trichlorofluoromethane,200-892-3,75-69-4,Acute Tox. 4;Ozone 1,Notified C&L,53,H420:42;H312:38;Not classified:15;H059:1
93973,"reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate;disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate",426-840-1,,Eye Dam. 1,Harmonised C&L,0,H318:0
93975,N-butylhyoscinium bromide,205-744-1,149-64-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,110,H332:57;H302:108;H318:9;H301:1;Not classified:1
93976,5-bromosalicylic acid,201-917-0,89-55-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
93981,Methyl 5-chloro-3- (chlorosulfonyl)thiophene-2- carboxylate,603-173-6,126910-68-7,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1;H317:1
93985,(2-fluoro-3-methoxyphenyl)boronic acid,609-099-0,352303-67-4,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,10,H402:1;H411:1;H302:2;H335:6;H315:7;H319:8;Not classified:1
93992,Methyl thiazolidine-4-carboxylate hydrochloride,256-726-5,50703-06-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
93995,Isothipendyl hydrochloride,214-957-9,1225-60-1,Acute Tox. 4,Notified C&L,38,H302:38
93997,"4,4'-ethylenedianiline",210-716-7,621-95-4,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,171,H400:92;H410:92;H315:79;H319:79;H335:39;H312:1;H341:1;H302:1;H332:1
93998,"Hexasodium 4,4'-[1,4-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]bis[5-hydroxy-6-[(2-sulphonatophenyl)azo]naphthalene-2,7-disulphonate]",269-284-3,68214-04-0,Skin Sens. 1B,REACH registration C&L,135,H317:96;Not classified:33;H319:10;H335:4;H334:3
93999,1-[2-(2-METHOXY-1-METHYLETHOXY)-1-METHYLETHOXY]PROPAN-2-OL,609-385-5,37286-64-9,Acute Tox. 4,Notified C&L,73,H302:72;H412:14;H319:3
94002,Dimethylbis[2-[(1-oxooctadecyl)oxy]ethyl]ammonium chloride,267-382-0,67846-68-8,Aquatic Chronic 3,REACH registration C&L,134,H412:46;H315:101;H319:101
94005,Potassium L-glutamate,246-336-3,24595-14-0,Not Classified,Notified C&L,2,Not classified:2
94006,Aluminum potassium fluoride,262-153-1,60304-36-1,Eye Irrit. 2;Acute Tox. 4;Lact.;STOT RE 1;Aquatic Chronic 3,Notified C&L,18,H319:18;H412:18;H372:18;H362:18;H332:18
94009,Lithium sulfate monohydrate,600-157-0,10102-25-7,Acute Tox. 4,Notified C&L,71,H302:71;H335:4;H315:4;H319:5
94010,Potassium dicyanocuprate,237-192-2,13682-73-0,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H330:1;H400:1;H300:1;H310:1
94014,"4-bromo-2,6-xylidine",246-337-9,24596-19-8,Skin Irrit. 2;Resp. Sens. 1,Notified C&L,47,H334:39;H315:45;H312:7;H302:7;H319:6;H373:4;H332:7;H335:1;H311:1;H301:1
94016,4-butylphenol,216-672-5,1638-22-8,Skin Corr. 1B,Notified C&L,133,H314:133;H302:40;H318:37;H312:2;H332:2
94020,"Distillates (petroleum), intermediate paraffinic, clay-treated;Gasoil - unspecified;[A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",309-669-6,100683-99-6,Carc. 1B,Harmonised C&L,0,H350:0
94022,"alkenes, C",435-660-2,243662-67-1,Skin Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H315:0
94023,"12-Hydroxy-senecionan-11,16-dione",603-379-6,130-01-8,Acute Tox. 3,Notified C&L,40,H301:40;H311:2;H373:1;H331:2
94027,Methyl 2-benzoylbenzoate,210-112-3,606-28-0,STOT RE 2;Aquatic Chronic 2,REACH registration C&L,2284,H373:13;H411:13;H412:2138;Not classified:88;H400:39;H410:39;H319:20
94029,"13-Docosenamide, N-[3-(dimethylamino)propyl]-, (13Z)-",604-714-9,149968-48-9,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,2,H318:1;H411:1;Not classified:1
94030,α-hydroxy-4'-methoxyacetophenone,223-955-7,4136-21-4,Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H319:2;H315:1
94032,"3,3'-dithiobis[N-methylpropionamide]",213-665-9,999-72-4,Not Classified,Notified C&L,157,Not classified:157
94038,2-methyloctanal,232-093-0,7786-29-0,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,1373,H412:1363;H315:1363;Not classified:10
94041,"Amides, C8-18 and C18-unsatd., N-(hydroxyethyl)",273-927-3,69227-24-3,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,110,H318:107;H411:84;H315:108;Not classified:2;H319:1
94042,Morpholine-4-carbonitrile,216-235-9,1530-89-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H312:39;H302:39;H319:39;H315:39;H335:39;H332:39
94043,9H-carbazole-9-methanol,219-313-0,2409-36-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H318:38;H302:38
94048,Tetrasodium enneatitanium icosaoxide hydrate,601-472-6,117314-20-2,Eye Irrit. 2,REACH registration C&L,2,H319:2
94049,2-(butylthio)ethanol,226-229-8,5331-37-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H318:38;H302:38
94050,Benz[c]isoxazole,205-980-5,271-58-9,Acute Tox. 2,Notified C&L,194,H302:194
94051,"Alkenes, C15-20 α-, isomerized",271-651-8,68603-32-7,Not Classified,Notified C&L,148,Not classified:148
94052,3-(difluoromethyl)pyridine,278-487-6,76541-44-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H226:38;H335:38;H315:38;H319:38
94053,Hexyl phenylacetate,226-537-2,5421-17-0,Not Classified,Notified C&L,89,Not classified:89
94054,"2,5-di-tert-butylhydroquinone",201-841-8,88-58-4,Acute Tox. 3;Skin Sens. 1B;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,156,H410:9;H400:9;H317:63;H401:2;H301:8;H335:59;H302:87;H315:52;H319:52;Not classified:2;H371:1;H411:1
94055,"3-[(6-O-α-L-arabinopyranosyl-β-D-glucopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one",245-555-1,23284-18-6,Not Classified,Notified C&L,1,Not classified:1
94057,Dipotassium tridecan-1-yl phosphate,271-342-8,68541-11-7,,Notified C&L,32,Not classified:32
94060,"1,3-bis(2,3-epoxypropoxy)-2,2-bis[(2,3-epoxypropoxy)methyl]propane",221-507-5,3126-63-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,59,H317:59;H315:59;H319:59
94063,"Oils, neat's-foot",232-314-0,8002-64-0,Not Classified,Notified C&L,228,Not classified:207;H315:21;H319:21
94066,"2,7-Naphthalenedisulfonic acid, 5-(benzoylamino)-4-hydroxy-3-[2-[1-sulfo-6-[[2-(sulfooxy)ethyl]sulfonyl]-2-naphthalenyl]diazenyl]-, sodium salt (1:4)",615-840-9,72828-03-6,Not Classified,Notified C&L,2048,Not classified:2048
94067,"4'-ethoxy[1,1'-biphenyl]-4-carbonitrile",261-417-3,58743-78-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H332:1
94068,1-aminocinnamic acid hydrochloride,258-940-4,54057-95-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
94071,"Chromate(2-), [3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-7-nitro-1-naphthalenesulfonato(3-)][N-[7-hydroxy-8-[(2-hydroxy-5-nitrophenyl)azo]-1-naphthalenyl]acetamidato(2-)]-, lithium sodium",288-602-1,85828-75-7,Aquatic Chronic 2,Notified C&L,50,H411:46;Not classified:4
94075,6-amino-2-methyl-1H-pyrimidin-4-one,212-182-0,767-16-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H335:38;H318:38;H315:38;H302:38;Not classified:1;H319:1
94077,"isoprene (stabilised);2-methyl-1,3-butadiene",201-143-3,78-79-5,Flam. Liq. 1;Muta. 2;Carc. 1B;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H341:0;H350:0;H224:0
94079,Dibutyl itaconate,218-451-9,2155-60-4,Not Classified,REACH registration C&L,6,Not classified:5;H413:1;H319:1
94085,"4,4'-cyclohexylidenedi-o-toluidine",229-236-4,6442-08-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
94088,"Fatty acids, C8-18 and C18-unsatd., lithium salts",283-963-1,84776-37-4,Not Classified,Notified C&L,10,Not classified:10
94098,"Dialuminium tris[2-(2,4,5,7-tetrabromo-6-oxido-3-oxoxanthen-9-yl)-3,4,5,6-tetrachlorobenzoate]",240-012-5,15876-58-1,Not Classified,REACH registration C&L,33,Not classified:33
94099,"Sulfonium compounds, C11-14-alkylbis(hydroxyethyl), 2-hydroxyethyl sulfates (salts)",278-855-6,78169-20-7,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,84,H302:84;H318:84;H400:84;H411:84;H373:84;H314:84
94100,7-[[2-acetamido-2-deoxy-β-D-glucopyranosyl]oxy]-4-methyl-2H-1-benzopyran-2-one,253-333-0,37067-30-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
94106,"Gelatins, polymers with keratin hydrolyzates and L-lysine, hydroxy-N,N,N-trimethyl-1-propanaminium chloride-quaternized, reaction products with isostearoyl chloride, compds. with 2-amino-2-methyl-1-propanol",605-069-6,156715-41-2,Not Classified,Notified C&L,1,Not classified:1
94121,N-acetyl-L-methionine,200-617-7,65-82-7,Not Classified,Notified C&L,6,Not classified:4;H335:1;H315:1;H319:1;H318:1
94122,Potassium hexadecyl hydrogen phosphate,242-768-1,19035-79-1,Eye Dam. 1,REACH registration C&L,274,H318:244;Not classified:27;H315:22;H319:4
94123,"3-methoxy-2,2-dimethylpropionaldehyde",247-549-4,26254-86-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H226:1;H335:1;H315:1;H319:1
94124,"2-(8-heptadecenyl)-4,5-dihydro-1H-imidazole-1-ethylamine",222-551-8,3528-63-0,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,3,H314:3;H410:3;H317:3
94127,"Hydrocarbons, C",307-757-9,97722-08-2,Carc. 1B,Harmonised C&L,0,H350:0
94129,"2,6-diiodo-4-nitrophenol",206-170-4,305-85-1,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H312:39;H319:43;H315:43;H301:43;H335:43;H332:39
94136,"Fatty acids, C6-12, C16-18-alkyl esters",285-213-9,85049-43-0,Not Classified,Notified C&L,1,Not classified:1
94138,"reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C",427-740-0,,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H318:0;H317:0
94141,"3,3'-diaminobenzophenone",210-281-3,611-79-0,Skin Sens. 1,Notified C&L,43,H317:38;H335:4;H315:5;H319:5;H341:1
94145,"2-Methylpropene, trimers",500-001-0,7756-94-7,Asp. Tox. 1;Skin Irrit. 2,REACH registration C&L,526,H315:6;H304:7;Not classified:452;H226:68;H413:18
94156,(3R)-piperidin-3-amine dihydrochloride,608-870-9,334618-23-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,49,H302:43;H319:8;H318:43;H315:49;H335:48
94157,p-tolylarsonic acid,223-588-2,3969-54-8,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38;H331:38;H301:38
94159,"4''-Chlor-2',2''-difluor-4-pentyl-1,1':4',1''-terphenyl",604-796-6,151358-93-9,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
94160,Gliadins,232-707-7,9007-90-3,Not Classified,Notified C&L,1,Not classified:1
94164,Sodium 5-hydroxy-6-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-1-sulphonate,227-494-2,5858-58-2,Not Classified,Notified C&L,1,Not classified:1
94165,"Salicylic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",218-531-3,2174-16-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H302:41;H319:42
94170,"Calcines, zinc ore-conc.",273-776-3,69012-79-9,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;Carc. 1A;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,17,H302:16;H410:17;H318:16;H400:16;H315:16;H372:16;H373:17;H350:17;H360:17;H362:16;H332:16
94174,Tetrabutylammonium nitrate,217-726-0,1941-27-1,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H272:43;H315:44;H319:44
94175,Methylthioacetonitrile,252-383-0,35120-10-6,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H312:44;H302:44;H319:43;H335:43;H332:44;H315:5;H318:1;H314:1
94176,Guanidine,204-021-8,113-00-8,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3;STOT SE 1,REACH registration C&L,3,H302:1;H318:1;H370:1;H314:1;H301:1;H331:1;H311:1;H225:1;Not classified:2
94177,"(1R,5R,7S,10R,14S,16S,18S)-5,7-dihydroxy-10,14-dimethylhexacyclo[9.8.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁹.0¹⁶,¹⁸]nonadecan-15-one",617-347-4,82543-16-6,Not Classified,REACH registration C&L,6,Not classified:4;H312:1;H302:1;H319:1;H315:1;H335:1;H332:1;H373:1
94178,"1,2,3,4,5,6-cyclohexanehexacarboxylic acid",218-699-8,2216-84-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,14,H335:13;H315:14;H319:14
94180,"4,4'-[(9-butyl-9H-carbazol-3-yl)methylene]bis[N-methyl-N-phenylaniline",266-957-3,67707-04-4,,Notified C&L,92,Not classified:92
94184,5-methoxy-2-nitrobenzoic acid,606-135-7,1882-69-5,Acute Tox. 4,REACH registration C&L,8,H302:1;H335:6;H315:7;H319:7
94185,2-butoxyethyl dihydrogenphosphate,238-141-7,14260-98-1,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,3,H318:2;H314:3;H302:2
94187,6-chloro-o-toluidine,201-759-2,87-63-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:40;H315:45;H319:45;H312:6;H373:7;H301:5;H332:6;H302:3;H370:1;H372:1;H331:2;H311:2;H341:1;H410:1
94191,Tetramethylammonium tetrahydroborate,240-917-5,16883-45-7,Water-react. 2;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,43,H315:39;H261:43;H301:43;H319:39;H311:4;H314:4
94194,"1-Propanone, 2-methyl-1-[4- (methylthio)phenyl]-2-(4-morpholinyl)-",615-621-8,71868-10-5,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,165,H411:164;H302:164;H360:41;Not classified:1;H317:1;H413:1
94195,2-[2-(piperidyl)ethoxy]ethanol,276-108-9,71872-99-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,2,H312:2;H318:2;H315:2;H302:2
94196,S-isopropyl 3-methylthiocrotonate,251-966-7,34365-79-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1376,H315:1286;H319:1286;Not classified:90
94200,"Condensates (petroleum), vacuum tower",265-049-4,64741-49-7,Flam. Liq. 3;Skin Irrit. 2;Acute Tox. 4;Carc. 2;STOT RE 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,34,H411:32;H315:33;H373:33;H226:16;H332:32;H351:32;H304:18;H361:1;H410:1;H336:1;H400:1
94202,"Stannane, tetrachloro-, pentahydrate",600-048-8,10026-06-9,Skin Corr. 1B,Notified C&L,41,H314:40;H412:2;H318:2;H315:1
94203,"Strawberry, Fragaria chiloensis, ext.",305-877-6,95193-64-9,Not Classified,Notified C&L,1,Not classified:1
94206,"5-hydroxy-1-methyl-2-(1-methyl-1-phenoxycabonylamino-ethyl)-6-oxo-1,6-dihydro-pyrimidine-4-carboxylic acid 4-fluorobenzylamide",610-732-8,518048-02-7,Not Classified,REACH registration C&L,1,Not classified:1
94207,tripropylammonium dihydrogenphosphate,433-700-3,35687-90-2,Acute Tox. 4,Harmonised C&L,0,H302:0
94211,"5,10-Dihydro-5,10-dimethylphenazine",605-010-4,15546-75-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,40,H319:40;H315:40;H331:38;H301:38;H335:38;H311:38;H312:2;H302:2;H332:2
94213,"(2S)-1-tert-butoxycarbonyl-2,3-dihydropyrrole-2-carboxylic acid;N-cyclohexylcyclohexanamine",618-453-3,90104-21-5,Not Classified,Notified C&L,1,Not classified:1
94217,3-nitroanisole,209-079-8,555-03-3,Acute Tox. 4,Notified C&L,39,H302:38;H412:1;H301:1
94220,"2,2'-methylenebis-(3,4,6-trichlorophenol);hexachlorophene",200-733-8,70-30-4,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H311:0;H410:0;H400:0;H301:0
94223,"1-Naphthalenesulfonic acid, 2-amino-6-[[2-(sulfooxy)ethyl]sulfonyl]-",617-233-4,81417-89-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2,Notified C&L,1,H311:1;H301:1;H330:1
94224,5-(chloromethyl)-2-methylpyridine hydrochloride,600-763-5,106651-81-4,,Notified C&L,2,H335:2;H315:2;H319:1;H318:1
94230,Ethyl 3-(4-hydroxy-3-methoxyphenyl)propionate,262-689-6,61292-90-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
94231,"Formaldehyde, polymer with 1,2-ethanediol, methanol and 1,3,5-triazine-2,4,6-triamine",600-346-8,102763-16-6,Not Classified,Notified C&L,1,Not classified:1
94233,"BORIC ACID (HBO2), SODIUM SALT, TETRAHYDRATE",600-663-1,10555-76-7,Eye Irrit. 2;Repr. 1B,Notified C&L,133,H360:67;H319:107;H361:39;H335:4;H315:5
94236,"4-amino-5-methoxy-N,2-dimethylbenzenesulphonamide",256-380-5,49564-57-0,Acute Tox. 3,REACH registration C&L,38,H301:38
94237,1-aminocyclohexane-1-carboxylic acid hydrochloride,254-594-3,39692-17-6,,Notified C&L,4,H335:4;H315:4;H319:4
94238,Sodium tetrafluoroborate,237-340-6,13755-29-8,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,147,H318:33;H314:40;Not classified:102;H335:5;H315:4;H372:1;H319:1
94241,Dodec-2-en-1-al,225-402-5,4826-62-4,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,1642,H317:1334;H400:1394;H315:1642;H319:1641;H410:60
94242,"1-Naphthalenesulfonic acid, 4-amino-3-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, sodium salt (1:2)",607-526-5,250688-43-8,,Notified C&L,1,H318:1
94246,"Bis[13-hydroxy-7-[2-(2-hydroxypropoxy)-1-methylethoxy]-1,5,9-trimethyl-3,6,8,11-tetraoxa-7-phosphatetradec-1-yl][2-(2-hydroxypropoxy)-1-methylethyl]phosphine",236-753-9,13474-96-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H315:2;H319:2;Not classified:2
94252,Sodium p-ethylbenzenesulphonate,239-080-9,14995-38-1,Eye Irrit. 2,Notified C&L,38,H319:38
94256,"1,1,2,2-tetrachloro-1,2-dimethyldisilane",224-844-6,4518-98-3,Flam. Liq. 3;Water-react. 1;Skin Corr. 1B,Notified C&L,62,H226:61;H260:39;H314:62;H318:2;H290:1;H312:1
94260,Rhodium tris(2-ethylhexanoate),244-079-1,20845-92-5,Repr. 2;Aquatic Chronic 4,REACH registration C&L,49,H361:34;H413:4;H335:13;H315:13;H319:13;H302:1
94261,(3-chloropropyl)dimethoxymethylsilane,242-056-0,18171-19-2,Flam. Liq. 3;Acute Tox. 4,REACH registration C&L,73,H226:11;H302:32;H335:40;H315:41;H319:41
94269,2-carboxymethylpyridinium chloride,240-316-8,16179-97-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:46;H315:48;H319:48
94270,4-fluoro-2-nitrobenzaldehyde,220-884-3,2923-96-8,,Notified C&L,2,H335:2;H315:2;H319:2
94271,sodium,274-357-8,70161-44-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT SE 3;Muta. 2;Carc. 1B,Harmonised C&L,0,H341:0;H302:0;H319:0;H315:0;H317:0;H350:0;H335:0;H332:0
94285,1-octylazepin-2-one,420-040-6,59227-88-2,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H314:0;H411:0;H317:0
94286,(Benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate,603-290-2,128625-52-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,69,H335:66;H315:67;H319:67;H410:2;H317:2;H302:4;H312:2;H332:2;Not classified:1
94291,N-(4-chloro-2-methylphenyl)acetamide,225-991-9,5202-86-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H335:38;H318:38;H315:38;H302:42
94293,iodoacetic acid,200-590-1,64-69-7,Acute Tox. 3;Skin Corr. 1A,Harmonised C&L,0,H314:0;H301:0
94295,"Malic acid, compound with (E)-3-[2-(1,4,5,6-tetrahydro-1-methylpyrimidin-2-yl)vinyl]phenol (1:1)",302-893-5,94135-23-6,Acute Tox. 4,REACH registration C&L,2,H302:2
94297,1-Chlor-4-(trans-4-propylcyclohexyl)-benzen,617-882-3,86579-52-4,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
94298,"1,3-butadiene;buta-1,3-diene",203-450-8,106-99-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
94302,(R)-lactic acid,233-713-2,10326-41-7,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,46,H318:46;H315:45;H290:1;H314:1
94304,"Liquidambar orientalis, ext.",305-627-6,94891-27-7,Skin Sens. 1,Notified C&L,115,H317:115;H412:36
94305,D-2-hydroxy-2-phenylacetic acid,241-240-8,17199-29-0,Eye Dam. 1,REACH registration C&L,180,H318:165;H335:69;H315:70;H302:55;H319:12;Not classified:2;H314:1
94307,"Tetrahydro-2,2,5,5-tetramethylfuran",239-117-9,15045-43-9,Flam. Liq. 2;Acute Tox. 4,Notified C&L,43,H225:43;H302:39
94313,POLY(ETHYLENE GLYCOL) METHYL ETHER METHACRYLATE,608-019-1,26915-72-0,Not Classified,Notified C&L,170,Not classified:55;H335:97;H317:110;H315:112;H319:112;H314:3;H318:1
94314,4-(phenylamino)benzenediazonium hydrogen sulfate formaldehyde (1:1),609-923-9,41432-19-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,56,H315:45;H302:46;H319:49;Not classified:7;H242:1;H410:1;H400:1;H336:1
94318,Protein hydrolyzates,310-296-6,9015-54-7,Not Classified,Notified C&L,169,Not classified:167;H319:1;H317:1
94328,"salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid",425-210-3,169939-84-8,Skin Sens. 1,Harmonised C&L,0,H317:0
94330,1-(4-ethoxyphenyl)ethan-1-one,216-825-6,1676-63-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:3;H315:3;H319:3
94331,2-aminobenzenethiol,205-277-3,137-07-5,Not Classified,REACH registration C&L,2096,Not classified:2041;H410:48;H314:54;H400:51;H302:53;H317:11;H373:5;H319:1;H290:1;H315:1;H335:1;H371:1;H341:1;H318:1;H312:1;H332:1
94332,Buprofezin,614-948-3,69327-76-0,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,204,H373:199;H400:201;H410:201;Not classified:3
94333,"1,1,3-Triphenyl-2-propyn-1-ol",604-834-1,1522-13-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H312:40;H302:40;H319:41;H315:41;H335:40;H332:40
94338,4'-nitrophenyl-2-acetamido-2-deoxy-β-glucopyranoside,222-398-7,3459-18-5,Not Classified,Notified C&L,3,Not classified:3
94343,"hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate)",405-160-9,124537-30-0,Acute Tox. 3;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0;H301:0
94344,"terbuthylazine (ISO);N-tert-butyl-6-chloro-N′-ethyl-1,3,5-triazine-2,4-diamine",227-637-9,5915-41-3,Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H373:0;H400:0;H302:0
94347,9-[3-(dimethylamino)propyl]-2-(trifluoromethyl)thioxanthen-9-ol,219-054-3,2340-57-0,Acute Tox. 4,REACH registration C&L,2,H302:2
94348,"N-(methoxymethyl)-1,3,5-triazine-2,4,6-triamine",224-239-7,4261-70-5,Not Classified,Notified C&L,1,Not classified:1
94353,N-(3-chloro-2-methylphenyl)acetamide,231-254-2,7463-35-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
94354,"Protein hydrolyzates, yeast",309-709-2,100684-36-4,Not Classified,Notified C&L,85,Not classified:85
94355,Di[carbonato(2-)]hexahydroxypentazinc,226-076-7,5263-02-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,135,H410:93;H400:86;H315:93;H319:92;H413:38;Not classified:2;H320:1;H411:1
94356,"2,3-Difluorpropoxybenzol",485-470-9,,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H302:2
94357,Octadecene,248-205-6,27070-58-2,Asp. Tox. 1,REACH registration C&L,104,H304:46;Not classified:58
94360,Triiron tetraoxide,215-277-5,1317-61-9,Not Classified,REACH registration C&L,1958,Not classified:910;H252:239;H251:129;H335:656;H315:656;H319:666;H318:10;H372:14;H332:5;H361:1;H373:2;H225:1;H304:1
94362,"N-(2,4,5-trichlorophenyl)acetamide",245-793-6,23627-24-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
94364,"N-ethyl-4-[[4-(ethylamino)-m-tolylphenyl][4-(ethylimino)-3-methylcyclohexa-2,5-dien-1-ylidene]methyl]-m-toluidine monoacetate",305-170-2,94349-52-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,85,H302:85;H319:85;H410:85;H400:85;H315:85;H317:85
94365,"Fatty alcohol ethoxylate , sulphate, sodium",600-404-2,103171-18-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,55,H315:55;H319:55
94366,L-Carnitine-L-Tartrate,459-550-9,,Not Classified,Notified C&L,2,Not classified:2
94368,"2-chloro-1,1,2-trifluoro-1-methoxyethane",207-038-9,425-87-6,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H310:2
94372,4-(3-hydroxyprop-1-en-1-yl)phenol,609-308-5,3690-05-9,Not Classified,Notified C&L,2,Not classified:1;H312:1;H302:1;H319:1;H315:1;H335:1;H332:1
94374,Digoxin,244-068-1,20830-75-5,Acute Tox. 2;Eye Irrit. 2;Acute Tox. 1;STOT RE 1;Aquatic Acute 1,Notified C&L,119,H330:96;H319:61;H400:67;H372:53;H300:102;H302:8;H315:8;Not classified:8;H331:12;H311:8;H332:8;H301:9;H373:6;H412:1;H411:1
94375,Iodine bromide,232-159-9,7789-33-5,Skin Corr. 1B,Notified C&L,49,H314:48;H335:6;Not classified:3
94376,Cholest-5-en-3-β-yl stearate,252-637-0,35602-69-8,Not Classified,Notified C&L,2,Not classified:2
94377,"3,9-bis(isodecyloxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane",247-779-5,26544-27-4,Not Classified,Notified C&L,17,Not classified:17
94378,Allene,207-335-3,463-49-0,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,207,H220:172;H280:205;H221:1;Not classified:1;H231:1
94381,Isobutyl vinyl ether,203-678-8,109-53-5,Flam. Liq. 2;Skin Irrit. 2,REACH registration C&L,188,H225:180;H315:95;H319:85;H412:51;Not classified:8;H335:1
94383,1-(1-methyl-2-propoxyethoxy)propan-2-ol,249-949-4,29911-27-1,Not Classified,REACH registration C&L,2493,Not classified:1450;H302:942;H319:959
94384,"Hexanedioic acid, polymer with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 1,6-hexanediol and 1,2-propanediol",607-989-3,26702-48-7,,Notified C&L,33,Not classified:33
94385,"Diphosphoric acid, strontium salt (1:2), europium-doped",272-262-6,68784-61-2,Not Classified,Notified C&L,2,Not classified:2
94387,"Fatty acids, C8-18, ethoxylated",614-567-2,68525-91-7,Not Classified,Notified C&L,1,Not classified:1
94391,"Tetrasodium 4,5-dihydroxy-3-[(8-hydroxy-3,6-disulphonato-1-naphthyl)azo]naphthalene-2,7-disulphonate",257-273-6,51550-25-5,,Notified C&L,5,H335:4;H315:5;H319:5
94396,"(3,4-dimethylphenyl)boronic acid",611-277-8,55499-43-9,,Notified C&L,7,H335:6;H315:7;H319:7;H302:1
94399,"2,3-Dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one",601-651-9,120014-06-4,Acute Tox. 2,Notified C&L,7,H300:6;H302:1;H413:1;H319:1
94409,Trifluoro(trifluoromethoxy)ethylene,214-703-7,1187-93-5,Flam. Gas 1;Press. Gas (Comp.);Acute Tox. 4,REACH registration C&L,41,H220:40;H280:8;H332:40;H335:34;H315:2;H319:2
94413,"2,6,10,14-tetramethylhexadecane",211-332-2,638-36-8,Not Classified,Notified C&L,5,Not classified:5
94417,"Silicic acid, zirconium salt, cadmium pigment-encapsulated",310-077-5,102184-95-2,Not Classified,REACH registration C&L,44,Not classified:44
94420,"Resin acids and Rosin acids, magnesium salts",270-461-2,68440-56-2,Not Classified,REACH registration C&L,2,Not classified:2
94421,2-[(4-methyl-2-nitrophenyl)azo]-3-oxo-N-phenylbutyramide,219-730-8,2512-29-0,Not Classified,REACH registration C&L,520,Not classified:512;H317:6;H302:1;H318:1
94424,4-hydroxy-3-nitrophenylacetic acid,233-948-0,10463-20-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
94427,"Oxirane, 2-(chloromethyl)-, homopolymer",607-468-0,24969-06-0,Not Classified,Notified C&L,34,Not classified:34
94428,"3,4-dimethylhexane-2,5-dione",246-746-2,25234-79-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
94429,"4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-1(2H)-NAPHTHALENE-1-ONE",616-703-6,79560-19-3,Aquatic Chronic 1,Notified C&L,36,H410:31;H335:3;H315:3;H319:3;H302:2
94431,Bismuth succinate,205-356-2,139-16-2,Not Classified,Notified C&L,1,Not classified:1
94434,"1-(4-aminophenyl)-1H-pyrrole-2,5-dione",249-824-4,29753-26-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:1;H319:1;H302:1
94435,Valeraldehyde,203-784-4,110-62-3,Flam. Liq. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,1851,H319:1807;H317:1388;Not classified:1292;H335:1557;H225:1851;H332:1805;H315:463;H318:44;H412:1
94437,phosphoryl trichloride,233-046-7,10025-87-3,Acute Tox. 4;Skin Corr. 1A;Acute Tox. 2;STOT RE 1,Harmonised C&L,0,H372:0;H314:0;H302:0;H330:0
94438,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with maleic anhydride and methacrylic acid",500-090-6,36425-16-8,Skin Sens. 1B,REACH registration C&L,13,H317:10;Not classified:3
94441,"5β,14-dihydroxy-19-oxocard-20(22)enolide 3β-acetate",200-474-0,60-38-8,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,38,H300:38;H330:38;H310:38
94445,"alkanes, C",287-477-0,85535-85-9,Lact.;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H362:0;H400:0;H410:0
94448,Dimethyl ether--boron trifluoride,206-532-1,353-42-4,Water-react. 1;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT RE 1,REACH registration C&L,132,H302:84;H372:84;H314:132;H260:132;H332:84;H318:83
94449,"1,3,5-triazine-2,4,6(1H,3H,5H)-trione, compound with 1,3,5-triazine-2,4,6-triamine (1:1)",253-575-7,37640-57-6,STOT RE 2,REACH registration C&L,1134,H373:1035;Not classified:98;H335:2;H319:2;H315:1
94450,7-methylquinoline,210-316-2,612-60-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H335:43;H318:39;H315:44;H341:4;H319:5
94451,"allidochlor (ISO);N,N-diallylchloroacetamide",202-270-7,93-71-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H312:0;H302:0;H319:0;H411:0;H315:0
94452,"Acetic acid, 2-[4-[(2,4-dimethoxyphenyl)[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]methyl]phenoxy]-",604-455-1,145069-56-3,Not Classified,Notified C&L,2,Not classified:2
94455,4-chlorophthalic anhydride,204-251-9,118-45-6,Eye Dam. 1,Notified C&L,6,H318:4;H315:3;H319:2;H335:2
94460,"2-Fluoro-L-phenylalanine, N-BOC protected",601-330-3,114873-00-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
94465,"2,5-dibromohexane-3,4-dione",254-275-9,39081-91-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
94473,Tetradecyl laurate,244-966-3,22412-97-1,Not Classified,REACH registration C&L,2,Not classified:2
94476,Sebaconitrile,217-494-0,1871-96-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:38;H315:39;H301:39;H319:39;H312:4;H302:4;H331:1;H311:1
94482,Sodium 4-amino-m-xylene-5-sulphonate,264-925-3,64501-85-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,37,H335:37;H315:37;H319:37
94485,2-fluoro-6-nitroaniline,241-779-9,17809-36-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
94486,(+)-Dibenzoyl-D-tartaric acid monohydrate,617-176-5,80822-15-7,,Notified C&L,9,H319:8;H335:1;H315:1;Not classified:1
94493,"Benzene, C10-12-alkyl derivs., distn. residues, sulfonated, sodium salts",295-131-5,91844-64-3,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,31,H318:31;Not classified:31;H411:31;H315:31
94502,"L-Ascorbic acid, 2-(dihydrogen phosphate), sodium salt (1:3)",613-904-0,66170-10-3,Not Classified,Notified C&L,37,Not classified:37
94506,2-[ethyl[3-methyl-4-[(5-nitrothiazol-2-yl)azo]phenyl]amino]ethanol,271-183-4,68516-81-4,Acute Tox. 4;Resp. Sens. 1,Notified C&L,41,H334:38;H302:38;H317:2;Not classified:1
94507,Isobutylamine,201-145-4,78-81-9,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3;STOT SE 3,Notified C&L,264,H318:154;H314:263;H301:163;H331:116;H335:117;H311:117;H225:264;H302:101;H400:11
94510,"3-Oxazolidineacetic acid, 4-methyl-2,5-dioxo-α-(2-phenylethyl)-, ethyl ester, (αS,4S)-",617-627-6,84793-24-8,Skin Sens. 1;Eye Dam. 1,Notified C&L,43,H318:43;H317:43
94512,"4-{[4-(3-amino-4-sulfoanilino)-6-chloro-1,3,5-triazin-2-yl]amino}-6-[(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydropyridin-3-yl)diazenyl]benzene-1,3-disulfonic acid",926-027-6,,Not Classified,REACH registration C&L,2,Not classified:2
94515,"(3S,3'S)-3,3'-dihydroxy-β,β-carotene-4,4'-dione",207-451-4,472-61-7,Not Classified,Notified C&L,3,Not classified:2;H413:1
94518,"Tannins, salts with N-[4-[[4-(diethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]-N-ethylethanaminium",271-019-1,68513-85-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H410:2;H400:2;H302:3;H319:3;H312:1
94520,"4'-propyl[1,1'-biphenyl]-4-carbonitrile",261-415-2,58743-76-3,Aquatic Chronic 4,Notified C&L,2,Not classified:1;H413:1;H312:1;H302:1;H319:1;H315:1;H332:1
94522,"1,1,1,2-tetrachloro-2,2-difluoroethane",200-934-0,76-11-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
94524,"5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4-benzopyrone",207-570-1,481-53-8,Acute Tox. 2,Notified C&L,194,H300:194
94533,1-amino-4-hydroxy-2-methoxyanthraquinone,219-170-4,2379-90-0,Not Classified,Notified C&L,22,Not classified:22
94536,"Plantain, Plantago lanceolata, ext.",285-388-1,85085-64-9,Flam. Liq. 3,Notified C&L,4,H226:4
94537,"2-[2-[4-isopropylphenyl]-1-methylethyl]-1,3-dioxolane",276-935-5,72845-85-3,Not Classified,Notified C&L,233,Not classified:233
94539,"N,N'-cyclohexa-2,5-diene-1,4-diylidenebis[4-(dibutylamino)-N-[4-(dibutylamino)phenyl]anilinium] bis[hexafluoroantimonate(1-)]",226-831-0,5496-71-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,36,H302:34;H319:36;H411:34;H315:36;H332:34;H335:2
94541,RED MOC 61,439-160-5,,Not Classified,Notified C&L,1,Not classified:1
94545,"cis-1,3-dibenzyl-2-oxoimidazolidine-4,5-dicarboxylic acid",257-308-5,51591-75-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
94546,3-[(4-amino-2-methoxyphenyl)azo]-4-hydroxybenzenesulphonic acid,288-768-5,85895-92-7,Not Classified,REACH registration C&L,2,Not classified:2
94547,Isobutyl 2-naphthyl ether,218-529-2,2173-57-1,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,229,H400:4;H410:4;Not classified:224;H412:1
94548,Sodium thiocyanate,208-754-4,540-72-7,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,815,H312:800;H302:814;H412:701;H318:223;H332:800;H319:130;H317:36;H410:22;H400:22;Not classified:12;H311:10;H331:10;H373:1
94549,"2,4-di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzoate",224-166-0,4221-80-1,Not Classified,REACH registration C&L,132,Not classified:132
94553,4-fluorosalicylic acid,206-459-5,345-29-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:47;H315:48;H319:48
94557,Alpha-bromo-γ-valerolactone,247-380-6,25966-39-6,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H314:38
94560,L-arginine 2-oxoglutarate,240-882-6,16856-18-1,Not Classified,Notified C&L,3,Not classified:3
94562,(R)-2-(4-hydroxyphenoxy)propanoic acid,407-960-3,94050-90-5,Eye Dam. 1,Harmonised C&L,0,H318:0
94563,"Diammonium hydrogen 2-hydroxypropane-1,2,3-tricarboxylate",221-146-3,3012-65-5,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,280,H315:37;H319:218;Not classified:62;H335:165;H302:1
94568,"1,2,3,5-tetrahydro-6-methyl-s-indacene",606-482-4,202667-45-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
94576,Hexadecylethyldimethylammonium bromide,204-672-8,124-03-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,48,H315:47;H302:47;H319:46;H335:4;H318:1;H400:1;H314:1;H317:1
94581,Bis(acetato-O)dihydroxyzirconium,238-251-5,14311-93-4,,Notified C&L,1,H335:1;H315:1;H319:1
94582,"Benzoic acid, 2-[[[3-[2-[1-[[(2-chlorophenyl)amino]carbonyl]-2-oxopropyl]diazenyl]-4-hydroxyphenyl]sulfonyl]amino]-",617-523-0,84045-68-1,Not Classified,REACH registration C&L,2,Not classified:2
94584,trans-4-Methylcyclohexyl isocyanate,608-715-5,32175-00-1,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Resp. Sens. 1;Aquatic Chronic 2,REACH registration C&L,7,H330:3;H302:4;H334:4;H411:3;H314:3;H317:4;H226:3;H312:2;H318:1;H315:3;H335:3;H332:1;H304:1;H319:2;H331:1;H301:3;H311:2;H341:1;H351:1
94588,"3-chloropropane-1,2-diol",202-492-4,96-24-2,Met. Corr. 1;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;Carc. 2;Repr. 1B;STOT SE 1;STOT RE 1,REACH registration C&L,165,H330:113;H318:155;H290:14;H315:103;H370:96;H372:106;H360:159;H301:23;H351:141;H312:146;H300:142;H331:38;Not classified:8;H341:5;H335:6;H226:3;H319:4;H314:1;H311:2;H361:2;H332:1;H350:1
94592,"α-d-Glucopyranosiduronic acid, (3β,20β)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-β-d-glucopyranuronosyl-, sodium salt",260-308-8,56649-78-6,Not Classified,Notified C&L,2,Not classified:2
94593,"1,3-Bis(3-methacryloyloxypropyl)-1,1,3,3-tetrakis(trimethylsiloxy)disiloxane",617-155-0,80722-63-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
94594,α-[(2R)-2-(dimethylamino)propyl]-α-phenyl-benzeneacetonitrile,616-258-8,7576-16-1,Acute Tox. 3;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,2,H336:2;H411:2;H301:2
94600,"Lanolin, acetate",262-979-2,61788-48-5,Not Classified,REACH registration C&L,49,Not classified:49
94604,"Chromate(1-), [4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonamidato(2-)][2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]-, sodium",297-960-8,93776-32-0,Not Classified,Notified C&L,1,Not classified:1
94607,β-methyl-3-(1-methylethyl)-benzenepropanal,412-050-4,125109-85-5,Aquatic Chronic 2,Harmonised C&L,0,H411:0
94608,3-methylvaleraldehyde,240-014-6,15877-57-3,Flam. Liq. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H335:1;H225:1;H318:1;H315:1
94609,"Alcohols, C12-13, ethoxylated",500-165-3,66455-14-9,Eye Irrit. 2,Notified C&L,984,H319:491;H412:207;H400:393;H410:83;H318:307;Not classified:46;H302:63;H315:91;H411:3
94612,2-[2-(2-ethoxyethoxy)ethoxy]ethyl methacrylate,254-588-0,39670-09-2,Not Classified,REACH registration C&L,174,Not classified:40;H319:134;H315:134;H317:87;H335:133;H225:87
94615,sodium alkyl naphthalene sulfonate blend,600-693-5,105864-15-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,14,H315:14;H319:14
94616,"2-Butenedioic acid (2E)-, monooctadecyl ester",605-713-6,1741-93-1,Not Classified,REACH registration C&L,2,Not classified:2
94618,Sodium 2-ethylhexyl (2-ethylhexyl)(2-sulphonatoethyl)carbamate,276-936-0,72845-89-7,Eye Irrit. 2,Notified C&L,31,H319:31
94620,"1,1,1,3,3,3-hexafluoropropan-2-ol",213-059-4,920-66-1,Skin Corr. 1C;Repr. 2,REACH registration C&L,175,H361:11;H314:175;H318:54;H373:1;H312:58;H302:165;H335:110;H332:168;H225:8;H290:3;Not classified:2
94621,"4,4,13,13-tetraethoxy-3,14-dioxa-4,13-disilahexadecane",610-801-2,52217-60-4,,Notified C&L,2,H335:2;H315:2;H319:2
94625,"Glycine, N-(2-aminoethyl)-N-(2-hydroxyethyl)-, N-C12-20 acyl derivs., monosodium salts",291-351-0,90387-75-0,Eye Irrit. 2,Notified C&L,4,H319:4
94628,"1-(1,3-dioxolan-2-yl)acetone",212-176-8,767-04-4,Acute Tox. 3,Notified C&L,38,H301:38
94630,Diphenyl disulphide,212-926-4,882-33-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,137,H335:136;H315:137;H319:137;H410:40;H400:41
94631,"Maleic acid, sodium salt",241-923-0,18016-19-8,Not Classified,Notified C&L,82,Not classified:81;H302:1
94635,Allyl acrylate,213-662-2,999-55-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,44,H335:42;H411:38;H315:44;H319:44;H302:4;H330:6;H226:6;H311:6;H301:2
94638,Molybdenum zinc oxide,262-858-4,61583-60-6,Not Classified,Notified C&L,52,Not classified:35;H372:17;H351:17;H301:17;H370:17
94642,"Turpentine, oil, sulfurized",268-783-3,68140-22-7,Flam. Liq. 3;Acute Tox. 4,Notified C&L,5,H226:3;H332:3;H312:1;H302:1;H319:1;H411:2;H315:1;H317:1;H304:1;Not classified:1
94644,"Gas oils (petroleum), hydrotreated vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-162-9,64742-59-2,Carc. 1B,Harmonised C&L,0,H350:0
94646,Isocyanatocarbonyl chloride,248-631-2,27738-96-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,39,H312:39;H302:39;H334:39;H314:39;H317:39;H332:39
94649,cycloxydim (ISO);2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one,405-230-9,101205-02-1,Repr. 2,Harmonised C&L,0,H361:0
94655,Nitrogen monoxide,233-271-0,10102-43-9,Ox. Gas 1;Press. Gas (Comp.);Skin Corr. 1B;Eye Dam. 1;Acute Tox. 1,REACH registration C&L,276,H280:238;H270:276;H330:238;H318:89;H314:276;H373:83;H331:38
94656,"[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt",415-820-8,137590-32-0,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0;H317:0
94657,"CIS-2-CHLORO-3-[4-(4-CHLOROPHENYL)CYCLOHEXYL]1,4-NAPHTHALENEDIONE",600-797-0,1071223-07-8,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H317:1;H413:1;H315:1
94663,[carbonato(2-)] tetrahydroxytrinickel,235-715-9,12607-70-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H341:0;H302:0;H410:0;H334:0;H315:0;H372:0;H400:0;H317:0;H350:0;H360:0;H332:0
94664,"Decahydronaphthalene-1,5-diol",266-487-9,66818-21-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H315:38
94667,1-Octanol reaction products with epichlorhydrin and 2-mercaptoethanol,473-730-4,928768-73-4,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,48,H317:47;H411:48;H319:48;H332:1
94669,Oxydi(acetic acid),203-823-5,110-99-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,192,H335:157;H315:158;H302:191;H319:158;Not classified:1;H318:1;H314:1
94672,Benzyl isobutyrate,203-095-9,103-28-6,Eye Irrit. 2,REACH registration C&L,1669,H319:26;Not classified:1604;H226:39
94677,Tributyl(trichloroacetoxy)stannane,224-398-2,4342-33-0,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H312:38;H410:38;H319:38;H400:38;H315:38;H372:38;H301:38
94678,"2-{}{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}}-2-aminopropyl formate",424-260-3,784157-49-9,Eye Dam. 1;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H361:0;H318:0;H411:0
94679,N-(3-chlorophenyl)naphthalen-2-amine,226-664-3,5447-28-9,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H413:38;H302:38
94680,Oxytetracycline emiketale hydrochloride,917-753-4,,Not Classified,Notified C&L,1,Not classified:1
94687,Ethylene distearate,211-014-3,627-83-8,Not Classified,REACH registration C&L,494,Not classified:494
94691,"Gases (petroleum), catalytic cracked overheads;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately – 48 °C to 32 °C (– 54 °F to 90 °F).]",270-071-2,68409-99-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
94692,(±)-neomenthol,222-824-1,3623-51-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,169,H315:169;H319:97;H317:2;H335:38;H318:38
94697,C.I. Acid Brown 189,612-240-9,61724-15-0,Not Classified,Notified C&L,1,Not classified:1
94700,"4,5-dimethylisoxazol-3-amine",237-802-7,13999-39-8,Acute Tox. 4,Notified C&L,39,H302:39;H335:1;H315:1;H319:1
94703,"Yew, Taxus baccata, ext.",290-448-5,90147-55-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H302:1;H319:1
94708,"Cassava, ext.",296-251-0,92456-72-9,Not Classified,REACH registration C&L,26,Not classified:26
94710,Glycine Soja ext,617-621-3,84776-91-0,Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1
94713,Ethyl diethoxyacetate,227-999-8,6065-82-3,Not Classified,REACH registration C&L,33,Not classified:32;H335:1;H315:1;H319:1
94718,Solanine,243-879-8,20562-02-1,Acute Tox. 4,Notified C&L,41,H302:40;H301:1
94719,Non-2-enal,219-562-5,2463-53-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1549,H315:1549;H319:1549;H335:1;H225:1
94725,"Benzenesulfonic acid, mono-C9-17-alkyl derivs., sodium salts",273-233-0,68953-95-7,Not Classified,Notified C&L,236,Not classified:236
94727,1-hydroxy-2-naphthylammonium chloride,255-548-5,41772-23-0,Eye Dam. 1,Notified C&L,41,H318:39;H312:1;H302:1;H319:2;H315:3;H350:1;H335:2;H332:1
94728,"1,4-Difluoro-2,5-dimethoxybenzene",606-413-8,199866-90-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H315:43;H319:43
94731,1-piperazinylpyrazine,252-221-9,34803-68-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2;H302:1;H314:1
94733,"Alcohols, C13-15-branched and linear",287-625-4,85566-16-1,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,187,H410:186;H400:187;H315:187
94734,"7,8-dihydroxycoumarin",207-632-8,486-35-1,Not Classified,Notified C&L,2,Not classified:1;H315:1;H319:1
94741,6-amino-1-isobutyl-3-methyl-5-nitrosouracil,258-937-8,54052-67-4,Acute Tox. 3;Eye Dam. 1,Notified C&L,38,H318:38;H301:38
94745,"Alkanes, C4-5;Petroleum gas",270-654-1,68475-60-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
94751,Ketene,207-336-9,463-51-4,Flam. Gas 1;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 1;STOT SE 3,Notified C&L,121,H220:121;H330:83;H318:121;H315:121;H335:83;H319:38;H301:38
94753,4-fluoro-1-naphthoic acid,209-346-9,573-03-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:43;H315:43;H319:43
94754,Tetradecane-1-thiol,218-209-2,2079-95-0,Skin Sens. 1;Eye Dam. 1,Notified C&L,40,H318:39;H317:39;H319:1
94757,Cesium tungsten oxide,466-380-9,52350-17-1,Not Classified,REACH registration C&L,7,Not classified:6;H319:1
94758,Thorium,231-139-7,7440-29-1,Ox. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 2,Notified C&L,4,H302:2;H319:2;H272:2;H315:2;H373:2;H335:2;Not classified:2
94759,"2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol",230-237-7,6976-37-0,Eye Dam. 1,REACH registration C&L,175,H318:54;H335:116;H315:119;H319:119;Not classified:2;H290:2
94762,"Phosphoric acid, octadecyl ester, branched and linear, compds. with triethanolamine",306-502-9,97281-05-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
94764,"1-[4-(chloromethyl)-1,3-thiazol-2-yl)guanidine hydrochloride",614-902-2,69014-12-6,Not Classified,REACH registration C&L,4,Not classified:4
94767,Limonite,215-278-0,1317-63-1,Not Classified,Notified C&L,5,Not classified:5
94768,"6,6'-di-tert-butyl-4,4'-methylenedi-o-cresol",202-521-0,96-65-1,Not Classified,Notified C&L,17,Not classified:17
94769,"6-amino-1,3,5-triazine-2,4(1H,3H)-dione",211-456-7,645-93-2,Not Classified,Notified C&L,5,Not classified:3;H315:2;H319:2;H335:1
94770,"trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-)",402-500-8,104105-46-6,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0
94778,"N,N'-bis(2,4-dinitrophenyl)-3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diamine",249-605-3,29398-96-7,Not Classified,Notified C&L,5,Not classified:5
94780,"(S)-2,2,3-trimethylcyclopent-3-ene-1-acetaldehyde",245-846-3,23727-15-3,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1,H315:1;H319:1
94782,Naphazoline hydrochloride,208-989-2,550-99-2,Acute Tox. 2,Notified C&L,49,H300:43;H302:4;H312:1;H332:1;H301:2;H311:1;H373:1;H319:1
94784,Iron(3+) hexafluorosilicate(2-),235-048-3,12062-26-9,Not Classified,Notified C&L,1,Not classified:1
94786,4-[(4-amino-m-tolyl)amino]phenol,228-294-8,6219-89-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H413:38;H315:38;H302:38;H319:38
94789,"Sodium diaquabis[salicylato(2-)-O1,O2]chromate(1-)",269-291-1,68214-27-7,Not Classified,Notified C&L,83,Not classified:83
94790,2-(piperidin-4-yl)-1H-benzimidazole,609-547-5,38385-95-4,Not Classified,REACH registration C&L,6,Not classified:2;H317:3;H319:4;H335:2;H315:2;H302:2;H341:1;H361:1;H413:1;H351:1
94793,1-butylpyrrolidin-2-one,222-437-8,3470-98-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,190,H315:190;H302:149;H319:190;H335:40
94794,"4,4'-[(6-chloro-1,3,5-triazine-2,4-diyl)diimino]bis[5-hydroxy-6-[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonic] acid, sodium salt",303-152-9,94158-79-9,Not Classified,REACH registration C&L,31,Not classified:30;H317:1
94797,"Celery, ext.",289-668-4,89997-35-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1646,H410:1419;H400:1381;H315:1633;H317:1608;H226:1594;H304:1605;Not classified:10;H413:1;H319:2;H411:4;H412:1
94798,Ulexite,603-535-3,1319-33-1,Eye Irrit. 2;Repr. 1A,Notified C&L,30,H360:23;H319:22;Not classified:7
94799,"1,3-dichloropropene",208-826-5,542-75-6,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H335:0;H410:0;H319:0;H400:0;H315:0;H317:0;H301:0;H226:0;H311:0;H332:0;H304:0
94801,"Benzenesulfonic acid, mono-C10-13-branched alkyl derivs., compds. with triethanolamine",290-667-6,90194-55-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:2;H315:2;H302:2
94804,sec-butyl chloroformate,241-475-6,17462-58-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2,REACH registration C&L,37,H302:37;H330:37;H318:4;H315:4;H226:4;H335:33;H314:33
94806,"Benzo[b]thiophene 1,1-dioxide",212-544-8,825-44-5,Acute Tox. 3;Skin Sens. 1,Notified C&L,39,H317:39;H301:39
94812,"(-)-TRANS-4-(4-FLUOROPHENYL)-3-(3,4-METHYLENEDIOXY-PHENOXYMETHYL)PIPERIDINE HYDROCHLORIDE HEMIHYDRATE",600-962-7,110429-35-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,77,H335:51;H315:43;H302:76;H319:72;H411:31;H361:10;H318:4;H372:3;H312:1
94813,"Galactosidase, β-",232-864-1,9031-11-2,Resp. Sens. 1,Notified C&L,1506,H334:1504;Not classified:1;H315:1;H317:1
94814,Pentazinc chromate octahydroxide,256-418-0,49663-84-5,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1B;Acute Tox. 2;STOT SE 3;Muta. 2;Carc. 1A;Repr. 2;Aquatic Acute 1,REACH registration C&L,51,H312:2;H341:2;H361:2;H330:4;H302:49;H410:51;H400:51;H317:51;H350:51;H301:2;H335:2;H318:2;H315:2;H300:2;H310:2
94816,"Poly(oxy-1,2-ethanediyl), a,a',a''-phosphinylidynetris[w-hydroxy-, tri-C12-14-alkyl ethers",601-753-3,121158-62-1,Not Classified,Notified C&L,67,Not classified:36;H315:31
94823,"4,4,4-trifluoro-3-(trifluoromethyl)crotonic acid",217-180-3,1763-28-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H312:1;H302:1;H319:1;H315:1;H335:1;H332:1;H314:1
94827,"Mustard, black, ext.",290-076-3,90064-15-6,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,96,H335:41;H330:59;H319:59;H410:59;H400:59;H315:59;H301:41;H226:59;H311:39;Not classified:36;H310:20;H317:1
94828,"4-oxo-1,4-dihydroquinoline-3-carboxylic acid",604-008-0,13721-01-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:3;H319:3;H335:1;H302:1
94829,Diethyl chlorophosphite,209-652-2,589-57-1,Flam. Liq. 2;Skin Corr. 1B;STOT SE 3,Notified C&L,44,H335:38;H225:40;H314:44;H226:4;H318:2
94830,"Corn, steep liquor",266-113-4,66071-94-1,Not Classified,REACH registration C&L,28,Not classified:28
94832,"L-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1)",617-268-5,81919-14-4,Not Classified,REACH registration C&L,1,Not classified:1
94833,N-isopropylpropylamine,244-688-2,21968-17-2,,Notified C&L,5,H314:5;H224:4;H225:1
94838,"4'-trans-propyl-1,1'-bicyclohexyl-4-trans-carboxaldehyde",600-558-0,104358-16-9,Skin Sens. 1,REACH registration C&L,1,H317:1
94842,Spirit soluble chlorophyl,232-471-5,8049-84-1,Not Classified,Notified C&L,113,Not classified:113
94846,"2,5-dibromo-3-methylthiophene",236-147-4,13191-36-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,43,H318:38;H315:43;H302:38;H319:5
94849,"3,4,5-trihydroxybenzamide",210-561-5,618-73-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
94853,Di-tert-butyl diperoxyphthalate,218-454-5,2155-71-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
94854,"Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine",220-260-0,2691-41-0,Expl. 1.1;Acute Tox. 4;Acute Tox. 3,REACH registration C&L,101,H311:50;H201:78;H302:19;H204:20;H312:8;H412:5;H370:6;Not classified:3;H332:4;H335:1;H319:1;H360:1
94856,"Methylium, triphenyl-, tetrakis(pentafluorophenyl)borate(1-).",472-690-5,,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H302:1;H317:1
94858,1-Brom-4-(4-propylcyclohexyl)-benzol,617-883-9,86579-53-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H335:3;H315:3;H319:2;H312:1;H302:2;H332:1;H318:1;H413:1;Not classified:1
94862,Tallow,263-099-1,61789-97-7,Not Classified,Notified C&L,85,Not classified:85
94865,Disodium 4-dodecyl 2-sulphonatosuccinate,236-149-5,13192-12-6,Eye Dam. 1,Notified C&L,8,H318:5;Not classified:2;H312:1;H302:1;H319:1;H315:1;H335:1
94866,"(2S-cis)-5-benzyl-3,6-dioxopiperazine-2-acetic acid",226-075-1,5262-10-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;H302:1
94868,L-cystine dihydrochloride,250-391-9,30925-07-6,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,11,H318:8;H314:8;Not classified:2;H335:1;H315:1;H319:1
94870,valeric acid,203-677-2,109-52-4,Skin Corr. 1B;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H314:0
94871,Potassium sulphite,233-321-1,10117-38-1,Not Classified,REACH registration C&L,282,Not classified:195;H335:48;H315:49;H319:86;H412:1
94873,"Fatty acids, olive-oil, calcium salts",295-378-9,92044-98-9,Not Classified,Notified C&L,1,Not classified:1
94879,"Elder, Sambucus nigra, ext.",283-259-4,84603-58-7,Flam. Liq. 2,Notified C&L,1382,H225:1289;Not classified:91;H226:3;H319:2
94880,"5,5-diphenylimidazolidine-2,4-dione, calcium salt (2:1)",241-241-3,17199-74-5,,Notified C&L,1,H312:1;H351:1;H332:1;H302:1
94884,"Liquidambar styraciflua, ext.",305-628-1,94891-28-8,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1390,H317:1365;H411:1286;H315:1337;H412:25;H413:25;H319:1
94886,"disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate",414-040-5,149530-93-8,Acute Tox. 4;Skin Sens. 1,Harmonised C&L,0,H317:0;H302:0
94888,1-benzyl-4-phenylpiperidine-4-carbonitrile monohydrochloride,275-305-7,71258-18-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,REACH registration C&L,45,H335:43;H318:43;H400:43;H315:44;H312:1;H332:1;H301:2;H319:1;H331:1;H311:1
94892,NQD-TP-3M,424-880-4,,Flam. Sol. 1;Carc. 2,Notified C&L,1,H228:1;H351:1
94893,(Z)-octadec-9-enyl (Z)-docos-13-enoate,241-654-9,17673-56-2,Not Classified,REACH registration C&L,89,Not classified:89
94897,Bentonite QAV modified,601-813-9,121888-68-4,Not Classified,Notified C&L,166,Not classified:153;H400:13;H410:13
94898,Coke black,215-669-6,1339-82-8,Not Classified,Notified C&L,5,Not classified:5
94899,2-chloroethyl methyl sulphide,208-828-6,542-81-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Carc. 1A,Notified C&L,41,H302:40;H314:41;H350:39;H331:39;H226:41;H311:39;H312:1;H318:1;H332:1
94901,(Z)-hex-3-enyl lactate,263-337-4,61931-81-5,Not Classified,Notified C&L,206,Not classified:165;H335:40;H315:41;H319:41
94902,"2-chloro-[1,3]thiazolo[4,5-b]pyridine",604-828-9,152170-30-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H335:1;H332:1
94903,"trans,trans-4'-Ethylbicyclohexyl-4-carboxylic Acid",617-650-1,84976-67-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,Not classified:1;H400:1;H410:1;H315:1;H319:1
94906,"Benzenesulfonic acid, mono-C15-36-branched alkyl derivs., magnesium salts",290-669-7,90194-57-3,Not Classified,Notified C&L,567,Not classified:567
94912,Benzyl hydrogen γ-L-glutamate,216-826-1,1676-73-9,Not Classified,REACH registration C&L,6,Not classified:5;H335:1;H315:1;H319:1
94915,"1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride",222-397-1,3459-02-7,,Notified C&L,4,H335:4;H315:4;H319:4
94918,Succinamic acid,211-331-7,638-32-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,200,H335:200;H315:200;H319:200
94919,(S)-(-)-Propylene carbonate,610-639-2,51260-39-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
94928,"3,7-dimethyloct-6-en-1-yn-3-ol",249-482-6,29171-20-8,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,261,H317:1;H315:261;H319:261
94929,"reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde;3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde",410-480-7,,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
94930,Oxepane,209-777-2,592-90-5,,Notified C&L,5,H225:5
94935,Methyl 5-chloroanthranilate,225-992-4,5202-89-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
94937,"4-bromo-3,5-xylenol",231-255-8,7463-51-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,203,H335:202;H315:203;H319:203;H312:5;H302:5
94944,2-chloroethyldiisopropylammonium chloride,224-238-1,4261-68-1,Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Acute Tox. 1;STOT SE 3;STOT SE 3;Muta. 2,REACH registration C&L,45,H341:2;H330:40;H318:6;H315:6;H301:45;H335:6;H310:44;H314:39;H311:1;H412:1
94945,Dimethoxydiphenylsilane,229-929-1,6843-66-9,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,103,H411:58;H315:102;H319:6;H302:1;H370:1;H372:1;H360:1;H225:1
94947,"Plumeria rubra acutifolia, ext.",296-311-6,92457-29-9,Aquatic Chronic 3,Notified C&L,12,H412:12;H317:1
94948,POLYAMIC ACID POLYMER R,434-470-7,,,Notified C&L,32,Not classified:32
94949,(1R)-1-(3-methoxyphenyl)ethanamine,618-126-5,88196-70-7,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,126,H402:1;H302:88;H412:84;H318:84;H314:126;H317:84;H332:83;H331:38
94951,But-1-yne,203-451-3,107-00-6,Flam. Gas 1;Press. Gas (Liq.),Notified C&L,162,H220:157;H280:157;Not classified:5
94953,[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium hydrogen sulphate,286-184-5,85187-94-6,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H412:2;H318:2
94957,Daunorubicin,244-069-7,20830-81-3,Acute Tox. 3;Muta. 2;Carc. 2;Repr. 2,Notified C&L,52,H341:52;H351:52;H361:52;H301:52
94958,(2-bromophenyl)acetonitrile,243-091-4,19472-74-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,REACH registration C&L,54,H319:54;H315:54;H331:10;H301:10;H335:54;H311:10;H312:44;H302:44;H332:44
94960,"Protein hydrolyzates, jojoba",309-708-7,100684-35-3,Not Classified,Notified C&L,1,Not classified:1
94968,2-methylpropyl isocyanate,217-495-6,1873-29-6,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3;Resp. Sens. 1,Notified C&L,1,H319:1;H334:1;H331:1;H301:1;H311:1;H225:1
94970,[[(2-hydroxyethyl)imino]bis(methylene)]bisphosphonic acid,227-833-4,5995-42-6,,Notified C&L,48,H318:48;H290:2
94974,"(2S,5R,6R)-6-[[(2R)-Carboxy-3-thienylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid disodium salt",628-059-3,4697-14-7,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,44,H335:41;H334:44;H315:41;H319:41;H317:5
94976,"Cotinus coggygria, ext.",289-734-2,89997-96-6,Not Classified,Notified C&L,5,Not classified:3;H410:2;H400:2;H317:2;H226:2;H304:2
94977,Methyl 4-formylbenzoate,216-385-5,1571-08-0,Not Classified,REACH registration C&L,44,Not classified:39;H335:4;H315:5;H319:5;H312:1;H302:1;H332:1
94983,"Tetralithium 5,5'-[vinylenebis[(3-sulphonato-4,1-phenylene)azo]]bis[3-methylsalicylate]",258-605-2,53523-90-3,Not Classified,REACH registration C&L,9,Not classified:9
94984,2-methoxybenzenethiol,230-605-7,7217-59-6,Acute Tox. 4,Notified C&L,290,H302:290;H335:47;H315:48;H319:48;H312:2;H332:2
94988,"Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, (2Z)-2-butenedioate",639-956-4,37310-95-5,,Notified C&L,34,Not classified:33;H319:1
94991,Diammonium bis[carbonato-O]dihydroxyzirconate,269-682-7,68309-95-5,Not Classified,REACH registration C&L,149,Not classified:142;H335:7;H315:7;H319:7
94993,Docosyl methacrylate,240-714-1,16669-27-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,123,H335:105;H315:105;H319:105;H317:14;Not classified:4
94994,Magnesium dihydrogen di-DL-aspartate,214-702-1,1187-91-3,Not Classified,Notified C&L,1,Not classified:1
94996,"Hydrogenated dimerization products of 1-decene, 1-dodecene and 1-octene",700-308-1,,Asp. Tox. 1;Acute Tox. 4,REACH registration C&L,2,H332:2;H304:2
94999,Nitrilotriacetic acid,205-355-7,139-13-9,Eye Irrit. 2A;Carc. 2,REACH registration C&L,514,H351:352;H319:429;Not classified:77;H340:23;H302:111;H315:23;H373:23;H301:6;H314:4;H412:1;H361:1;H332:1
95001,1-iodooctane,211-084-5,629-27-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:40;H315:45;H319:45;H312:1;H332:1;H302:1
95002,antimony trichloride,233-047-2,10025-91-9,Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H314:0;H411:0
95007,2-lauroyloxyethyltrimethylammonium chloride,246-745-7,25234-60-0,Not Classified,REACH registration C&L,1,Not classified:1
95013,(4R)-Tetrahydro-4-hydroxy-4-methyl-2H-Pyran-2-one,433-160-9,,Not Classified,REACH registration C&L,2,Not classified:2
95014,Cresol propoxylate~,618-605-9,9064-13-5,Skin Sens. 1,Notified C&L,128,H317:102;Not classified:26
95016,2-chloroquinoline,210-317-8,612-62-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
95017,acetamide,200-473-5,60-35-5,Carc. 2,Harmonised C&L,0,H351:0
95019,"alkanes, C",287-476-5,85535-84-8,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H351:0
95021,Isohexadecyl stearate,246-868-6,25339-09-7,Not Classified,Notified C&L,172,Not classified:172
95022,"10H-Thieno(2,3-b)(1,5)benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-",603-618-4,132539-06-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,57,H315:44;H319:54;H317:14;H301:16;H351:4;H361:2;H373:7;H302:2;H336:8;H413:1;H362:1;H410:4;H411:1;H412:1;H332:1;H360:1
95026,"Tetrachloro-1,2-difluoroethane",200-935-6,76-12-0,Ozone 1,REACH registration C&L,4,H420:1;Not classified:3
95028,Ethyl trifluoromethanesulphonate,207-037-3,425-75-2,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,71,H226:71;H314:71;H341:25;H302:27;H318:27;H312:1;H332:1
95029,Fructose 6-(barium phosphate),227-914-4,6035-54-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H302:38
95030,"4,4'-isopropylidenedianiline",219-612-6,2479-47-2,,Notified C&L,34,Not classified:34
95031,"Dimethoxymethyl(3,3,3-trifluoropropyl)silane",206-619-4,358-67-8,Flam. Liq. 3,Notified C&L,44,H226:44;H335:5;H315:6;H319:6
95033,"1,2,3,4-tetrachloro-5-methoxybenzene",213-349-0,938-86-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:38;H315:38;H319:38;Not classified:4
95035,nickel(II) isooctanoate,249-555-2,29317-63-3,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H341:0;H410:0;H334:0;H400:0;H372:0;H317:0;H350:0;H360:0
95036,"Fatty acids, C14-18-unsatd., ammonium salts",268-370-8,68082-26-8,Not Classified,Notified C&L,1,Not classified:1
95039,4-(isopropyl)-1-methylcyclohexyl acetate,247-546-8,26252-11-9,Not Classified,Notified C&L,271,Not classified:215;H411:56;H317:13;H319:13
95045,"N-(2,4-dimethylphenyl)-N'-methylformamidine monohydrochloride",257-274-1,51550-40-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 3,Notified C&L,2,H319:2;H412:2;H315:2;H317:2;H335:2
95047,Ammonium formate,208-753-9,540-69-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,310,H335:110;H315:111;H319:221;Not classified:88;H314:1;H400:1
95050,"Fatty acids, C6-18, hydrogenated",292-955-7,91031-52-6,Not Classified,Notified C&L,1,Not classified:1
95052,(diethylamino)sulphur trifluoride,253-771-2,38078-09-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,57,H312:50;H302:50;H314:57;H226:57;H332:50;H331:4;Not classified:2;H318:1
95054,"1,1-dimethoxyacetone",228-735-4,6342-56-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,50,H226:50;H315:50;H319:50;H335:4
95055,4-chloro-4'-hydroxybenzophenone,255-627-4,42019-78-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,57,H335:52;H315:53;H319:53;Not classified:3;H302:1
95056,"Reaction mass of 2-hydroxy-1-{3-[4-(2-hydroxy-2-methylpropanoyl)phenyl]-1,1,3-trimethyl-2,3-dihydro-1H-inden-5-yl}-2-methylpropan-1-one and 2-hydroxy-1-{1-[4-(2-hydroxy-2-methylpropanoyl)phenyl]-1,3,3-trimethyl-2,3-dihydro-1H-inden-5-yl}-2-methylpropan-1-one",445-510-8,,Aquatic Chronic 4,REACH registration C&L,5,H413:5
95057,"1,3-Benzenedimethanamine, reaction products with epichlorohydrin",603-922-7,135470-04-1,Acute Tox. 4;Acute Tox. 4;Resp. Sens. 1,Notified C&L,76,H312:39;H334:39;H302:61;H318:22;H315:22;Not classified:14;H411:1
95058,"7-methoxy-1,2,3,4-tetrahydronaphthalen-2-one",223-954-1,4133-34-0,Not Classified,REACH registration C&L,3,Not classified:3
95059,1-(tert-Butoxycarbonyl)-3-pyrrolidinol,600-388-7,103057-44-9,,Notified C&L,8,H335:6;H315:7;H319:7;H311:1;H331:1;H301:1;H312:2;H302:2;H332:2
95061,[No public or meaningful name is available],479-470-8,,Not Classified,Notified C&L,33,Not classified:33
95065,"Amines, N-C16-22-alkyltrimethylenedi-",292-564-1,90640-45-2,Skin Corr. 1B;Eye Dam. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:1;H318:2;H400:2;H372:1;H314:1;H315:1
95066,Lithium bis[3-[[5-[(2-chloro-4-nitrophenyl)azo]-2-hydroxybenzylidene]amino]-4-hydroxybenzenesulphonamidato(2-)]chromate(1-),280-334-3,83249-66-5,,Notified C&L,33,Not classified:33
95071,Ferritins,232-704-0,9007-73-2,Not Classified,Notified C&L,3,Not classified:3
95073,2-methylacetophenone,209-408-5,577-16-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,1374,H312:1374;H332:1374
95075,N-(2-hydroxypropyl)benzenesulphonamide,252-512-0,35325-02-1,Not Classified,REACH registration C&L,17,Not classified:17
95079,5-oxo-DL-proline,205-748-3,149-87-1,Not Classified,REACH registration C&L,110,Not classified:60;H335:48;H315:49;H302:40;H319:43;H318:7
95081,Fatty acid (C8-18)ester of PEG-Monomethylethers,616-525-9,77846-79-8,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,3,H412:2;H315:3;H319:3
95084,"Tetrachlorozincate(2-) of bis[5-[[4-(dimethylamino)phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium]",310-210-7,82608-74-0,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,5,H412:5;H302:5;H319:5
95086,2-(4-aminophenyl)propiononitrile,249-164-7,28694-90-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H335:1;H332:1
95092,N-(4-hydroxyphenyl)dodecanamide,203-164-3,103-98-0,Aquatic Chronic 4,Notified C&L,38,H413:38
95094,Sodium hydroxy[3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulphonato(3-)]chromate(1-),285-672-5,85118-18-9,Not Classified,REACH registration C&L,2,Not classified:2
95096,1-aminocyclohexanecarbonitrile,226-830-5,5496-10-6,Skin Corr. 1B,Notified C&L,1,H314:1
95102,8-amino-2-naphthol,204-252-4,118-46-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
95107,"Hydrocarbons, C5, n-alkanes, isoalkanes",921-577-3,,Flam. Liq. 1;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,6,H411:6;H336:6;H224:6;H304:6
95113,"(6R-trans)-7-amino-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",250-099-1,30246-33-4,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,13,H317:2;H334:2;H335:11;H315:11;H302:11;H319:11
95114,"2,5-dichloro-4-[[4-[(2-cyanoethyl)ethylamino]phenyl]azo]-N,N-dimethylbenzenesulphonamide",264-924-8,64501-19-5,Not Classified,Notified C&L,31,Not classified:31
95118,"2H-1-Benzopyran-2-one, 7-methoxy-8-(3-methyl-2-buten-1-yl)-",610-421-7,484-12-8,Not Classified,Notified C&L,1,Not classified:1
95120,"3,3-dimethylpent-1-ene",222-286-8,3404-73-7,Flam. Liq. 2;Eye Dam. 1,Notified C&L,39,H225:39;H318:38
95123,Dipentyl pentylfosfonate,229-144-4,6418-56-0,Aquatic Chronic 4,Notified C&L,39,H413:38;H412:1;H315:1;H302:1;H319:1
95124,"Isononanoic acid, mixed esters with dipentaerythritol, heptanoic acid and pentaerythritol",282-775-7,84418-63-3,Not Classified,REACH registration C&L,23,Not classified:23
95127,ELDEW PS-203,429-630-8,,Not Classified,REACH registration C&L,1,Not classified:1
95128,"Calcium pantothenate , D-form",205-278-9,137-08-6,Not Classified,Notified C&L,26,Not classified:26
95129,"Disodium 3,3'-dithiobis(benzenesulphonate)",248-630-7,27738-87-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
95132,α-D-glucose,207-757-8,492-62-6,,Notified C&L,50,Not classified:49;H335:1;H315:1;H319:1
95133,"2,3-dimethylpent-1-ene",222-285-2,3404-72-6,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,39,H225:39;H304:39
95134,Benzyl thiocyanate,221-144-2,3012-37-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H312:43;H332:44;H302:44;H318:1;H314:1
95141,"Glycine, N-(2-aminoethyl)-N-(2-hydroxyethyl)-, N-coco acyl derivs., monosodium salts",291-352-6,90387-76-1,Eye Irrit. 2,Notified C&L,11,H319:8;Not classified:3
95143,"4,8-Dithia-6,10-diazadodec-5-ene-1-sulfonic acid, 10-ethyl-7-methyl-5-(methylphenylamino)-9-thioxo-",610-345-4,474044-09-2,Not Classified,Notified C&L,1,Not classified:1
95144,Potassium 16-methylheptadecanoate,270-218-0,68413-46-7,Not Classified,Notified C&L,6,Not classified:6
95145,"(Reaction product of 4-[2-(4-hydroxyphenyl)propan-2-yl]phenol, 2-(2-hydroxyethylamino)ethanol and formaldehyde), propoxylated",926-000-9,,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H317:1;H315:1
95147,"Trisodium 5-[[4-chloro-6-(ethylphenylamino)-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(1-sulphonato-2-naphthyl)azo]naphthalene-2,7-disulphonate",281-866-9,84045-65-8,Not Classified,REACH registration C&L,39,Not classified:38;H319:1
95149,Tetraaluminium calcium heptaoxide,234-463-7,12004-88-5,Not Classified,Notified C&L,1,Not classified:1
95151,"1,2,3,4-tetrahydronaphthalen-1-one",208-460-6,529-34-0,Acute Tox. 4,REACH registration C&L,57,H302:57;H332:3;Not classified:2
95153,m-phenetidine,210-680-2,621-33-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2,Notified C&L,71,H311:38;H373:38;H331:38;H301:38;Not classified:33
95158,"1,8-bis(4-dodecylphenyl)amino-9,10-anthracenedione",403-820-0,,Not Classified,Notified C&L,2,Not classified:2
95161,potassium chlorate,223-289-7,3811-04-9,Ox. Sol. 1;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H271:0;H332:0;H411:0;H302:0
95162,Disodium [N-[7-hydroxy-8-[(2-hydroxy-5-mesylphenyl)azo]-1-naphthyl]acetamidato(2-)][2-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]-5-nitrobenzenesulphonato(3-)]chromate(2-),259-452-4,55039-14-0,Aquatic Chronic 2,REACH registration C&L,15,H411:7;Not classified:8
95168,"Chromate(1-), [4-[4-[(5-chloro-2-hydroxyphenyl)azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonamidato(2-)][4-[4-[(3,5-dichloro-2-hydroxyphenyl)azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonamidato(2-)]-, sodium",297-961-3,93776-33-1,Not Classified,Notified C&L,1,Not classified:1
95172,"Titanium 2,2',2''-nitrilotrisethanolate",240-015-1,15879-01-3,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,37,H315:27;H319:27;H335:20;H317:20;H225:6;Not classified:4;H226:5
95175,4-hydroxy-3-methoxyphenylacetic acid,206-176-7,306-08-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
95178,"Rosin, fumarated, oligomeric reaction products with pentaerythritol",500-164-8,65997-11-7,Not Classified,Notified C&L,54,Not classified:39;H317:15;H319:15;H413:1
95180,"3-chloro-4,5,α, α,α-pentafluorotoluene",401-930-3,77227-99-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H226:0;H332:0;H400:0;H302:0
95182,"1,2-epithiopropane",214-007-3,1072-43-1,Flam. Liq. 2;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,39,H319:38;H315:38;H301:39;H225:39;H332:38;H331:1
95183,2-Bromo-4-fluorobenzaldehyde,611-803-6,59142-68-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H335:3;H315:4;H319:4
95184,"Oleic acid, compound with N-(2-aminoethyl)ethane-1,2-diamine",241-924-6,18016-43-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,86,H315:85;H319:85;H318:1;H314:1;H411:1
95189,"sodium 2-(2,4-dihydroxyphenyl)-3,4,5,7-tetrahydroxy-4H-chromene-4-sulfonate",918-540-9,,Aquatic Chronic 2,REACH registration C&L,1,H411:1
95191,"(R)-5-isopropyl-2-methylcyclohexa-1,3-diene",224-167-6,4221-98-1,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,256,H410:4;H400:4;H317:5;H226:256;H304:254;H319:1
95193,Aminomethylphenylketone hydrochloride,226-787-2,5468-37-1,,Notified C&L,8,H335:8;H315:8;H319:8;H302:1;H332:1
95197,"Naphthalenedisulfonic acid, dinonyl-, branched, compds. with morpholine (1:2)",601-184-0,112400-78-9,Not Classified,Notified C&L,1,Not classified:1
95200,γ-methoxybenzenebutyronitrile,275-236-2,71172-63-9,Acute Tox. 4,Notified C&L,38,H302:38
95203,"Amines, N-C12-18-alkyltrimethylenedi-, diacetates",292-565-7,90640-46-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,1,H400:1;H315:1;H302:1;H319:1
95206,2-Aminothiazole-5-carboxaldehyde,600-083-9,1003-61-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H302:40;H319:44;H315:44;H317:39;H335:44;H332:1
95207,2-aminothiazol-4-acetic acid,249-769-6,29676-71-9,Not Classified,REACH registration C&L,49,Not classified:1;H335:47;H315:48;H319:48;H373:2
95212,"Hydrocarbon waxes (petroleum), hydrotreated microcryst.",265-163-4,64742-60-5,Not Classified,REACH registration C&L,361,Not classified:361
95213,2-hydroxypropylacrylate,213-663-8,999-61-1,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3,Harmonised C&L,0,H314:0;H317:0;H331:0;H301:0;H311:0
95214,"Aluminum oxide (Al2O3), chromium-doped",308-964-7,99328-47-9,Muta. 2,REACH registration C&L,2,H341:2
95218,6-methylpyridazin-3(2H)-one,236-367-0,13327-27-0,,Notified C&L,6,H335:5;H315:6;H319:6
95220,(-)-pin-2(10)-ene,242-060-2,18172-67-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,488,H410:350;H400:349;H315:259;H317:482;H226:487;H304:482;H312:40;H335:44;H302:40;H319:77;H332:40;H411:1;Not classified:3
95221,"1,3-dichloro-2-propanol",202-491-9,96-23-1,Acute Tox. 3;Acute Tox. 4;Carc. 1B,Harmonised C&L,0,H312:0;H350:0;H301:0
95225,"Propanenitrile, 3-(C12-14-alkyloxy) derivs.",270-940-6,68511-43-3,Carc. 1B;Aquatic Acute 1,REACH registration C&L,1,H350:1;H400:1
95231,Di[carbonato(2-)]hexahydroxypentacobalt,235-714-3,12602-23-2,Skin Sens. 1;Resp. Sens. 1;Carc. 2,Notified C&L,46,H317:46;H334:38;H351:38;H350:8
95233,2-bromobenzoyl chloride,230-507-4,7154-66-7,Skin Corr. 1B,Notified C&L,47,H314:47;H318:1;H290:1
95235,Phlogopite (Mg3K(Si3Al)[(OH)0.5-1F0-0.5]2O10),612-075-2,61076-94-6,,Notified C&L,33,Not classified:33
95237,Benzyltrichlorosilane,212-219-0,770-10-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
95238,"Proteinase, submandibular gland serine, A",279-893-6,82047-85-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H317:38;H315:38;H319:38
95241,Tributylstannyl salicylate,224-397-7,4342-30-7,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H312:38;H410:38;H319:38;H400:38;H315:38;H372:38;H301:38
95242,Isooctyl 3-mercaptopropionate,250-157-6,30374-01-7,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 1,REACH registration C&L,178,H410:84;H317:84;H400:84;H302:139;H225:38;H335:1
95244,2-ethylisonicotinonitrile,216-238-5,1531-18-6,,Notified C&L,1,H335:1;H302:1;H319:1;H315:1;H226:1
95246,"3,6,9,12-tetraoxatetradecane-1,14-diol",225-341-4,4792-15-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,142,H335:135;H315:138;H319:142
95247,C.I. Acid Brown 165,612-239-3,61724-14-9,Not Classified,Notified C&L,12,Not classified:12
95248,Ammonium hydrogen glutarate,249-822-3,29750-34-3,,Notified C&L,33,Not classified:33
95249,"3,3'-oxydi(propylene glycol)",211-013-8,627-82-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,62,H335:39;H315:39;H319:39;Not classified:23
95250,"5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-[2-(formylamino)-4-thiazolyl]-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, 1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester, (6R,7R)-",619-239-2,96680-30-7,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1
95252,"(2,3,4-trimethoxyphenyl)acetic acid",245-024-4,22480-91-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
95253,N-benzyloxycarbonyl-L-leucine,217-960-3,2018-66-8,Not Classified,Notified C&L,3,Not classified:3
95255,"Mate, ext.",277-364-4,73296-98-7,Flam. Liq. 3;Acute Tox. 4,REACH registration C&L,1415,H226:4;H302:2;H317:1286;H411:1286;H412:104;Not classified:21
95256,Ethyl 2-cyano-3-methylvalerate,230-765-8,7309-45-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H315:38
95262,N-butylbenzenesulphonamide,222-823-6,3622-84-2,Aquatic Chronic 3,REACH registration C&L,635,H412:524;H373:520;Not classified:97;H371:32;H302:7;H315:4;H319:4;H312:3;H331:1
95264,"3,4-dihydro-5,7-dimethylnaphthalen-1(2H)-one",237-104-2,13621-25-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
95265,2-Amino-5-ethylphenol HCI,638-862-0,149861-22-3,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,37,H410:36;H302:37;H400:36;H314:36;H317:36;H335:1;H315:1;H319:1
95266,"Benzenesulfonic acid, C14-44-branched and linear alkyl derivs., calcium salts",294-232-1,91696-73-0,Not Classified,Notified C&L,1,Not classified:1
95268,5-methoxyindol-3-ylacetic acid,222-438-3,3471-31-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:1;H332:2;H302:2;H319:1;H315:1;H335:1
95272,"Gases (petroleum), hydrogenator effluent flash drum off;Refinery gas;[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",295-400-7,92045-18-6,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
95273,Magnesium didocosanoate,256-126-3,43168-33-8,Not Classified,Notified C&L,2,Not classified:2
95275,"ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate",422-360-1,100491-29-0,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
95276,Gestodene,262-145-8,60282-87-3,Repr. 2,Notified C&L,87,H361:41;H410:25;H400:25;H362:26;H360:45;H351:25;H312:1;H332:2;H302:3
95277,"Ethanol, 2,2'-[[3-[(2-hydroxyethyl)amino]propyl]imino]bis-, N-C12-18-alkyl derivs.",291-269-5,90367-21-8,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,1,H314:1;H400:1;H302:1
95280,"7-[[2-[(aminocarbonyl)amino]-4-[[4-chloro-6-[[4-[vinylsulphonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]phenyl]azo]naphthalene-1,3,6-trisulphonic acid, sodium salt",303-153-4,94158-80-2,Not Classified,REACH registration C&L,84,Not classified:84
95287,"Adipic acid, potassium salt",247-175-1,25666-61-9,Not Classified,Notified C&L,85,Not classified:85
95295,(3S)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-aminehydrochloride,611-209-7,54910-89-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;STOT SE 3;STOT RE 2;Aquatic Chronic 1,Notified C&L,4,H302:4;H330:4;H410:4;H318:4;H336:4;H315:4;H373:4
95301,"Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.'-phosphinicobis[.omega.-hydroxy-, di-C12-14 (even numbered)-alkyl ethers",601-752-8,121158-61-0,Skin Irrit. 2,Notified C&L,53,H315:31;H318:22;H314:22
95302,"Carbamic chloride, N-ethyl-N-methyl-",610-003-4,42252-34-6,Not Classified,Notified C&L,31,Not classified:11;H335:16;H315:16;H319:16;H318:3;H290:2;H314:4;H302:4;H332:3;H351:3;H330:1
95306,4-bromo-1-chloro-2-methoxybenzene,605-507-6,16817-43-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
95309,"Soaps, stocks, mustard seed-oil, acidulated",284-016-5,84776-89-6,Not Classified,Notified C&L,1,Not classified:1
95310,Isobutyl isovalerate,209-653-8,589-59-3,Flam. Liq. 3,Notified C&L,1645,H226:1644;H335:38;H315:39;H319:38;H411:1
95311,[No public or meaningful name is available],485-310-8,,,Notified C&L,1,Not classified:1
95313,Ethyl N-phenylformimidate,229-841-3,6780-49-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:44;H315:44;H319:44
95314,thiocyanic acid,207-337-4,463-56-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H312:0;H332:0;H412:0;H302:0
95316,"Alkanes, C3-4;petroleum gas",270-653-6,68475-59-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
95317,1-thio-β-D-glucopyranose 1-[5-(methylthio)-N-(sulphooxy)valerimidate],244-689-8,21973-56-8,Not Classified,Notified C&L,2,Not classified:2
95318,"(1,1'-Biphenyl)-2-ol, sodium salt, tetrahydrate",612-164-6,6152-33-6,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,550,H318:545;H314:446;H302:545;H400:99;H315:99;H335:99;Not classified:5
95321,"Carboxylic acids, C7-13, perfluoro, ammonium salts",277-138-5,72968-38-8,Acute Tox. 4;Repr. 1B;STOT RE 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H360:1;H302:1;H372:1
95328,(1-Hydroxycyclohexyl)(4-methoxyphenyl)acetonitrile,618-945-8,93413-76-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H332:1
95331,Dilithium metasilicate,233-270-5,10102-24-6,Eye Irrit. 2;STOT SE 3,Notified C&L,66,H335:40;H319:41;H314:25;H315:2
95332,Phenylmercury propionate,203-094-3,103-27-5,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H330:38;H410:38;H400:38;H373:38;H300:38;H310:38
95333,"2-Oxethanone, 4,4-dimethyl-",605-963-6,1823-52-5,Skin Corr. 1B,Notified C&L,42,H314:31;H225:11
95336,"4,4-isobutylethylidenediphenol",401-720-1,6807-17-6,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H360:0;H400:0;H410:0;H319:0
95337,Benzofenap,617-376-2,82692-44-2,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H332:38;H400:39;H410:39
95338,"8,8-dioctyl-1,4-dioxa-7,9-dithia-8-stannacycloundecane-5,11-dione",273-920-5,69226-44-4,Acute Tox. 4;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,4,H412:2;H302:2;H372:4;H361:2;H413:2
95339,"Hexanedioic acid, C16-20-branched alkyl esters",286-269-7,85203-78-7,Not Classified,Notified C&L,2,Not classified:2
95341,"1-Dodecene, dimer with 1-decene, hydrogenated",604-766-2,151006-58-5,Asp. Tox. 1;Acute Tox. 4,REACH registration C&L,450,H332:450;H304:448;H413:2
95342,"4,6-diamino-1,3,5-triazin-2(1H)-one",211-455-1,645-92-1,Not Classified,Notified C&L,11,Not classified:10;H317:1;H319:1
95346,"1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butane-1,3-dione",619-997-4,764667-65-4,Not Classified,Notified C&L,1,Not classified:1
95348,"3-methyl-1-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-1,4-dien-3-ol",226-006-5,5208-93-5,Skin Sens. 1A;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,91,H317:91;H401:8;H411:91
95350,Limestone,215-279-6,1317-65-3,Not Classified,Notified C&L,2039,Not classified:1911;H318:86;H315:118;H319:31;H350:11;H372:11;H335:11
95355,3-chloro-2-methylpropyl(dimethyl)ammonium chloride,224-237-6,4261-67-0,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,REACH registration C&L,50,H335:50;H314:4;H302:8;H318:38;H315:46;H301:38;H319:4
95358,"Siloxanes and Silicones, Me myristyl",616-369-1,76684-67-8,Not Classified,Notified C&L,1,Not classified:1
95360,adipic acid,204-673-3,124-04-9,Eye Irrit. 2,Harmonised C&L,0,H319:0
95364,"1-Naphthalenamine, N-[(1,1,3,3-tetramethylbutyl)phenyl]-, polymer with 4-octyl-N-(4-octylphenyl)benzenamine",614-828-0,68938-84-1,Not Classified,Notified C&L,41,Not classified:41
95372,Iron manganese trioxide,235-049-9,12062-81-6,Not Classified,REACH registration C&L,106,Not classified:106
95374,"Ammonium diaquabis[salicylato(2-)-O1,O2]chromate(1-)",269-290-6,68214-26-6,Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H317:83;H350:83;H400:83;H410:83
95376,Lithium hydrogen sebacate,301-742-0,94042-76-9,Not Classified,Notified C&L,2,Not classified:2
95378,1-(2-pyridyl)piperazine,252-220-3,34803-66-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:42;H315:42;H319:42;H314:5;H312:1;H302:3;H332:1
95381,"1,5-dimethyl-1-vinylhept-4-enyl acetate",263-336-9,61931-80-4,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1762,H317:38;H411:1762;H315:47;H319:47
95383,"Celeriac, ext.",289-667-9,89997-34-2,Not Classified,Notified C&L,89,Not classified:52;H410:36;H315:37;H317:37;H226:37;H304:37;H319:1;H411:1
95385,3-chloropropiononitrile,208-827-0,542-76-7,Acute Tox. 2;Acute Tox. 3,Notified C&L,46,H300:43;H331:38;H315:4;H301:3;H319:4
95386,"metconazole (ISO);(1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol",603-031-3,125116-23-6,Acute Tox. 4;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H361:0;H411:0;H302:0
95387,"Benzenesulfonic acid, mono-C15-36-branched alkyl derivs., C24-rich",290-668-1,90194-56-2,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,63,H412:63;H318:63;H314:63
95390,"1,4,7-trioxa-10-azacyclododecane",255-549-0,41775-76-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
95392,N-Methyl Paroxetine,600-963-2,110429-36-2,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H410:38;H400:38;H301:38;Not classified:1;H302:1;H315:1;H319:1
95405,"Phosphoric acid, octadecyl ester, branched and linear, potassium salt",306-503-4,97281-06-6,Not Classified,Notified C&L,15,Not classified:14;H318:1;H315:1
95408,"Methanamine, N-methyl-, reaction products with epichlorohydrin",271-840-5,68609-88-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,3,H410:3;H315:3;H319:3
95409,Disodium deceth-5 sulfosuccinate,614-672-3,68630-97-7,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,125,H412:83;H318:118;Not classified:7
95410,Nitromethylidynetrimethanol,204-769-5,126-11-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,136,H410:71;H400:71;H302:116;H335:38;H315:58;H319:58;H332:17
95411,"Benzenesulfonic acid, mono-C16-24-branched and linear alkyl derivs., magnesium salts",307-990-6,97808-69-0,Skin Irrit. 2,Notified C&L,1,H315:1
95414,Cyclopentanepropanol,212-177-3,767-05-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:39;H319:39
95417,"N-cyano-N',N''-dimethylguanidine",250-846-1,31857-31-5,,Notified C&L,1,H302:1
95420,"α-d-Glucopyranoside, β-d-fructofuranosyl, octadecanoate",253-459-6,37318-31-3,Not Classified,Notified C&L,107,Not classified:106;H319:1
95421,"4-hydroxy-3,5-diiodobenzoic acid",210-562-0,618-76-8,,Notified C&L,4,H335:4;H315:4;H319:4
95422,Bis(2-ethylhexyl) 2-hydroxyethyl phosphate,249-606-9,29398-98-9,Not Classified,Notified C&L,1,Not classified:1
95423,"6,6'-di-tert-butyl-4,4'-thiodi-o-cresol",202-522-6,96-66-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
95432,"5-methyl-5-phenylimidazolidine-2,4-dione",229-928-6,6843-49-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:39;H319:39
95434,"5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine",610-648-1,51322-75-9,Acute Tox. 4;Acute Tox. 4;Repr. 2,REACH registration C&L,3,H361:2;H332:3;H302:3
95436,"Butane-1,4-diol",203-786-5,110-63-4,Acute Tox. 4;STOT SE 3,REACH registration C&L,1008,H336:634;H302:896;Not classified:113;H315:55;H370:29;H335:13;H332:1;H312:1
95437,2-bromomesitylene,209-405-9,576-83-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
95438,Demeclocycline hydrochloride,200-592-2,64-73-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Muta. 2,Notified C&L,97,H312:52;H341:52;H302:53;H319:53;H315:53;H335:53;H332:52;H317:40;Not classified:4;H361:1;H362:1
95439,"Alcohols, C9-11-branched and linear",288-284-4,85711-26-8,,REACH registration C&L,12,Not classified:12
95444,"Heptane-1,7-diol",211-085-0,629-30-1,Not Classified,Notified C&L,3,Not classified:3
95451,1-(3-methoxypropyl)piperidin-4-one,605-486-3,16771-85-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:1;H302:1;H319:2;H341:1;H317:1
95452,"Carbamic acid, [5-(hydroxyamino)pentyl]-, phenylmethyl ester",618-800-9,91905-05-4,,Notified C&L,1,H302:1;H319:1
95453,Solvent naphtha (petroleum) heavy aliph.;Straight run kerosine;[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C,265-200-4,64742-96-7,Asp. Tox. 1,Harmonised C&L,0,H304:0
95456,"Cnicus benedictus, ext.",283-258-9,84603-57-6,Not Classified,Notified C&L,1,Not classified:1
95458,"9,10-Anthracenedione, 1,4,5,8-tetrakis[(4-butylphenyl)amino]-",600-862-3,108313-21-9,Not Classified,Notified C&L,56,Not classified:56
95461,6-fluoro-1H-indole-3-ethylamine monohydrochloride,259-533-4,55206-24-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:40;H315:40;H319:40
95462,"butene, mixed-1-and-2-isomers",203-452-9,107-01-7,Press. Gas;Flam. Gas 1,Harmonised C&L,0,H220:0;Not classified:0
95463,"4H-1-Benzopyran-4-one, 8-[2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-",613-695-6,64820-99-1,Not Classified,Notified C&L,2,Not classified:2
95470,3-guanidinopropionic acid,206-530-0,353-09-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
95477,1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone,606-942-4,221615-75-4,Skin Irrit. 2,Notified C&L,37,H315:36;H412:1
95481,"Crithmum maritimum, ext.",289-735-8,89997-98-8,Not Classified,Notified C&L,186,Not classified:185;H226:1;H411:1;H304:1
95482,"3,4-diaminobenzophenone",254-273-8,39070-63-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
95489,"(1R,2S,2'S,4R)-1,7,7-Trimethylbicyclo (2.2.1)heptane-2-spiro-4'-(2'-isopropyl-1',3'-dioxane)",443-460-1,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H318:1;H410:1;H400:1;H315:1
95491,mecrilate;methyl 2-cyanoacrylate,205-275-2,137-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H335:0;H315:0;H319:0
95492,"Tetrasodium 1,1'-[[5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diyl]diimino]bis[3-phenylpropane-1,3-disulphonate]",306-451-2,97259-87-5,Not Classified,Notified C&L,1,Not classified:1
95494,N-[benzoxycarbonyl]-O-[tert-butyl]-L-serine,216-827-7,1676-75-1,Not Classified,Notified C&L,2,Not classified:2
95495,[2-[[2-cyano-3-[4-(diethylamino)phenyl]-1-oxoallyl]oxy]ethyl][3-[[2-cyano-3-[4-(diethylamino)phenyl]-1-oxoallyl]oxy]propyl]dimethylammonium chloride,278-859-8,78181-99-4,Met. Corr. 1;Aquatic Chronic 3,REACH registration C&L,137,H412:91;H290:6;Not classified:43;H314:2;H411:3
95496,N-[(2-methylpropoxy)methyl]acrylamide,240-715-7,16669-59-3,Acute Tox. 4,REACH registration C&L,121,H302:114;H312:110;Not classified:7
95497,"Calcium 4-(1,1-dimethylethyl)benzoate",257-981-5,52509-84-9,Acute Tox. 4;Repr. 1B;STOT RE 1;STOT RE 1;STOT RE 1;Aquatic Chronic 2,Notified C&L,4,H411:3;H360:3;H302:4;H372:3;H332:1
95503,"Distillates (petroleum), depentanizer overheads;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C",270-771-8,68477-89-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
95505,Dichromium tris(hydrogen phosphate),261-643-2,59178-46-0,Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,32,H302:4;H318:4;H290:4;H411:4;H314:5;H317:4;H315:27;H319:27
95506,Tributylstibine,218-455-0,2155-73-9,Flam. Liq. 3;Pyr. Liq. 1;Water-react. 2;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,38,H250:38;H302:38;H411:38;H261:38;H226:38;H332:38
95507,Hematite (Fe2O3),215-275-4,1317-60-8,Not Classified,Notified C&L,380,Not classified:377;H312:3;H302:3;H318:3;H336:3;H315:3;H372:3;H413:3;H335:3
95509,"2,6,6-trimethyl-2-cyclohexene-1-acetaldehyde",207-453-5,472-64-0,Acute Tox. 4,Notified C&L,113,H302:113
95510,2-(trifluoromethoxy)benzonitrile,264-584-0,63968-85-4,,Notified C&L,7,H312:4;H302:4;H319:7;H315:7;H335:5;H332:4;H330:1;H301:2;H311:1
95511,"3,4-Dibromotoluene",612-055-3,60956-23-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:38;H315:45;H319:45
95520,2-(4-nitrophenyl)butyric acid,231-256-3,7463-53-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
95521,"DIBENZO[B,F][1,4]THIAZEPIN-11(10H)-ONE, 2-CHLORO",700-086-6,3159-04-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
95526,"sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid",435-350-7,141250-43-3,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
95527,"Amines, N-tallow alkyltripropylenetetra-, ethoxylated",618-774-9,916155-62-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,4,H410:4;H318:4;H314:4;H302:4
95530,2-methoxy-1-naphthoic acid,213-429-5,947-62-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
95531,Sodium 4-[[4-[(4-hydroxy-2-methylphenyl)azo]phenyl]amino]-3-nitrobenzenesulphonate,274-950-1,70865-20-2,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,87,H412:59;H317:46;Not classified:28;H319:1
95537,D-tryptophan hydrochloride (1:1),609-287-2,36760-44-8,Not Classified,REACH registration C&L,3,Not classified:2;H314:1
95538,"Disodium 1,1'-methylenedi(naphthalene-2-sulphonate)",219-172-5,2379-92-2,Not Classified,Notified C&L,19,Not classified:19
95543,4-Fluoro-3-hydroxybenzoic acid,434-190-5,,Not Classified,REACH registration C&L,1,Not classified:1
95546,cadmium cyanide,208-829-1,542-83-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H330:0;H410:0;H400:0;H373:0;H300:0;H351:0;H310:0
95550,ACID RED 52 LITHIUM SALT,405-940-9,,Not Classified,Notified C&L,1,Not classified:1
95553,"Mixture of octachloro, monomethoxy-heptachloro and bismethoxy-hexachloro derivatives of 3,3'-[(2-methyl-1,3-phenylene)diimino]bis[2,3-dihydro-1H-isoindol-1-one]",600-735-2,106276-79-3,Not Classified,REACH registration C&L,114,Not classified:114
95556,"Octadecyl (9Z,12Z)-octadeca-9,12-dienoate",241-653-3,17673-53-9,Not Classified,Notified C&L,1,Not classified:1
95557,"1,1'-(bromomethylene)bis[2,3,4,5,6-pentafluorobenzene]",227-246-3,5736-49-2,Skin Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38
95558,"1,3-propanediyl bismethacrylate",214-705-8,1188-09-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
95559,Valeryl chloride,211-330-1,638-29-9,Flam. Liq. 3;Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 3,REACH registration C&L,137,H412:92;H318:92;H290:92;H314:136;H331:131;H226:137;H317:4;H302:5;H332:2
95561,Butene,246-689-3,25167-67-3,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,417,H220:328;H280:311;H224:56;Not classified:33
95563,3-(o-methoxyphenyl)propionic acid,228-738-0,6342-77-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1
95569,"3,4,5,6-tetrachlorophthalimide",216-386-0,1571-13-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,73,H335:39;H315:40;H319:40;Not classified:33
95572,"trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate",406-820-9,,Eye Irrit. 2,Harmonised C&L,0,H319:0
95574,Non-1-en-3-ol,244-686-1,21964-44-3,Not Classified,Notified C&L,90,Not classified:89;H312:1;H315:1;H319:1
95576,"Gaultheria fragrantissima punctata, ext.",296-004-7,92201-74-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,148,H302:148;H319:131;H412:2;H318:1
95579,Iridium trichloride,233-044-6,10025-83-9,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,143,H411:83;H302:84;H335:44;H315:44;H319:45;H318:13;H290:13;H314:15;Not classified:1
95582,"3,4,5-trihydroxybenzoic acid",205-749-9,149-91-7,Not Classified,REACH registration C&L,440,Not classified:51;H335:298;H315:311;H319:312;H318:77;H317:1
95583,Ethyl 2-hydroxy-2-methylbutyrate,201-050-8,77-70-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H335:90;H319:90;H315:90;H226:91;H304:80;H302:10
95587,"Phosphatidylserines, C12-24 and C12-24-unsatd.",295-816-9,92129-15-2,Not Classified,Notified C&L,1,Not classified:1
95589,Vanadium carbide,234-380-6,11130-21-5,Not Classified,Notified C&L,1,Not classified:1
95590,"4,5-dichloro-o-phenylenediamine",226-305-0,5348-42-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H312:41;H302:45;H319:45;H315:45;H335:44;H332:45;H311:4
95594,6-chloroquinoline,210-314-1,612-57-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
95598,"Alkenes, C10-13",287-479-1,85535-87-1,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 1,REACH registration C&L,4,H226:2;H400:4;H410:4;H304:4
95599,Mecamylamine,200-476-1,60-40-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H335:1;H332:1
95600,Diethyl pimelate,218-083-9,2050-20-6,,Notified C&L,1,H335:1;H315:1;H319:1
95603,"α-d-Glucopyranoside, β-d-fructofuranosyl, mixed palmitates and stearates",281-931-1,84066-95-5,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,64,H413:60;H319:58;Not classified:1
95605,"2-Imidazolidinone, 4,5-dihydroxy-1,3-dimethyl-, (4R,5S)-rel-",607-304-8,2402-07-5,Not Classified,Notified C&L,1,Not classified:1
95608,"Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, bis(hydrogenated tallow alkyl)dimethylammonium salt with hectorite",601-812-3,121888-67-3,Not Classified,Notified C&L,5,Not classified:5
95613,"2,4-dihydro-2,5-dimethyl-3H-pyrazol-3-one",220-389-2,2749-59-9,Acute Tox. 4;Eye Irrit. 2;Muta. 2;Aquatic Chronic 3,REACH registration C&L,45,H341:34;H412:45;H302:34;H319:45;H315:11
95615,Tralopyril,602-784-5,122454-29-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,241,H400:236;H410:236;H331:23;H301:23;H330:19;H372:19;H373:19;H300:19;H311:19;Not classified:5
95616,"3,5-dichloro-2,6-difluoropyrdine-4-amine",220-630-1,2840-00-8,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H312:0;H411:0;H302:0
95619,Sodium bis[3-[[5-[(2-chloro-4-nitrophenyl)azo]-2-hydroxybenzylidene]amino]-4-hydroxybenzenesulphonamidato(2-)]chromate(1-),280-335-9,83249-67-6,,Notified C&L,33,Not classified:33
95621,"6,10-dimethylundecan-2-one",216-509-8,1604-34-8,Skin Irrit. 2;Eye Irrit. 2A;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,42,H412:3;H402:3;H315:3;H319:41;H400:39;H410:39
95623,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecan-1-ol",211-648-0,678-39-7,,Notified C&L,87,Not classified:86;H335:1;H315:1;H319:1
95628,"Isopropyl N-benzoyl-N-(3-chloro-4-fluorophenyl)-D,L-alaninate",258-154-1,52756-22-6,Not Classified,Notified C&L,3,Not classified:3
95631,"Urea, phosphate (3:1)",603-526-4,13186-24-8,Not Classified,Notified C&L,1,Not classified:1
95641,"N-(4-chlorophenyl)-1,3,5-triazine-2,4-diamine monohydrochloride",217-962-4,2019-25-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
95642,(S)-(+)-2-(2-Chlorophenyl)-2-hydroxyacetic acid,700-307-6,52950-19-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
95644,Amylopectin,232-911-6,9037-22-3,Not Classified,Notified C&L,36,Not classified:36
95650,"reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane;(S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane",420-640-8,138495-42-8,Aquatic Chronic 3,Harmonised C&L,0,H412:0
95656,Polyether Polyol,613-381-9,63793-60-2,Not Classified,Notified C&L,111,Not classified:86;H410:25;H319:25
95658,"Residual oils (petroleum), hydrotreated;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C",265-160-8,64742-57-0,Carc. 1B,Harmonised C&L,0,H350:0
95660,"1,3-Benzenediol, 4-[4,6-Bis(2,4-Dimethylphenyl)-1,3,5-Triazin-2-Yl]-, Reaction Products With [(Dodecyloxy)Methyl]Oxirane And Oxirane Mono[(C10-16-Alkyloxy)Methyl] Derivatives",604-910-4,153519-44-9,Aquatic Chronic 1,Notified C&L,297,H410:201;Not classified:96;H400:24
95661,Isodecyl alcohol,246-869-1,25339-17-7,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,439,H411:135;H315:274;H319:345;Not classified:94;H373:55;H400:28;H335:5
95662,"9,10-Anthracenedione, 1-amino-4-hydroxy-2-phenoxy-",602-315-4,12223-37-9,,Notified C&L,1,H317:1
95671,Didodecyl fumarate,219-280-2,2402-58-6,Not Classified,REACH registration C&L,113,Not classified:113
95673,"Ethane-1,2-dithiol",208-752-3,540-63-6,Flam. Liq. 3;Acute Tox. 4,Notified C&L,308,H226:292;H302:236;H330:52;H319:44;H301:72;H310:43;H312:32;H331:16;H336:8;Not classified:2;H332:2;H304:1;H335:1;H315:1
95679,"Fatty acids, soya, epoxidized, Me esters",268-371-3,68082-35-9,Not Classified,REACH registration C&L,69,Not classified:69
95682,5-methylisoxazole-3-carboxylic acid,222-289-4,3405-77-4,,Notified C&L,10,H335:8;H315:9;H319:9;Not classified:1
95688,Dacarbazine,224-396-1,4342-03-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Muta. 1B;Carc. 1B,Notified C&L,42,H312:40;H340:39;H302:39;H319:41;H315:41;H350:41;H335:40;H332:40;H361:2;H351:1;H341:1;H372:1
95696,Disodium N-(1-oxooctadecyl)-L-glutamate,253-773-3,38079-62-8,Eye Irrit. 2,Notified C&L,40,H319:37;H413:2;H411:1
95698,"Fatty acids, butter, Me esters",287-507-2,85536-26-1,Not Classified,Notified C&L,1,Not classified:1
95699,"Gases (petroleum), naphtha steam cracking high-pressure residual;Refinery gas;[A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.]",295-401-2,92045-19-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
95702,"trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate",429-240-8,212652-59-0,Eye Dam. 1,Harmonised C&L,0,H318:0
95704,2-ethoxyethylmercury chloride,204-670-7,124-01-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H330:38;H410:38;H400:38;H373:38;H300:38;H310:38
95707,"4,4'-carbonyldiphthalic acid",219-613-1,2479-49-4,Skin Sens. 1,Notified C&L,51,H317:51
95708,"D-Gluconic acid, 4-O-β-D-galactopyranosyl-, calcium salt (2:1), dihydrate",600-978-4,110638-68-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,2,H312:2;H302:2;H319:2;H315:2;H335:2;H332:2
95711,Oxibendazole,243-877-7,20559-55-1,Not Classified,Notified C&L,1,Not classified:1
95714,"Zirconium, acetate lactate oxo ammonium complexes",272-702-7,68909-34-2,Acute Tox. 4,REACH registration C&L,26,H302:1;H315:25;H319:25
95715,"Bis(1,2,2,6,6-pentamethyl-4-piperidyl) [[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]butylmalonate",264-513-3,63843-89-0,Acute Tox. 4;STOT RE 1;Aquatic Chronic 1,REACH registration C&L,710,H410:176;H302:705;H372:187;H412:513;H373:150;H400:16;Not classified:5
95717,Disodium dihydrogen ethylenediaminetetraacetate,205-358-3,139-33-3,Acute Tox. 4;STOT RE 2,REACH registration C&L,2414,H373:455;H332:714;H335:1339;H315:1382;H302:1383;H319:1447;Not classified:189;H351:1;H412:1
95720,4-chloro-3-oxobutyryl chloride,255-301-1,41295-64-1,Aquatic Chronic 2,Notified C&L,1,H411:1
95721,2-tetradecyloctadecanoic acid,277-586-1,73756-39-5,Not Classified,Notified C&L,2,Not classified:2
95722,ethyl acetate,205-500-4,141-78-6,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H225:0;H336:0;H319:0
95726,"1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-ß,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, [R-(R,R)]-",806-698-0,134523-00-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2;Lact.,Notified C&L,1,H361:1;H319:1;H315:1;H362:1;H335:1
95727,Dibutyl [(dipropoxyphosphinothioyl)thio]succinate,270-219-6,68413-47-8,Skin Sens. 1B;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,37,H317:2;H401:2;H411:2;Not classified:35
95728,"4,6-bis(octylthiomethyl)-o-cresol",402-860-6,110553-27-0,Not Classified,REACH registration C&L,133,Not classified:131;H317:1;H413:1
95729,pentan-3-one;diethyl ketone,202-490-3,96-22-0,Flam. Liq. 2;STOT SE 3;STOT SE 3,Harmonised C&L,0,H335:0;H225:0;H336:0
95730,A mixture of: 1) a mixture of: a) dicholest-5-en-3-β-yl N-lauroylglutamate; b) 1-(cholest-5-en-3-β-yl)-5-(2-octyldodecyl) N-lauroylglutamate; c) 5-(cholest-5-en-3-β-yl)-1-(2-octyldodecyl) N-lauroylglutamate; d) 1-(cholest-5-en-3-β-yl) 5-docosanyl N-lauroylglutamate; e) 5-(cholest-5-en-3-β-yl) 1-docosanyl N-lauroylglutamate; 2) a mixture of: a) bis(2-octyldodecyl) N-lauroylglutamate; b) didocosanyl N-lauroylglutamate; c) 1-docosanyl 5-(2-octyldodecyl) N-lauroylglutamate; d) 5-docosanyl 1-(2-octyldodecyl) N-lauroylglutamate,415-370-2,,Not Classified,Notified C&L,1,Not classified:1
95731,"Disodium 5,5'-[sulphonylbis(3,1-phenyleneazo)]bis[6-amino-4-hydroxynaphthalene-2-sulphonate]",274-443-5,70210-45-6,Not Classified,Notified C&L,83,Not classified:83
95732,[[(phenylamino)thioxomethyl]amino]methyl diethyldithiocarbamate,228-137-3,6142-40-1,Aquatic Acute 1,Notified C&L,1,H400:1
95733,6-bromoquinoline,226-238-7,5332-25-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,41,H335:40;H318:39;H315:41;H302:40;H319:2
95734,"Bursera delpechiana, ext.",296-611-7,92874-96-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,56,H412:56;H317:56;H315:56;H319:56
95735,"2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, diazotized, coupled with resorcinol, coupled with diazotized 5-amino-2-(phenylamino)benzenesulfonic acid and diazotized 4-nitrobenzenamine",291-639-6,90432-09-0,Eye Dam. 1,REACH registration C&L,14,H318:1;Not classified:10;H319:3
95737,8-methyl-1-oxaspiro[4.5]decan-2-one,303-602-4,94201-19-1,Not Classified,Notified C&L,1410,Not classified:1410
95742,"Chromium, hydroxide 2-hydroxy-5-[(5-sulfo-2-naphthalenyl)azo]benzoate sulfate sodium complexes",307-993-2,97808-72-5,,Notified C&L,2,H319:1;Not classified:1
95744,"chloralose (INN);(R)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose;glucochloralose;anhydroglucochloral",240-016-7,15879-93-3,Acute Tox. 3;Acute Tox. 4;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H336:0;H400:0;H301:0;H332:0
95752,Benzyl methyl sulphide,212-174-7,766-92-7,Acute Tox. 4,Notified C&L,1374,H302:1373;Not classified:1
95753,3-Fluorphenylboric acid,476-720-8,768-35-4,Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,14,H318:2;H314:2;H411:2;H302:11;H315:1;H319:1
95754,Galactoarabinan,232-910-0,9036-66-2,Not Classified,Notified C&L,139,Not classified:139
95758,"propan-2-yl 2-[(4R,6R)-6-{2-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]ethyl}-2,2-dimethyl-1,3-dioxan-4-yl]acetate",700-243-9,1112262-71-1,Not Classified,REACH registration C&L,4,Not classified:4
95759,Methyl 5-sulphamoyl-o-anisate,251-358-1,33045-52-2,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,13,H315:8;H302:9;Not classified:3;H312:1;H332:1;H319:1
95762,3-p-cumenyl-2-methylpropionaldehyde,203-161-7,103-95-7,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,1947,H412:1469;H317:1862;H315:1925;H361:254;H411:312;H410:33;H400:33;H319:1;Not classified:1
95764,"Reaction product of 4,4'-methylenediphenyl diisocyanate (MDI) (101-68-8), Octylamine (111-86-4) and p-Toluidine (106-49-0)",925-245-9,,Not Classified,Notified C&L,1,Not classified:1
95767,"Nitric acid, barium salt, reaction products with ammonia, chromic acid (H2CrO4) diammonium salt and copper(2+) dinitrate, calcined",308-967-3,99328-50-4,Skin Sens. 1;Eye Dam. 1;Muta. 2;Carc. 1B;Aquatic Chronic 1,REACH registration C&L,2,H341:2;H410:2;H318:2;H317:2;H350:2
95768,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione",614-938-9,69-22-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,3,H302:3;H319:2;H318:1;H332:1
95769,"(E)-1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one",245-844-2,23726-93-4,Skin Irrit. 2;Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,289,H317:289;H411:289;H315:89
95770,Neryl butyrate,213-660-1,999-40-6,Not Classified,Notified C&L,89,Not classified:89
95771,"Fatty acids, C14-22, ethylene esters, bisulfited, sodium salts",284-965-5,85005-32-9,Not Classified,REACH registration C&L,3,Not classified:3
95772,Aklomide,221-143-7,3011-89-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H302:38;H319:39
95773,8-Benzyloxy-5-(R)-oxiranyl-1H-quinolin-2-one,478-690-1,173140-90-4,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
95775,"2,3-dihydro-2-methyl-1H-indol-1-amine p-toluenesulfonate",928-401-4,,Not Classified,REACH registration C&L,2,Not classified:2
95776,Isonicotinic acid,200-228-2,55-22-1,Not Classified,REACH registration C&L,69,Not classified:14;H335:51;H315:53;H319:54;H318:2;H302:1
95779,"Titanium, (S) - lactate polyethylene glycol triisopropanolamine ammonium complexes",410-660-5,1072830-14-8,Not Classified,Notified C&L,1,Not classified:1
95780,(2-phenoxyethyl)triphenylphosphonium bromide,244-963-7,22409-83-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
95782,5-Methoxy-4’-(triflluoromethyl)valerophenone(E)-O-(2-aminoethyl) oxime,611-193-1,54739-18-3,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Aquatic Chronic 1,REACH registration C&L,133,H410:132;H302:133;H319:90;H331:90;H335:132;H318:42;H332:42
95785,N2-[[(1-carboxyphenethyl)amino]carbonyl]-L-arginyl-N-[4-[(aminoiminomethyl)amino]-1-formylbutyl]-L-valinamide,253-631-0,37691-11-5,Acute Tox. 4,Notified C&L,38,H302:38
95786,"Trisodium 5-[[5-[[4-chloro-6-[(3-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulphonatophenyl]azo]-1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-3-methanesulphonate",281-865-3,84045-63-6,Not Classified,REACH registration C&L,140,Not classified:96;H317:43;H334:1
95788,"Cedrus libani, ext.",289-666-3,89997-33-1,Not Classified,Notified C&L,184,Not classified:184
95790,3-phenylpropyl isothiocyanate,220-094-9,2627-27-2,,Notified C&L,5,H312:4;H314:4;H332:4;H302:4;H335:1;H315:1;H319:1
95791,Isobutyronitrile,201-147-5,78-82-0,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3,REACH registration C&L,103,H225:70;H331:33;H301:17;H319:41;H315:51;H300:86;H335:40;H311:86;H371:20;H370:11;H372:11;H224:12;H330:16;H310:15
95792,3-ethoxyphenol,210-681-8,621-34-1,,Notified C&L,5,H315:5;H319:5
95796,"Alpha-bromo-2,3,4,5,6-pentafluorotoluene",217-182-4,1765-40-8,Skin Corr. 1B,Notified C&L,52,H314:51;H335:5;H319:6;H318:1;H290:1;H334:1;H315:1
95799,"Dihydrogen [3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxy-5-nitrobenzenesulphonato(3-)][2-[(2-hydroxy-5-methoxyphenyl)azo]-4,6-dinitrophenolato(2-)]chromate(2-)",258-315-6,53036-44-5,Aquatic Chronic 2,Notified C&L,4,H411:3;Not classified:1
95800,Cabreuva oil (Myrocarpus frondosus & M. fastigiatus),614-364-9,68188-03-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,33,H400:26;H410:31;Not classified:2;H317:1
95801,Thallium nitrate,233-273-1,10102-45-1,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,50,H411:50;H373:50;H300:50;H330:50;Not classified:1;H272:1;H400:1
95803,"8-ethyl-1,5-dimethylbicyclo[3.2.1]octan-8-ol",283-553-2,84681-92-5,Acute Tox. 4,Notified C&L,113,H302:113
95807,Pargyline hydrochloride,206-175-1,306-07-0,Acute Tox. 3,Notified C&L,244,H301:244
95809,4-methylheptane,209-650-1,589-53-7,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H336:0;H400:0;H315:0;H225:0;H304:0
95811,5-oxo-1-(4-sulphophenyl)-2-pyrazoline-3-carboxylic acid,204-254-5,118-47-8,Not Classified,REACH registration C&L,79,Not classified:40;H319:39;H335:1;H315:1
95818,"Dolomite (CaMg(CO3)2), dead-burned refractory",273-923-1,69227-00-5,,Notified C&L,1,Not classified:1
95821,p-phenylbenzoyl chloride,237-804-8,14002-51-8,Skin Corr. 1,REACH registration C&L,50,H314:50;H318:40;H290:1
95823,"5-[5-amino-4-substituted-phenylazo-phenylanilino]-chloro-heteromonocyclylamino-3- (naphthalen-2-ylazo)-4-hydroxynaphthalene-polysulfonic acid, sodium salt",455-860-3,,Skin Sens. 1;Eye Dam. 1,REACH registration C&L,1,H318:1;H317:1
95828,Indium trichloride,233-043-0,10025-82-8,Skin Corr. 1C;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,94,H412:6;H314:91;H372:2;H302:80;Not classified:2;H361:2;H318:1;H290:1;H335:1;H315:1;H319:1
95831,Glycine Tert butyl Ester hydrochloride,608-108-5,27532-96-3,Not Classified,Notified C&L,8,Not classified:3;H335:3;H315:5;H319:5
95833,"5,5-dimethylhydantoin",201-051-3,77-71-4,Not Classified,REACH registration C&L,475,Not classified:295;H315:180;H302:179;H319:180
95835,1-Acetoxy-2-methylnaphthalene,454-690-7,5697-02-9,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,36,H317:36;H411:36
95836,Isopentyl oleate,211-016-4,627-89-4,Not Classified,REACH registration C&L,8,Not classified:8
95839,"oxiranemethanol, 4-methylbenzene-sulfonate, (S)-",417-210-7,70987-78-9,Eye Dam. 1;Skin Sens. 1;Muta. 2;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H341:0;H318:0;H411:0;H317:0;H350:0
95840,Dimethyl[3-[(2-methyl-1-oxoallyl)amino]propyl]-3-sulphopropylammonium hydroxide,226-003-9,5205-95-8,Acute Tox. 4;Acute Tox. 4;Muta. 2,Notified C&L,1,H312:1;H332:1;H341:1
95841,"Disodium 2,2'(or 3,3')-oxybis[5(or 2)-dodecylbenzenesulphonate]",246-688-8,25167-32-2,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,721,H318:301;H411:574;H413:126;H302:126;H319:264
95843,"Diethyl N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamate",256-127-9,43170-88-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Muta. 1B;Carc. 2;Repr. 1B,Notified C&L,1,H340:1;H319:1;H315:1;H360:1;H331:1;H301:1;H335:1;H311:1;H351:1
95846,"Oils, fish, oxidized, bisulfited, sodium salts",307-037-4,97488-98-7,Not Classified,REACH registration C&L,80,Not classified:80
95849,N-acetylleucine,214-706-3,1188-21-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,6,H335:4;H315:4;H319:4;Not classified:2
95850,Indium 2-ethylhexanoate,267-208-3,67816-06-2,Flam. Sol. 1,Notified C&L,1,H228:1
95851,"Uridine 5'-(trihydrogen diphosphate), mono[2-(acetylamino)-2-deoxy-α-d-glucopyranosyl] ester, disodium salt",293-820-5,91183-98-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
95853,Methyl N-[3-(acetylamino)-4-[(4-nitrophenyl)azo]phenyl]-N-(3-methoxy-3-oxopropyl)-β-alaninate,262-732-9,61355-92-8,Not Classified,Notified C&L,41,Not classified:41
95856,Fluoren-9-one,207-630-7,486-25-9,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,12,H411:6;H319:8;Not classified:4;H335:1;H315:1;H412:1
95858,"Cytidine, 5'-deoxy-5-fluoro-, 2',3'-diacetate",605-260-4,161599-46-8,Muta. 2;Carc. 1B;Repr. 1B,REACH registration C&L,7,H341:4;H350:5;H360:6;H315:2;H319:2;Not classified:1;H411:1;H351:1
95860,1-(2-aminoethyl)-2-methyl-5-nitroimidazole dihydrochloride,256-385-2,49575-10-2,Acute Tox. 4;Carc. 2,Notified C&L,1,H351:1;H302:1
95861,"5,8-bis(carboxymethyl)]-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetreazatridecan-13-oic acid",601-640-9,119895-95-3,Eye Irrit. 2;Repr. 2;Aquatic Chronic 2,Notified C&L,1,H361:1;H411:1;H319:1
95864,Cyclohex-1-ene-1-acetonitrile,230-235-6,6975-71-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H312:40;H302:40;H319:41;H315:41;H335:41;H332:40
95869,"Rosin, oligomers",500-163-2,65997-05-9,Not Classified,REACH registration C&L,814,Not classified:456;H317:358;H334:267;H335:90;H315:90;H319:90;H228:1;H320:1;H316:1;H332:1
95870,toluene-α-sulphonyl chloride,217-717-1,1939-99-7,Skin Corr. 1B,Notified C&L,49,H314:49;H335:2;H318:2;H290:1
95871,"1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetyl chloride",229-840-8,6780-38-7,Acute Tox. 3;Skin Corr. 1B,Notified C&L,39,H314:39;H301:39
95873,"Gentian, Gentiana lutea, ext.",277-139-0,72968-42-4,Flam. Liq. 2,Notified C&L,1377,H225:1286;H226:89;Not classified:2;H319:1
95874,Aerosil R 972,612-048-5,60842-32-2,,Notified C&L,31,Not classified:31
95878,"1,1-diisopropoxycyclohexane",413-740-8,1132-95-2,Skin Corr. 1B,Harmonised C&L,0,H314:0
95879,Sodium bis[1-[(2-hydroxy-5-nitrophenyl)azo]naphthalen-2-olato(2-)]cobaltate(1-),277-367-0,73297-09-3,Aquatic Chronic 2,Notified C&L,84,H411:83;Not classified:1
95880,3-amino-2-hydroxy-5-nitrobenzenesulphonic acid,202-523-1,96-67-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,134,H317:4;H315:48;H319:132;H412:83;H335:43;Not classified:1;H314:1
95881,N-benzylacetoacetamide,212-928-5,882-36-0,Acute Tox. 4,Notified C&L,39,H302:38;Not classified:1
95884,4-Chloro-3-fluoroanisole,610-503-2,501-29-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
95886,"1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-rape-oil acyl derivs., Et sulfates",305-488-1,94552-41-7,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,20,H400:2;H410:2;H319:2;Not classified:18
95887,Lisuride,241-925-1,18016-80-3,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2,Notified C&L,1,H300:1;H330:1;H310:1
95888,"Disodium aniline-2,5-disulphonate",255-250-5,41184-20-7,Not Classified,REACH registration C&L,3,Not classified:3
95889,2-hydroxy-5-methylisophthalaldehyde,230-768-4,7310-95-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:41;H315:42;H319:42
95890,"Gases (petroleum), depropanizer dry, propene-rich;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]",270-772-3,68477-90-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
95891,Cathine,207-754-1,492-39-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H301:38;H319:38
95894,2-(tert-butoxy)ethan-1-ol,616-267-7,7580-85-0,Flam. Liq. 3,Notified C&L,6,H226:4;H302:2;H319:3;H315:3;H373:2;H335:3
95898,N2-(1-oxododecyl)-L-arginine,255-851-2,42492-22-8,Not Classified,Notified C&L,3,Not classified:2;H318:1;H400:1
95900,"Fatty acids, montan-wax, 1-methyl-1,3-propanediyl esters",277-290-2,73138-44-0,Not Classified,Notified C&L,249,Not classified:249
95904,bis(1-methylethyl)-dimethoxysilane,421-540-7,18230-61-0,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H226:0;H412:0;H317:0;H315:0
95906,Ammonium hexafluoroniobate(1-),235-046-2,12062-13-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H312:38;H332:38;H302:38;H335:5;H315:5;H319:5
95909,7-hydroxy-3H-phenoxazin-3-one 10-oxide,208-987-1,550-82-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:38;H315:38;H319:38;Not classified:3
95912,4-methyloxazole,211-763-6,693-93-6,Flam. Liq. 2;Eye Dam. 1,Notified C&L,1,H225:1;H318:1
95913,Lead dithiocyanate,209-774-6,592-87-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H312:43;H302:43;H410:43;H400:43;H373:43;H360:43;H332:43
95914,"Kinase (phosphorylating), glycerol",232-862-0,9030-66-4,Resp. Sens. 1,Notified C&L,7,H334:7
95915,"Fatty acids, rape-oil, potassium salts",289-103-1,85995-94-4,,Notified C&L,3,H315:2;H319:2;Not classified:1
95917,"1,4,7,10,13,16-hexaoxacyclooctadecane",241-473-5,17455-13-9,Acute Tox. 4,Notified C&L,205,H302:201;H335:41;H315:47;H319:52;H301:4;Not classified:2;H332:3;H312:2;H313:1
95921,"1,3,3-trimethyl-6-azabicyclo[3.2.1]octane",258-569-8,53460-46-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,84,H400:83;H410:83;H335:1;H315:1;H319:1
95923,Closantel,260-967-1,57808-65-8,Acute Tox. 3;Aquatic Chronic 4,Notified C&L,131,H413:128;H301:128;H302:3
95925,"2,4,6,8-tetramethyl-2,4,6,8-tetrakis[3-(oxiranylmethoxy)propyl]cyclotetrasiloxane",262-360-7,60665-85-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H319:38;H315:38;H317:38;H335:38
95926,Sodium silicate,239-981-7,15859-24-2,Not Classified,Notified C&L,75,Not classified:39;H335:36;H315:24;H319:24;H318:12;H290:12;H314:12
95928,acrolein;prop-2-enal;acrylaldehyde,203-453-4,107-02-8,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H330:0;H410:0;H400:0;H314:0;H300:0;H311:0;H225:0
95929,"1,1'-oxydipropan-2-ol",203-821-4,110-98-5,Not Classified,Notified C&L,1980,Not classified:1928;H315:51;H319:52;H373:1;H371:1;H335:1
95930,Black KK 80805,419-670-4,,Not Classified,REACH registration C&L,2041,Not classified:32;H412:2009
95931,"Methanedisulfonic acid, sodium salt (1:2)",611-606-5,5799-70-2,Not Classified,Notified C&L,8,Not classified:7;H319:1
95934,"N-Boc-1,4-cyclohexanediamine",606-334-9,195314-59-1,Aquatic Chronic 2,Notified C&L,40,H411:39;H335:1;H412:1;H315:1;H319:1
95936,"3,4-bis(benzyloxy)benzaldehyde",226-662-2,5447-02-9,Not Classified,REACH registration C&L,5,Not classified:4;H341:1;H410:1
95939,N-Acetoacetylanthranilic Acid Hydrate,609-120-3,35354-86-0,Not Classified,Notified C&L,32,Not classified:31;H315:1;H319:1
95941,C.I. Acid Brown 161,612-238-8,61724-13-8,Not Classified,Notified C&L,101,Not classified:101
95953,"Hydrocarbons, C5-C7, n-alkanes, >5% n-hexane",918-849-9,,Flam. Liq. 1;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,55,H361:55;H336:55;H411:55;H315:55;H373:55;H224:55;H304:55
95962,Decyl butyrate,226-700-8,5454-09-1,Not Classified,Notified C&L,89,Not classified:89
95969,"Pentasodium bis[2,4-dihydroxy-5-[(2-hydroxy-3-nitro-5-sulphophenyl)azo]benzoato(4-)]chromate(5-)",277-758-6,74196-15-9,Eye Irrit. 2,Notified C&L,2043,H319:2042;Not classified:1
95976,5-formylfurfuryl acetate,234-137-4,10551-58-3,Eye Irrit. 2,Notified C&L,42,H319:42;H335:4;H315:4
95979,"But-2-ene-1,4-diol",203-787-0,110-64-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:38;H315:41;H302:45;H319:40;H373:1
95981,Meclozine dihydrochloride,214-164-8,1104-22-9,Acute Tox. 4;Repr. 2,Notified C&L,43,H361:41;H302:43
95982,Antimony tributanolate,218-456-6,2155-74-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Notified C&L,42,H302:42;H319:38;H411:42;H315:38;H335:38;H332:42
95984,"Soaps, stocks, animal-oil, acidulated",284-014-4,84776-88-5,Not Classified,Notified C&L,5,Not classified:5
95985,"2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-β-L-erythro-pentofuranosyl)-5-methyl-",608-961-3,3424-98-4,Acute Tox. 4,Notified C&L,39,H302:38;Not classified:1
95986,Actinolite (Ca2Mg5H2(SiO3)8),604-486-0,14567-73-8,Not Classified,Notified C&L,29,Not classified:29
95987,3-methyl-4-nitro-1-p-nitrophenyl-5-pyrazolone,208-986-6,550-74-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45;H341:4;H242:1
95990,1-chloro-3-[ethyl[3-methyl-4-[(5-nitrothiazol-2-yl)azo]phenyl]amino]propan-2-ol,274-951-7,70865-21-3,Not Classified,Notified C&L,2,Not classified:2
95992,"Chelidonium majus, ext.",283-257-3,84603-56-5,Not Classified,Notified C&L,3,Not classified:2;H226:1
95994,"Fatty acids, C8-10-branched, barium salts",285-210-2,85049-40-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
95995,3-chloropropyl(dimethyl)amine,203-679-3,109-54-6,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,REACH registration C&L,46,H335:6;H314:7;H302:6;H319:39;H318:1;H315:1
95997,"5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane",433-530-1,143446-73-5,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1,Harmonised C&L,0,H317:0;H400:0;H302:0
95998,2-[(2-ethoxyphenoxy)methyl]morpholine hydrochloride,252-638-6,35604-67-2,Acute Tox. 4,Notified C&L,39,H302:39
96000,"1,1,2,2-tetrafluoro-1-methoxyethane",207-039-4,425-88-7,,Notified C&L,6,H225:6;H315:1;H319:1
96002,"Pyridine-2,3-dicarboxylic acid dimethyl ester",611-985-7,605-38-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H315:38
96004,"Glycerides, mixed C8-10 and succinyl",294-620-0,91744-56-8,Not Classified,REACH registration C&L,12,Not classified:12
96009,"1-methyl-2H-3,1-benzoxazine-2,4(1H)-dione",233-714-8,10328-92-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
96010,"Alcoholic beverages, rum, ext., nonalc.",292-323-0,90604-30-1,Flam. Liq. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3;Carc. 2,Notified C&L,108,H319:25;H336:25;H225:50;H332:25;H351:50;H226:25;H224:50;Not classified:8
96013,p-butoxybenzaldehyde,227-247-9,5736-88-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44;H312:1;H302:1;H332:1
96014,"Fatty acids, tall-oil, sulfated, sodium salts",268-372-9,68082-60-0,Not Classified,Notified C&L,1,Not classified:1
96015,"N-(1,3-dimethylbutyl)-N-phenylbenzene-1,4-diamine",263-339-5,61931-82-6,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H317:1;H400:1;H302:1
96018,"Benzenesulfonamide, ar-methyl-, reaction products with formaldehyde",215-667-5,1338-51-8,Skin Sens. 1,Notified C&L,3,H317:2;Not classified:1
96020,"Chromate(3-), bis[2-[2-[2-(hydroxy-κO)-4-hydroxy-3-[2-(5-sulfo-1-naphthalenyl)diazenyl-κN1]phenyl]diazenyl]benzoato(3-)-κO]-, sodium (1:3)",619-080-9,94933-05-8,,Notified C&L,33,Not classified:33
96027,"N,N''-hexane-1,6-diylbis[N'-benzylurea]",254-274-3,39072-70-3,Not Classified,REACH registration C&L,235,Not classified:197;H400:38
96029,Aminoacetonitrile,208-751-8,540-61-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,39,H312:38;H351:38;H332:38;H302:39;H226:1;H315:1;H319:1
96033,Heptylidene diacetate,260-182-4,56438-09-6,Not Classified,Notified C&L,114,Not classified:113;H335:1;H315:1;H319:1
96040,Methyl 3-methoxysalicylate,228-737-5,6342-70-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
96041,"Disodium 5-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-(phenylazo)naphthalene-2,7-disulphonate",241-776-2,17804-49-8,Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,48,H317:41;H334:41;H319:46;H412:5;Not classified:1
96042,"Guanidine, N-cyano-, polymer with N1-(2-aminoethyl)-1,2-ethanediamine",610-578-1,50862-68-5,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,89,H411:84;H302:83;Not classified:5;H335:1;H315:1;H319:1
96043,"4-acetamido-5-[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]anthranilic acid, sodium salt",303-156-0,94158-82-4,Skin Sens. 1,REACH registration C&L,57,H317:50;Not classified:5;H318:2
96044,Undec-2-enal,219-564-6,2463-77-6,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1375,H411:1287;H315:1288;Not classified:87;H319:1
96047,p-isopropylanisole,223-952-0,4132-48-3,,Notified C&L,1,H312:1;H332:1;H302:1
96050,Lead phthalate,229-927-0,6838-85-3,Acute Tox. 4;Acute Tox. 4;Repr. 2;STOT RE 2;Aquatic Chronic 1,Notified C&L,1,H361:1;H302:1;H410:1;H400:1;H373:1;H332:1
96052,Perfluorodecene,252-514-1,35328-43-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
96053,"2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4α,4aα,5aα,6β,12aα)]-",200-591-7,64-72-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,108,H335:103;H317:54;H315:103;H319:103;H361:5;H312:2;H332:1;H302:3;H305:1;H360:1;H362:2;H318:1;H400:1
96054,Diamindiisocyanoatozink,601-819-1,122012-52-6,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1;Aquatic Acute 1,Notified C&L,33,H302:33;H318:33;H400:33;H334:33;H317:33
96055,2-amino-5-chlorobenzamide,225-990-3,5202-85-7,,Notified C&L,15,H335:7;H315:8;H319:8;Not classified:6;H302:1
96061,"4-iodo-4'-nitro-1,1'-biphenyl",249-480-5,29170-08-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,39,H335:38;H318:38;H411:38;H315:39;H319:1
96063,"2,6,6-trimethyl-1-cyclohexene-1-acetaldehyde",207-454-0,472-66-2,Acute Tox. 4,Notified C&L,1438,H302:1399;H335:39;H315:39;H319:39
96065,"9-fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 17,21-di(propionate)",259-699-8,55541-30-5,Skin Sens. 1;Repr. 2,Notified C&L,1,H361:1;H317:1
96068,"1,3-diazaspiro[4.5]decane-2,4-dione",211-868-7,702-62-5,Acute Tox. 4,Notified C&L,38,H302:38
96071,"Fatty acids, C18-unsatd., dimers, polymers with azelaic acid and polyethylene glycol",614-588-7,68551-94-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
96074,"3,5-di-tert-butylaniline",219-173-0,2380-36-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43;H312:1;H302:1;H332:1
96076,"Hydrofluoric acid, homopolymer, compd. with pyridine",613-082-3,62778-11-4,Acute Tox. 2;Acute Tox. 1;Skin Corr. 1A;Acute Tox. 2,Notified C&L,43,H314:43;H300:43;H330:43;H310:43
96078,"(2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-19-[(2S,3S)-3-methyl-6-oxo-2,3-dihydropyran-2-yl]-8-oxononadeca-2,10,12,16,18-pentaenoic acid",617-954-4,87081-35-4,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT SE 1,Notified C&L,1,H370:1;H331:1;H301:1;H311:1;H225:1
96083,"1,3,3-trimethyl-2-(2-{2-chloro-3-[2-(1,3,3-trimethylindolin-2-ylidene)ethylidene]cyclohex-1-enyl}vinyl)-3H-indol-1-ium bromide",428-300-0,,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H318:1;H317:1;H400:1;H302:1
96085,(hydroxyimino)phenylacetonitrile,212-546-9,825-52-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,72,H312:39;H302:39;H319:39;H315:39;H335:39;H332:39;H412:33;H318:33
96086,"Residues (petroleum), catalytic reformer fractionator, sulfonated, polymers with formaldehyde, sodium salts",614-476-8,68425-94-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,259,H315:238;H319:255;H412:16;Not classified:3;H318:1
96090,Pyraclostrobin,605-747-1,175013-18-0,Skin Irrit. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,341,H410:341;H400:286;H331:338;H315:338;H335:84
96093,2-methylheptanoic acid,214-704-2,1188-02-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1447,H315:1341;H319:1297;Not classified:104;H335:45;H318:46;H314:2;H290:1
96096,"Saussurea lappa, ext.",290-278-1,90106-55-1,Asp. Tox. 1;Aquatic Chronic 3,Notified C&L,1400,H412:1286;H304:1400;H317:114;H315:99
96097,2-propylheptan-1-ol,233-126-1,10042-59-8,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,201,H412:96;H315:120;H319:120;H318:44;H302:44;Not classified:37;H335:4
96098,single-walled carbon nanotubes,922-749-0,,Aquatic Chronic 2,Notified C&L,1,H411:1
96101,Toluene-2-thiol,205-276-8,137-06-4,Acute Tox. 4;Skin Corr. 1B,Notified C&L,1451,H314:1286;H302:1409;H335:48;H318:44;H315:74;H319:30;H311:11;H331:11;H312:8;H332:8;H301:1
96104,(R)-(3-carboxy-2-hydroxypropyl)trimethylammonium hydrogen fumarate,291-749-4,90471-79-7,Not Classified,Notified C&L,9,Not classified:7;H315:2;H319:2
96106,7-bromoheptanoic acid,250-225-5,30515-28-7,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,7,H318:4;H314:7;H290:1
96109,"Spinels, aluminum-zinc",297-211-5,93348-67-5,Not Classified,Notified C&L,33,Not classified:33
96110,"1,2-bis(phenoxymethyl)benzene",428-620-0,10403-74-4,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
96117,"Carbamodithioic acid, diethyl-, reaction products with formaldehyde and N-methyl-N-phenylthiourea",601-774-8,121375-88-0,Aquatic Acute 1,Notified C&L,1,H400:1
96118,"Hexadecanoic acid, C18-unsatd. alkyl esters",309-410-7,100298-58-6,Not Classified,Notified C&L,33,Not classified:33
96119,"2-ketogluconic acid, calcium salt",919-553-2,,Not Classified,REACH registration C&L,2,Not classified:2
96120,Pentaaluminium triyttrium dodecaoxide,234-465-8,12005-21-9,Not Classified,REACH registration C&L,175,Not classified:175
96125,"3H-Pyrazol-3-one, 4-[(5-chloro-2-hydroxyphenyl)azo]-2,4-dihydro-5-methyl-2-phenyl-",616-495-7,7774-05-2,Not Classified,Notified C&L,2037,Not classified:2037
96126,"Fatty acids, C14-22 and C14-22-unsatd., Me esters, sulfated, ammonium salts",283-966-8,84776-40-9,Not Classified,Notified C&L,5,Not classified:5
96129,Pinacol,200-933-5,76-09-5,Flam. Sol. 1;Skin Irrit. 2,REACH registration C&L,64,H228:47;H315:64;H319:12;H335:7
96130,"Alkanes, C18-28, chloro",287-478-6,85535-86-0,Not Classified,Notified C&L,56,Not classified:45;H413:11
96132,"4'-ethyl[1,1'-biphenyl]-4-carbonitrile",261-414-7,58743-75-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,3,H312:1;H302:1;H319:1;H315:1;H332:1;Not classified:1;H413:1;H317:1
96134,3-methylquinoline,210-315-7,612-58-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,43,H312:39;H318:38;H315:43;H335:38;H332:39;H351:38;H341:4;H319:5;H302:1
96135,"11β,17-dihydroxy-21-(4-methyl-1-piperazinyl)pregna-1,4-diene-3,20-dione monohydrochloride",200-475-6,60-39-9,STOT RE 1;STOT RE 1,Notified C&L,2,H372:2
96140,5-hydroxyvaleraldehyde,224-165-5,4221-03-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
96145,"1,1'-(isopropylidenedi-p-phenylene) bis[2-[[5-amino-3-methyl-1-(3-sulphophenyl)-1H-pyrazol-4-yl]azo]benzenesulphonate], sodium salt",280-101-6,83006-51-3,Aquatic Chronic 3,Notified C&L,47,H412:47
96146,"Propane-1,2,3-triyl 3,5,5-trimethylhexanoate",260-257-1,56554-53-1,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,30,H317:12;H302:12;Not classified:18
96152,"Phosphatidylcholines, soya, hydrogenated",306-549-5,97281-48-6,Not Classified,REACH registration C&L,93,Not classified:93
96155,"Bromophenol blue, sodium salt",252-170-2,34725-61-6,Not Classified,Notified C&L,2,Not classified:2
96165,Methyl N-benzoyl-N-(3-chloro-4-fluorophenyl)-DL-alaninate,258-155-7,52756-25-9,Acute Tox. 4;Acute Tox. 3,Notified C&L,41,H311:38;H302:38;Not classified:3
96171,Dodecafluoropentane,211-647-5,678-26-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:3;H315:3;H319:3
96172,"[1aS-(1aα,2α,4aβ,8aR*)]-octahydro-2,4a,8,8-tetramethylcyclopropa[d]naphthalen-3(1H)-one",247-381-1,25966-79-4,Not Classified,Notified C&L,233,Not classified:233
96181,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-nonacosafluorohexadecyl acrylate",251-963-0,34362-49-7,Not Classified,Notified C&L,2,Not classified:2
96182,3-(isodecyloxy)propylammonium acetate,249-166-8,28701-67-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,96,H410:60;H302:92;H318:9;H400:5;H314:92;H411:34;H315:4
96183,"4-methoxy-3,3'-dimethylbenzophenone",255-300-6,41295-28-7,Aquatic Chronic 4,Notified C&L,1,H413:1
96189,Docusate sodium,209-406-4,577-11-7,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,5835,H318:3960;H315:5734;H302:1427;H319:1914;H226:151;H412:127;Not classified:20;H335:37;H336:17;H332:15;H413:10
96192,2-methyl-2-phenylsuccinimide,216-091-7,1497-17-2,,Notified C&L,4,H335:4;H315:4;H319:4
96196,Fluoroethane,206-531-6,353-36-6,Flam. Gas 1;Press. Gas (Liq.),Notified C&L,72,H220:72;H280:72
96199,Potassium [2-[[[5-[(2-chloro-5-sulphophenyl)azo]-2-hydroxyphenyl]methylene]amino]benzoato(3-)]hydroxychromate(1-),285-670-4,85118-17-8,Not Classified,Notified C&L,2,Not classified:2
96202,"Lubricating oils (petroleum), hydrotreated spent",265-161-3,64742-58-1,Not Classified,Notified C&L,243,Not classified:203;H304:23;H315:13;H319:13;H350:4
96203,"Fatty acids, C18-unsatd., dimers, bis[2-[[2,2-bis[[(1-oxo-2-propen-1-yl)oxy]methyl]butoxy]methyl]-2-[[(1-oxo-2-propen-1-yl)oxy]methyl]butyl] ester",610-499-2,500574-15-2,Not Classified,Notified C&L,26,Not classified:26
96204,4-methylpyrimidin-2-ol hydrochloride,226-306-6,5348-51-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H315:46;H319:46;H312:1;H302:1;H332:1
96205,(2-methoxyphenyl)hydrazine monohydrochloride,230-199-1,6971-45-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:39;H315:41;H319:40;H340:1;H350:1;H360:1;H312:1;H302:1;H332:1
96206,α-phenylbenzeneacetyl chloride,217-493-5,1871-76-7,Skin Corr. 1B;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H335:40;H314:46;H319:2;H318:2;H290:1
96213,"Hexanedioic acid, mixed esters with dipentaerythritol, pentaerythritol and stearic acid",281-932-7,84066-96-6,Not Classified,Notified C&L,7,Not classified:7
96218,2-methyloctadecanoic acid,230-607-8,7217-83-6,Aquatic Chronic 4,Notified C&L,1,H413:1
96219,"1H-Imidazole, reaction products with epichlorohydrin",282-773-6,84418-61-1,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H226:1;H312:2;H332:1;H302:2;Not classified:1;H319:1;H411:1;H315:1
96223,"Benzoic acid, 2-hydroxy-, mono-C14-18-alkyl derivs., calcium salts (2:1)",601-337-1,114959-46-5,Aquatic Chronic 3,Notified C&L,607,H412:572;Not classified:30;H317:5;H413:1
96224,"3,5,6,7-tetrahydro-2-methyl-s-Indacen-1(2H)-one",606-481-9,202667-44-5,Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H304:1
96229,N-methyldibutylamine,222-288-9,3405-45-6,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 4,Notified C&L,38,H302:38;H314:38;H226:38;H311:38;H332:38
96232,Ethyl 2-butynoate,224-395-6,4341-76-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47;H226:5;H302:1
96236,"Babul, ext.",296-870-6,93164-88-6,Not Classified,Notified C&L,1,Not classified:1
96237,"Alcohols, tallow, propoxylated (1 - 2.5 mol PO)",615-218-7,70955-07-6,Aquatic Chronic 3,Notified C&L,111,H412:83;H315:28;H319:28
96241,"Rhodium chloride (RhCl3), hydrate",606-630-8,20765-98-4,Met. Corr. 1;Acute Tox. 4;Eye Dam. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,166,H341:90;H302:166;H410:88;H318:128;H290:90;H400:88;H319:4;H312:1;H314:1;H332:1
96242,"Gases (petroleum), residue visbaking off;Refinery gas;[A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",295-402-8,92045-20-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
96251,Magnesium molybdenum oxide,234-581-9,12013-21-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H319:38;H315:38;H331:38;H301:38;H335:38;H311:38
96252,"reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene",411-070-0,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
96255,"[R-(R*,S*)]-α-(1-aminoethyl)benzyl alcohol",207-755-7,492-41-1,STOT SE 3,REACH registration C&L,40,H335:40;H315:40;H302:40;H319:40
96262,"1,3-Benzenediamine, 4-methyl-, reaction products with 4-nitrobenzenamine, p-phenylenediamine and sodium sulfide (Na2(Sx))",309-269-1,100208-66-0,Not Classified,REACH registration C&L,38,Not classified:38
96263,"Propanenitrile, 3-[[3-(tridecyloxy)propyl]amino]-, branched",272-701-1,68909-32-0,Flam. Liq. 3;Skin Corr. 1B;Aquatic Chronic 2,REACH registration C&L,35,H226:35;H314:35;H411:35
96264,Diphenoxylate hydrochloride,223-287-6,3810-80-8,Acute Tox. 2;Acute Tox. 1,Notified C&L,92,H300:52;H330:90;H334:39;H317:39;H301:40;H310:38;H319:1;H315:1;H335:1
96265,Ethyl 3-amino-3-[(aminocarbonyl)amino]butyrate,277-587-7,73758-52-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H317:38;H319:38
96266,1-[2-(trifluoromethyl)phenyl]piperazine,264-514-9,63854-31-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H312:1;H302:1;H319:3;H315:2;H335:1;H332:1;H301:1
96267,3-acetamidoanilinium chloride,210-682-3,621-35-2,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,92,H302:92;H319:92;H412:6
96268,"Bis(2-ethylhexyl) 2-(4-hydroxy-3,5-dimethoxybenzylidene)malonate",468-890-7,,Not Classified,Notified C&L,1,Not classified:1
96273,2-methylpropan-1-ol;iso-butanol,201-148-0,78-83-1,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT SE 3,Harmonised C&L,0,H335:0;H318:0;H336:0;H315:0;H226:0
96279,N-(bromomethyl)phthalimide,226-239-2,5332-26-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
96280,Rubidium dichloroiodate,239-982-2,15859-81-1,Not Classified,Notified C&L,25,Not classified:25
96282,nitrogen dioxide,233-272-6,10102-44-0,Press. Gas;Ox. Gas 1;Skin Corr. 1B;Acute Tox. 2,Harmonised C&L,0,Not classified:0;H270:0;H314:0;H330:0
96283,"1,2-diphenylethane",203-096-4,103-29-7,Aquatic Chronic 4,REACH registration C&L,92,H413:2;Not classified:90
96286,Hyoscyamine hydrobromide,206-174-6,306-03-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,2,H311:1;H331:1;H301:1;H300:1;H330:1
96289,Lead distearate,214-005-2,1072-35-1,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,117,H302:117;H410:117;H400:117;H373:117;H360:117;H332:117;H312:1
96300,Manganese glycerophosphate,215-301-4,1320-46-3,STOT SE 3,Notified C&L,1,H335:1
96309,"Laminaria digitata, ext.",289-980-0,90046-12-1,Asp. Tox. 1,Notified C&L,158,H304:154;Not classified:4
96310,"(Z)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one",245-845-8,23726-94-5,Acute Tox. 4;Skin Sens. 1,Notified C&L,273,H317:273;H302:273;H411:48
96311,"Fatty acids, C14-18 and C16-18-unsatd., esters with propylene glycol, oxidized, bisulfited, sodium salts",287-508-8,85536-27-2,Not Classified,Notified C&L,1,Not classified:1
96314,"N,N'-bis(1-methylheptyl)-p-phenylenediamine",203-162-2,103-96-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,71,H335:38;H413:38;H315:38;H319:38;H410:33;H317:33;H400:33;H302:33
96315,"1-naphthalenesulfonic acid, 5-amino-, diazotized, coupled with Dyer’s mulberry (Chlorophora tinctoria) extract, sodium salts",308-966-8,99328-49-1,Not Classified,Notified C&L,9,Not classified:9
96318,Diallylamine,204-671-2,124-02-7,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,149,H302:149;H412:92;H318:9;H314:66;H311:149;H225:149;H332:21;H319:83;H315:83;H335:83;H331:45;H411:6
96321,1-chloro-4-[(2-chloroethyl)sulphonyl]benzene,240-323-6,16191-84-7,Acute Tox. 4,Notified C&L,39,H302:39
96329,EC403-460-4,403-460-4,,Not Classified,REACH registration C&L,1,Not classified:1
96337,"DL-α-(aminomethyl)-3,4-dihydroxybenzyl alcohol",200-229-8,55-27-6,Acute Tox. 3,Notified C&L,39,H301:39
96344,Nitrilotrimethylenetris(phosphonic acid),229-146-5,6419-19-8,Met. Corr. 1;Eye Irrit. 2,REACH registration C&L,693,H290:280;H319:526;H315:271;Not classified:66;H412:35;H314:49;H318:32;H317:1;H303:1;H335:1
96347,"1-Bromo-2,5-dichloro-3-fluorobenzene",606-489-2,202865-57-4,,Notified C&L,7,H335:7;H315:7;H319:7
96351,"4H-3,1-benzoxazine-2,4(1H)-dione",204-255-0,118-48-9,Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H319:0
96352,Griseofulvin,204-767-4,126-07-8,Skin Sens. 1;Carc. 2;Repr. 1B,Notified C&L,207,H317:193;H360:205;H351:204;H341:11;H315:4;H411:3;H302:3;H332:2;Not classified:1;H340:3;H371:1;H373:1;H350:1
96353,"6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole",419-870-1,159038-16-1,Aquatic Chronic 4,Harmonised C&L,0,H413:0
96354,Yttrium oxide,234-382-7,11130-29-3,Aquatic Chronic 4,Notified C&L,5,H413:5
96358,4-hydroxybenzonitrile,212-175-2,767-00-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,59,H335:56;H315:57;H302:59;H319:57;H412:1;H413:1;H402:1
96360,Methyl 3-hydroxypivalate,237-805-3,14002-80-3,Not Classified,Notified C&L,3,Not classified:1;H335:1;H315:1;H319:2
96362,Isopentyl stearate,211-015-9,627-88-3,Not Classified,Notified C&L,6,Not classified:6
96363,"Aluminum oxide (Al2O3), solid soln. with iron oxide (Fe2O3)",310-073-3,102110-71-4,Not Classified,Notified C&L,1,Not classified:1
96365,"Glycine, N-coco acyl derivs., sodium salts",291-350-5,90387-74-9,Not Classified,REACH registration C&L,157,Not classified:36;H315:111;H319:112;H318:42
96367,1-methylpiperidine,210-959-9,626-67-5,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 3,REACH registration C&L,251,H312:86;H302:86;H319:1;H412:87;H314:251;H331:86;H225:251;H311:116;H301:116;H318:86;H332:1
96369,Dodecyltrimethylammonium methyl sulphate,237-106-3,13623-06-8,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,1,H314:1;H400:1;H302:1
96370,"Phosphorodithioic acid, O,O-di-C1-14-alkyl esters, zinc salts",272-028-3,68649-42-3,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1653,H315:1358;H319:176;H318:1306;H411:1497;H412:80;H400:51;Not classified:42;H317:15
96384,Ethyl 5-sulphamoyl-o-anisate,251-359-7,33045-53-3,Aquatic Chronic 2,REACH registration C&L,3,H411:1;Not classified:1;H302:1
96389,"Poly(oxy-1,2-ethanediyl), a-phosphono-w-hydroxy-, C12-14-alkyl ethers",601-754-9,121158-63-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,67,H318:36;H315:67
96394,Clofoctol,253-632-6,37693-01-9,Aquatic Chronic 4,Notified C&L,1,H413:1
96396,trans-decahydro-2-naphthol,212-545-3,825-51-4,Eye Irrit. 2,REACH registration C&L,1414,H319:1361;Not classified:53;H335:38;H315:40
96397,Dodecyl dihydrogen phosphate,220-095-4,2627-35-2,,Notified C&L,6,H335:5;H315:5;H319:5;H314:1
96399,"Tetracosahydrodibenz[b,n][1,4,7,10,13,16,19,22]octaoxacyclotetracosin",241-474-0,17455-23-1,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H319:38;H315:38;H331:38;H301:38;H335:38;H311:38
96402,[(±)-(4-amino-2-hydroxy-4-oxobutyl)trimethylammonium] chloride,226-073-0,5261-99-4,Not Classified,REACH registration C&L,39,Not classified:1;H335:38;H315:38;H319:38
96405,"Galipea officinalis, ext.",294-354-5,91697-93-7,Flam. Liq. 3,Notified C&L,1374,H226:1374
96407,Trihydrogen bis[3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(3-),258-316-1,53036-47-8,Not Classified,Notified C&L,3,Not classified:3
96409,Sodium [(6-hydroxy-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]acetate,306-060-7,95873-69-1,Not Classified,Notified C&L,38,Not classified:38
96410,"1,1'-iminodipropan-2-ol;di-isopropanolamine",203-820-9,110-97-4,Eye Irrit. 2,Harmonised C&L,0,H319:0
96412,"Tetradeca-1,13-diene",244-687-7,21964-49-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;H304:1
96414,1-vinylcyclohexan-1-ol,217-718-7,1940-19-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39;H227:1
96415,Sodium cyanide,205-599-4,143-33-9,Met. Corr. 1;Acute Tox. 1;Acute Tox. 1;Acute Tox. 1;STOT RE 1;Aquatic Acute 1,REACH registration C&L,430,H330:430;H410:430;H290:228;H400:426;H372:227;H300:430;H310:430;H319:66;H315:55;H314:74;H318:147;H370:85
96417,Heptan-4-ol,209-651-7,589-55-9,Flam. Liq. 3,Notified C&L,2,H226:2;H319:1
96418,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 3-aminopropyltriethoxysilane",500-162-7,65169-82-6,Skin Corr. 1B;Eye Irrit. 2,REACH registration C&L,3,H314:2;H319:2;Not classified:1
96419,"(11beta,16alpha)-9,21-Dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione",617-501-0,83919-23-7,Repr. 1A;STOT SE 1,Notified C&L,122,H372:78;H360:115;H370:53;H373:38;H410:38;H361:5;H312:1
96430,"N,N',N''-((2S,2'S,2''S)-(((1R,1'R,1''R)-(1,3,5,2,4,6-trioxatriborinane-2,4,6-triyl)tris(3-methylbutane-1,1-diyl))tris(azanediyl))tris(1-oxo-3-phenylpropane-2,1-diyl))tris(pyrazine-2-carboxamide)",605-854-3,179324-69-7,Acute Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Repr. 2;STOT RE 1;Aquatic Chronic 2,Notified C&L,103,H361:101;H319:100;H411:96;H315:101;H372:101;H300:100;H330:3;H373:1;H310:3;H311:1;H331:1;H301:1;H318:1;H360:1
96431,"Yarrow, Achillea moschata, ext.",290-445-9,90147-53-8,Not Classified,Notified C&L,88,Not classified:88
96432,"Zinc bis[O,O-bis(2-ethylhexyl)] bis(dithiophosphate)",224-235-5,4259-15-8,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,666,H318:594;H411:666;H315:2
96446,Selenic acid,231-979-4,7783-08-6,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H410:43;H318:39;H400:43;H315:39;H373:43;H331:42;H301:43;H330:1;H302:1
96447,"7-[[4-[(6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]-5-methoxy-o-tolyl]azo]naphthalene-1,3-disulphonic acid, lithium salt, compound with 2,2',2''-nitrilotriethanol",268-784-9,68140-23-8,Acute Tox. 4;Eye Dam. 1;STOT RE 2,Notified C&L,69,H318:36;H373:36;H302:36;Not classified:33
96448,Hept-2-enal,219-563-0,2463-63-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Sens. 1,Notified C&L,114,H226:114;H312:89;H317:114;H302:114;H311:25
96449,"Dodecylbenzenesulphonic acid, compound with diisopropylamine (1:1)",249-399-5,29061-61-8,,Notified C&L,1,H410:1
96450,lead(2+) phosphonate,603-832-8,13453-65-1,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1,Notified C&L,1,H302:1;H410:1;H400:1;H373:1;H360:1;H332:1
96451,(±)-2-hydroxypropiononitrile,255-852-8,42492-95-5,Acute Tox. 3;Acute Tox. 2;Acute Tox. 3,Notified C&L,38,H331:38;H301:38;H310:38
96452,1-methylcyclopentene,211-762-0,693-89-0,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,53,H225:53;H304:39
96453,Diallyl sulphide,209-775-1,592-88-1,Flam. Liq. 3,Notified C&L,1595,H226:1595;H335:43;H315:43;H319:43
96455,20532_ESS_9002-92-0,918-252-3,9002-92-0,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1,Notified C&L,7,H341:7;H302:7;H412:7;H318:7;H400:7;H315:7;H373:7;H350:7
96459,Domperidone,260-968-7,57808-66-9,Repr. 2,Notified C&L,108,H361:98;H412:7;H302:8;H373:1;Not classified:1;H360:1
96460,"Silsesquioxanes, 3-[(2-aminoethyl)amino]propyl Me, methoxy-terminated",604-492-3,145775-27-5,Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,22,H317:22;H400:22;H410:22;H319:22
96463,"Albumins, blood plasma, Cohn fraction V",292-322-5,90604-29-8,Not Classified,Notified C&L,2,Not classified:2
96466,N-(2-aminoethyl)pyrrolidine,230-509-5,7154-73-6,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,47,H226:47;H314:47;H318:1
96468,2-methyldecane,230-236-1,6975-98-0,Not Classified,Notified C&L,3,Not classified:3
96470,2-methoxy-5-nitropyridine,226-661-7,5446-92-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
96471,N-[3-(dimethylamino)propyl]hexadecan-1-amide,254-585-4,39669-97-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,133,H318:126;H315:126;Not classified:7
96473,"Glutens, corn",266-116-0,66071-96-3,,Notified C&L,1,Not classified:1
96474,"4-chloro-1,3-dioxolan-2-one",223-583-5,3967-54-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40;H341:1
96475,Ethyl perfluorononan-1-oate,250-159-7,30377-52-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:1;H315:2;H319:2
96477,"(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one",608-630-3,31528-46-8,Not Classified,REACH registration C&L,3,Not classified:2;H334:1;H302:1
96482,Tetraammonium ethylenediaminetetraacetate,245-022-3,22473-78-5,Eye Irrit. 2;Acute Tox. 4;STOT RE 2,REACH registration C&L,170,H373:87;H332:149;H319:170;H335:20;H315:20
96485,"3-[(4-chloro-2-nitrophenyl)azo]-2-methylpyrazolo[5,1-b]quinazolin-9(1H)-one",277-823-9,74336-59-7,Not Classified,REACH registration C&L,128,Not classified:128
96486,"Benzenemethanamine, 4-methoxy-.alpha.-methyl-, (.alpha.R)-",606-907-3,22038-86-4,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,128,H402:1;H302:127;H412:85;H318:86;H314:128;H317:85
96491,"Fatty acids, montan-wax, ethylene esters",277-291-8,73138-45-1,Not Classified,Notified C&L,488,Not classified:384;H413:84;H302:20
96492,"2,2-diphenyloxirane",212-929-0,882-59-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H317:1;H315:1;H319:1
96493,1-(m-tolyl)piperazine,255-251-0,41186-03-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:39;H319:39;H318:1;H314:1
96499,Ginger oleoresin,616-797-9,8002-60-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H302:1;H319:1;H412:1;H315:1;H335:1;H332:1
96500,Diethyl azelate,210-833-3,624-17-9,,Notified C&L,1,Not classified:1
96503,"Iron ores, agglomerates",265-996-3,65996-65-8,Not Classified,REACH registration C&L,99,Not classified:99
96504,"Capsicum annuum annuum, longum group, cayenne, ext.",283-256-8,84603-55-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1476,H318:1388;H315:1474;H302:1448;H226:57;H319:63;H335:1;H316:1
96505,1H-indole-6-carbonitrile,239-988-5,15861-36-6,,Notified C&L,7,H335:6;H315:7;H302:5;H319:7;H301:1
96508,Piperidine-4-carboxamide,254-501-6,39546-32-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50,H335:49;H315:50;H319:50
96512,Allyl 2-acetylacetoacetate,250-394-5,30926-51-3,Eye Irrit. 2,Notified C&L,38,H319:38
96514,"p,p'-(phenylphosphinylidene)bisphenol",212-347-7,795-43-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H335:38;H315:38;H319:38;Not classified:17
96515,"2H-Thieno[2,3-e]-1,2-thiazine-3-carboxylic acid, 4-hydroxy-2-methyl-, methyl ester, 1,1-dioxide",611-894-2,59804-25-0,Acute Tox. 4,REACH registration C&L,3,H315:2;H302:3;H335:1;H319:1
96516,"hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate",401-650-1,85665-96-9,Skin Sens. 1,Harmonised C&L,0,H317:0
96518,"4,4'-azoxyphenetole",225-347-7,4792-83-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H335:38;H400:38;H315:38;H319:38
96520,"Decanoic acid, mixed esters with dipentaerythritol, heptanoic acid, isononanoic acid, and octanoic acid",601-551-5,118685-22-6,Aquatic Chronic 3,Notified C&L,2,H412:2
96521,3-methoxypropanimidamide hydrochloride,605-097-9,157360-93-5,,Notified C&L,2,H335:2;H315:2;H319:2
96523,"(S)-3,7-dimethyloct-6-enal",227-707-9,5949-05-3,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,152,H317:114;H315:152;H319:151;H411:112;H335:38
96525,"Sulfuric acid, mono-C8-14-alkyl esters, ammonium salts",292-208-5,90583-10-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,107,H412:84;H318:106;H315:106;H302:83;H400:1
96529,"Formaldehyde, oligomeric reaction products with 1-chloro-2,3-epoxypropane and phenol, reaction products with 3-aminomethyl-3,5,5-trimethylcyclohexylamine",500-611-7,161278-21-3,Not Classified,Notified C&L,82,Not classified:77;H314:5;H411:4;H317:5;H312:2;H302:2;H412:1;H318:1
96531,5-methylbenzo[b]thiophene,238-256-2,14315-14-1,,Notified C&L,5,H302:5
96533,1-(p-hydroxyphenyl)imidazole,233-121-4,10041-02-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:44;H315:44;H319:44
96541,ND-Abgasvorlage B1616 zur NPV B1011,928-210-6,,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H302:1;H318:1;H411:1;H315:1;H317:1;H335:1;H225:1;H332:1
96543,"3,4-difluorophenylacetic acid",211-527-2,658-93-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
96545,4-methyl-1-tetradecylpyridinium chloride,220-387-1,2748-88-1,Acute Tox. 3,Notified C&L,17,H301:17
96546,POLYDIMETHYLSILOXANE POLYMER,614-822-8,68937-54-2,Not Classified,Notified C&L,306,Not classified:252;H319:45;H335:13;H315:13;H332:10;H411:10;H412:9
96547,"1H-Pyrazole, 1,4-dimethyl-",600-813-6,1072-68-0,Flam. Liq. 3;Acute Tox. 4;Eye Dam. 1,REACH registration C&L,87,H226:85;H318:86;H302:86;H370:1;H331:1;H301:1;H311:1;H225:1;H332:1;H315:1;H319:1
96549,(hydroxyethyl)urea,215-304-0,1320-51-0,Not Classified,Notified C&L,39,Not classified:39
96551,3-chloro-4-morpholinoaniline,259-456-6,55048-24-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H335:1;H332:1
96552,"reaction mass of: N,N'-Ethane-1,2-diylbis(decanamide);12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;N,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide)",430-050-2,,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
96553,2-chloroacrylonitrile,213-055-2,920-37-6,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B;Acute Tox. 1;Resp. Sens. 1;Carc. 1B;Aquatic Acute 1,Notified C&L,45,H330:43;H334:38;H400:40;H314:42;H350:40;H300:40;H225:45;H310:38;H301:5;H311:6;H319:2;H315:2;H331:1;H335:1;H351:1;H317:1
96557,p-tert-butylaniline,212-215-9,769-92-6,Acute Tox. 4;Skin Corr. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,134,H410:2;H302:64;H319:92;H400:2;H314:12;H315:90;H335:89;H332:48;Not classified:32;H412:9;H318:9;H312:4
96559,"2,4-difluorobenzoic acid",216-430-9,1583-58-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47
96561,N-(2-hydroxypropyl)oleamide,203-828-2,111-05-7,Not Classified,Notified C&L,249,Not classified:162;H315:51;H319:51;H318:35;H317:3;H411:2;H335:1
96563,"1,3-dibutyl-2-thiourea",203-674-6,109-46-6,Acute Tox. 4;Skin Sens. 1A;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,225,H312:57;H411:56;H372:56;H317:131;H401:2;H302:170;H319:74;H412:99;H315:74;H400:1;H318:1
96564,Calcium iodide,233-276-8,10102-68-8,,Notified C&L,9,H315:6;H319:6;Not classified:3
96566,Hexylsilane,214-001-0,1072-14-6,Flam. Liq. 2,Notified C&L,38,H225:38
96567,Diphenyl[(phenylthio)phenyl]sulphonium hexafluorophosphate(1-),269-006-0,68156-13-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,2207,H317:2176;H319:2203;H413:27;H315:28;H411:2;H318:1;H400:2;H410:1;H312:1;H302:1
96568,Isooctyl (4-chloro-2-methylphenoxy)acetate,247-775-3,26544-20-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,16,H400:16;H410:16
96569,"Chromate(3-), bis[3-[[1-(3-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]-4-hydroxy-5-nitrobenzenesulfonato(3-)]-, potassium sodium",294-072-2,91672-63-8,,Notified C&L,40,Not classified:37;H319:3
96574,"1,1'-(decane-1,10-diyl)bis[4-amino-2-methylquinolinium] diiodide",217-964-5,2019-42-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
96575,1-Isocyanato-2-phenyl-benzene,605-677-1,17337-13-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,41,H312:39;H302:39;H319:41;H315:41;H335:41;H332:39;H331:2;H301:2;H311:1
96576,cobalt sulfide,215-273-3,1317-42-6,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0
96577,Ethyl 5-chloro-5-oxovalerate,226-000-2,5205-39-0,Skin Corr. 1B,Notified C&L,39,H314:39;H318:1;H290:1
96584,"Propanol, 1(or 2)-(2-hydroxymethylethoxy)-, monobenzoate",608-768-4,32686-95-6,Not Classified,Notified C&L,233,Not classified:194;H411:39
96585,"(S) (2Z,4E)-4-carboxy-11-methoxy-3,7,11-trimethyl-2,4-dodecadienoic acid disodium salt",918-890-2,,Not Classified,REACH registration C&L,2,Not classified:2
96587,"1,1'-(chloromethylene)bis[4-fluorobenzene]",248-201-4,27064-94-4,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,44,H335:39;H318:39;H314:43;H315:1;H290:1
96590,N-propylsalicylamide,231-250-0,7461-94-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H315:38
96591,4-bromobenzoic acid,209-581-7,586-76-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,62,H335:50;H315:59;H302:59;H319:53;H400:8;Not classified:10;H331:8;H311:8;H332:9;H312:1
96597,"Sunflower oil, hydrogenated",293-750-5,91082-37-0,Not Classified,Notified C&L,6,Not classified:6
96598,3-(4-bromobenzoyl)propionic acid,228-732-8,6340-79-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
96599,1-Methylpiperidin-4-amine,609-960-0,41838-46-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,7,H312:1;H302:2;H319:2;H315:3;H335:3;H332:1;H226:2;H318:3;H314:4
96602,4-styrylpyridine,203-099-0,103-31-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H335:38;H318:38;H315:39;H319:1
96605,3-(3-(prop-1-en-2-yl)phenyl)butanal,924-149-4,,Not Classified,REACH registration C&L,1,Not classified:1
96606,α-Escin,266-482-1,66795-86-6,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H332:1;H302:1;H319:1
96607,9H-fluoren-9-ylmethyl chloroformate,249-313-6,28920-43-6,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,77,H318:7;H314:77;H332:13;H302:13;Not classified:2;H312:5;H311:1;H331:1;H301:1;H304:1;H290:1
96608,"[3-(2,3-epoxypropoxy)propyl]triethoxysilane",220-011-6,2602-34-8,Not Classified,REACH registration C&L,185,Not classified:73;H302:53;H335:56;H332:41;H315:59;H319:59
96609,"4,4'-(1,4-Phenylenediisopropylidene)bisphenol",606-820-0,2167-51-3,Eye Irrit. 2,Notified C&L,39,H319:39;H315:1
96614,"Fatty acids, C18-unsatd., dimers, polymers with diethylenetriamine and tall-oil fatty acids",614-310-4,68139-75-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H315:29;H319:29;Not classified:9;H412:5;H317:1;H332:1
96615,"4'-(dodecyloxy)[1,1'-biphenyl]-4-carbonitrile",260-575-0,57125-50-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H332:1
96616,12-METHYL-TRIDECANAL,616-272-4,75853-49-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1377,H335:1376;H315:1376;H319:1376;Not classified:1
96618,"2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate",427-570-7,193486-83-8,Aquatic Chronic 2,Harmonised C&L,0,H411:0
96623,"Spinels, aluminum zinc zirconium",270-465-4,68441-06-5,Not Classified,Notified C&L,1,Not classified:1
96635,"[1,1'-Biphenyl]-2-carboxylic acid, 4'-methyl-, methyl ester",601-324-0,114772-34-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
96636,"2,2',2''-Nitrilotriethanol, propoxylated",500-094-8,37208-53-0,Not Classified,REACH registration C&L,79,Not classified:74;H317:5
96638,"Amines, C12-14-tert-alkyl, 2-(2-benzothiazolylthio)butanedioates (2:1)",603-293-9,128686-03-3,Not Classified,Notified C&L,5,Not classified:5
96639,4-chloro-2-(1H-pyrazol-3-yl)phenol,242-516-0,18704-67-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
96641,"Alcohols, C8-10",287-621-2,85566-12-7,Not Classified,Notified C&L,506,Not classified:481;H319:25;H335:6;H315:6;H412:2
96644,Isodecyl diphenyl phosphate,249-828-6,29761-21-5,Not Classified,REACH registration C&L,498,Not classified:42;H413:447;H400:9;H410:9
96647,Hexyl formate,211-087-1,629-33-4,Flam. Liq. 3,Notified C&L,1496,H226:1496;H335:38;H315:67;H319:67
96650,"(E)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)pent-1-en-3-one",264-140-6,63429-28-7,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,2,H317:2;H411:2;H315:2
96652,Miristalkonium chloride,205-352-0,139-08-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,329,H410:96;H302:324;H318:132;H400:286;H314:317;H312:275;H315:11;H319:11;H301:3;H332:3;H371:1;H373:2;H330:2;H317:1;H335:1;H311:1;H411:1;Not classified:2
96654,"Silane, tris(1-methylethyl)-",613-702-2,6485-79-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,166,H226:166;H335:162;H315:162;H319:162;Not classified:2
96655,"3,4,5,6-tetrabromo-o-cresol",209-403-8,576-55-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40;H312:1;H302:2;H332:1
96656,"Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",297-829-5,93763-11-2,Carc. 1B,Harmonised C&L,0,H350:0
96658,6-[methyl(phenylsulphonyl)amino]hexanoic acid,256-289-0,46948-72-5,Eye Dam. 1,Notified C&L,35,H318:35
96660,pentaerythritol tetraacrylate,225-644-1,4986-89-4,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H315:0;H319:0
96663,"Disodium ar,ar'-[(9,10-dihydro-9,10-dioxo-1,4-anthrylene)diimino]bis[(4-chlorophenoxy)benzenesulphonate]",275-912-7,71720-84-8,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,52,H412:50;H319:43;H318:7;H413:2
96664,Methyl 4-bromocrotonate,214-251-0,1117-71-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H335:38;H318:40;H315:38;H314:7;H312:2;H302:2;H332:2
96665,"4,4'-carbonimidoylbis(N,N-dimethylaniline) monohydrochloride",219-567-2,2465-27-2,Acute Tox. 4;Acute Tox. 3;Carc. 2,Notified C&L,62,H311:41;H351:60;H302:61;H411:18;H319:19;Not classified:1;H332:1;H373:1
96666,"6-methylhepta-3,5-dien-2-one",216-507-7,1604-28-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1607,H317:1564;H315:1607;H319:1607;H335:43
96667,reaction mass of isomers of branched tetracosane,417-060-2,151006-61-0,Acute Tox. 4;Aquatic Chronic 4,Harmonised C&L,0,H332:0;H413:0
96671,Bis(4-nitrophenyl)methane,217-330-8,1817-74-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H315:38
96674,"Residual oils (petroleum);Heavy Fuel oil;[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 °C.]",298-754-0,93821-66-0,Carc. 1B,Harmonised C&L,0,H350:0
96675,"sulcotrione (ISO);2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione",619-394-6,99105-77-8,Skin Sens. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H361:0;H410:0;H400:0;H373:0;H317:0
96678,"1,2,4,5-tetramethylbenzene-α,α'-dithiol",233-551-2,10230-61-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
96685,"1,3-Difluor-5-[trans-4-(trans-4-pentylcyclohexyl)-cyclohexyl ]-benzen",604-058-3,138074-23-4,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
96686,"Alcohols, C13-15",292-324-6,90604-31-2,Skin Irrit. 2,REACH registration C&L,298,H315:230;Not classified:68
96687,"Fatty acids, C16-18 and C18-unsatd., branched and linear, oligomeric reaction products with methyl hydrogen maleate and triethylenetetramine",500-460-7,160901-23-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4,Notified C&L,1,H312:1;H302:1;H314:1;H317:1;H332:1
96690,"Dihydrogen [P,P-dibutyl diphosphato(2-)-O'',O''''][P,P-dioctyl diphosphato(2-)-O'',O''''][hydroxyacetato(2-)-O1,O2]titanate(2-), branched and linear",271-578-1,68585-70-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H335:1;H315:1;H319:1
96692,tert-butyl L-prolinate hydrochloride,226-835-2,5497-76-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H315:3;H319:3;Not classified:1;H335:1
96694,Diphenylsilanediol,213-427-4,947-42-2,Aquatic Chronic 2,REACH registration C&L,73,H411:24;H228:44;Not classified:5;H315:1;H319:1
96695,Triprolidine hydrochloride,208-985-0,550-70-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:3;H315:3;H302:3;H319:3
96700,Dodecaaluminium calcium nonadecaoxide,234-468-4,12005-50-4,Not Classified,REACH registration C&L,1,Not classified:1
96709,"Trisodium bis[4-amino-3-[(2-hydroxy-3,5-dinitrophenyl)azo]naphthalene-1-sulphonato(3-)]chromate(3-)",277-759-1,74196-16-0,Not Classified,REACH registration C&L,1315,Not classified:1315
96711,"Xylanase, endo-1,3-",232-798-3,9025-55-2,Resp. Sens. 1,Notified C&L,2,H334:2
96713,2-phenylethyl heptanoate,226-701-3,5454-11-5,Not Classified,Notified C&L,1,Not classified:1
96719,"Tetradecahydro-1,4,7,10,13-benzopentaoxacyclopentadecin",241-471-4,17454-48-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:38;H315:42;H319:42
96720,"1,2-dichloro-3-isocyanatobenzene",255-253-1,41195-90-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,46,H319:46;H315:46;H331:41;H301:44;H335:46;H311:41;H330:5;H334:4;H302:1;H300:1
96724,"Fatty acids, C6-18, tetraesters with pentaerythritol",296-002-6,92201-72-4,Not Classified,Notified C&L,2,Not classified:2
96727,Piribedil,222-764-6,3605-01-4,Acute Tox. 4,Notified C&L,2,H302:1;H362:1;H412:1;H373:1;H336:1
96730,"1,5,6,7-tetrahydro-6-thioxo-4H-pyrazolo[3,4-d]pyrimidin-4-one",246-296-7,24521-76-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H302:39;H319:38
96732,"Ethyl 2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate",261-020-5,57934-97-1,Aquatic Chronic 3,Notified C&L,1581,H412:1323;Not classified:258
96734,Benzo[2'-[1-benzyl-4-piperidyl]]hydrazide,257-838-7,52313-55-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
96735,Tetrachlorocyclopropene,228-418-0,6262-42-6,Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H319:38;H312:1;H332:1;H302:1
96736,2-aminopyridin-3-ol,240-886-8,16867-03-1,Acute Tox. 4;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,187,H373:117;H401:6;H411:28;H302:59;H311:52;H335:66;H315:57;H319:114;H317:12;H301:28;H300:5
96737,"Bacopa monnieri, ext.",296-871-1,93164-89-7,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1
96738,"Smilax officinalis, ext.",290-320-9,90131-10-5,Flam. Liq. 3,Notified C&L,1,H226:1
96739,Fluoranthen-3-ylamine,220-263-7,2693-46-1,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,39,H411:39;H302:38;H319:39;H315:1
96740,Fuller's Earth,617-052-0,8031-18-3,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1070,H411:558;H302:558;Not classified:383;H335:128;H332:40;H319:40
96743,"2,1,3-benzoselenadiazole",205-986-8,273-15-4,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H410:40;H400:40;H373:40;H331:40;H301:40
96744,"3,3-TETRAMETHYLENEGLUTARIMIDE",600-836-1,1075-89-4,Acute Tox. 3;Aquatic Chronic 2,Notified C&L,46,H411:45;H301:46
96749,5-fluorosalicylic acid,206-455-3,345-16-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
96750,"11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione",237-731-1,13951-70-7,Not Classified,REACH registration C&L,36,Not classified:4;H361:21;H373:10;H362:9;H360:9;H317:3;H372:3;H302:2;H335:1;H315:1;H319:1
96758,"Amides, from Me epoxyhydroxyoctadecanoate, tetraethylenepentamine and vegetable-oil fatty acids",614-510-1,68443-08-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;STOT SE 3,Notified C&L,629,H312:495;H302:531;H314:531;H317:495;H335:495;H400:83;H410:83;H318:23;Not classified:15
96760,"Fatty acids, montan-wax, esters with pentaerythritol",277-292-3,73138-47-3,Not Classified,Notified C&L,32,Not classified:32
96762,"1,2-dichloroethylene",208-750-2,540-59-0,Flam. Liq. 2;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H225:0;H332:0
96763,"Fatty acids, vegetable-oil, sodium salts",268-373-4,68082-64-4,Not Classified,Notified C&L,9,Not classified:8;H319:1
96764,Chromium trinitrate,236-921-1,13548-38-4,Ox. Sol. 3;Skin Sens. 1A;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,297,H317:140;H272:197;H411:136;H332:40;H319:198;H315:198;Not classified:41;H335:40;H271:56;H302:25;H412:5;H314:8;H318:3;H301:1;H311:1
96765,"Aluminum, 2-(2-quinolinyl)-1H-indene-1,3(2H)-dione sulfo derivs. complexes",309-264-4,100208-62-6,Not Classified,REACH registration C&L,17,Not classified:17
96768,"Phenol, styrenated",262-975-0,61788-44-1,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,466,H411:320;H400:10;H413:65;Not classified:42;H317:77;H315:104;H319:65;H335:2;H410:2
96770,2-[[4-[(2-cyano-3-nitrophenyl)azo]-2-chlorophenyl](2-acetoxyethyl)amino]ethyl acetate,277-584-0,73755-70-1,Not Classified,Notified C&L,2,Not classified:2
96773,"Manganese, dichloro(4,11-diethyl-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-κN1,κN4,κN8,κN11)-, (OC-6-22)-",608-027-5,269729-99-9,Not Classified,Notified C&L,36,Not classified:36
96774,Bis(2-trichloroethyl) chlorophosphonate,241-650-7,17672-53-6,Skin Corr. 1B,Notified C&L,38,H314:38
96775,"Phenol, ethyl-",607-726-2,25429-37-2,Not Classified,Notified C&L,84,Not classified:83;H311:1;H314:1;H301:1
96776,Methyl 4-methoxy-3-oxobutyrate,255-188-9,41051-15-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H335:51;H315:51;H319:52;H225:1
96778,"Sodium hydrogen 8-aminonaphthalene-1,6-disulphonate",277-918-5,74543-22-9,Not Classified,REACH registration C&L,10,Not classified:10
96780,"4-(m-hydroxyphenyl)-4-phenylperhydroimidazole-2,5-dione",250-025-8,30074-03-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
96786,"2-ethylhexanoic acid, monoester with propane-1,2-diol",285-503-5,85114-00-7,Repr. 2,REACH registration C&L,4,H361:4
96787,C.I. Solvent Red 195,605-352-4,164251-88-1,Not Classified,Notified C&L,77,Not classified:77
96788,3-hydroxy-2-pyridone,240-887-3,16867-04-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,135,H335:134;H315:135;H319:135
96789,"clomazone (ISO); 2-(2-chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one",617-258-0,81777-89-1,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,263,H410:134;H332:258;H400:217;H302:262;H312:85;H412:86;H319:45;H411:38;H315:45;H331:1
96790,"Naphtha (petroleum), solvent-refined hydrodesulfurized heavy;Gasoil - unspecified",307-035-3,97488-96-5,Carc. 1B,Harmonised C&L,0,H350:0
96792,2-hydroxyethyl lactate,249-764-9,29671-83-8,,Notified C&L,9,H319:6;Not classified:3
96796,Sodium 6-amino-5-[[3-[(ethylphenylamino)sulphonyl]-4-methylphenyl]azo]-4-hydroxynaphthalene-2-sulphonate,275-308-3,71278-42-7,Not Classified,Notified C&L,85,Not classified:85
96799,"Chromic acid, potassium zinc salt",255-252-6,41189-36-0,Acute Tox. 4;Skin Sens. 1;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,10,H410:10;H302:10;H400:10;H317:10;H350:10
96801,"fludioxonil (ISO); 4-(2,2-difluoro-1,3-benzodioxol-4-yl)-1H-pyrrole-3-carbonitrile",603-476-3,131341-86-1,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
96805,"Hydrocarbons, C",307-760-5,97722-10-6,Carc. 1B,Harmonised C&L,0,H350:0
96807,"N,N-dimethylallylamine",218-458-7,2155-94-4,,Notified C&L,125,Not classified:84;H225:42;H314:39;H332:39;H318:1;H315:3;H319:3;H335:1
96808,6-methylpyridin-3-ol,214-337-8,1121-78-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H335:43;H318:39;H315:44;H302:39;H319:5
96810,Cyclopropanecarbonitrile,226-836-8,5500-21-0,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,49,H335:40;H319:41;H315:41;H301:47;H331:43;H226:48;H311:47;H330:6;H300:2;H310:2;Not classified:1;H225:1
96811,"4-bromo-2,5-dichlorophenol",217-719-2,1940-42-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H302:2;H319:2;H413:1;H335:1
96817,"4,5-Dihydroxynaphthalene-2,7-disulfonic acid disodium salt dihydrate",611-619-6,5808-22-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H335:46;H315:46;H319:46;Not classified:2
96819,"3-allyloxy-2-hydroxypropyl [3-(4-methoxynaphthalene-1,8-dicarboximido) propyl] dimethylammonium chloride",461-080-4,,Eye Irrit. 2,Notified C&L,2,H319:1;H412:1
96823,3(or 5)-nitrosalicylic acid,250-222-9,30501-22-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H335:2;H315:2;H319:2
96824,"9-Octadecenoic acid (Z)-, sulfonated, potassium salts",271-843-1,68609-93-8,Eye Irrit. 2;Repr. 1B,REACH registration C&L,32,H360:1;H319:27;H315:25;Not classified:5
96826,potassium {[(2Z)-4-ethoxy-4-oxobut-2-en-2-yl]amino}acetate,615-497-5,71809-65-9,Eye Irrit. 2,REACH registration C&L,2,H319:2
96827,"1,1''-isopropylidenediferrocene",235-719-0,12609-95-9,Acute Tox. 4;Acute Tox. 4;Repr. 1B;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,11,H410:2;H302:2;H373:2;H360:2;H332:2;Not classified:9
96828,"3,5-dinitro-o-toluic acid",248-880-7,28169-46-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
96831,"Sodium 2-(2,3-dihydro-1,3-dioxo-1H-inden-2-yl)quinoline-6-sulphonate",284-392-0,84864-68-6,Not Classified,REACH registration C&L,2,Not classified:2
96833,Chloromethyltrimethylsilane,219-058-5,2344-80-1,Flam. Liq. 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,78,H225:70;H401:2;H411:28;H335:45;H315:45;H319:45;H224:4;Not classified:5;H312:1;H302:1;H318:1;H314:1;H332:1
96837,"Phenol, 4,4'-(1-methylethylidene)bis-, reaction products with isobutylene and styrene",272-267-3,68784-69-0,Not Classified,Notified C&L,288,Not classified:288
96842,"Wool wax, oxidized, sulfited, sodium salt",297-217-8,93348-73-3,Skin Irrit. 2,Notified C&L,28,H315:28
96847,"2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methylene]-",604-444-1,144809-28-9,Not Classified,Notified C&L,1,Not classified:1
96852,"1-phosphino-2,4,4-trimethylpentane",416-550-3,82164-75-8,Pyr. Liq. 1;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,2,H250:2;H318:2;H314:2
96854,Tripotassium hexakis(nitrito-N)iridate,254-191-2,38930-18-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
96856,Vinyl neoundecanoate,298-612-8,93820-32-7,Not Classified,Notified C&L,1,Not classified:1
96860,1-bromodocosane,230-069-4,6938-66-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
96861,"1,3-Isobenzofurandione, reaction products with diethylenetriamine",291-513-0,90412-31-0,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,22,H411:13;H302:13;Not classified:9
96862,"Amines, dimethylsoya alkyl",263-017-4,61788-91-8,,Notified C&L,1,H314:1;H400:1;H302:1
96867,Dimethyl 2-methyl-5-methyleneadipate,224-837-8,4513-62-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H302:1;H319:1;H412:1;H315:1;H335:1
96869,"2,2'-[propane-1,3-diylbis(oxy)]bis(3'',5,5''-tri-tert-butyl-5'-methyl-1,1':3',1''-terphenyl-2'-ol)",600-548-6,1042662-40-7,Not Classified,REACH registration C&L,1,Not classified:1
96870,"Portulaca oleracea, ext.",290-201-1,90083-07-1,Not Classified,Notified C&L,2,Not classified:2
96871,N-(2-carboxyethyl)-N-[(4-methylphenyl)sulphonyl]-β-alanine,226-660-1,5446-58-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,160,H335:160;H315:160;H319:160
96872,"Fatty acids, coco, monoesters with sorbitan",268-910-2,68154-36-9,Aquatic Chronic 3,Notified C&L,140,H412:83;Not classified:57
96873,Isonicotinaldehyde 1-oxide,230-602-0,7216-42-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
96874,"1,3-bis(2-hydroxyethyl)-5,5-dimethylimidazolidine-2,4-dione",248-052-5,26850-24-8,Not Classified,REACH registration C&L,20,Not classified:20
96876,Propane-1-thiol,203-455-5,107-03-9,Flam. Liq. 2;Acute Tox. 4;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1506,H410:40;H302:1506;H400:47;H317:40;H225:1506;H319:1438;H318:64;H315:68;H335:64;H334:24;H332:25;H331:5;Not classified:2;H336:1
96878,Alafosfalin,262-362-8,60668-24-8,Acute Tox. 4,Notified C&L,39,H302:38;H335:1;H315:1;H319:1
96885,2-chloro-4-(dimethylamino)pyrimidine,250-450-9,31058-81-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H319:1
96886,"Pentasodium 7-[[2-[(carbamoylamino]-4-[4-[[5-[(4-amino-9,10-dihydro-9,10-dioxo-3-sulphonato-1-anthryl)amino]-2-sulphonatoanilino]-6-chloro-1,3,5-triazin-2-yl]amino]phenyl]azo]naphthalene-1,3,6-sulphonate",274-445-6,70210-47-8,Not Classified,Notified C&L,2,Not classified:2
96888,4-amino-1-butanol,236-364-4,13325-10-5,Skin Corr. 1B,Notified C&L,61,H314:61;H302:7;H318:2
96890,"Potassium 2,3,3,3-tetrafluoro-2-[1,1,2,3,3,3-hexafluoro-2-(heptafluoropropoxy)propoxy]propionate",266-579-9,67118-57-4,Not Classified,Notified C&L,1,Not classified:1
96893,4-methylpent-3-en-2-one;mesityl oxide,205-502-5,141-79-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H226:0;H312:0;H332:0;H302:0
96896,"Decanoic acid, reaction products with 2-[(2-aminoethyl)amino]ethanol, carboxymethylated, disodium salts",274-836-1,70750-05-9,Not Classified,Notified C&L,2,Not classified:2
96901,"Disodium p-[4,5-dihydro-4-[[2-methoxy-5-methyl-4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate",247-170-4,25664-81-7,Not Classified,Notified C&L,26,Not classified:13;H317:12;H334:13;H318:1
96904,"α,o-toluenedicarbonitrile",223-167-3,3759-28-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,47,H312:45;H332:45;H302:46;H319:7;H315:7;H335:6;H331:1;H301:1;H311:1
96907,3-hydroxy-4'-methoxy-2-naphthanilide,202-190-2,92-79-5,Aquatic Chronic 2,REACH registration C&L,36,H411:2;Not classified:34
96908,"Emblic, ext.",289-817-3,90028-28-7,Skin Mild Irrit. 3,Notified C&L,1,H316:1
96910,Sodium trithiocarbonate,208-592-4,534-18-9,Skin Corr. 1B,Notified C&L,41,H314:41;H411:1
96911,Phthalaldehyde,211-402-2,643-79-8,Acute Tox. 3;Skin Corr. 1;Skin Sens. 1A;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,208,H410:182;H318:148;H400:198;H314:147;H317:202;H301:203;H335:64;H228:83;H373:83;H315:61;H319:5;H290:5;Not classified:2;H311:1;H331:1
96912,4-[(4-methylphenyl)sulphonyl]morpholine,228-731-2,6339-26-0,Acute Tox. 4,Notified C&L,38,H302:38
96913,"4-amino-N,N-diethylaniline sulphate",227-995-6,6065-27-6,Acute Tox. 4,Notified C&L,39,H302:39;H312:1
96915,C.I. ACID ORANGE 95,601-871-5,12217-33-3,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H411:1;H319:2
96922,Neostigmine metilsulfate,200-109-5,51-60-5,Acute Tox. 3;Acute Tox. 1;Acute Tox. 1,Notified C&L,97,H330:58;H301:55;H310:58;H319:41;H334:40;H315:40;H300:42;H335:40;H317:2;H411:2;H362:1
96923,m-(trifluoromethyl)phenethylamine,257-988-3,52516-30-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:40;H315:40;H319:40;H318:1;H314:3;H312:1;H302:1;H332:1
96924,Cytochrome c,232-700-9,9007-43-6,Not Classified,Notified C&L,4,Not classified:3;H332:1;H302:1
96927,(R)-[[(phenylmethoxy)carbonyl]amino]phenylacetic acid,241-582-8,17609-52-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
96928,Pyridin-4-ol,210-958-3,626-64-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,48,H335:47;H318:41;H315:48;H302:42;H319:7;H312:1;H332:1
96933,"Sage, Salvia lavandulifolia, ext.",290-272-9,90106-49-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 2;Aquatic Chronic 3,REACH registration C&L,1395,H319:9;H412:8;H371:1390;H315:77;H317:1395;H226:84;H304:1394;H410:1386;H400:1361;H332:1371;H341:5;H361:1;H411:1
96937,"(3S,4S,6S,9S)-4-Hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-Thiazolylmethyl Ester",605-001-5,155213-67-5,Acute Tox. 4;Eye Irrit. 2;Carc. 2;Repr. 2,Notified C&L,93,H361:49;H351:51;H302:84;H319:48;H312:40;H332:40;H373:6;H335:1;H315:3
96939,"Bis(ethyl acetoacetato-O1',O3)[propane-1,3-diolato(2-)-O,O']titanium",253-063-3,36497-11-7,Not Classified,Notified C&L,5,Not classified:5
96940,"6,6'-di-tert-butyl-4,4'-thiodi-m-cresol",202-525-2,96-69-5,Skin Sens. 1;Aquatic Acute 1,REACH registration C&L,825,H317:709;H400:272;H410:276;H319:552;Not classified:57;H361:32;H315:21;H335:12
96941,Mucochloric acid,201-752-4,87-56-9,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,128,H311:1;H318:85;H314:128;H301:128;H341:88;H412:83;H317:121
96946,"3-bromo-1-chloro-5,5-dimethylimidazolidine-2,4-dione",204-766-9,126-06-7,Ox. Sol. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,50,H312:38;H302:50;H272:38;H314:49;H332:38;H400:11;H317:11
96949,"2-Bromo-4,5-difluorophenyl methyl ether",606-490-8,202865-58-5,Acute Tox. 3,Notified C&L,43,H301:38;H315:5;H319:5;H335:1
96951,"Aromatic hydrocarbons, C",270-658-3,68475-70-7,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0;H304:0
96958,4-bromobutyronitrile,226-236-6,5332-06-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45,H312:39;H332:43;H302:39;H319:6;H315:6;H301:6;H311:5;H335:1;H331:1
96959,"β,4-dimethylcyclohex-3-ene-1-propan-1-al",229-846-0,6784-13-0,Skin Sens. 1B,REACH registration C&L,1409,H317:1408;H412:38;H315:2;H302:2;Not classified:1
96960,"trans-4'-Methyl-[1,1'-bicyclohexyl]-4-on",604-815-8,151772-66-6,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
96961,"Disodium 5-[[(2-carboxyphenyl)amino]sulfonyl]-2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoate",310-215-4,130032-94-9,Eye Irrit. 2,Notified C&L,1,H319:1
96962,m-tolylacetic acid,210-683-9,621-36-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
96969,"4H,5aH,9H-Furo[2,3-b]furo[3',2':2,3]cyclopenta[1,2-c]furan-2,4,7(3H,8H)-trione, 9-(1,1-dimethylethyl)-10,10a-dihydro-8,9-dihydroxy-, (3aS,5aR,8R,8aS,9R,10aS)-",608-892-9,33570-04-6,Not Classified,Notified C&L,2,Not classified:2
96970,"Glycerides, C8-18 and C18-unsatd. mono-",294-359-2,91697-98-2,Not Classified,Notified C&L,6,Not classified:6
96972,Isobutyraldehyde,201-149-6,78-84-2,Flam. Liq. 2;Eye Irrit. 2,REACH registration C&L,4064,H225:4064;H319:3992;H335:244;H302:260;H318:11;H315:11;H341:1
96978,Vinyltoluene,246-562-2,25013-15-4,Flam. Liq. 3;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,585,H226:551;H401:2;H411:225;H315:546;H319:286;H332:249;H335:160;H412:62;H336:56;H304:131;H302:20;Not classified:17;H361:16;H341:4;H372:1
96979,Chloropentafluoroethane,200-938-2,76-15-3,Press. Gas (Liq.),Notified C&L,112,H280:112;H420:38
96987,4-hydroxy-3-nitrobenzaldehyde,221-141-6,3011-34-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47
96989,Disodium 1-octadecyl 2-sulphonatosuccinate,265-673-7,65277-59-0,,Notified C&L,1,H318:1
96990,Equimolecular mixture of - Disodium 2-Hexadecylsulfanyl-1-(4-sulfo-butyl)-1H- benzoimidazole-5-sulfonate - Disodium 2-Hexadecylsulfanyl-3-(4-sulfo-butyl)-1H- benzoimidazole-5-sulfonate,452-830-1,,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1
96992,Dihydrogen selenide,231-978-9,7783-07-5,Flam. Gas 1;Press. Gas (Liq.);Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H220:83;H280:83;H410:82;H330:83;H400:82;H319:1;H315:1;H370:1;H372:1;H373:1
96993,"2,7-dimethoxynaphthalene",222-433-6,3469-26-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39;H401:1
96997,"4-methoxybenzene-1,3-diamine sulphate",228-290-6,6219-67-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 1B,Notified C&L,1,H312:1;H332:1;H350:1;H302:1
97000,Carbomer 940,616-286-0,76050-42-5,Not Classified,Notified C&L,3,Not classified:3
97002,"Dodecanedioic acid, compound with hexane-1,6-diamine (1:1)",236-143-2,13188-60-8,,REACH registration C&L,33,Not classified:33
97003,5-hydroxyisophthalic acid,210-565-7,618-83-7,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,50,H315:47;H319:48;Not classified:2;H335:43
97004,"2,2,3,3,4,4,4-heptafluorobutylamine",206-780-0,374-99-2,Skin Corr. 1B,Notified C&L,46,H314:46;H335:4;H318:1
97005,"Protein hydrolyzates, silk, reaction products with C10-20 and C10-20-unsatd. alkyl, (3-chloro-2-hydroxypropyl)dimethyl ammonium chlorides",500-696-0,162353-59-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,30,H315:18;H319:29;Not classified:1
97007,3-methylpentan-3-ol,201-053-4,77-74-7,Acute Tox. 4,Notified C&L,127,H302:127;H226:39
97010,Europium diiodide,244-721-0,22015-35-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;Repr. 1B,Notified C&L,38,H319:38;H334:38;H315:38;H317:38;H360:38
97013,Trifluoromethanesulphonic anhydride,206-616-8,358-23-6,Ox. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,112,H302:108;H318:7;H272:4;H314:112;H335:40;H290:2;Not classified:1
97015,Bromotrifluoroethylene,209-948-1,598-73-2,Flam. Gas 1;Press. Gas (Liq.);Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,119,H220:72;H280:72;H319:72;H315:72;H335:119;H332:72;H330:47
97021,"Glycerides, C16-18 mono-, di- and tri-",293-215-6,91052-54-9,Not Classified,REACH registration C&L,11,Not classified:11
97024,2-(6-hydroxy-3-oxo-(3H)-xanthen-9-yl)-5-isothiocyanatobenzoic acid,222-042-0,3326-32-7,Skin Sens. 1;Resp. Sens. 1,Notified C&L,166,H317:166;H334:166;H302:2;H319:2;H315:2;H335:2;H332:1
97028,"N,N',N''-[(2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tris[methylene(3,5,5-trimethylcyclohexane-3,1-diyl)]]tris[hexahydro-2-oxo-1H-azepine-1-carboxamide]",273-482-5,68975-83-7,,Notified C&L,43,Not classified:25;H330:18;H319:18;H334:18;H315:18;H317:18;H335:18
97029,Octadecyl isocyanate,204-019-7,112-96-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,137,H335:78;H315:135;H301:4;H319:135;H312:38;H302:38;H334:131;H332:38;H331:86;H317:28;H411:7;H413:1;H311:1;H330:2;H400:1
97030,"Ethanaminium, N-[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, molybdatetungstatephosphate",215-410-7,1325-87-7,Self-heat. 2;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,420,H252:3;H411:3;H315:3;H319:15;H318:399;H410:410;H413:119;H400:231;Not classified:6
97031,"2-(2H-benzotriazol-2-yl)-4,6-ditertpentylphenol",247-384-8,25973-55-1,STOT RE 2;Aquatic Chronic 4,REACH registration C&L,1686,H373:1574;H413:1492;Not classified:75;H411:72;H412:39;H302:22;H372:17;H332:6;H319:12;H334:2;H315:6;H335:5;H312:2
97032,1-(4-methoxyphenyl)cyclopropane-1-carboxylic acid,240-788-5,16728-01-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
97034,Bromochlorodifluoromethane,206-537-9,353-59-3,Ozone 1;Press. Gas (Liq.),Notified C&L,128,H280:128;H059:123;H420:5
97039,(3S)-5'-[(3-amino-3-carboxylatopropyl)methylsulphonio]-5'-deoxyadenosine,249-946-8,29908-03-0,Not Classified,Notified C&L,5,Not classified:4;H312:1;H332:1;H302:1;H319:1
97041,"Calluna vulgaris, ext.",283-255-2,84603-54-3,Not Classified,Notified C&L,86,Not classified:83;H226:3
97046,Bis(2-ethoxyethyl) adipate,203-673-0,109-44-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:40;H315:40;H319:40
97048,Sodium nonyl sulphate,214-002-6,1072-15-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,17,H318:13;H315:17;H302:13;H228:2;H335:6;H332:2;H319:4
97051,Iron sinter,265-997-9,65996-66-9,Not Classified,REACH registration C&L,26,Not classified:26
97053,5-bromo-3-nitro-2-pyridone,239-989-0,15862-34-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46,H335:45;H318:39;H315:46;H302:39;H319:7
97055,"Fatty acids, lanolin, esters with cholesterol-low lanolin alcs.",295-374-7,92044-94-5,Not Classified,REACH registration C&L,7,Not classified:7
97059,triphenylsulfonium nonafluorobutanesulfonate,477-300-7,,Acute Tox. 3;Aquatic Chronic 4,Notified C&L,1,H413:1;H301:1
97060,Calcium fumarate (1:2),222-310-7,3416-22-6,Eye Irrit. 2,Notified C&L,1,H319:1
97066,"Sulfuric acid, mono-C12-14-alkyl esters, ammonium salts",292-209-0,90583-11-2,Met. Corr. 1;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,112,H302:88;H412:84;H318:112;H290:84;H315:112
97067,[No public or meaningful name is available],694-666-5,35779-39-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
97070,Cinchonine sulphate,227-708-4,5949-16-6,Acute Tox. 4,Notified C&L,2,H302:2;H317:1
97079,N2-Phenylacetylguanosine,603-646-7,132628-16-1,Not Classified,REACH registration C&L,2,Not classified:2
97093,Bromo(1-methylethyl)magnesium,213-056-8,920-39-8,Flam. Liq. 1;Water-react. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,68,H302:5;H318:4;H336:2;H314:68;H260:67;H224:2;H225:28;H250:1;H312:1;H332:1
97094,"N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride",405-300-9,17339-60-5,Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H302:0;H319:0;H400:0;H317:0
97097,"3,5-dimethylthio-2,4-toluenediamine; 3,5-dimethylthio-2,6-toluenediamine-(mixture)",600-731-0,106264-79-3,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,107,H410:106;H317:106;H400:106;H302:106;Not classified:1
97101,"2,3-dihydroxypropyl oleate",203-827-7,111-03-5,Not Classified,Notified C&L,238,Not classified:238
97105,Isopentyl methacrylate,230-849-4,7336-27-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H317:1;H315:1;H319:1
97107,Vinyl benzoate,212-214-3,769-78-8,Flam. Liq. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,46,H410:2;H412:2;H400:2;H317:2;H227:2;H335:42;H315:43;H319:43;Not classified:1
97116,7-(dimethylamino)-3H-phenothiazin-3-one,219-733-4,2516-05-4,Not Classified,Notified C&L,1,Not classified:1
97118,2-(2-hydroxyethoxy)phenol,225-346-1,4792-78-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
97120,"Nickel, 5,5'-azobis-2,4,6(1H,3H,5H)-pyrimidinetrione complexes",270-944-8,68511-62-6,Not Classified,Notified C&L,295,Not classified:206;H319:49;H350:32;H410:8;H317:8;H400:8;H351:8
97122,(pyridin-3-yl)boronic acid,605-544-8,1692-25-7,,Notified C&L,11,H335:9;H315:10;H319:10;H312:1;H332:1;H302:2
97123,4-[2-(diethylamino)ethoxy]benzophenone,212-348-2,796-77-0,Not Classified,REACH registration C&L,2,Not classified:2
97124,Bevonium metilsulfate,226-001-8,5205-82-3,Acute Tox. 4,Notified C&L,38,H302:38
97127,"Hydrocarbons, C4, steam-cracker distillate;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 °C to 5 °C (10.4 °F to 41 °F).]",295-405-4,92045-23-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
97128,Sodium picosulfate,233-120-9,10040-45-6,Not Classified,Notified C&L,3,Not classified:2;H335:1;H315:1;H302:1;H319:1
97131,"Ethyl 2,3-epoxybutyrate",243-300-9,19780-35-9,Flam. Liq. 3;Acute Tox. 4,Notified C&L,38,H226:38;H302:38
97137,4-bromobenzoyl chloride,209-580-1,586-75-4,Skin Corr. 1B,Notified C&L,64,H314:64;H335:16;Not classified:2;H319:1;H318:2;H290:1
97139,Hydrogen (2-ethylhexan-1-olato)tris(propan-2-olato)aluminate,269-686-9,68309-99-9,Not Classified,Notified C&L,4,Not classified:3;H225:1
97140,Acid orange 43 (xylene fast orange p),601-868-9,12217-31-1,Skin Irrit. 2,Notified C&L,38,H315:38
97142,"1,1-dimethylprop-2-ynyl acetate",216-508-2,1604-29-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H226:1;H335:1;H315:1;H319:1
97143,9-anthryl trifluoromethyl ketone,258-609-4,53531-31-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
97144,"9,10-dihydroacridine",202-192-3,92-81-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
97146,"Silicic acid, aluminum magnesium sodium salt",234-919-5,12040-43-6,Not Classified,REACH registration C&L,54,Not classified:54
97148,"4-trans-Propyl-4-trans-(3,4,5-trifluorphenyl)-[1,1-bicyclohexyl]",603-522-2,131819-23-3,Aquatic Chronic 4,REACH registration C&L,1,H413:1
97152,"Laminaria, ext.",295-780-4,92128-82-0,Not Classified,Notified C&L,159,Not classified:134;H226:25
97153,Dichromic acid,236-881-5,13530-68-2,Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,15,H317:15;H350:15;H400:15;H410:15
97154,(+)-2-aminopropan-1-ol,220-388-7,2749-11-3,Skin Corr. 1B,Notified C&L,97,H314:97;H318:2
97155,Glucose 6-(dipotassium phosphate),227-837-6,5996-17-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
97159,"4'-dodecyl[1,1'-biphenyl]-4-carbonitrile",260-574-5,57125-49-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H332:1
97162,Oct-2-enoic acid,217-491-4,1871-67-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H318:39;H314:44;H290:1
97163,Amidinourea,205-504-6,141-83-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:39;H319:39
97166,"(3,4-difluorophenyl)acetonitrile",211-528-8,658-99-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H312:44;H302:44;H319:45;H315:45;H335:45;H332:44;H330:1;H301:1;H311:1
97167,"2,4,4'-trimethoxychalcone",242-378-1,18493-34-0,Aquatic Acute 1,Notified C&L,38,H400:38
97169,Disodium β-glycerophosphate,212-464-3,819-83-0,Eye Irrit. 2,REACH registration C&L,89,H319:2;Not classified:87
97170,"1-bromo-3,5-difluorobenzene",416-710-2,461-96-1,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H400:0;H315:0;H373:0;H317:0;H226:0
97176,"Titanate(2-), [P,P-dibutyl diphosphato(2-)-O'',O''''][P,P-dioctyl diphosphato(2-)-O'',O''''][hydroxyacetato(2-)-O1,O2]-, dihydrogen, branched and linear, compds. with branched and linear dioctyl phosphonate (1:1)",271-579-7,68585-71-7,Skin Irrit. 2,Notified C&L,1,H335:1;H315:1
97179,"Esterification reaction product of disproportionated rosin acid, maleic anhydride, polymerized steam cracked petroleum distillate and trimethylol propane",921-011-5,,Not Classified,Notified C&L,71,Not classified:71
97180,4-(cyclohexylamino)piperidine-4-carboxamide,281-156-9,83877-87-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H315:38;H302:38
97186,4-aminonaphthalene-1-carbonitrile,261-412-6,58728-64-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H332:38;H302:38
97187,1-nitro-2-naphthol,208-984-5,550-60-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1
97189,"Dodecylbenzenesulphonic acid, compound with 2-amino-2-methylpropan-1-ol (1:1)",253-518-6,37475-84-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,8,H318:7;H315:7;H302:7;Not classified:1;H334:1
97192,Benzododecinium chloride,205-351-5,139-07-1,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,200,H410:5;H302:199;H318:66;H400:186;H314:196;H312:153;Not classified:1;H315:1;H332:1;H330:1;H311:1
97199,"3-[1-Methoxy-1-phenyl-meth-(E)-ylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid methyl ester",927-895-9,1168150-46-6,Not Classified,REACH registration C&L,2,Not classified:2
97201,"Alcohols, C8-12",287-622-8,85566-13-8,Not Classified,Notified C&L,1,Not classified:1
97207,"Resin acids and Rosin acids, maleated, esters with pentaerythritol",305-516-2,94581-17-6,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,75,H317:13;H413:6;H319:9;Not classified:62
97209,Diisopropyl 5-nitroisophthalate,234-139-5,10552-74-6,Not Classified,Notified C&L,3,Not classified:3
97210,Ammonium bis[4-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]benzenesulphonamidato(2-)]cobaltate(1-),264-585-6,63971-70-0,Not Classified,Notified C&L,3,Not classified:3
97212,Brucite (Mg(OH)2),215-274-9,1317-43-7,Not Classified,Notified C&L,2,Not classified:2
97214,"(1R, 4R, 5S) 4-hydroxy-6,6-dimethyl-3-Oxabicyclo[3.1.0]hexan-2-one",619-753-7,73611-02-6,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H318:1;H317:1;H302:1
97215,5-pentylfuran-2(5H)-one,244-685-6,21963-26-8,Not Classified,Notified C&L,113,Not classified:113
97216,"(R)-3,7-dimethyloct-6-en-1-ol",214-250-5,1117-61-9,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,288,H317:250;H315:288;H319:100;H335:38;H411:13
97217,"Fatty acids, C14-18-unsatd., compds. with triethanolamine",268-911-8,68154-44-9,Not Classified,Notified C&L,1,Not classified:1
97218,(2-ethoxyethyl)benzene,217-331-3,1817-90-9,Not Classified,Notified C&L,88,Not classified:88
97219,"FORMALDEHYDE, POLYMER WITH N,N-DIMETHYL-1,3-PROPANEDIAMINE AND PHENOL",610-196-5,445498-00-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,50,H410:50;H400:50;H302:50
97221,Decylmalonic acid,224-469-8,4372-29-6,Acute Tox. 4,Notified C&L,38,H302:38
97225,"1,1'-oxybis[(methoxymethyl)benzene]",249-396-9,29060-60-4,Aquatic Chronic 3,Notified C&L,1,H412:1
97235,Ethyl 3-cyclopropyl-3-oxopropanoate,607-452-3,24922-02-9,,Notified C&L,6,H335:6;H315:6;H319:6
97238,"4,5,6,7-tetrachloro-3-[[3-methyl-4-[[4-[(4,5,6,7-tetrachloro-1-oxo-1H-isoindol-3-yl)amino]phenyl]azo]phenyl]amino]-1H-isoindol-1-one and trichloro-methoxy-3-[[3-methyl-4-[[4-[(4,5,6,7-tetrachloro-1-oxo-1H-isoindol-3-yl)amino]phenyl]azo]phenyl]amino]-1H-isoindol-1-one and 4,5,6,7 tetrachloro-3-[[3-methyl-4-[[4-[(trichloro-methoxy-1-oxo-1H-isoindol-3-yl)amino]phenyl]azo]phenyl]amino]-1H-isoindol-1-one",600-734-7,106276-78-2,Not Classified,REACH registration C&L,85,Not classified:85
97240,"(1-hydroxyethylidene)bisphosphonic acid, sodium salt",249-559-4,29329-71-3,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,346,H413:133;H319:239;H302:101;H318:59;Not classified:33;H315:20;H290:2;H410:1
97246,"[2-[[4-[(2,6-dibromo-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium methyl sulphate",286-180-3,85187-91-3,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H411:2;H302:2;H319:2
97249,Ethyl bromofluoroacetate,206-928-4,401-55-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H312:41;H302:41;H319:41;H315:45;H335:44;H332:41;H330:4;H318:4;H301:6;H311:6;H331:2;H341:1
97250,2-methylpropan-2-ol;tert-butyl alcohol,200-889-7,75-65-0,Flam. Liq. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H335:0;H225:0;H332:0;H319:0
97254,"Orthophosphoric acid, propoxylated",500-093-2,37200-29-6,Skin Corr. 1B,Notified C&L,71,H314:71
97255,"2,2-dimethylpent-4-enal",226-834-7,5497-67-6,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H302:38;H319:46;H315:46;H335:46;H225:46;H412:8
97256,2-(chloromethyl)oxirane; formaldehyde; 2-methylphenol,608-398-3,29690-82-2,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,154,H317:82;H411:80;H335:42;H315:44;H319:43;Not classified:28
97257,Quinoline-8-sulphonyl chloride,242-515-5,18704-37-5,Skin Corr. 1B,Notified C&L,45,H314:45;H318:1;H290:1
97260,Dioctylbis(oleoyloxy)stannane,248-518-8,27550-52-3,STOT RE 2;Aquatic Chronic 4,Notified C&L,56,H373:56;H413:56
97264,"Decasodium hexahydrogen [ethane-1,2-diylbis[[(phosphonatomethyl)imino]ethane-2,1-diyl[(phosphonatomethyl)imino]ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate",299-569-8,93892-82-1,Not Classified,Notified C&L,1,Not classified:1
97266,1-benzyl-3-methyl-4-piperidone,252-176-5,34737-89-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,4,H318:2;H314:4;H302:3
97268,Dichloromethanesulphonyl chloride,255-254-7,41197-29-9,Acute Tox. 3,Notified C&L,43,H301:39;H314:5;H330:5;H227:1
97271,"1,3-diphenylacetone",203-000-0,102-04-5,Not Classified,Notified C&L,89,Not classified:89
97273,Dichromium tris(sulphate) hydrate,604-853-5,15244-38-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,43,H312:38;H314:38;H332:42;H302:42;H319:5;H315:5;H317:4;H335:1
97278,"Triallyl benzene-1,2,4-tricarboxylate",220-264-2,2694-54-4,Not Classified,Notified C&L,34,Not classified:33;H335:1;H315:1;H319:1
97281,Dimethyl 3-methylpent-2-enedioate,257-839-2,52313-87-8,Not Classified,REACH registration C&L,9,Not classified:9
97290,2-amino-2'-fluoro-5-nitrobenzophenone,206-454-8,344-80-9,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H411:1;H302:1
97292,"Pyrido[2,3-d]imidazole",205-987-3,273-21-2,Acute Tox. 4,Notified C&L,129,H302:128;H335:2;H315:2;H319:2
97294,4-Bromo-2-[imino(2-pyridinyl)methyl]aniline,613-018-4,62375-31-9,Not Classified,REACH registration C&L,1,Not classified:1
97297,1-(benzylthio)acetone,233-552-8,10230-69-0,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,39,H335:39;H334:38;H315:39;H319:39
97299,2-fluor-4-methoxybenzonitrile,619-054-7,94610-82-9,,Notified C&L,8,H312:4;H302:6;H319:6;H315:6;H335:6;H332:5;H331:1;H301:2;H311:2;H412:1
97302,"1-(3,5,6-trimethyl-3-cyclohexen-1-yl)ethan-1-one",270-891-0,68480-14-8,Not Classified,Notified C&L,88,Not classified:88
97304,"Fatty acids, montan-wax, esters with trimethylolpropane",277-293-9,73138-48-4,Not Classified,Notified C&L,31,Not classified:31
97305,2-dodecyl palmitate,277-585-6,73756-37-3,Not Classified,Notified C&L,3,Not classified:3
97307,"7-bromo-1,1,2-trimethyl-benzo[e]indole",620-221-1,879713-65-2,Not Classified,Notified C&L,2,Not classified:1;H335:1;H315:1;H319:1
97312,"Benzene, 1-[(1R)-1-(bromomethoxy)ethyl]-3,5-bis(trifluoromethyl)-",610-947-7,530441-95-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H319:1
97313,"1-chloro-3,3-dimethylbutan-2-one",236-920-6,13547-70-1,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,45,H330:44;H302:41;H319:45;H315:45;H335:44;H311:44;H301:4;H332:1
97314,"1-methyl-N,N',N''-tris(1-methylpropyl)silanetriamine",253-634-7,37697-65-7,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,3,H226:3;H318:3;H314:3;H302:3
97316,m-hydroxyphenylacetic acid,210-684-4,621-37-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47
97317,5-amino-1-β-D-ribofuranosyl-1H-imidazole-4-carboxamide,220-097-5,2627-69-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:41;H315:42;H319:42;Not classified:2;H312:1;H332:1;H302:1
97323,Hemicellulase,232-799-9,9025-56-3,Resp. Sens. 1,Notified C&L,184,H334:182;Not classified:2
97324,Benzoxazole,205-988-9,273-53-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,58,H335:53;H315:54;H302:45;H319:54;H332:13;H228:6;H226:1
97327,"1,2,3-Propanetriol, homopolymer, diisooctadecanoate",613-333-7,63705-03-3,Not Classified,REACH registration C&L,104,Not classified:104
97331,2-cyclohexylethyl acetate,244-543-3,21722-83-8,Not Classified,REACH registration C&L,1554,Not classified:1553;H412:1
97337,complex reaction mass of Chinese gum rosin post reacted with acrylic acid,434-230-1,144413-22-9,Aquatic Chronic 4,Harmonised C&L,0,H413:0
97338,Everzol Red LF-B,464-390-8,,Skin Sens. 1,Notified C&L,1,H317:1
97340,"2',4',5',7'-tetrabromo-4,5,6,7-tetrachloro-3',6'-dihydroxyspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",236-747-6,13473-26-2,Not Classified,REACH registration C&L,62,Not classified:62
97341,"2-amino-2',5-dichlorobenzophenone oxime",237-730-6,13949-49-0,Not Classified,REACH registration C&L,2,Not classified:2
97345,"Piperazine, 2-hydroxy-1,2,3-propanetricarboxylate (3:2), hydrate",609-919-7,41372-10-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;Not classified:1
97346,PIGMENTADDITIV RL,404-110-3,,Not Classified,Notified C&L,34,Not classified:34
97351,"Potato, ext.",290-202-7,90083-08-2,Not Classified,Notified C&L,26,Not classified:26
97356,tert-butylamine,200-888-1,75-64-9,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 3,REACH registration C&L,407,H302:383;H412:385;H318:185;H314:407;H301:64;H331:399;H225:407;H332:17;H300:5
97357,"Residues (petroleum), steam-cracked light;Heavy Fuel oil;[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C",271-013-9,68513-69-9,Carc. 1B,Harmonised C&L,0,H350:0
97358,Sodium 6-hydroxynaphthalene-2-sulphonate,240-019-3,15883-56-4,Not Classified,Notified C&L,1,Not classified:1
97360,"Glycerides, C12-18 mono-, di- and tri-",293-214-0,91052-53-8,Not Classified,REACH registration C&L,9,Not classified:9
97363,Sodium [2-[(2-amino-1-naphthyl)azo]-5-nitrophenolato(2-)][N-(2-chlorophenyl)-2-[[2-hydroxy-5-[(methylamino)sulphonyl]phenyl]azo]-3-oxobutyramidato(2-)]cobaltate(1-),297-965-5,93776-36-4,Aquatic Chronic 3,Notified C&L,47,H412:33;Not classified:9;H411:5
97365,Tetratungsten undecaoxide,235-718-5,12608-26-3,,Notified C&L,7,Not classified:7
97368,3-(cyclohexyloxy)propan-1-amine,605-472-7,16728-63-5,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H335:1;H314:1;H302:1
97371,"amines, hydrogenated tallow alkyl",262-976-6,61788-45-2,Skin Irrit. 2;Eye Dam. 1;Asp. Tox. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H318:0;H400:0;H315:0;H373:0;H304:0
97374,"1-amino-4-(2'-(4',6'-dichloro-s-triazin-2-yl)amino)phenylamino)9,10-dihydro-9,10-dioxoanthracene-2,4'-disulphonic acid",236-363-9,13324-20-4,Eye Irrit. 2,Notified C&L,49,H319:49;H412:3
97380,"N-tert-Butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide",601-185-6,112410-23-8,Aquatic Chronic 2,Notified C&L,38,H411:38
97385,D-mannose,222-392-4,3458-28-4,Not Classified,REACH registration C&L,102,Not classified:102
97386,"Sodium [6R-[6α,7β(R*)]]-7-(aminophenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",254-192-8,38932-40-0,Skin Sens. 1;Resp. Sens. 1,Notified C&L,2,H317:2;H334:2
97387,barban (ISO);4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate,202-930-4,101-27-9,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H317:0;H400:0;H302:0
97392,1-(3-pyridyl)propan-1-one,216-380-8,1570-48-5,,Notified C&L,5,H315:5;H319:5
97393,Chloroformamidinium chloride,249-765-4,29671-92-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,4,H312:3;H302:3;H319:4;H315:4;H335:3;H332:3
97394,α-methyl-α-(1-methylcyclopropyl)benzyl alcohol,275-232-0,71172-46-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H315:38;H302:38
97395,3-tridecyloxy-propyl-ammonium 9-octadecenoate,418-990-1,778577-53-0,Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H319:0;H400:0;H315:0;H373:0
97398,"Fatty acids, C7-9-branched, calcium salts",297-413-3,93571-86-9,Not Classified,Notified C&L,1,Not classified:1
97401,Benzyl hexanoate,230-068-9,6938-45-0,Not Classified,Notified C&L,90,Not classified:90
97402,"2,4-dimethylbenzenethiol",237-100-0,13616-82-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,54,H226:49;H335:51;H315:54;H319:52;H312:5;H302:6;H331:4;H332:1
97409,N-(2-ethylhexyl)isononan-1-amide,298-613-3,93820-33-8,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,45,H411:2;H400:2;H410:2;Not classified:33;H302:7;H319:7;H315:3
97410,Suberonitrile,211-089-2,629-40-3,Acute Tox. 3,REACH registration C&L,183,H301:183;H311:39;H331:39
97411,2-bromoethyl methacrylate,224-836-2,4513-56-8,,Notified C&L,2,H335:1;H315:2;H319:2
97413,(isononanoato-O)(isooctanoato-O)nickel,287-471-8,85508-46-9,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H341:0;H410:0;H334:0;H400:0;H372:0;H317:0;H350:0;H360:0
97414,cis-2-tert-butylcyclohexan-1-ol,230-601-5,7214-18-8,Not Classified,REACH registration C&L,109,Not classified:109
97415,"reaction product of 2,2'-iminodiethanol and boric acid",922-158-8,,Not Classified,Notified C&L,1,Not classified:1
97420,2-furylacetone,230-234-0,6975-60-6,Not Classified,Notified C&L,94,Not classified:88;H335:6;H315:6;H319:6;H314:1
97422,ethephon;2-chloroethylphosphonic acid,240-718-3,16672-87-0,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0;H314:0;Not classified:0;H311:0;H332:0
97423,"Tetrachlorotricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaene, mixed isomers",250-223-4,30501-29-2,Not Classified,Notified C&L,1,Not classified:1
97424,"Benzoyl chloride, 4-chloro-2-fluoro-",609-681-4,394-39-8,Skin Corr. 1B,Notified C&L,1,H314:1
97425,1-bromo-2-chloroethane,203-456-0,107-04-0,,REACH registration C&L,61,H312:55;H319:14;H315:61;H301:61;H335:59;H332:55;H351:4;H350:51;H341:3;H336:1
97429,(3-chloropropyl)trimethylsilane,219-059-0,2344-83-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H226:42;H335:42;H315:42;H319:42
97430,Potassium dibutyl phosphate,246-749-9,25238-98-6,Carc. 2;STOT RE 2,Notified C&L,76,H373:32;H351:32;H315:31;H319:41;Not classified:3
97432,Malonic acid,205-503-0,141-82-2,Eye Irrit. 2,REACH registration C&L,278,H319:210;H318:62;H302:223;H315:122;H335:35;Not classified:7;H332:2;H314:1
97442,"1,1,2,3-tetrachloropropane",242-379-7,18495-30-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H302:1;H319:1
97445,Methyl toluenesulphonate,249-237-3,28804-47-9,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,178,H302:175;H319:175;H315:175;H317:176;Not classified:121;H311:167;H411:21;H372:18;H331:19;H335:20;H312:1;H301:2;H314:1
97448,"Placenta, ext.",282-364-2,84195-59-5,Not Classified,Notified C&L,1,Not classified:1
97453,3-hydroxy-N-(2-hydroxyethyl)naphthalene-2-carboxamide,202-191-8,92-80-8,Acute Tox. 4,Notified C&L,38,H302:38
97454,"Soybean oil, polymer with ethylene glycol, pentaerythritol and phthalic anhydride",614-106-5,67700-76-9,Not Classified,Notified C&L,5,Not classified:5
97456,"Gases (petroleum), steam-cracker C3-rich;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately – 70 °C to 0 °C (– 94 °F to 32 °F).]",295-404-9,92045-22-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
97458,Disodium 1-[2-[(12-hydroxy-1-oxooctadec-9-enyl)amino]ethyl] 2-sulphosuccinate,265-672-1,65277-54-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
97459,"Oils, Euterpe oleracea",618-602-2,906351-38-0,Not Classified,Notified C&L,1,Not classified:1
97460,Methyl 4-methylvalerate,219-320-9,2412-80-8,Flam. Liq. 3,Notified C&L,1412,H226:1411;Not classified:1
97463,"2,5-dihydroxybenzaldehyde",214-789-6,1194-98-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H317:39;H315:46;H319:46
97464,Perfluoroethane,200-939-8,76-16-4,Press. Gas (Liq.),REACH registration C&L,142,H280:142
97466,N-(4-CYANOMETHYLPHENYL)-2-ISOPROPYL-5-METHYLCYCLOHEXANECARBOXAMIDE,482-450-1,,Aquatic Chronic 2,Notified C&L,1286,H411:1286
97468,4-iodo-1H-pyrazole,222-434-1,3469-69-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:45;H315:46;H302:43;H319:46;H334:1;H317:1;H351:1;H312:1;H332:1;H270:1
97469,"2-Propenoic acid, 3-ethoxy-, ethyl ester, (2E)-",611-826-1,5941-55-9,,Notified C&L,4,H315:4;H319:4
97470,Strychnine sulphate,200-477-7,60-41-3,Acute Tox. 2;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H410:42;H400:42;H300:42;H330:42
97474,"Rye, ext.",290-271-3,90106-48-2,Not Classified,REACH registration C&L,2,Not classified:2
97475,"Tetrahydrothiophen-3-amine 1,1-dioxide",228-730-7,6338-70-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H311:38;H331:38;H301:38
97477,"1,2-dichloro-4-iodobenzene",243-874-0,20555-91-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,19,H312:13;H302:13;H319:19;H315:19;H335:18;H332:13
97481,"3a,4,7,7a-tetrahydro-4,7-methanoindene",201-052-9,77-73-6,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H319:0;H411:0;H315:0;H335:0;H225:0;H332:0
97483,4-amino-3-chlorophenol,241-583-3,17609-80-2,Skin Irrit. 2;Acute Tox. 4;Repr. 1B;Aquatic Acute 1,Notified C&L,3,H332:3;H400:2;H360:2;H315:3;H312:1;H302:1;H319:1;H335:1
97484,Pentylamine,203-780-2,110-58-7,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,159,H312:149;H302:159;H318:27;H314:159;H331:79;H225:159;H332:80;H412:38;H311:10
97486,"(1-hydroxyethylidene)bisphosphonic acid, potassium salt",267-956-0,67953-76-8,Acute Tox. 4,REACH registration C&L,598,H302:73;H411:441;H315:63;H319:114;Not classified:21;H318:7;H290:7
97487,"Tall oil, potassium salt",271-968-1,68647-71-2,Aquatic Chronic 2,REACH registration C&L,452,H411:6;Not classified:444;H319:2
97488,L-menthol,218-690-9,2216-51-5,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2069,H315:2024;H319:660;H335:52;H318:43;H412:34;Not classified:8;H302:2;H317:1
97495,N-[3-(dimethylamino)propyl]methacrylamide,226-002-3,5205-93-6,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,591,H318:585;H317:128;H315:124;H412:8;Not classified:3;H319:3
97496,trans-stilbene,203-098-5,103-30-0,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,48,H411:44;H302:45;H319:44;Not classified:2;H317:1
97497,"Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(phenylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, molybdatetungstatephosphate",215-411-2,1325-94-6,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1;H319:1
97498,"2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene",203-826-1,111-02-4,Asp. Tox. 1,REACH registration C&L,285,H304:201;Not classified:80;H315:3;H319:4
97501,Iron arsenate,233-274-7,10102-49-5,Acute Tox. 3;Acute Tox. 3;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1;H350:1;H331:1;H301:1
97504,3-bromoquinoline,226-237-1,5332-24-1,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,47,H315:47;H319:47;H335:44
97508,2-pentylcyclopentan-1-ol,283-187-3,84560-00-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,75,H315:75;H319:75
97510,3-(Polyoxyethylene)propylheptamethyltrisiloxane,924-374-8,,Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H332:1;H411:1;H331:1;H319:1
97511,"(8S,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-one",612-953-5,6218-29-7,Carc. 2;Repr. 1A,REACH registration C&L,9,H360:9;H351:9;H362:6
97514,"reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol",433-640-8,,Pyr. Sol. 1;Aquatic Chronic 4,Harmonised C&L,0,H250:0;H413:0
97517,Sodium 5-[(dimethylphenyl)azo]-6-hydroxynaphthalene-2-sulphonate,258-153-6,52749-23-2,Not Classified,Notified C&L,5,Not classified:5
97518,"4,7,7-trimethyl-6-thiabicyclo[3.2.1]oct-3-ene",229-845-5,6784-08-3,Not Classified,Notified C&L,61,Not classified:36;H410:25;H319:25;H400:25;H315:25;H317:25;H226:25;H304:25
97520,"3,4-dihydro-2H-1-benzothiopyran-8-ol",250-024-2,30073-50-8,Not Classified,Notified C&L,1,Not classified:1
97523,"Tetrahydrogen [5-acetamido-4-hydroxy-3-[[5-hydroxy-6-[[2-hydroxy-4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]-7-sulpho-2-naphthyl]azo]naphthalene-2,7-disulphonato(6-)]cuprate(4-)",271-186-0,68516-98-3,Not Classified,Notified C&L,7,Not classified:7
97525,"Distillates (coal), coke-oven light oil, naphthalene cut;Naphthalene Oil;[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148°C (298°F).]",285-076-5,85029-51-2,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
97527,"Trisodium 5-[[4-chloro-6-(methylphenylamino)-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(4-methyl-2-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",274-444-0,70210-46-7,,Notified C&L,11,Not classified:11
97532,tert-butyl-4-methoxyphenol,246-563-8,25013-16-5,Skin Irrit. 2;Eye Irrit. 2;Carc. 2;Repr. 2;Aquatic Chronic 2,REACH registration C&L,944,H361:141;H319:690;H411:298;H315:494;H351:573;H302:513;H335:374;H312:83;H350:120;H332:91;Not classified:55;H318:125;H410:35;H317:15;H400:9;H331:8;H311:8;H336:3
97533,Chromium(III) fluoride trihydrate,605-449-1,16671-27-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,38,H312:38;H314:38;H332:38;H302:38
97534,2'-Chloro-4'-fluoroacetophenone,615-053-0,700-35-6,,Notified C&L,8,H335:5;H315:8;H319:8;H302:2
97535,"5H-1,2-oxathiole 2,2-dioxide",606-834-7,21806-61-1,Acute Tox. 3;Skin Sens. 1B;Eye Irrit. 2;Muta. 2;Aquatic Chronic 2,REACH registration C&L,6,H341:3;H319:3;H411:2;H317:2;H301:4;H302:1;Not classified:1;H315:1;H331:1;H335:1;H311:1
97541,β-bromocumene,215-948-2,1459-00-3,Acute Tox. 4;Resp. Sens. 1,Notified C&L,43,H334:39;H302:39;H315:4;H319:4
97542,hydrogen sulphide,231-977-3,7783-06-4,Press. Gas;Flam. Gas 1;Acute Tox. 2;Aquatic Acute 1,Harmonised C&L,0,H220:0;Not classified:0;H400:0;H330:0
97544,"3,3'-[azoxybis[(2-methoxy-p-phenylene)azo]]bis[4,5-dihydroxynaphthalene-2,7-disulphonic] acid, lithium sodium salt",285-749-3,85136-25-0,,Notified C&L,92,Not classified:92
97545,"3,5,7-trihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-1-benzopyrylium chloride",211-403-8,643-84-5,Not Classified,Notified C&L,12,Not classified:12
97547,2-methoxybenzophenone,219-857-9,2553-04-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
97553,[(4-nitrophenyl)amino]oxoacetic acid,203-160-1,103-94-6,,Notified C&L,4,H335:4;H315:4;H319:4
97555,"C18-C50 branched, cyclic and linear hydrocarbons - Distillates",482-220-0,848301-69-9,Asp. Tox. 1,REACH registration C&L,465,H304:463;Not classified:2
97558,1-naphthyl chloroformate,223-168-9,3759-61-3,Skin Corr. 1B,Notified C&L,39,H314:39;H335:1;H301:1
97560,2-tert-butyl-4-ethylphenol,202-526-8,96-70-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:38;H314:38;H315:1;H319:1
97561,Iodocyclohexane,210-957-8,626-62-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
97562,Ethyl 4-(methylthio)butyrate,244-720-5,22014-48-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:1;H315:2;H319:2
97564,"2,2,3-tris(4-chlorophenyl)propiononitrile",218-526-6,2172-51-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H332:38;H302:38
97565,"3,5-dinitrotoluene",210-566-2,618-85-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 2;Aquatic Chronic 3;Repr. 2,Harmonised C&L,0,H341:0;H361:0;H412:0;H373:0;H350:0;H331:0;H301:0;H311:0
97566,Zinc methacrylate,236-144-8,13189-00-9,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,195,H318:155;H317:32;H400:32;H302:32;H335:163;H315:163;H334:39;H319:40;H410:13;H412:13
97569,"Protein hydrolyzates, wheat, reaction products with cocoyl chloride, potassium salts",500-697-6,162353-60-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,17,H315:17;H319:17
97570,"2H-1-Benzopyran-2-one, 3-(1H-benzimidazol-2-yl)-7-(diethylamino)-",602-763-0,12239-58-6,Not Classified,Notified C&L,21,Not classified:21
97574,"Fatty acids, C14-22 and C14-22-unsatd., Me esters, sulfated, sodium salts",283-969-4,84776-43-2,Not Classified,Notified C&L,2,Not classified:2
97576,"2,2,4,4-tetramethylcyclobutane-1,3-diol, mixed isomers",221-140-0,3010-96-6,Acute Tox. 4,REACH registration C&L,135,H302:95;H335:39;H228:39;H315:40;H319:40
97578,"1,2-dimethylpropylamine",209-949-7,598-74-3,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,46,H312:41;H225:46;H314:46;H302:46;H311:5;H332:5;H318:1
97579,Lignocellulose,234-384-8,11132-73-3,Not Classified,Notified C&L,55,Not classified:55
97581,Icosane,204-018-1,112-95-8,Asp. Tox. 1,REACH registration C&L,179,H304:64;Not classified:115
97585,"Chromium, hydroxide 2-hydroxy-5-[(8-sulfo-2-naphthalenyl)azo]benzoate sulfate sodium complexes",307-994-8,97808-73-6,,Notified C&L,1,H317:1
97587,"Diammonium 2,2'-azinobis[3-ethyl-2,3-dihydrobenzothiazole-6-sulphonate]",250-396-6,30931-67-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
97591,"Octadecanoic acid, 12-hydroxy-, potassium salt",920-164-5,34160-06-0,Not Classified,REACH registration C&L,1,Not classified:1
97592,"Benzoic acid, 3-fluoro-4-methoxy-, methyl ester",609-314-8,369-30-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
97594,"3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomers, 2-Hydroxy-1(2)- methylethyl carbamate blocked",921-910-2,,Not Classified,REACH registration C&L,2,Not classified:2
97598,Ammonium cumenesulphonate,253-519-1,37475-88-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,164,H315:164;H319:164
97599,Indole-5-carbonitrile,239-986-4,15861-24-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H335:47;H315:48;H319:48;H302:10;Not classified:1;H312:3;H332:3
97600,imidazole,206-019-2,288-32-4,Acute Tox. 4;Skin Corr. 1C;Repr. 1B,Harmonised C&L,0,H314:0;H360:0;H302:0
97603,"6-amino-2,4-dichloro-m-cresol hydrochloride",254-503-7,39549-31-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:41;H315:43;H319:43
97604,"1,3,5-trichloro-2-nitrobenzene",242-518-1,18708-70-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 4,Notified C&L,43,H413:38;H373:38;H331:38;H301:38;H311:38;H312:4;H302:5;H319:4;H315:4;H335:4;H332:4
97605,calcium sulphide,243-873-5,20548-54-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Harmonised C&L,0,H335:0;H400:0;H315:0;H319:0
97606,"Iron, furnace",265-998-4,65996-67-0,,Notified C&L,38,Not classified:38
97607,"Benzo[b]thiophene-6-ol, 2-(4-methoxyphenyl)-",607-110-3,225648-21-5,Repr. 2,Notified C&L,33,H361:33
97609,Carbonyl difluoride,206-534-2,353-50-4,Press. Gas (Liq.);Skin Corr. 1A;Eye Dam. 1;Acute Tox. 1,REACH registration C&L,215,H318:1;H280:136;H314:167;H330:184;H370:48;H290:31;H331:31;H319:1;H315:1
97610,"3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester",618-119-7,88150-42-9,Acute Tox. 3;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H410:2;H318:2;H400:2;H373:2;H301:3;H341:1;H314:1;H411:1
97611,Cambendazole,247-459-5,26097-80-3,Repr. 2,Notified C&L,38,H361:38
97614,Tetramethylenediamine,203-782-3,110-60-1,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 2,REACH registration C&L,199,H302:164;H330:150;H318:24;H314:173;H226:149;H311:33;H312:141;Not classified:24;H225:10;H331:18;H290:2;H228:2;H332:1
97615,(N-(2-methyl-1-phenyl-2 propanyl) acetamide,611-254-2,5531-33-9,Acute Tox. 4,REACH registration C&L,1,H302:1
97618,"1-Propene, 2-methyl-, sulfurized",270-943-2,68511-50-2,Aquatic Chronic 4,Notified C&L,748,H413:477;Not classified:245;H412:26
97619,Hydroxyaluminium di(acetate),205-354-1,139-12-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,152,H315:83;H319:83;Not classified:69
97622,"Residual oils (petroleum), oxidized",265-204-6,64742-99-0,Not Classified,Notified C&L,126,Not classified:126
97630,"Alcohols, C6-24 and C6-24-unsatd., distn. residues",310-079-6,102242-48-8,Muta. 2,REACH registration C&L,84,H341:84
97631,Ethyl 5-chloroindole-2-carboxylate,225-345-6,4792-67-0,,Notified C&L,5,H335:4;H315:5;H319:5
97633,N-(3-aminopropyl)iminodiethanol,225-642-0,4985-85-7,Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,82,H318:4;H314:82;H411:3
97635,"Pentadecanol, branched and linear",291-807-9,90480-71-0,Aquatic Chronic 1,REACH registration C&L,3,H410:3
97638,ethylene bis(trichloroacetate),219-732-9,2514-53-6,Skin Irrit. 2,Harmonised C&L,0,H315:0
97639,Levonorgestrel,212-349-8,797-63-7,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1A,Notified C&L,87,H312:54;H332:54;H360:83;H351:85;H362:27;H302:17;H341:1;H361:1;H319:1;H315:1;H335:1
97642,"Copper, [29H,31H-phthalocyaninetetrasulfonyl tetrachloridato(2-)-N29,N30,N31,N32]-, reaction products with 2-[[4-[(2-aminoethyl)amino]-6-chloro-1,3,5-triazin-2-yl]amino]-1,4-benzenedisulfonic acid and ammonium hydroxide, sodium salts",307-997-4,97808-76-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,8,H320:8;H335:8;H315:8
97643,D-threonine,211-171-8,632-20-2,Not Classified,Notified C&L,1,Not classified:1
97644,"2,4,6-Tribromo-3-hydroxybenzoic Acid [for Biochemical Research]",619-514-7,14348-40-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H312:39;H302:44;H319:44;H315:44;H335:43;H332:39
97646,4-hydroxy-m-phenylenediammonium dichloride,205-279-4,137-09-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H335:47;H315:47;H301:48;H319:47;H341:4;H334:7;H317:7;Not classified:2;H302:1;H314:1;H331:1;H311:1
97647,"Isononanoic acid, zinc salt, basic",282-776-2,84418-64-4,Not Classified,Notified C&L,1,Not classified:1
97651,"bis-[4-(2,3-epoxipropoxi)phenyl]propane",216-823-5,1675-54-3,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H315:0;H319:0
97654,"Hydrogen [4-[4-(p-ethoxyanilino)-4'-[ethyl(m-sulphonatobenzyl)amino]-2'-methylbenzhydrylene]-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)(m-sulphonatobenzyl)ammonium, monosodium salt",228-058-4,6104-58-1,Not Classified,REACH registration C&L,125,Not classified:124;H319:1
97655,Dipotassium 2-(6-oxido-3-oxoxanthen-9-yl)benzoate,229-143-9,6417-85-2,Not Classified,Notified C&L,7,Not classified:7
97658,"2-benzo[f]quinolin-3-yl-2,3-dihydro-1,3-dioxo-1H-indenesulphonic acid, compound with 2-(diethylamino)ethanol (1:1)",285-072-3,85027-49-2,Flam. Liq. 3;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,83,H226:83;H412:83;H318:83
97660,3-ethylheptan-3-ol,243-301-4,19780-41-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H335:38;H318:38;H315:38;H302:38;Not classified:1
97663,Rhodanine,205-505-1,141-84-4,Acute Tox. 4;Eye Dam. 1,Notified C&L,48,H318:44;H302:48;H319:1
97665,"1,1'-[methylenebis(oxy)]dibutane",219-909-0,2568-90-3,Not Classified,REACH registration C&L,123,Not classified:2;H226:121;H412:102;H315:102
97668,Ethyl L-valinate hydrochloride,241-580-7,17609-47-1,Flam. Liq. 3,Notified C&L,6,H226:6
97669,"3-ethyl, 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-6-methyl-2-[(2-phthalimidoethoxy)methyl]-3,5-pyridinedicarboxylate compound with propan-2-one (1:1)",929-019-0,,Not Classified,Notified C&L,1,Not classified:1
97671,Butylquinoline,258-564-0,53452-65-6,Not Classified,Notified C&L,88,Not classified:88
97672,Metochalcone,242-377-6,18493-30-6,Not Classified,Notified C&L,1,Not classified:1
97675,"N-(2-aminoethyl)-1,3-propanediamine",236-882-0,13531-52-7,Acute Tox. 4;Acute Tox. 2;Skin Corr. 1A;Skin Sens. 1A;Eye Dam. 1,REACH registration C&L,148,H302:84;H318:122;H317:84;H314:126;H310:84;H315:22;H319:22
97676,Phenazine,202-193-9,92-82-0,,Notified C&L,35,Not classified:35
97679,"4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoic acid",250-392-4,30926-22-8,Acute Tox. 3;Aquatic Acute 1,Notified C&L,38,H400:38;H301:38
97681,Methoxypropanol,215-306-1,1320-67-8,Flam. Liq. 3,Notified C&L,32,H226:30;Not classified:1;H225:1
97682,Calcium L-glutamate (1:2),227-838-1,5996-22-5,Not Classified,Notified C&L,1,Not classified:1
97683,"Benzoic acid, 3-bromo-5-fluoro-, methyl ester",608-871-4,334792-52-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
97691,"1,1,2-trichlorotrifluoroethane",200-936-1,76-13-1,Ozone 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,268,H059:125;H411:254;H319:207;H420:127;Not classified:15
97692,Calcium bromate,233-278-9,10102-75-7,,Notified C&L,4,H335:4;H272:4;H315:4;H319:4
97693,(2S-trans)-4-hydroxy-N-2-naphthylpyrrolidine-2-carboxamide,222-045-7,3326-64-5,Carc. 2,Notified C&L,39,H351:38;H350:1
97695,5-potassium hydrogen L-glutamate,243-094-0,19473-49-5,Not Classified,Notified C&L,5,Not classified:5
97698,"1,8-dihydroxy-3-methylanthraquinone",207-572-2,481-74-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,43,H315:43;H319:43;H335:4
97700,4-[(4-aminophenyl)azo]-5-methyl-o-anisidine,228-341-2,6232-57-1,Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H317:38;H319:38
97701,4-Maleimidobutyric Acid,611-461-8,57078-98-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
97702,3-chloropyridine,210-955-7,626-60-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,49,H312:41;H332:41;H302:45;H226:6;H314:4;H315:7;H335:3;H319:3;H318:1;H227:1
97706,"1,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline hydrochloride",607-218-0,2328-12-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47
97711,2-nitro-4-(trifluoromethyl)phenol,206-927-9,400-99-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
97712,Copper sulphide,215-271-2,1317-40-4,Not Classified,REACH registration C&L,151,Not classified:48;H413:102;H411:1;H317:1;H334:1
97714,"Sulfuric acid, mono-C12-16-alkyl esters, sodium salts",277-362-3,73296-89-6,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,615,H412:233;H318:565;H315:565;H228:124;H335:124;Not classified:51;H302:2
97716,Sodium 2-[(2-aminoethyl)amino]ethanesulphonate,252-173-9,34730-59-1,Eye Dam. 1,REACH registration C&L,150,H318:88;H314:55;Not classified:7
97723,"1,3-bis-(2-ethyl-hexyl)-5-methyl-hexahydro-pyrimidin-5-ylammonium 3-hydroxy-[2]naphtoate",922-966-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
97726,"Amines, N-(C16-18 and C16-18-unsatd. alkyl)[methylenebis(imino-3,1-propanediyl)]di-",300-207-9,93924-15-3,Not Classified,Notified C&L,441,Not classified:441
97727,S-methyl-L-cysteine,214-701-6,1187-84-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H319:1
97730,"Castor oil, dehydrated, polymd.",614-233-6,68038-02-8,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,78,H302:71;H410:71;H400:71;H373:71;H360:71;H332:71;Not classified:7
97732,4-chloro-1-fluoro-2-nitrobenzene,206-457-4,345-18-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:2;H319:2;H314:1;H302:1
97733,5-methyl-2-phenyl-1H-imidazole-4-methanol,237-187-5,13682-32-1,Acute Tox. 4,Notified C&L,42,H302:41;Not classified:1
97737,"2,2,3,3,4,4,4-heptafluorobutan-1-ol",206-782-1,375-01-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,52,H226:52;H315:48;H319:48;H335:44;H332:5;H336:3;H312:1;H302:1;Not classified:1;H350:1
97739,docosanyl 4-hydroxybenzoate,920-338-0,109236-76-2,Not Classified,REACH registration C&L,1,Not classified:1
97751,"ε-Caprolactone, oligomeric reaction products with 2,2'-oxydiethanol",500-092-7,36890-68-3,Not Classified,REACH registration C&L,145,Not classified:24;H315:83;H319:121
97752,sec-butyl butyrate,212-465-9,819-97-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H226:1;H315:1;H319:1
97755,hyoscyamine,202-933-0,101-31-5,Acute Tox. 2;Acute Tox. 2,Harmonised C&L,0,H300:0;H330:0
97756,"1,3,5-triphenylbenzene",210-318-3,612-71-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
97758,Lithium (2H)hydride,237-018-5,13587-16-1,Water-react. 1;Skin Corr. 1B,Notified C&L,44,H260:43;H314:43;H261:1
97760,"Decanoic acid, mixed esters with heptanoic acid, isononanoic acid, octanoic acid and pentaerythritol",601-552-0,118685-24-8,Aquatic Chronic 4,Notified C&L,17,H413:16;H412:1
97763,"Benzenesulfonic acid, dodecyl-, branched, compd. with ethanolamine",273-235-1,68953-98-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1;H302:1
97766,Iridium tetrachloride,233-048-8,10025-97-5,,Notified C&L,5,H335:5;H315:5;H302:5;H319:5
97768,"Benzoic acid, 5-(2-bromoacetyl)-2-(phenylmethoxy)-, methyl ester",608-104-3,27475-14-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H315:1;H302:1;H319:1
97769,"Sodium hydrogen 4-aminoazobenzene-3,4'-disulphonate",277-916-4,74543-21-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,41,H315:39;H319:39;Not classified:2
97772,"2-Pyrrolidinone, 1-ethenyl-, polymer with 1-hexadecene",608-741-7,32440-50-9,Not Classified,Notified C&L,66,Not classified:66
97777,4'-(imidazol-1-yl)methyl phenyl ketone,233-123-5,10041-06-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39;H302:1
97778,3-(2-aminoethyl)phenol hydrochloride,222-396-6,3458-98-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
97779,"Phosphoric acid, mono(2-aminoethyl) mono(2,3-dihydroxypropyl) ester, monohydrate, (R)-",609-192-6,35907-34-7,Not Classified,REACH registration C&L,1,Not classified:1
97781,Methyl D-alaninate hydrochloride,238-258-3,14316-06-4,Not Classified,REACH registration C&L,5,Not classified:3;H335:2;H315:2;H319:2
97785,4-methylthiazol-2-ylamine,216-505-6,1603-91-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46;H302:7;H312:1;H332:2
97786,"Amides, from C18-unsatd. fatty acids dimers and diethanolamine",614-569-3,68526-59-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,21,H315:20;H319:20;Not classified:1
97788,Methyl 3-methoxypropionate,223-358-1,3852-09-3,Flam. Liq. 3;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 2,REACH registration C&L,122,H361:19;H335:58;H319:115;H226:115;H332:19;H302:55;H315:41;Not classified:6;H370:1
97789,Fluphenazine O-enantate,220-385-0,2746-81-8,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,16,H312:16;H302:16;H334:16;H317:16;H332:16
97793,p-nitrophenyl 6-deoxy-α-L-galactopyranoside,233-553-3,10231-84-2,Not Classified,Notified C&L,2,Not classified:2
97795,1-HYDROXY-2-BUTANONE ACETATE,605-102-4,1575-57-1,Acute Tox. 4,Notified C&L,38,H302:38
97799,Hex-3-yn-2-ol,203-676-7,109-50-2,Flam. Liq. 3;Aquatic Acute 1,Notified C&L,42,H226:42;H400:38
97800,Acibenzolar-S-methyl,603-901-2,135158-54-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,195,H410:195;H319:195;H400:195;H315:195;H317:195;H335:195
97801,Isodecyl diphenyl phosphite,247-777-4,26544-23-0,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,162,H317:148;H411:127;H315:90;H373:35;H400:16;H410:17;Not classified:10;H412:2;H312:1;H302:1;H319:3;H332:1
97803,6-ethylpyridin-2-amine,244-540-7,21717-29-3,,Notified C&L,4,H302:4;H319:4;H315:4;H311:4;H332:4
97808,"Phosphatase, alkaline",232-631-4,9001-78-9,Not Classified,Notified C&L,2,Not classified:2
97811,profenofos (ISO);O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate,255-255-2,41198-08-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H410:0;H302:0;H400:0;H332:0
97814,N-[(2-chlorophenyl)methyl]thiophene-3-ethylamine,273-851-0,69061-17-2,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,2,H318:2;H317:2;H411:2;H315:2
97815,Decyl propionate,226-703-4,5454-19-3,Not Classified,Notified C&L,88,Not classified:88
97816,Ethyl 3-phenylpropionate,217-966-6,2021-28-5,Not Classified,Notified C&L,92,Not classified:91;H335:1;H315:1;H319:1
97817,"1-({[(7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methyl]sulfonyl}oxy)pyrrolidine-2,5-dione",428-080-6,,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,1,H413:1;H319:1
97825,"(S)-4-methyloxazolidine-2,5-dione",218-750-4,2224-52-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,42,H335:41;H318:3;H315:41;H319:38;H312:1;H332:1;H302:1
97827,"Quinoxaline-2,3-diol",239-901-0,15804-19-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H335:39;H318:38;H315:40;H302:38;H319:2
97829,"Myristic acid, monoester with propane-1,2-diol",249-395-3,29059-24-3,Not Classified,Notified C&L,4,Not classified:4
97831,"2,6,6-trimethylcyclohex-1-enecarbonitrile",921-141-2,,Not Classified,REACH registration C&L,1,Not classified:1
97832,"(E)-5,9,14,18-tetramethyl-20-(2,6,6-trimethylcyclohexenyl)-3,5,7,9,11,13,15,17,19-icosanonaen-2-one",222-762-5,3604-90-8,,Notified C&L,83,Not classified:83
97834,"2-[[4-(diethylamino)-2-methylphenyl]azo]-5-nitrobenzene-1,3-dicarbonitrile",284-395-7,84870-65-5,Not Classified,REACH registration C&L,57,Not classified:57
97839,"Oils, lard, Me esters",268-375-5,68082-78-0,Not Classified,Notified C&L,24,Not classified:24
97840,"4,4'-(vinylene)bis[3-sulphobenzenediazonium] dichloride",237-733-2,13954-62-6,Not Classified,Notified C&L,1,Not classified:1
97844,2-hydroxyethyl palmitate,224-160-8,4219-49-2,Not Classified,REACH registration C&L,13,Not classified:13
97846,N-benzoyl-2'-deoxycytidine 3'-benzoate,257-271-5,51549-49-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,38,H312:38;H302:38;H319:38;H315:38;H335:38;H332:38;H351:38
97852,7-(diethylamino)-3-(1-methyl-1H-benzimidazol-2-yl)-2-benzopyrone,255-186-8,41044-12-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
97856,Disodium 7-[[carboxylato(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,265-288-4,64953-12-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,39,H317:39;H334:39
97859,"amines, coco alkyl",262-977-1,61788-46-3,Acute Tox. 4;Skin Corr. 1B;Asp. Tox. 1;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H410:0;H400:0;H373:0;H314:0;H335:0;H304:0
97862,"Corallina officinalis, ext.",289-730-0,89997-92-2,Flam. Liq. 3,Notified C&L,1,H226:1
97864,"1,2,3-tris(2,3-epoxypropoxy)propane",236-211-1,13236-02-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,68,H335:67;H317:65;H315:67;H319:67;H318:1;H302:1
97865,"Annatto, hydrolyzed, potassium salts",309-266-5,100208-63-7,Not Classified,Notified C&L,52,Not classified:52
97866,Glucuronic acid,209-401-7,576-37-4,Not Classified,Notified C&L,1,Not classified:1
97869,4-chloro-o-cresol;4-chloro-2-methyl phenol,216-381-3,1570-64-5,Skin Corr. 1A;Acute Tox. 3;Aquatic Acute 1,Harmonised C&L,0,H314:0;H400:0;H331:0
97870,Hexamethyl diorthosilicate,224-467-7,4371-91-9,Not Classified,Notified C&L,6,Not classified:5;H226:1
97875,Diethyl 3-oxoadipate,230-479-3,7149-59-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
97880,"2-methyl-1,1'-biphenyl",211-400-1,643-58-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
97883,Trimethylsilyl trichloroacetate,246-980-5,25436-07-1,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H312:38;H335:38;H302:38;H319:38;H315:38;H226:38;H332:38
97885,Icosanyl propionate,265-839-9,65591-14-2,Not Classified,Notified C&L,2,Not classified:2
97886,"N-{5-[bis(2-methoxyethyl)amino]-2-[(6-cyano-2-ethyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)diazenyl]phenyl}acetamide",443-970-4,,Aquatic Chronic 4,Notified C&L,1,H413:1
97889,"Lavender, Lavandula spica, ext.",307-762-6,97722-12-8,Skin Irrit. 2;Skin Sens. 1,Notified C&L,77,H317:40;H315:77;H412:37;H304:37
97891,3-fluoroiodobenzene,214-339-9,1121-86-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H315:46;H319:46
97892,"3,5,7-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone",210-050-7,603-61-2,Not Classified,Notified C&L,2,Not classified:2
97895,Benzyl 2-naphthyl ether,612-134-2,613-62-7,Aquatic Chronic 4,Notified C&L,51,H413:42;H410:9
97899,Tetrahydrofuran-2-propan-1-ol,212-178-9,767-08-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
97900,3-pyridylacetonitrile,229-241-1,6443-85-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45,H315:45;H319:45;H312:5;H302:5;H335:5;H332:5;H331:2;H301:2;H311:2
97902,"Butanedioic acid, sulfo-, mono (C16-18 and C18-unsatd. alkyl) esters, ammonium sodium salts",604-617-1,147993-66-6,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,3,H318:3;H400:3;H315:3
97905,Sodium bis[5-[(5-chloro-2-hydroxyphenyl)azo]-6-hydroxynaphthalene-2-sulphonamidato(2-)]cobaltate(1-),297-962-9,93776-34-2,Not Classified,Notified C&L,1,Not classified:1
97906,Sodium docosanoate,226-234-5,5331-77-1,Not Classified,Notified C&L,1,Not classified:1
97907,"1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid methyl ester",601-924-2,122188-02-7,Acute Tox. 3;Repr. 2,REACH registration C&L,8,H361:7;H301:8;H311:1;H331:1
97908,"A mixture of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate; 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane",406-750-9,129757-67-1,Not Classified,REACH registration C&L,672,Not classified:73;H412:177;H413:422
97909,"Shellac, hydrolyzed",298-756-1,93821-68-2,Not Classified,Notified C&L,1,Not classified:1
97911,Methyl abietate,204-832-7,127-25-3,Skin Irrit. 2,REACH registration C&L,299,H315:12;Not classified:248;H334:39;H319:39;H413:10
97912,4-(2-hydroxy-2-propyl)cyclohexene-1-methanol,226-838-9,5502-74-9,Acute Tox. 4,Notified C&L,1,H302:1
97913,"Phosphoric acid, mixed esters with Bu alc. and ethylene glycol",284-716-0,84962-20-9,Met. Corr. 1;Eye Dam. 1,REACH registration C&L,34,H318:32;H290:32;Not classified:2
97915,"2-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthryl)oxy]ethyl phenyl carbonate",248-882-8,28173-59-3,Not Classified,REACH registration C&L,1,Not classified:1
97916,"2,5-bis(tert-nonyldithio)-1,3,4-thiadiazole",289-493-3,89347-09-1,Not Classified,Notified C&L,571,Not classified:501;H412:64;H317:6
97921,L-α-methylbenzylamine,220-098-0,2627-86-3,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B,REACH registration C&L,614,H311:50;H314:614;H302:612;H312:564;H319:441;H318:558;H331:2;H301:2
97923,"1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole",419-540-7,160194-26-3,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0;H302:0
97928,"Tall oil, reaction products with diethylenetriamine, dodecylbenzenesulfonates",305-519-9,94581-20-1,Skin Corr. 1B,Notified C&L,3,H314:3
97929,4-chloro-2-methylquinoline,224-300-8,4295-06-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
97932,trans-hex-2-enal,229-778-1,6728-26-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1787,H302:1782;H319:1330;H411:1722;H315:26;H317:1779;H226:1783;H311:1780;H335:6;H301:3;H312:1;H332:1;H412:1
97934,"7,8-dihydromorphine",208-100-8,509-60-4,Acute Tox. 4,Notified C&L,39,H302:38;H361:1;H317:1;H331:1;H301:1
97937,"5-methoxy-3,4-dihydronaphtalen-2(1H)-one",608-804-9,32940-15-1,Not Classified,Notified C&L,5,Not classified:4;H317:1;H400:1;H315:1;H302:1
97940,"4-amino-N,N-dimethylaniline sulphate",228-292-7,6219-73-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,11,H319:11;H315:11;H317:11;H301:11;H331:11;H335:11;H311:11
97946,Methyl (2H)formate,245-848-4,23731-38-6,Flam. Liq. 1;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H319:38;H335:38;H332:38;H224:38
97947,methyl 3-(4-chlorophenyl)-3-[[](2S)-3-methyl-2-{[[](propan-2-yloxy)carbonyl]amino}butanamido]propanoate,608-192-3,283159-90-0,Aquatic Chronic 2,Notified C&L,1,H411:1
97949,3-methylenenorbornan-2-one,227-009-4,5597-27-3,Flam. Liq. 3,Notified C&L,39,H226:39
97950,DL-2-amino-5-ureidovaleric acid,211-012-2,627-77-0,Not Classified,Notified C&L,3,Not classified:3
97955,Methylpentynol,201-055-5,77-75-8,Flam. Liq. 3;Acute Tox. 4;Eye Dam. 1;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,147,H402:1;H302:147;H412:85;H318:85;H226:147;H319:22
97960,(2-oxo-heptyl)-triphenylphosphonium iodide,922-041-1,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H335:1;H413:1;H315:1;H319:1
97971,Bromotrifluoromethane,200-887-6,75-63-8,Press. Gas (Liq.);STOT SE 3;Ozone 1,REACH registration C&L,250,H420:45;H280:167;H336:7;Not classified:83;H319:39;H315:39;H335:39;H059:1
97973,"2',4'-dimethylacetanilide",218-088-6,2050-43-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H302:38;H319:38
97976,"Hexanedioic acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, octadecanoate",601-364-9,115470-91-2,Not Classified,Notified C&L,7,Not classified:7
97979,Methyl 5-nitrohydrogen.isophthalate,217-793-6,1955-46-0,Not Classified,REACH registration C&L,7,Not classified:3;H315:3;H319:3;H302:1
97983,Dodecylbenzenesulphonic acid,248-289-4,27176-87-0,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,1677,H314:1537;H302:1670;H311:490;H318:729;H411:296;H315:130;H412:67;H413:35;H290:46;Not classified:6;H410:3;H371:3;H400:3;H317:4;H312:1;H335:3;H226:1
97984,Glucosamine,222-311-2,3416-24-8,Not Classified,Notified C&L,5,Not classified:5
97991,4-nitrophenyl trifluoroacetate,211-524-6,658-78-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
97992,Ammonium chromium bis(sulphate),236-923-2,13548-43-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H332:1;H315:1;H302:1;H319:1
97998,Reaction products of hydrogenated tallow alkyl amines with sebacic acid and calcium hydroxide,433-090-9,,Not Classified,REACH registration C&L,11,Not classified:11
97999,"Kerosine (petroleum), solvent-refined hydrodesulfurized;Kerosine - unspecified",307-033-2,97488-94-3,Asp. Tox. 1,Harmonised C&L,0,H304:0
98005,Silver carbonate,208-590-3,534-16-7,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,86,H318:44;H400:37;H410:39;H335:41;H315:41;H319:41;H332:2;Not classified:1
98009,4-[3-chloro-1-(1-methylethoxy)propyl]toluene,275-235-7,71172-61-7,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,38,H411:38;H302:38
98011,5-(morpholinomethyl)-3-[[(5-nitro-2-furyl)methylene]amino]oxazolidine-2-one hydrochloride,223-169-4,3759-92-0,Acute Tox. 4,Notified C&L,41,H302:41
98017,2-chloro-5-nitrobenzenesulphonamide,202-527-3,96-72-0,Skin Sens. 1,Notified C&L,38,H317:38
98021,[2H]formic [2]acid,213-057-3,920-42-3,Flam. Liq. 3;Skin Corr. 1A,Notified C&L,44,H226:38;H314:44;H290:2;Not classified:1
98026,Ethytrimethylammonium Hydroxide,608-473-0,30382-83-3,Skin Corr. 1A;Eye Dam. 1,Notified C&L,54,H318:32;H314:54
98027,Benzyltrimethylsilane,212-218-5,770-09-2,Flam. Liq. 3,Notified C&L,44,H226:43;H312:2;H332:2;H302:2
98028,"Zircon, cadmium yellow",277-135-9,72968-34-4,Not Classified,REACH registration C&L,14,Not classified:14
98032,Bis(2-phenylvinyl)phenol,250-220-8,30498-86-3,Not Classified,Notified C&L,1,Not classified:1
98034,3-amino-p-anisic acid,220-634-3,2840-26-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
98037,"Ethanone, 1-(5-bromo-2-methoxyphenyl)-",605-479-5,16740-73-1,Skin Corr. 1B;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H314:1;H319:1
98040,"D-gluconic acid, compound with 2,2'-iminobisethanol (1:1)",266-485-8,66808-27-3,Not Classified,Notified C&L,27,Not classified:27
98041,"Dichlorotricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaene, mixed isomers",249-236-8,28804-46-8,Skin Sens. 1B;STOT RE 2,REACH registration C&L,2,H373:1;H317:1;H335:1;H315:1;H302:1;H319:1
98048,Trititanium pentaoxide,601-730-8,12065-65-5,Not Classified,REACH registration C&L,3,Not classified:3
98050,"4,4'-Isopropylidenediphenol, polymer with 1-chloro-2,3-epoxypropane, propane-1,2-diol acrylate and succinic anhydride",500-240-0,68958-77-0,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,40,H317:26;H413:8;Not classified:14;H315:1;H319:1
98056,"Starch, 2-hydroxy-3-(trimethylammonio)propyl ether, chloride",611-425-1,56780-58-6,Aquatic Chronic 3,Notified C&L,143,H412:85;Not classified:58
98057,"di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates",416-180-2,12222-04-7,Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H411:0;H302:0
98059,"Trisodium [2-[[α-[[3-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]-2-hydroxy-5-sulphophenyl]azo]benzyl]azo]-5-sulphobenzoato(5-)]cuprate(3-)",279-785-9,81611-05-4,Not Classified,Notified C&L,37,Not classified:37
98061,"3-Amino-2-bromo-4,6-dimethylpyridine",600-607-6,104829-98-3,Flam. Sol. 2,Notified C&L,1,Not classified:1;H228:1
98062,(+)-neomenthyl acetate,219-856-3,2552-91-2,Flam. Sol. 1;Aquatic Chronic 2,Notified C&L,38,H411:38;H228:38
98065,Disulphuric acid,231-976-8,7783-05-3,Skin Corr. 1A;STOT SE 3,Notified C&L,8,H335:8;H314:8
98072,Dipentylphenylphosphine,275-541-0,71501-08-1,,Notified C&L,4,H315:4;H302:4;H319:4
98074,"3,5-bis(phenylmethoxy)benzoic acid",249-311-5,28917-43-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2
98079,"reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol",423-520-3,156137-33-6,Skin Sens. 1,Harmonised C&L,0,H317:0
98082,(dibutylamino)methanol,267-957-6,67953-77-9,Skin Corr. 1B;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H412:1;H314:1;H332:1
98083,(+)-neomenthol,218-691-4,2216-52-6,Skin Irrit. 2,REACH registration C&L,233,H315:233;H319:68;H335:38;H318:38;Not classified:1
98088,3-methylphthalic anhydride,225-344-0,4792-30-7,,Notified C&L,5,H335:4;H315:5;H319:5
98089,1-methyl-4-(9H-thioxanthen-9-ylidene)piperidinium hydrogen maleate,236-141-1,13187-06-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H302:39;H319:38
98094,"Phosphoric acid, mono-C12-14-alkyl esters, compds. with ethanolamine and morpholine",305-740-0,95009-12-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:2;H315:3;H319:1
98097,Valeronitrile,203-781-8,110-59-8,Flam. Liq. 3;Acute Tox. 4,REACH registration C&L,64,H226:63;H302:17;H301:47;H311:3;H330:3;H225:1;H315:1;H319:1
98098,"2,6-dichloro-4-nitrophenol",210-563-6,618-80-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H312:43;H302:43;H319:44;H315:44;H335:43;H332:43;H331:1;H301:1;H311:1
98100,Tribromofluoromethane,206-535-8,353-54-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
98102,3-chloropropene;allyl chloride,203-457-6,107-05-1,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Muta. 2;Carc. 2;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0,H312:0;H341:0;H302:0;H319:0;H400:0;H315:0;H373:0;H335:0;H225:0;H332:0;H351:0
98103,(R)-(-)-alpha-methoxyphenylacetic acid,223-580-9,3966-32-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
98104,"Sulfite liquors and Cooking liquors, spent",266-111-3,66071-92-9,Not Classified,Notified C&L,2,Not classified:2
98105,Potassium sulphanilate,249-942-6,29901-62-0,Skin Sens. 1,Notified C&L,83,H317:83
98107,"5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(1R,S)-(trifluoromethyl)thio]-1H-pyrazole-3-carbonitrile",930-638-3,,Acute Tox. 3;Acute Tox. 3;Acute Tox. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,2,H330:2;H412:2;H400:2;H372:2;H301:2;H311:2
98108,Octadecan-1-ol,204-017-6,112-92-5,Not Classified,REACH registration C&L,1696,Not classified:1044;H412:261;H411:259;H400:256;H319:388;H410:128;H312:64;H302:64;H318:64;H336:64;H335:64;H225:64
98109,"Cinchonan-9-ol, (9R)-",610-424-3,485-70-1,Acute Tox. 4,Notified C&L,38,H302:38
98113,"Tetrahydro-2H-thiopyran-3-ol 1,1-dioxide",303-075-0,94158-05-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
98115,"2,6,10,15,19,23-hexamethyltetracosane",203-825-6,111-01-3,Not Classified,REACH registration C&L,308,Not classified:267;H335:27;H315:28;H319:28;H413:13
98117,Esters of rosin oligomers with pentaerythritol,613-868-6,65997-12-8,Not Classified,REACH registration C&L,19,Not classified:19
98120,tert-butyldichlorophosphine,247-386-9,25979-07-1,Skin Corr. 1B,Notified C&L,45,H314:45;H318:2
98121,Isoxazole,206-018-7,288-14-2,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1,Notified C&L,128,H225:128;H314:83;H318:83;H335:1;H315:1;H319:1
98122,"Fatty acids, C16-18, oxybis(2-hydroxy-3,1-propanediyl) esters",295-372-6,92044-92-3,Not Classified,Notified C&L,1,Not classified:1
98123,"Glycerides, olive-oil",294-624-2,91744-60-4,Not Classified,Notified C&L,1,Not classified:1
98124,"2,4-dihydro-5-methyl-4-phenyl-3H-1,2,4-triazole-3-thione",228-342-8,6232-82-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39;H312:1;H302:1;H332:1
98125,"α,α-diphenylpiperidine-1-butanol hydrochloride",221-850-0,3254-89-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,91,H312:90;H332:90;H302:91
98128,Dioctyltin maleate,240-253-6,16091-18-2,Acute Tox. 4,Notified C&L,58,H302:38;H361:15;H412:13;H372:15;Not classified:5;H318:2;H413:2
98131,"4'-hydroxy-3',5'-dimethoxyacetophenone",219-610-5,2478-38-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47
98133,"1,8-dihydroxy-3-(hydroxymethyl)anthraquinone",207-571-7,481-72-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:41;H315:42;H319:42;H302:1
98134,Hex-5-en-2-one,203-675-1,109-49-9,Flam. Liq. 3,Notified C&L,1420,H226:1420
98135,Di-2-pyridylethanedione,207-759-9,492-73-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
98138,[(dimethylamino)methyl]phenol,246-866-5,25338-55-0,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 4;Muta. 2;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,106,H341:3;H302:59;H412:3;H318:46;H314:92;H373:3;H332:59;H312:56;H411:14;H315:14;H319:14
98142,N-methylphthalimide,208-982-4,550-44-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,131,H335:130;H315:131;H319:131
98143,5-(2-chloro-4'-fluorobenzhydryl)-4-hydroxypyrimidine,264-071-1,63284-71-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,197,H302:197;H319:197
98146,"Carbamic acid, N-[3-fluoro-4-(4-morpholinyl)phenyl]-, phenylmethyl ester",605-533-8,168828-81-7,Not Classified,REACH registration C&L,39,Not classified:1;H302:38
98148,4-chloroindole,246-747-8,25235-85-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:40;H315:41;H319:41
98149,[No public or meaningful name is available],465-270-8,,Flam. Sol. 1;Water-react. 1;Acute Tox. 4;Skin Sens. 1,Notified C&L,1,H260:1;H317:1;H228:1;H302:1
98150,"Benzonitrile, 3-methyl-4-nitro-",619-245-5,96784-54-2,,Notified C&L,5,H312:4;H302:4;H319:4;H315:4;H335:4;H332:4;H311:1;H331:1;H301:1
98155,"Distillates (petroleum), oxidized light",265-203-0,64742-98-9,Asp. Tox. 1,Notified C&L,567,H304:441;Not classified:126
98156,"Phosphoric acid, 2-ethylhexyl ester, ammonium salt",289-108-9,86014-62-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,13,H315:11;H302:5;H319:11;H318:1;Not classified:1
98157,"2,3-dimethylthiophene",211-170-2,632-16-6,,Notified C&L,7,H226:5;H332:5;H335:2;H315:2;H319:2;H302:2;H312:1;H225:1
98159,Copper selenide,215-272-8,1317-41-5,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 1,Notified C&L,175,H410:175;H400:175;H373:175;H331:175;H301:175
98160,Succinonitrile,203-783-9,110-61-2,Acute Tox. 4;Repr. 2;Aquatic Chronic 3,REACH registration C&L,138,H361:1;H412:1;H302:134;H311:90;H410:89;H400:89;H335:41;H315:41;H319:41;H312:4;H332:5;H301:4;Not classified:2;H331:1
98163,Azelaonitrile,216-824-0,1675-69-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H332:38;H302:42;H312:4;H319:1;H315:1;H331:1;H301:1;H311:1
98164,"Oils, neroli, water",617-046-8,8030-28-2,Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,92,H412:55;H317:56;H332:55;H315:56;Not classified:36;H411:1
98169,"3,6-bis(methylamino)xanthylium chloride",219-568-8,2465-29-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,38,H317:38;H334:38
98171,"Caseins, potassium complexes",614-299-6,68131-54-4,Not Classified,Notified C&L,83,Not classified:83
98173,"Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, molybdatetungstatephosphate",215-413-3,1326-03-0,Aquatic Chronic 1,REACH registration C&L,61,H410:2;H412:32;Not classified:27
98174,"α,α,α,2-tetrachlorotoluene",218-377-7,2136-89-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B;Aquatic Chronic 3,REACH registration C&L,89,H302:87;H319:83;H412:12;H315:83;H350:6;H335:45;H351:81;H314:6;H318:1
98176,"3,3'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonic] acid, potassium salt, compound with 2,2',2''-nitrilotriethanol",286-577-1,85283-47-2,,Notified C&L,36,Not classified:36
98177,"Flue dust, portland cement",270-659-9,68475-76-3,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,REACH registration C&L,198,H335:198;H318:198;H317:198;H315:197;H314:1
98178,"2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2-methylphenyl)-3-oxobutyramide]",226-789-3,5468-75-7,Not Classified,REACH registration C&L,508,Not classified:492;H335:15;H315:15;H319:15;H317:1
98179,4-chloro-N-(2-chlorophenyl)-3-oxobutyramide,254-278-5,39082-01-4,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H302:38
98180,Ethyl (R)-(amino)phenylacetate hydrochloride,241-581-2,17609-48-2,Eye Dam. 1,Notified C&L,39,H318:38;H335:1;H315:1;H302:1;H319:1
98184,"6,8-dimethylnonan-2-ol",274-447-7,70214-77-6,Not Classified,Notified C&L,1399,Not classified:1398;H317:1;H315:1
98197,"Amines, N-C12-14-alkyltrimethylenedi-",292-562-0,90640-43-0,Acute Tox. 3;Skin Corr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,36,H410:5;H400:36;H372:34;H370:3;H314:36;H301:34;H302:2
98199,DL-α-(aminomethyl)-p-hydroxybenzylic alcohol hydrochloride,212-216-4,770-05-8,Acute Tox. 4,REACH registration C&L,50,H302:49;H412:1;H319:1;H312:40;H332:40
98200,Aluminium sodium bis(sulphate),233-277-3,10102-71-3,Not Classified,Notified C&L,2,Not classified:2
98201,"2,2-difluoro-1,3-benzodioxole",216-431-4,1583-59-1,Flam. Liq. 3;Skin Irrit. 2,REACH registration C&L,239,H226:201;H315:238;H335:204;H319:204;H317:39
98202,Ethyl(1-naphthyl)amine,204-250-3,118-44-5,Acute Tox. 4;Acute Tox. 3;Aquatic Chronic 2,Notified C&L,160,H311:83;H411:84;H302:160;H312:77;H332:44;H400:39
98205,(S)-α-amino-N-2-naphthyl-1H-indole-3-propionamide,222-044-1,3326-63-4,Carc. 1A,Notified C&L,1,H350:1
98207,"α,α,α-trifluoro-2-nitro-p-toluidine",206-926-3,400-98-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H312:39;H302:43;H319:44;H315:44;H335:43;H332:43;H311:5;H331:1;H301:1
98210,2-ethoxybenzyl alcohol,275-749-1,71648-21-0,Flam. Liq. 3,Notified C&L,38,H226:38
98212,"Sodium α,4-dihydroxy-3-methoxytoluene-α-sulphonate",243-093-5,19473-05-3,Not Classified,Notified C&L,1,Not classified:1
98213,"1,2,3,6-Tetrahydrophthalic anhydride, oligomeric reaction products with 2,2-dimethylpropane-1,3-diol",500-091-1,36621-20-2,Not Classified,Notified C&L,11,Not classified:9;H335:2;H319:2
98223,Bicyclo[2.2.1]hept-5-ene-2-carbonyl chloride,248-200-9,27063-48-5,Skin Corr. 1B,Notified C&L,38,H314:38
98224,"p-(3,4-dihydro-2,2,4-trimethyl-2H-1-benzopyran-4-yl)phenol",207-450-9,472-41-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,38,H335:38;H411:38;H315:38;H319:38
98225,4-methylpiperidine,210-954-1,626-58-4,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1A;Acute Tox. 3,REACH registration C&L,57,H302:6;H314:14;H331:3;H311:3;H225:57;H335:41;H315:42;H319:42;H318:1;H312:1;H332:1;H412:1
98226,"2,3,4-trichlorobenzenesulphonyl chloride",252-174-4,34732-09-7,Skin Corr. 1B,Notified C&L,42,H314:42
98230,"Isooctadecanoic acid, ester with oxybis[propanediol]",277-361-8,73296-86-3,Not Classified,REACH registration C&L,25,Not classified:25
98233,"(methylimino)diethane-1,2-diyl distearate",237-800-6,13998-76-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,7,H315:7;H319:7
98235,"Acetamide, 2-chloro-N-[2-[2-(2-cyano-4-nitrophenyl)diazenyl]-5-(diethylamino)phenyl]-",613-570-6,64294-88-8,Not Classified,Notified C&L,2,Not classified:2
98236,N-methylacrylamide,214-700-0,1187-59-3,,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H335:1;H332:1
98238,Calcium 3-hydroxy-4-[(1-sulphonato-2-naphthyl)azo]-2-naphthoate,229-142-3,6417-83-0,Not Classified,REACH registration C&L,306,Not classified:305;H412:1
98240,"3-Fluorobenzene-1,2-diol 99%",609-233-8,363-52-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,44,H312:38;H302:42;H318:39;H314:44;H332:38;H317:4
98244,"4,4-bis(4-hydroxyphenyl)valeric acid",204-763-2,126-00-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:38;H315:39;H319:43
98245,"Gas oils (petroleum), hydrotreated light vacuum",295-407-5,92045-24-4,Asp. Tox. 1;Skin Irrit. 2;Acute Tox. 4;Carc. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,6,H411:6;H315:6;H373:6;H332:6;H351:6;H304:6;H226:3
98246,2-chloro-5-nitrobenzenesulphonic acid,202-528-9,96-73-1,Skin Corr. 1B;Skin Sens. 1,Notified C&L,38,H314:38;H317:38
98250,"(Z)-7,7-diethoxyhept-3-ene",242-376-0,18492-65-4,Not Classified,Notified C&L,88,Not classified:88
98251,Heptafluorobutyronitrile,206-781-6,375-00-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H311:1;H331:1;H301:1
98252,1-chloro-4-fluoro-2-nitrobenzene,206-456-9,345-17-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H312:39;H302:39;H319:44;H315:44;H335:39;H332:39;H373:5;H301:5;H311:5;H331:1
98253,2-methyltetrahydrofuran-3-thiol,260-572-4,57124-87-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1453,H335:1427;H315:1429;H319:1429;H226:556;H302:60;H301:1
98254,3-chloroanilinium chloride,205-506-7,141-85-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:38;H315:39;H302:39;H319:39;H410:4;H400:4;H373:4;H331:4;H301:4;H311:4
98258,Methyl 3-(methylthio)propionate,236-883-6,13532-18-8,Acute Tox. 4,Notified C&L,151,H302:146;H335:5;H315:5;H319:5;Not classified:1;H312:2;H332:1
98260,"Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethoxylated propoxylated (V=800 cSt)",614-823-3,68937-55-3,Not Classified,Notified C&L,361,Not classified:207;H413:125;H412:22;H332:7
98262,7-(acetyloxy)-4-methyl-2-benzopyrone,220-386-6,2747-05-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:39;H315:40;H319:40;H302:1
98264,"(5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diyl bispyridine-3-carboxylate hydrochloride",234-917-4,12040-41-4,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,16,H317:16;H332:16;H334:16;H302:16
98265,"Succinimide, silver(1+) salt",259-455-0,55047-82-0,Not Classified,Notified C&L,1,Not classified:1
98268,"4-(1H,3H,5H-oxazolo[3,4-c]oxazol-7a(7H)-ylmethyl) hydrogen 2-octadec-2-enylsuccinate",298-247-4,93783-52-9,Not Classified,Notified C&L,22,Not classified:22
98269,Xanthene,202-194-4,92-83-1,Skin Sens. 1,Notified C&L,39,H317:39;H334:1
98272,N2-(1-oxohexadecyl)-L-arginine,261-410-5,58725-47-6,Not Classified,Notified C&L,2,Not classified:2
98275,"3,3'-dimethylbiphenyl",210-319-9,612-75-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:2;H315:2;H319:2;Not classified:1
98276,Hydroxycyclohexyl phenyl ketone,213-426-9,947-19-3,Not Classified,REACH registration C&L,2710,Not classified:2682;H319:26;H332:2;H315:3;H335:1
98278,"2-Butenedioic acid (2Z)-, polymer with methoxyethene",607-572-6,25153-40-6,Not Classified,Notified C&L,42,Not classified:42
98283,"[2-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium methyl sulphate",253-636-8,37713-38-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H411:2;H302:2;H319:2
98285,"[1aR-(1aα,4α,4aβ,7bα)]-1a,2,3,4,4a,5,6,7b-octahydro-1,1,4,7-tetramethyl-1H-cycloprop[e]azulene",207-695-1,489-40-7,Not Classified,Notified C&L,127,Not classified:109;H304:18
98286,Luxol™ Brilliant Green BL,615-464-5,71799-14-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 1B,Notified C&L,38,H311:38;H350:38;H331:38;H301:38
98288,Methyl 6-quinolyl ether,226-077-2,5263-87-6,,Notified C&L,9,H335:8;H315:9;H319:9;H312:2;H302:2;H332:2
98289,"Tall oil, reaction products with diethylenetriamine, acetates",305-518-3,94581-19-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2
98290,"Manganese, 2-ethylhexanoate isooctanoate complexes",291-589-5,90431-63-3,Not Classified,Notified C&L,1,Not classified:1
98296,Dicesium tungsten tetraoxide,237-019-0,13587-19-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,28,H335:27;H315:27;H302:27;H319:27;Not classified:1;H361:1
98298,"1,1,3,3-tetramethyl-1,3-divinyldisiloxane",220-099-6,2627-95-4,Flam. Liq. 2;Repr. 2,REACH registration C&L,140,H361:28;H225:121;H335:47;H315:49;H319:49;H413:13;H226:20;H312:1;H302:1;H412:1;H332:1
98299,Dipotassium tetrachloropalladate,233-049-3,10025-98-6,Acute Tox. 3;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,129,H410:83;H318:83;H400:83;H317:83;H301:83;H335:43;H315:41;H319:46;H302:3;H290:3;H312:1;H413:1;H332:1
98318,"Fatty acids, C16-24 and C16-24-unsatd., Me esters",297-410-7,93571-83-6,Not Classified,Notified C&L,21,Not classified:21
98320,"1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylindenemethyl) piperidine",601-652-4,120014-07-5,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Repr. 2,Notified C&L,1,H312:1;H361:1;H302:1;H319:1;H317:1;H332:1
98321,"4-amino-5-hydroxy-3-[(4-nitrophenyl)azo]-6-(phenylazo)naphthalene-2,7-disulphonic acid, sodium salt",280-105-8,83006-55-7,Not Classified,Notified C&L,3,Not classified:3
98322,sec-butylamine;2-aminobutane,237-732-7,13952-84-6,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H302:0;H400:0;H314:0;H225:0;H332:0
98323,2-chloro-9-[3-(dimethylamino)propyl]thioxanthen-9-ol,224-302-9,4295-65-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,41,H335:40;H315:40;H302:2;H319:40;H301:1
98327,4-cyanophenyl 4-trans-(4-ethylcyclohexyl)benzoate,289-491-2,89331-97-5,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
98329,Methyl 3-methoxyisobutyrate,223-359-7,3852-11-7,Flam. Liq. 3,Notified C&L,2,H226:2;H319:1
98331,Esterification product of pentaerythritol with disproportionated tall oil fatty acids and sunflower oil fatty acids conjugated,920-355-3,,Not Classified,Notified C&L,71,Not classified:71
98332,4-phenylpiperidine-4-methanol,224-161-3,4220-08-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H335:1;H318:1;H315:1;H302:1
98334,"1,4-dihydro-3,5-diiodo-4-oxo-1-pyridylacetic acid",202-932-5,101-29-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
98336,"Sulfite liquors and Cooking liquors, spent, Kiliani reaction products",271-016-5,68513-75-7,Not Classified,Notified C&L,59,Not classified:59
98337,Propyl octanoate,210-830-7,624-13-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;Not classified:1
98338,Ammonium Laureth Sulfate,608-760-0,32612-48-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,603,H315:544;H319:299;H318:245;Not classified:92;H412:1
98339,"Phosphatase, acid",232-630-9,9001-77-8,Resp. Sens. 1,Notified C&L,5,H334:5
98345,"Iron(1+), chloro[dimethyl 9,9-dihydroxy-3-methyl-2,4-di(2-pyridinyl-kN)-7-[(2-pyridinyl-kN)methyl]-3,7-diazabicyclo[3.3.1]nonane-1,5-dicarboxylate-kN3,kN7]-, chloride",610-388-9,478945-46-9,Acute Tox. 3;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,75,H412:75;H373:75;H317:75;H301:75
98346,"1,2,3,4,4a,5,6,7-octahydro-2,5,5-trimethyl-2-naphthol",255-256-8,41199-19-3,Not Classified,Notified C&L,175,Not classified:112;H412:62;H315:63;H411:1;H319:1
98350,"2-methyl-2H-1,2,3,4-tetrazol-5-amine",612-169-3,6154-04-7,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H228:1;H315:1;H319:1
98352,β-2-thienyl-DL-alanine,217-967-1,2021-58-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
98356,Bis(4-nitrophenyl) sulphide,214-950-0,1223-31-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H318:38;H302:39
98365,"(E,Z)-2,6-dimethylocta-2,4,6-triene",230-603-6,7216-56-0,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H400:2;H315:2;H317:2;H304:2
98371,2-bromo-5-chlorothiophene,220-708-5,2873-18-9,,Notified C&L,5,H312:4;H302:4;H319:5;H315:5;H332:4
98372,2-hydroxypropan-1-aminium 12-{2-[2-(sulfonatooxy)ethoxy]ethoxy}dodecylidyne,617-428-4,83016-76-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,26,H318:23;H315:23;H319:3
98376,Ethyl 2-hydroxyvalerate,230-066-8,6938-26-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:38;H315:40;H319:39
98384,"Rape oil, sulfonated, ammonium salt",307-046-3,97489-07-1,Not Classified,Notified C&L,1,Not classified:1
98385,"(17α)-13-ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one",258-936-2,54048-10-1,Carc. 2;Repr. 1B,Notified C&L,103,H360:103;H351:66;H410:36;H312:17;H411:17;H332:17;H361:1;H362:2;H372:1;H302:1
98386,Difenoxuron,238-068-0,14214-32-5,Acute Tox. 4;Acute Tox. 3,Notified C&L,38,H331:38;H302:38
98387,m-tolyl-2-thiourea,210-686-5,621-40-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2;H302:1
98390,"1H-Indole, 3-(4-fluorophenyl)-1-(1-methylethyl)-",618-987-7,93957-49-4,Aquatic Chronic 4,Notified C&L,4,H413:4
98400,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, [2-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]ethyl]amino sulfo derivs., sodium salts",272-705-3,68909-43-3,Not Classified,Notified C&L,1,Not classified:1
98401,1-(1-oxopropyl)-1H-indole,277-583-5,73747-53-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H315:38;H302:38
98402,"reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)",407-890-3,111381-11-4,Aquatic Chronic 4,Harmonised C&L,0,H413:0
98403,"5-[[4-chloro-6-[[4-(vinylsulphonyl)phenyl]amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(2-sulphophenyl)azo]naphthalene-2,7-disulphonic acid, sodium salt",303-151-3,94158-78-8,Not Classified,Notified C&L,5,Not classified:5
98408,"(S)-[2-(phenylmethoxy)propylidene]hydrazinecarboxylate, tert-butyle",439-220-0,,Acute Tox. 4,REACH registration C&L,1,H302:1
98417,"Amines, coco alkyldimethyl, N-oxides",263-016-9,61788-90-7,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,444,H318:443;H400:415;H315:427;H319:56;H302:17;H314:14;H311:14;H411:3
98418,3-Fluor-4-methoxyphenylessigsäure,610-231-4,452-14-2,Eye Dam. 1,Notified C&L,3,H318:2;Not classified:2;H335:1;H315:1;H319:1
98421,"3-[[3-[[(2-cyanoethyl)amino]methyl]-3,5,5-trimethylcyclohexyl]amino]propiononitrile",300-496-1,93940-97-7,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,85,H302:85;H319:85;H412:85;H373:2;H317:85
98424,"(R,S)-2-butyloctanedioic acid",431-210-4,50905-10-7,Eye Dam. 1,Harmonised C&L,0,H318:0
98425,Phenylselenol,211-457-2,645-96-5,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46,H410:46;H400:46;H373:45;H331:45;H301:46;H330:1
98429,5-chloro-2-mercaptobenzothiazole,226-235-0,5331-91-9,,Notified C&L,5,H335:4;H315:5;H319:5
98434,5-Chloro-2-iodoaniline,614-394-2,6828-35-9,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H335:44;H318:40;H315:45;H301:40;H312:5;H302:5;H319:5;H332:5;H412:1
98437,Bromotrichloromethane,200-886-0,75-62-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A,REACH registration C&L,133,H315:95;H302:132;H319:95;H312:42;H332:38;H331:5;H335:4;H301:1;H311:1
98438,"Alcohols, C9-11, branched and linear, ethoxylated, sulfates, ammonium salts",500-464-9,160901-27-9,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,17,H318:15;H315:16;H319:1;Not classified:1
98439,2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methylbenzothiazolium chloride,248-053-0,26850-47-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,37,H410:34;H400:34;H302:34;H319:36;H411:1;H301:1
98447,"Benzenesulfonic acid, mono-C11-13-branched alkyl derivs., calcium salts",273-234-6,68953-96-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,319,H312:191;H318:318;H411:201;H315:318;H302:22;H335:22;H336:22;H226:22;Not classified:1
98451,"1,4-Dihydroxy-2,3-naphthalenedicarbonitrile",600-244-3,1018-79-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
98452,"Octanal, 7-hydroxy-3,7-dimethyl-, reaction products with 1H-indole",272-683-5,68908-82-7,Aquatic Chronic 2,REACH registration C&L,120,H411:15;Not classified:80;H317:25;H319:25
98453,"Nona-2,4-dien-1-ol",263-571-7,62488-56-6,Not Classified,Notified C&L,88,Not classified:88
98454,"Motilin (pig), 13-l-norleucine-14-l-glutamic acid-",256-825-3,50881-15-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H332:38;H302:38
98456,"4,6-dichloro-o-cresol",216-382-9,1570-65-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H335:38;H318:38;H315:39;H302:39;H319:1;H400:1
98457,"Lubricating oils (petroleum), C",307-034-8,97488-95-4,Carc. 1B,Harmonised C&L,0,H350:0
98461,(3Z)-hex-3-en-1-yl 2-methylprop-2-en-1-yl ether,439-790-0,292605-05-1,Skin Irrit. 2,Notified C&L,38,H315:37;H226:1;H411:1
98462,"Petrolatum (petroleum), clay-treated;[A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C",309-706-6,100684-33-1,Carc. 1B,Harmonised C&L,0,H350:0
98463,Triammonium citrate,222-394-5,3458-72-8,Eye Irrit. 2A,REACH registration C&L,143,H319:136;H335:121;H315:121;Not classified:7
98464,propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate,431-000-2,198705-81-6,Aquatic Chronic 4,Harmonised C&L,0,H413:0
98466,"4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt",417-640-5,161935-19-9,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H318:0;H317:0
98467,"2-chlorobenzene-1,4-diammonium sulphate",228-291-1,6219-71-2,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,61,H317:25;H319:61;H302:7;H400:6;H315:10;H335:10;H410:6;H331:6;H301:6;H311:6;H312:3;H332:4
98468,5-chlorothiophene-2-sulfonyl chloride,700-248-6,2766-74-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,46,H318:39;H314:46;H290:1
98469,Hexadecylmalonic acid,224-466-1,4371-64-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
98470,Diethyl dipropylmalonate,227-998-2,6065-63-0,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H302:38;Not classified:1
98481,"Reaction products of pentaerythritol and trimethylol propane with 2-methylbutyric acid, n-pentanoic acid, n-heptanoic acid, 3,5,5 trimethylhexanoic acid, n-octanoic acid and n-decanoic acid",430-320-1,,Not Classified,Notified C&L,1,Not classified:1
98485,Dichloromethyl(2-phenylpropyl)silane,237-102-1,13617-28-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,13,H318:13;H315:13
98489,(±)-isomenthol,222-825-7,3623-52-7,Skin Irrit. 2,Notified C&L,72,H315:71;H319:1
98492,1-butylpyrrolidine,212-179-4,767-10-2,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H226:38;H311:38;H301:38
98494,"3-(3,4-dimethoxyphenyl)acrylonitrile",229-240-6,6443-72-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H332:38;H302:38
98496,"Bismuth, [μ-[carbonato(2-)-O:O']]dioxodi-, reaction products with acetylene, copper acetylide (Cu(C2)) and formaldehyde",270-469-6,68441-43-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H335:1;H332:1
98497,"Fatty acids, C18-unsatd., dimers, polymers with acetic acid and ethylenediamine",600-688-8,105839-21-2,Not Classified,Notified C&L,22,Not classified:22
98499,Aluminum magnesium oxide,234-386-9,11137-98-7,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,155,H318:1;H411:1;Not classified:154
98500,"9-Octadecenoic acid (Z)-, epoxidized, ester with propylene glycol",271-842-6,68609-92-7,Not Classified,Notified C&L,2,Not classified:2
98506,"1,2-diethoxybenzene",218-089-1,2050-46-6,Eye Irrit. 2A,REACH registration C&L,48,H319:9;H318:38;Not classified:1;H412:1
98508,Fludrocortisone,204-833-2,127-31-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,2,H312:2;H332:2;H361:2;H302:2;H319:1;H315:1;H335:1
98509,"Naphthalenesulfonic acid, polymer with formaldehyde",618-502-9,9017-33-8,Skin Corr. 1C;Eye Dam. 1,Notified C&L,3,H318:3;H314:3
98510,zinc 2-hydroxy-5-C,402-280-3,149144-82-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0;H319:0
98514,"Benzamide, N-[3-chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-methyl-",605-500-8,168079-32-1,Acute Tox. 4,Notified C&L,1,H302:1
98515,N-glycyl-L-tyrosine,211-525-1,658-79-7,Not Classified,REACH registration C&L,2,Not classified:2
98517,C.I. Solvent Blue 44,612-341-8,61725-69-7,Not Classified,Notified C&L,69,Not classified:69
98522,"2,2':6',2''-terpyridine",214-559-5,1148-79-4,Acute Tox. 1;Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H318:40;H315:45;H300:45;H335:44;H310:45;H319:5
98523,Dimethylfuran,249-235-2,28802-49-5,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H335:1;H225:1;H332:1
98524,"Octanoic acid, reaction products with 2-[(2-aminoethyl)amino]ethanol",274-839-8,70750-12-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:1;H318:1
98528,"Isotridecanol, ethoxylated",500-241-6,69011-36-5,Aquatic Chronic 3,REACH registration C&L,3016,H412:429;H318:2701;H302:2443;H315:229;H319:146;Not classified:16;H301:26;H411:6
98529,"4-Morpholineethanamine, hydrochloride (1:2)",611-095-9,5409-41-6,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B,REACH registration C&L,2,H311:2;H314:2;H302:2
98530,"1,3-Benzenedicarbonyl dichloride, 5,5'-[(1,3-dioxo-1,3-propanediyl)bis(methylimino)]bis[2,4,6-triiodo-",617-122-0,80601-33-8,,Notified C&L,1,Not classified:1
98531,Copper chromate,236-922-7,13548-42-0,Acute Tox. 4;Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,95,H410:95;H302:83;H400:95;H317:95;H350:95;H340:2;H319:2;H315:2
98533,4-bromobutan-1-ol,251-355-5,33036-62-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H225:40;H315:45;H319:45;H226:5;H302:1;H371:1
98538,"dichlobenil (ISO);2,6-dichlorobenzonitrile",214-787-5,1194-65-6,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H312:0;H411:0
98539,Cryofluorane,200-937-7,76-14-2,Press. Gas (Liq.),Notified C&L,119,H280:119;H420:39;H059:6
98540,Caesium carbonate,208-591-9,534-17-8,Eye Dam. 1;Repr. 2;STOT RE 2,REACH registration C&L,180,H361:98;H318:98;H373:97;H335:82;H315:83;H319:80;Not classified:2
98544,(Z)-hept-4-enal,229-779-7,6728-31-0,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1,Notified C&L,1500,H312:1286;H317:1286;H302:1286;H226:214
98548,"Yucca, ext.",290-449-0,90147-57-2,Not Classified,Notified C&L,143,Not classified:142;H319:1
98551,Methacryloyl chloride,213-058-9,920-46-7,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 1,REACH registration C&L,52,H225:52;H314:52;H302:50;H330:48;H412:40;H317:40;Not classified:1;H335:1;H318:1
98555,"Balsams, Canada, sulfurized, rhodium salts",294-749-2,91745-77-6,Flam. Sol. 1,Notified C&L,1,H228:1
98557,3-Dimethylamino-1-(3-pyridinyl)-2-propen-1-one,611-255-8,55314-16-4,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Notified C&L,92,H412:90;H373:90;H317:90;H302:91;H315:1;H319:1;H312:1
98560,"Soybean oil, ester with pentaerythritol",271-966-0,68647-68-7,Not Classified,Notified C&L,7,Not classified:7
98563,(2R)-but-3-yn-2-ol,610-091-4,42969-65-3,Flam. Liq. 3;Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 1;STOT SE 3;Carc. 2,Notified C&L,47,H335:44;H330:43;H318:39;H315:47;H317:38;H300:41;H226:46;H351:38;H319:8;H301:6;H311:4;H310:5;H412:2;H225:1
98566,"Amides, C12-22, N,N-bis(hydroxyethyl)",277-136-4,72968-36-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
98567,"Octadecanoic acid, 12-hydroxy-, homopolymer, ester with 1,2,3-propanetriol homopolymer",604-416-9,144470-58-6,Not Classified,Notified C&L,1,Not classified:1
98569,"2-chloro-1,3-dimethylbenzene",229-843-4,6781-98-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
98571,N-[4-(cyclopropylcarbamoyl)phenyl]sulfonyl-2-methoxybenzamide,619-679-5,221667-31-8,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,16,H412:16;H332:16
98577,"Glycerides, C16-22 mono-, di- and tri-",293-216-1,91052-55-0,Not Classified,Notified C&L,3,Not classified:3
98578,5-amino-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid,222-043-6,3326-34-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,84,H335:83;H315:84;H302:83;H319:84;H332:1
98590,"2-[2-[4-(diethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium dihydrogen phosphate",278-248-6,75535-16-9,Acute Tox. 3;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H410:4;H330:4;H318:4;H400:4;H301:2;H300:2;Not classified:1
98592,"6,8-dimethylnona-3,5-dien-2-one",274-446-1,70214-76-5,Skin Irrit. 2,REACH registration C&L,2,H315:2;H411:1
98599,"Glycerides, sunflower-oil mono- and di-",294-519-1,91723-15-8,Not Classified,Notified C&L,7,Not classified:7
98602,"4-trans-Methyl-4-trans-(3,4,5-trifluorphenyl)-[1,1-bicyclohexyl]",608-170-3,281680-30-6,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
98603,"Fatty acids, coco",262-978-7,61788-47-4,Eye Irrit. 2,Notified C&L,1026,H319:792;H315:165;Not classified:148;H412:84;H318:86
98606,Alcohol ethoxylate phosphate ester,615-892-2,73038-25-2,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,488,H412:217;H318:412;H315:401;H411:172;H314:81;Not classified:6;H400:4
98608,3-methylbenzophenone,211-401-7,643-65-2,Not Classified,Notified C&L,2,Not classified:2
98609,"1,1,1,3,3,3-hexafluoropropane",425-320-1,690-39-1,Press. Gas (Liq.),REACH registration C&L,5,H280:5;H336:2
98610,Allyltrimethoxysilane,219-855-8,2551-83-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,69,H226:68;H335:46;H315:42;H319:47;H302:5
98613,"Ethyl 2,6-dimethyl-4-morpholinepropionate",275-234-1,71172-51-5,Acute Tox. 4,Notified C&L,38,H302:38
98616,Dihydrogen wolframate,231-975-2,7783-03-1,Not Classified,REACH registration C&L,130,Not classified:42;H335:89;H319:89;H315:6
98618,"2-[2-(2,3-dihydro-5-methoxy-2,3,3-trimethyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium chloride",254-190-7,38926-38-4,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H318:42;H410:42;H400:33;H301:42
98621,"(methyl-1,3-phenylene)bis[iminocarbonyloxy-2,1-ethanediyloxy-4,1-phenylene(1-methylethylidene)-4,1-phenyleneoxy-2,1-ethanediyl] diacrylate",288-695-9,85865-95-8,Not Classified,Notified C&L,1,Not classified:1
98622,C.I. Acid Brown 191,612-241-4,61724-16-1,Not Classified,Notified C&L,2,Not classified:2
98625,"1-Propanaminium, 2-hydroxy-N-(2-hydroxypropyl)-N,N-dimethyl-, diesters with vegetable-oil fatty acids, Me sulfates (salts)",305-741-6,95009-13-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,22,H315:22;H319:21;H318:1
98630,"1H-Pyrrolizine-1,7-dicarboxylic acid, 2,3-dihydro-",613-969-5,66635-69-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1,H302:1;H319:1
98631,2-bromododecane,236-142-7,13187-99-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
98634,Pentyl valerate,218-528-7,2173-56-0,Not Classified,REACH registration C&L,165,Not classified:140;H315:25
98639,Hept-3-enoic acid,249-943-1,29901-85-7,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H290:1;H314:1
98643,Z-75,481-890-1,,Not Classified,Notified C&L,442,Not classified:442
98644,"Aconitum napellus, ext.",283-252-6,84603-50-9,,Notified C&L,1,H225:1;H332:1;H302:1
98649,"1,2-dichloroethane;ethylene dichloride",203-458-1,107-06-2,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B,Harmonised C&L,0,H302:0;H319:0;H315:0;H350:0;H335:0;H225:0
98652,Oleonitrile,204-016-0,112-91-4,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,37,H410:4;H400:37;H315:37
98658,"Isooctanoic acid, zinc salt, basic",282-777-8,84418-65-5,Skin Irrit. 2,Notified C&L,20,H315:18;Not classified:2
98659,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, [[3-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-sulfophenyl]amino]sulfonyl aminosulfonyl sulfo derivs., sodium salts",307-996-9,97808-75-8,Not Classified,Notified C&L,10,Not classified:10
98660,Tributylstannyl benzoate,224-399-8,4342-36-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H410:39;H319:39;H400:39;H315:39;H372:39;H301:39;H311:39;Not classified:1
98661,"Silane, trichlorooctyl-, branched",292-176-2,90552-53-7,Skin Corr. 1;Eye Dam. 1,Notified C&L,14,H318:14;H314:14
98662,"Phenol, isobutylenated",271-847-3,68610-06-0,Skin Corr. 1B;Skin Sens. 1,Notified C&L,59,H314:59;H317:53;H341:6;H410:6;H318:6;H373:6;H331:6;H301:6;H311:6;H361:1;H335:1;H411:1
98663,"α,α,α-trifluoro-m-cresol",202-645-5,98-17-9,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,90,H412:44;H318:7;H314:49;H302:13;H335:39;H315:40;H319:38;H312:43;H301:35;H332:7;Not classified:1;H311:1;H331:1;H227:1
98664,2-cyclohexylaminoethanol,220-636-4,2842-38-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H335:42;H318:38;H315:43;H302:38;H319:5
98665,C.I. Direct Red 224,602-232-3,12222-48-9,Not Classified,Notified C&L,5,Not classified:5
98666,"1,4-Pentadien-3-one, 1,5-diphenyl-, (1E,4E)-",609-096-4,35225-79-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
98671,"Poly(oxy-1,2-ethanediyl), α-sulfo-ω-(dodecylphenoxy)-, sodium salt (1:1)",611-814-6,59269-54-4,Not Classified,Notified C&L,36,Not classified:36
98672,Tritylnorfloxacin,926-957-2,,Not Classified,Notified C&L,1,Not classified:1
98674,Methyl valerate,210-838-0,624-24-8,Flam. Liq. 3;Skin Sens. 1B,REACH registration C&L,1595,H226:14;H317:2;H225:1579;H331:38;H332:7;Not classified:1;H224:1
98676,Gabapentin,262-076-3,60142-96-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,103,H335:60;H360:56;H315:58;H319:67;Not classified:32;H361:10;H350:2;H351:6;H362:1;H312:1;H302:1;H332:1;H317:1
98677,"3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one",613-192-1,63234-80-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H315:3;H319:3;H335:2
98681,N-[2-[(2-chloro-4-nitrophenyl)azo]-5-(diethylamino)phenyl]acetamide,274-697-7,70609-95-9,Not Classified,Notified C&L,1,Not classified:1
98686,"Benzyl 3-isobutyryloxy-1-isopropyl-2,2-dimethylpropyl phthalate",240-920-1,16883-83-3,Not Classified,Notified C&L,87,Not classified:84;H410:3;H400:3;H302:3
98690,Pyridine-2-carbaldehyde,214-333-6,1121-60-4,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,71,H302:71;H318:57;H314:22;H317:68;H331:10;H341:1;H330:55;H411:18;H315:49;H335:47;H226:13;H312:1;H319:2;H332:1
98692,Melaleuca quinquenervia extract,616-951-5,8014-68-4,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,93,H317:93;H411:93;H304:93;H315:3;H226:3;H319:1
98695,"Dodecanoic acid, C12-18-alkyl esters",291-193-2,90342-54-4,Not Classified,Notified C&L,6,Not classified:6
98696,"Gases (petroleum), Girbotol unit feed;Petroleum gas;[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]",270-778-6,68477-95-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
98698,2-methyl-1H-pyrrole,211-255-4,636-41-9,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 3;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1;H301:1;H331:1;H226:1;H311:1
98701,2-Ethoxy-5-nitropyridine,608-647-6,31594-45-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
98702,Acetoxytrimethylsilane,220-404-2,2754-27-0,Flam. Liq. 2,REACH registration C&L,48,H225:48;H315:1;H319:1;H332:1
98703,2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one,425-150-8,94723-86-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3;Repr. 1B,Harmonised C&L,0,H412:0;H317:0;H360:0;H302:0
98705,"Kerosine (petroleum), hydrodesulfurized thermal cracked;Cracked kerosine;[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C",285-507-7,85116-55-8,Asp. Tox. 1,Harmonised C&L,0,H304:0
98708,4-(Dimethylamino)butyraldehyde Dimethyl Acetal,606-363-7,19718-92-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
98710,Dimethylpiperazine,246-682-5,25155-35-5,,Notified C&L,33,Not classified:33
98711,"1-amino-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-4-[(2,4,6-trimethylphenyl)amino]anthraquinone",275-875-7,71701-33-2,Not Classified,Notified C&L,2127,Not classified:2127
98720,3-hydroxy-4-[[2-methyl-5-[(1-methylethoxy)carbonyl]phenyl]azo]-2-naphthoic acid,280-458-8,83487-95-0,Not Classified,REACH registration C&L,2,Not classified:2
98723,"2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2,4-triazolidine-3-thione",606-964-4,222408-90-4,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H317:1;H413:1
98724,"5-(2-chloroethyl)-4-methyl-1,3-thiazole hydrochloride (1:1)",611-928-6,6001-74-7,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,44,H318:39;H317:39;H302:43;H335:4;H412:4;H319:4;H315:2
98725,Sodium toluene-4-sulphonate,211-522-5,657-84-1,Eye Irrit. 2,REACH registration C&L,392,H319:376;H312:235;H341:235;H410:235;H400:235;H317:235;H301:235;H332:235;H351:235;H315:70;Not classified:15;H335:8;H318:1;H302:1
98728,N-acetyl-2-fluoro-3-phenyl-DL-alanine,266-409-3,66574-84-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
98734,"reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate",410-070-8,141880-36-6,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H317:0
98735,Methyl L-tyrosinate hydrochloride,222-313-3,3417-91-2,Not Classified,REACH registration C&L,82,Not classified:3;H335:78;H315:79;H319:79
98736,colchicine,200-598-5,64-86-8,Acute Tox. 2;Muta. 1B,Harmonised C&L,0,H340:0;H300:0
98737,Cerium tris(2-ethylhexanoate),260-386-3,56797-01-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,762,H312:544;H302:544;H315:745;H335:564;H332:544;H319:59;Not classified:13;H361:4
98738,"3-mercapto-6-methyl-1,2,4-triazin-5(2H)-one",210-445-4,615-76-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:1;H302:2;H335:1;H315:1;H319:1
98740,2-chlorobenzohydrazide,227-380-2,5814-05-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
98742,"3,4,5,6-tetrafluorobenzene-1,2-dicarbonitrile",217-400-8,1835-65-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H312:39;H302:39;H319:40;H315:40;H335:39;H332:39;H301:1
98743,(tris[2-(2-hydroxyethoxy)ethyl] borate ),615-244-9,71035-05-7,,REACH registration C&L,2,H302:2
98745,Bis(dodecylthio)dioctylstannane,244-841-3,22205-30-7,Acute Tox. 4;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,91,H412:4;H302:91;H372:26;H317:87;H413:87;H361:22;H373:10
98746,Ethyl trans-2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate,257-522-9,51931-66-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Resp. Sens. 1;STOT RE 2,Notified C&L,1,H312:1;H302:1;H334:1;H373:1;H332:1
98751,"1,2-Ethylenediphosphonic Acid",620-149-0,6145-31-9,,Notified C&L,5,H314:5;H318:1;H290:1
98756,"2-Pentanone, 4-methyl-, reaction products with 2-(2-aminoethoxy)ethanol",615-768-8,72480-17-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,11,H318:2;H314:2;H302:2;Not classified:9
98759,Indan-2-ol,224-230-8,4254-29-9,,Notified C&L,8,H302:7;H319:7;H315:3;Not classified:1
98764,"2,6-dimethoxy-3-nitrobenzoic acid",259-814-1,55776-17-5,,Notified C&L,4,H335:4;H315:4;H319:4
98765,"2,7-Naphthalenedisulfonic acid, 5-[[4-[[5-amino-4-sulfo-2-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[2-(1-sulfo-2-naphthalenyl)diazenyl]-, sodium salt (1:5)",610-205-2,446300-47-6,Not Classified,Notified C&L,1,Not classified:1
98766,"α,α-difluoro-p-methylanisole",216-434-0,1583-83-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
98767,"Fatty acids, C8-10, compds. with 2-(diethylamino)ethanol",297-418-0,93571-90-5,Not Classified,Notified C&L,54,Not classified:54
98768,BENZOXAZINE (R52/53),604-960-7,154505-70-1,Aquatic Chronic 3,Notified C&L,9,H412:9
98771,"Creosote oil, high-boiling distillate;Wash Oil;[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5°C (41°F).]",274-565-9,70321-79-8,Carc. 1B,Harmonised C&L,0,H350:0
98777,"2-Propenenitrile, reaction products with 2,2,4(or 2,4,4)-trimethyl-1,6-hexanediamine",292-059-6,90530-20-4,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,30,H318:10;H314:30;H411:10;H302:30;H412:20;H317:20
98778,Henicosafluoro-10-iododecane,207-030-5,423-62-1,,Notified C&L,92,Not classified:47;H335:44;H315:45;H319:45
98784,"2-Propenoic acid, 2-methyl-, butyl ester, polymer with ethenylbenzene and 2-ethylhexyl 2-propenoate",607-979-9,26655-10-7,,Notified C&L,1,Not classified:1
98787,"9-Octadecenoic acid (Z)-, ester with 2,2-dimethyl-1,3-propanediol",268-008-9,67989-24-6,Not Classified,Notified C&L,48,Not classified:48
98790,"Alcohols, C12-18, ethoxylated and propoxylated",500-242-1,69227-21-0,Eye Irrit. 2,Notified C&L,241,H319:91;Not classified:58;H318:64;H400:90;H312:22;H302:23;H412:13;H315:36;H410:1
98791,"Sulfuric acid, mono-C18-28-alkyl esters, ammonium salts",306-338-8,97102-88-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,7,H315:7;H319:7
98793,6-hexyltetrahydro-2H-pyran-2-one,211-915-1,710-04-3,Not Classified,REACH registration C&L,1506,Not classified:1464;H335:41;H315:42;H319:42
98796,"7-chloroquinoline-3,8-dicarboxylic acid",618-628-4,90717-07-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H335:2;H315:2;H302:2;H319:2
98801,"(2,5-difluorophenyl)acetonitrile",274-051-4,69584-87-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H312:43;H302:43;H319:44;H315:44;H335:43;H332:43;H301:2;H330:1;H311:1
98805,Benzyl formate,203-214-4,104-57-4,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,1697,H315:15;H302:1697;H312:47;H226:1;H225:1
98807,"(R)-5-(1,5-dimethyl-4-hexenyl)-o-cresol",250-090-2,30199-26-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Repr. 1B,Notified C&L,1,H335:1;H360:1;H315:1;H319:1
98810,"1-phenylpentane-1,3-dione",226-232-4,5331-64-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H335:2;H315:2;H302:2;H319:2
98812,"Bis(pentane-2,4-dionato-O,O')iron",237-851-4,14024-17-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
98817,"1,4-dinitrosopiperazine",205-434-6,140-79-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Carc. 1B,Notified C&L,2,H319:2;H315:2;H350:2;H301:2;H335:2
98821,Sodium (Z)-N-9-octadecyl-β-alaninate,262-515-9,60884-97-1,Acute Tox. 4;Skin Corr. 1B,Notified C&L,33,Not classified:33;H314:33;H302:33
98825,"Decanoic acid, mixed triesters with octanoic acid and trimethylolpropane",297-291-1,93384-77-1,Not Classified,Notified C&L,1,Not classified:1
98826,2-Amino-5-bromo-3-nitropyridine,614-971-9,6945-68-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44;H302:4
98829,Acrinathrin,600-147-6,101007-06-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,127,H332:127;H400:127;H410:127
98835,2-[ethyl[4-[(4-nitrophenyl)azo]phenyl]amino]ethanol,220-704-3,2872-52-8,Skin Sens. 1,Notified C&L,77,H317:75;H315:32;Not classified:2
98838,"2,4,5-TB",202-278-0,93-80-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H302:38;H319:38
98839,"3,6,9-trithiaundecamethylene-1,11-dimethacrylate",432-210-7,141631-22-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
98845,"2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)-, pentanedioate (salt)",469-910-7,,Eye Dam. 1;Muta. 2;Carc. 1B;Repr. 2;Aquatic Chronic 3,REACH registration C&L,3,H341:3;H361:3;H412:3;H318:3;H350:3
98847,"Ethanol, 2,2'-[[3-chloro-4-[2-(2,6-dibromo-4-nitrophenyl)diazenyl]phenyl]imino]bis-",610-874-0,52623-75-3,Not Classified,Notified C&L,1,Not classified:1
98848,REZOLYN,447-770-8,,Acute Tox. 4;Skin Corr. 1B;Muta. 2;Aquatic Chronic 2,Notified C&L,1,H341:1;H302:1;H411:1;H314:1;H317:1
98850,5-chloro-2-nitrobenzoic acid,219-738-1,2516-95-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,REACH registration C&L,50,H302:41;H318:41;H400:41;H315:50;H335:49;H319:9;Not classified:2
98853,Methyl 8-quinolyl ether,213-341-7,938-33-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
98854,"D-Alloisoleucine, methyl ester, hydrochloride (1:1)",612-007-1,60667-85-8,Not Classified,Notified C&L,11,Not classified:11
98855,"Sodium [2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)] chromate(1-)",277-508-6,73507-65-0,Not Classified,Notified C&L,6,Not classified:4;H411:2;H319:2
98856,(2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide,618-534-3,90357-06-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,196,H335:181;H315:182;H319:182;H411:5;H360:14;H351:13;H400:1;H372:3;H301:1;H373:2;H302:1;H410:2
98857,Dibenzyl trithiocarbonate,460-390-7,,Flam. Liq. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H410:1;H319:1;H336:1;H400:1;H317:2;H225:1;H413:1
98860,Ethyl cyanoacetylcarbamate,229-615-4,6629-04-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H312:39;H302:39;H319:39;H315:39;H335:39;H332:39
98870,Isopropylhydrazine monohydrochloride,240-784-3,16726-41-3,Acute Tox. 3,Notified C&L,44,H301:39;H312:3;H302:4;H319:4;H315:4;H335:3;H332:4
98875,(3-aminophenyl)pyridin-3-ylmethanone,428-230-0,79568-06-2,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H400:0;H410:0
98876,4-chloro-5-chlorosulphonyl-3-nitrobenzoic acid,245-309-3,22892-95-1,Eye Dam. 1,Notified C&L,38,H318:38
98877,Isophthaldiamide,217-104-9,1740-57-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H335:1;H332:1
98881,"Butane-1,4-disulfonic acid",700-472-4,27665-39-0,Skin Corr. 1B;STOT SE 3,Notified C&L,39,H335:38;H314:39
98882,1-(2-Ethyl-butyl)-cyclohexanecarboxylic acid,619-508-4,381209-09-2,Flam. Liq. 3;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,2,H226:2;H412:2;H302:2
98887,"2,6-dibromo-4-fluorophenol",206-451-1,344-20-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H312:39;H302:43;H319:43;H315:43;H335:42;H332:39
98888,Fenamole,226-780-4,5467-78-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:39;H319:39;H335:1;H315:1
98892,"2,2,3,4,4,4-hexafluorobutan-1-ol",206-842-7,382-31-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,201,H302:194;H319:201;H315:201;H335:200;H332:194;H226:6
98894,Divinyl sulphone,201-057-6,77-77-0,Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,52,H318:41;H315:42;H300:51;H335:42;H310:52;H319:4;H314:10;H341:3;Not classified:2;H301:1
98898,"methyl 6-chloro- 4-hydroxy- 2-methyl- 2H-thieno [2,3-e][1,2] thiazine-3- carboxylate 1,1-dioxide",615-114-1,70415-50-8,Acute Tox. 3;Aquatic Chronic 3,Notified C&L,2,H412:1;H301:1;H332:1
98900,2-(2-methoxyethoxy)aniline,276-852-4,72806-66-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H335:1;H332:1
98903,"1,3-dimethyl-4-piperidone",225-046-0,4629-80-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1
98909,Butvar B-98,613-158-6,63148-65-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,776,H335:638;H315:658;H319:690;Not classified:86
98912,1-methylpyrene,219-178-8,2381-21-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:41;H315:42;H319:42;H312:1;H302:1;H332:1
98914,Molybdenum diboride,234-502-8,12007-27-1,Not Classified,Notified C&L,2,Not classified:2
98920,"α-d-Glucopyranoside, β-d-fructofuranosyl, benzoate",235-795-5,12738-64-6,STOT RE 2,REACH registration C&L,60,H373:7;Not classified:52;H360:1;H413:1
98923,4'-chlorovalerophenone,246-566-4,25017-08-7,Acute Tox. 4;Skin Sens. 1,Notified C&L,42,H317:38;H302:38;H335:4;H315:4;H319:4
98924,sodium dithionite;sodium hydrosulphite,231-890-0,7775-14-6,Self-heat. 1;Acute Tox. 4,Harmonised C&L,0,H251:0;H302:0
98925,Diethyl benzylphosphonate,214-097-4,1080-32-6,,Notified C&L,4,H335:4;H315:4;H319:4
98933,"(1’S, 2R)-2-(1’, 2’-Dihydroxyethyl)-6-fluorochromane",608-458-9,303176-43-4,Not Classified,REACH registration C&L,2,Not classified:1;H412:1
98937,lithium perfluorooctane sulfonate;lithium heptadecafluorooctanesulfonate,249-644-6,29457-72-5,Acute Tox. 4;Acute Tox. 4;Carc. 2;Lact.;STOT RE 1;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0,H302:0;H411:0;H372:0;H362:0;H360:0;H332:0;H351:0
98938,"3-[(2,2-Dimethyl-1,2-azasilolidin-1-yl)(dimethyl)silyl]-1-propanamine",609-592-0,388606-32-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,34,H312:34;H302:34;H318:34;H315:34;H317:34
98939,(2R)-2-(4-{[[]5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoic acid,617-435-2,83066-88-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H335:1;H412:1;H315:1;H319:1
98955,"Fatty acids, C14-18 and C16-18-unsatd., esters with ethylene glycol",288-459-5,85736-49-8,Not Classified,Notified C&L,90,Not classified:90
98956,hydroxylamine 4-methylbenzenesulfonate,258-872-5,53933-48-5,Expl. 1.1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Carc. 2;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0,H312:0;H302:0;H319:0;H400:0;H315:0;H317:0;H373:0;H351:0;H201:0
98957,Clays,603-400-9,1302-87-0,Not Classified,Notified C&L,37,Not classified:37
98958,"N,N,N'-tris(1-methylpropyl)benzene-1,4-diamine",264-857-4,64381-97-1,,Notified C&L,33,Not classified:33
98961,Iron tris(isononanoate),297-968-1,93776-39-7,Not Classified,Notified C&L,2,Not classified:2
98969,TETRABROMOBISPHENOL A DIGLYCIDYL ETHER,614-817-0,68928-70-1,,Notified C&L,56,Not classified:36;H315:20;H319:20
98973,2-methyl-1-phenylpiperazine,220-961-1,2946-76-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:39;H319:38;H335:1;H318:1;H315:1
98979,Methyl N-benzyl-N-(3-methoxy-3-oxopropyl)-β-alaninate,212-343-5,793-19-1,Acute Tox. 4,Notified C&L,46,H302:46;H341:7;H319:7;H317:7;H226:7
98984,"bromoxynil heptanoate (ISO);2,6-dibromo-4-cyanophenyl heptanoate",260-300-4,56634-95-8,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H361:0;H410:0;H302:0;H400:0;H317:0;H332:0
98985,4-nitrophenol;p-nitrophenol,202-811-7,100-02-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT RE 2,Harmonised C&L,0,H312:0;H373:0;H332:0;H302:0
98988,[No public or meaningful name is available],471-940-0,,Not Classified,Notified C&L,6,Not classified:6
98990,Otilonium bromide,247-457-4,26095-59-0,Acute Tox. 4,Notified C&L,3,H302:3;H312:1;Not classified:1;H332:1
98991,Trifluoro(pentafluoroethoxy)ethylene,234-018-7,10493-43-3,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,6,H220:6;H280:6;H332:1
98992,2-methylquinazolin-4(1H)-one,217-189-2,1769-24-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H302:40;H319:40
98993,2-bromo-4-butanolide,225-764-4,5061-21-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
98995,"1,1,3,3-tetramethyl-1-vinyldisiloxane",259-923-4,55967-52-7,,Notified C&L,1,H335:1;H225:1;H315:1;H319:1
98997,1-(tert-Butoxycarbonyl)piperidine,616-270-3,75844-69-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,41,H319:41;H400:38;H315:41;H301:38;H335:40
99000,3-ethyl-3-methylglutaric anhydride,230-194-4,6970-57-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
99003,3-methylisothiazol-5-amine,246-176-4,24340-76-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H335:1;H302:1;H319:1;H315:1;H226:1;H332:1
99006,"3,3'-[[4-[(2-chloro-4-nitrophenyl)azo]-3-methylphenyl]imino]bispropiononitrile",224-303-4,4297-28-3,Skin Sens. 1,Notified C&L,1,H317:1
99011,"reaction mass of (2S,3R,4S,5R)-2-[(2R)-2-hydroxypropyl]tetrahydro-2H-pyran-3,4,5-triol and (2S,3R,4S,5R)-2-[(2S)-2-hydroxypropyl]tetrahydro-2H-pyran-3,4,5-triol",456-880-5,,Not Classified,REACH registration C&L,3,Not classified:3
99012,"Dihydro-3-(nonenyl)furan-2,5-dione",249-317-8,28928-97-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
99013,"4,5-dimethoxy-1,3-dimethylimidazolidin-2-one",236-678-1,13464-10-3,Not Classified,Notified C&L,1,Not classified:1
99014,"triticonazole (ISO);(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol",603-543-7,131983-72-7,Aquatic Chronic 2,Harmonised C&L,0,H411:0
99018,"Ethylenediamine, N1-BOC protected",611-490-6,57260-73-8,Skin Corr. 1B,Notified C&L,52,H314:51;H318:3;H335:2;H315:2;H319:2
99020,"4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]-α,α-dimethyl-ethyl ester benzeneacetic acid",616-391-1,76812-02-7,Not Classified,REACH registration C&L,1,Not classified:1
99026,Ethyl 4-cyanobenzoate,230-500-6,7153-22-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H312:39;H302:39;H319:39;H315:39;H335:38;H332:39
99028,"1,3-Benzenediol, 4-[(3R)-3,4-dihydro-8,8-dimethyl-2H,8H-benzo[1,2-b:3,4-b']dipyran-3-yl]-",611-908-7,59870-68-7,,Notified C&L,39,Not classified:38;H312:1;H332:1;H302:1
99029,2-amino-2-cyanoacetamide,229-771-3,6719-21-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Notified C&L,40,H312:38;H302:38;H319:38;H411:38;H315:38;H335:38;H332:38;H318:1;H314:2;H301:2;H311:1;H331:1
99032,2-naphthylamino-6-sulfomethylamide,412-120-4,104295-55-8,Skin Sens. 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H317:0;H411:0
99035,"4,7,13,18-tetraoxa-1,10-diazabicyclo[8.5.5]icosane",250-531-9,31250-06-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H312:38;H302:38;H319:38;H315:38;H335:38;H332:38
99036,Tripotassium hexachlororuthenate,246-983-1,25443-63-4,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H335:42;H332:38;H315:42;H319:42
99039,"2-butyl-2-ethyl-1,5-diaminopentane",412-700-7,137605-95-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H312:0;H302:0;H412:0;H373:0;H314:0;H317:0
99043,Ethoxydimethylsilane,238-921-7,14857-34-2,Flam. Liq. 2;Skin Irrit. 2,Notified C&L,98,H225:98;H315:60;H335:5;H319:5
99044,"Fatty acids, C18-unsatd., dimers, reaction products with m-phenylenebis(methylamine)",500-340-4,157627-90-2,Not Classified,Notified C&L,1,Not classified:1
99052,"1,3-dimethylbarbituric acid",212-211-7,769-42-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,49,H318:49;H302:49
99053,Calcium 4-[(4-chloro-5-methyl-2-sulphonatophenyl)azo]-3-hydroxy-2-naphthoate,241-808-5,17852-99-2,Not Classified,Notified C&L,111,Not classified:111
99055,(2-thienylmethyl)amine,248-639-6,27757-85-3,Skin Corr. 1B,Notified C&L,45,H314:45;H318:2
99057,N-propylacetamide,226-231-9,5331-48-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
99060,cyprofuram (ISO);N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide,274-050-9,69581-33-5,Acute Tox. 3;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H410:0;H400:0;H301:0
99062,"Petasites hybridus, ext.",290-153-1,90082-63-6,Not Classified,Notified C&L,1,Not classified:1
99063,"2,4'-dichloro-2'-o-chlorobenzoylacetanilide",238-376-5,14405-03-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H400:38;H302:38;H319:38
99065,Dodecyl stearate,226-150-9,5303-25-3,Not Classified,Notified C&L,2,Not classified:2
99067,1-Ethenyl-3-methyl-1H- imidazolium chloride polymer with 1-ethenyl-2-pyrrolidone,619-671-1,95144-24-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,221,H400:221;H410:183
99071,"1-benzyl hydrogen (R)-pyrrolidine-1,2-dicarboxylate",229-021-5,6404-31-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,7,H335:6;H315:6;H319:6;Not classified:1
99079,"1,7-Naphthalenedisulfonic acid",611-488-5,5724-16-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,33,H318:33;H314:33
99085,1-chloro-3-(trichloromethyl)benzene,218-376-1,2136-81-4,,Notified C&L,33,Not classified:33
99088,"1,3-Bis(4-hydroxybutyl)-1,1,3,3-tetramethyldisiloxane",611-816-7,5931-17-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
99089,N-methoxymethylamine,214-255-2,1117-97-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H335:1;H315:1;H319:1
99090,bis(2-(2-methox­yethoxy)ethyl)ether; tetraglyme,205-594-7,143-24-8,Repr. 1B,Harmonised C&L,0,H360:0
99095,Lead carbonate,209-943-4,598-63-0,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,56,H302:56;H410:56;H400:53;H373:56;H360:56;H332:56
99096,p-cyanobenzamide,221-223-1,3034-34-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,246,H335:245;H315:246;H302:246;H319:246;H412:83
99097,"Lead, bullion",308-011-5,97808-88-3,Acute Tox. 4;Acute Tox. 4;Carc. 1A;Repr. 1A;Lact.;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,213,H302:129;H411:126;H372:210;H362:210;H350:128;H360:210;H332:129;H412:84;H317:84;H351:42;H410:3
99098,"Ballota lanata, ext.",294-747-1,91745-75-4,Flam. Liq. 3,Notified C&L,1,H226:1
99101,Diyttrium tricarbonate,209-119-4,556-28-5,Not Classified,REACH registration C&L,10,Not classified:10
99102,3-(methylsulphonyl)-2-oxoimidazolidine-1-carbonyl chloride,255-540-1,41762-76-9,Skin Corr. 1B,Notified C&L,40,H314:39;H335:1;H319:1;H318:1;H290:1
99103,"3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionic acid",243-556-1,20170-32-5,Acute Tox. 4,Notified C&L,33,H302:26;H335:7;H315:8;H319:8
99104,Tetrazepam,233-837-7,10379-14-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,5,H311:2;Not classified:2;H331:2;H301:2;H317:1;H336:1;H411:1;H302:2;H341:1;H410:1
99105,"[1aR-(1aα,4aα,7α,7aβ,7bα)]-decahydro-1,1,7-trimethyl-4-methylene-1H-cycloprop[e]azulene",207-694-6,489-39-4,Asp. Tox. 1,Notified C&L,8,H304:8
99107,3'-hydroxyacetophenone,204-494-0,121-71-1,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,135,H315:95;H319:95;H335:91;H302:42;H317:2
99108,Calcium disilicide,234-588-7,12013-56-8,Water-react. 2,Notified C&L,224,H261:216;H260:5;Not classified:3;H312:1;H302:1;H319:1;H315:1;H332:1
99111,"Bis[3-[(4-chlorophenyl)azo]quinoline--2,4(1H,3H)-dionato]nickel",257-521-3,51931-46-5,Not Classified,Notified C&L,5,Not classified:5
99116,C.I. Reactive Blue 220,603-268-2,128416-19-3,Not Classified,Notified C&L,3,Not classified:2;H317:1
99117,"1,1-diethoxypentane",222-909-3,3658-79-5,,Notified C&L,1,H226:1
99120,"Plantain, Plantago psyllium, ext.",284-643-4,84961-55-7,Not Classified,Notified C&L,1,Not classified:1
99124,"(4S,4aS,5aR,12aS)-9-amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride (1:1)",604-710-7,149934-21-4,Skin Sens. 1,REACH registration C&L,3,H317:3;H318:1;H400:1;H411:1;H360:1
99133,"1,7-dihydro-6H-purine-6-thione hydrate (1:1)",612-090-4,6112-76-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,59,H335:39;H315:39;H302:56;H319:39;H341:17;H360:11;H361:7;H301:3;H351:3;H331:1;H340:1;H372:1;H412:1;H362:1
99134,6-bromohex-1-ene,220-267-9,2695-47-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H226:50;H335:46;H315:48;H319:48;H302:1
99141,ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate;fenoxaprop-ethyl,266-362-9,66441-23-4,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0
99143,Calcium pyruvate,257-599-9,52009-14-0,Not Classified,REACH registration C&L,4,Not classified:4
99153,3-methylpiperidine,210-953-6,626-56-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,80,H335:42;H225:48;H315:43;H319:43;H412:32;H318:32;H314:37;H302:34
99162,"Fatty acids, babassu-oil, cetyl esters",612-124-8,613236-40-1,Not Classified,Notified C&L,1,Not classified:1
99163,2-chloropropyldimethylamine,203-554-3,108-14-5,Skin Corr. 1C,Notified C&L,2,H314:1;H335:1;H315:1;H302:1;H319:1
99165,"3(or5)-[[4-[benzylmethylamino]phenyl]azo]-1,2(or1,4)-dimethyl-1H-1,2,4-triazolium bromide",289-660-0,89959-98-8,,Notified C&L,31,H412:15;H318:23;H302:22;Not classified:4;H411:3;H315:3;H319:4
99169,"2,4-Dibromo-2,4-dimethyl-3-pentanone",605-680-8,17346-16-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
99171,"1,6-Heptadien-3-one, 2-cyclohexyl-",441-580-9,313973-37-4,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,17,H410:17;H319:1;H412:1;H400:14;H315:17;H318:16
99173,Methyl 3-methyl-4-nitrobenzoate,607-315-8,24078-21-5,Acute Tox. 4,Notified C&L,39,H302:38;H335:1;H315:1;H319:1
99174,Tribenzyl phosphite,604-823-1,15205-57-9,Not Classified,REACH registration C&L,2,H335:2;H315:2;H319:2
99175,Zinc iodide,233-396-0,10139-47-6,Skin Corr. 1B,Notified C&L,56,H314:53;H400:10;H410:5;H318:2;H335:2;H315:2;H319:2;Not classified:1
99176,Dodecyl lactate,228-504-8,6283-92-7,Eye Irrit. 2B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,160,H320:2;H411:3;H400:4;Not classified:152;H319:6
99180,1-(aminomethyl)cyclohexaneacetic acid hydrochloride,262-075-8,60142-95-2,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,3,H318:3;H314:3
99181,Sulphur hexafluoride,219-854-2,2551-62-4,Press. Gas (Liq.),REACH registration C&L,232,H280:232;H336:47;H335:5;H315:5;H319:5
99182,9-β-D-ribofuranosyl-9H-purine,208-981-9,550-33-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
99183,α-bromotoluic acid,228-343-3,6232-88-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:39;H315:39;H319:39;H314:7;H318:2
99184,Ethyl 1-methylpyrrole-2-carboxylate,245-677-5,23466-27-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
99185,"L-Serine, N2-(1-oxohexadecyl)-L-lysyl-L-threonyl-L-threonyl-L-lysyl-",606-757-9,214047-00-4,Not Classified,Notified C&L,36,Not classified:36
99186,"Benzenesulfonic acid, 2-methyl-5-nitro-, alkaline condition products",215-393-6,1325-37-7,Not Classified,Notified C&L,87,Not classified:74;H319:10;H317:3
99187,Ethyl L-serinate hydrochloride,247-624-1,26348-61-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H319:1
99188,Siduron,217-844-2,1982-49-6,,Notified C&L,42,Not classified:38;H335:3;H412:3;H315:3;H319:3;H410:1
99189,"Disodium 4-[[5-(aminocarbonyl)-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridyl]azo]-6-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]benzene-1,3-disulphonate",274-956-4,70865-29-1,Skin Sens. 1;Eye Irrit. 2,Notified C&L,29,H317:27;H319:27;Not classified:2
99193,Silicon,231-130-8,7440-21-3,Not Classified,REACH registration C&L,3258,Not classified:3140;H228:115;H335:5;H315:8;H319:9;H373:1
99194,"mexacarbate (ISO);3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate",206-249-3,315-18-4,Acute Tox. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H410:0;H300:0;H400:0
99197,Selenious acid,231-974-7,7783-00-8,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,205,H410:204;H400:202;H373:87;H331:204;H301:205
99205,"Cobaltate(3-), hexakis(cyano-.kappa.C)-, zinc (2:3), (OC-6-11)-",604-194-3,14049-79-7,Aquatic Chronic 1,Notified C&L,92,H410:84;H311:8;H411:8;H331:8;H301:8
99206,m-aminobenzenesulphonamide,202-646-0,98-18-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1
99208,1-iodohexane,211-339-0,638-45-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H335:43;H318:38;H315:44;H302:39;H319:6;H411:1;H312:1;H332:2
99213,"5-chloro-2,3,3-trimethyl-3H-indole",247-387-4,25981-83-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
99215,Bis(acetonitrile)dichloroplatinum,237-619-2,13869-38-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H312:38;H332:38;H302:38;H330:4;H334:5;H317:5;H301:4;H311:4;H340:1;H319:1;H315:1;H350:1;H300:1;H360:1;H362:1;H335:1
99217,1-(Tetrahydro-2-furoyl)piperazine,613-137-1,63074-07-7,Not Classified,Notified C&L,89,Not classified:42;H319:45;H335:4;H315:6;H373:1;H302:2;H312:1;H332:1
99219,"Synthetic resin, a reaction product of 4,4'-bis(N-maleimido)diphenylmethane with 3-aminobenzoic acid hydrazide",619-370-5,98725-11-2,Skin Sens. 1A;Acute Tox. 3;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H341:2;H410:2;H400:2;H317:2;H331:2
99227,3-methyldodecanonitrile,286-729-7,85351-07-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1377,H400:1297;H410:1298;Not classified:79;H315:1
99234,"6 alpha-Fluoro-16 alpha-methyl-21-valeryloxy-1,4,9(11)-pregnatriene-3,20-dione",613-915-0,66233-43-0,Acute Tox. 3;Repr. 1A;STOT RE 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H360:1;H301:1;H372:1
99236,Cyclohept-2-en-1-one,214-334-1,1121-66-0,Acute Tox. 4,Notified C&L,39,H302:39
99238,Methyl L-lysinate dihydrochloride,247-625-7,26348-70-9,,Notified C&L,1,H335:1;H315:1;H319:1
99239,"Alcohols, C12-18",267-006-5,67762-25-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,93,H315:57;H319:71;H400:36;H410:27;H411:14
99240,5-Bromo-2-fluorobenzyl alcohol,619-456-2,99725-13-0,,Notified C&L,6,H335:6;H315:6;H319:6
99246,Potassium hydrogen 2-octadecenylsuccinate,296-086-4,92218-39-8,Not Classified,Notified C&L,1,Not classified:1
99248,"1,2,3-Trifluor-5-[4-(trans-4-pentylcyclohexyl)-1-cyclohexen- 1-yl]-benzen",604-432-6,144675-92-3,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
99250,p-phenylenebis[dimethylsilanol],220-405-8,2754-32-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
99253,"Amides, C12-18-unsatd., N,N'-(methylenedi-4,1-phenylene)bis-",602-922-4,123237-14-9,Not Classified,Notified C&L,131,Not classified:131
99257,Sodium dodecane-1-sulphonate,219-200-6,2386-53-0,Not Classified,Notified C&L,4,Not classified:4
99261,Endo-8-isopropyl-8-azabicyclo[3.2.1]octan-3-ol,222-314-9,3423-25-4,,Notified C&L,2,Not classified:1;H302:1
99266,C.I. Disperse Yellow 198,613-226-5,63439-92-9,Not Classified,Notified C&L,8,Not classified:8
99268,"Isononanoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",267-170-8,67801-51-8,Not Classified,Notified C&L,37,Not classified:26;H315:8;H319:11
99274,p-isopropylcinnamaldehyde,230-230-9,6975-24-2,Not Classified,Notified C&L,10,Not classified:10
99275,"Acetic acid, calcium salt, monohydrate",611-528-1,5743-26-0,,Notified C&L,38,Not classified:38
99276,"Phosphoric acid, 2-methylpropyl ester",283-250-5,84593-27-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,30,H318:28;H314:30
99278,3-amino-4-chlorobenzoic acid,220-635-9,2840-28-0,Aquatic Chronic 2,Notified C&L,131,H411:85;H335:44;H315:45;H319:45;Not classified:1;H412:1
99281,"cis-1,2-Cyclohexanedicarboxylic Acid",445-870-6,610-09-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
99288,"(8S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-1,2,4,7,8,10,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolane]-17-carbonitrile",601-332-4,114882-16-5,Not Classified,REACH registration C&L,1,Not classified:1
99290,"Gases (petroleum), gas recovery plant depropanizer overheads;Petroleum gas;[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]",270-777-0,68477-94-1,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
99293,2-Acetylbenzeneboronic acid,608-542-5,308103-40-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:45;H315:45;H319:45
99297,"(2S)-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-phenylpropanoic acid",610-635-0,5123-55-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1
99301,3-fluorophthalic acid,216-433-5,1583-67-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
99309,N-[(7-hydroxy-4-methyl-2-oxo-2H-1-benzopyran-6-yl)methyl]sarcosine,279-666-1,81028-96-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
99312,"1,1'-oxybis[m-(m-phenoxyphenoxy)benzene]",223-048-6,3705-62-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
99315,(S)-3-(allylsulphinyl)-L-alanine,209-118-9,556-27-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
99317,exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol,402-470-6,87172-89-2,Acute Tox. 4;Eye Dam. 1,Harmonised C&L,0,H318:0;H302:0
99318,Cyclopropanemethylamine,219-737-6,2516-47-4,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,47,H225:47;H314:47;Not classified:1;H318:1
99322,Bis[2-[2-isopropyloxazolidin-3-yl]ethyl] adipate,248-409-5,27325-78-6,Not Classified,Notified C&L,27,Not classified:27
99324,"2,3,5,6-tetramethylbenzoic acid",220-015-8,2604-45-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
99326,BMS 435736-01,467-320-4,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1;H315:1;H302:1
99327,"Agave americana, ext.",286-037-5,85186-53-4,Not Classified,Notified C&L,1,Not classified:1
99331,Lithium tetrachloroaluminate,237-850-9,14024-11-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,59,H312:41;H302:41;H318:41;H314:41;H332:41;Not classified:18
99333,methyl 4'-(bromomethyl)biphenyl-2-carboxylate,601-325-6,114772-38-2,Skin Sens. 1A,REACH registration C&L,6,H317:1;H315:2;H319:2;H335:1;Not classified:1;H302:1;H413:1
99335,Dioctylbis(stearoyloxy)stannane,244-840-8,22205-26-1,STOT RE 2;Aquatic Chronic 4,Notified C&L,78,H373:78;H413:78;H361:9
99337,"Poly[oxy(methyl-1,2-ethanediyl)], α,α'-1,2-ethanediylbis[ω-[(1-oxo-2-propenyl)oxy]-",602-951-2,123813-18-3,Skin Sens. 1,Notified C&L,2,H317:2;H411:1
99338,Cinnamaldehyde,203-213-9,104-55-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,2768,H312:2269;H317:2759;H315:2714;H319:2639;H412:22;H335:45;H302:15;H400:5;Not classified:6;H314:1;H301:1;H332:2;H318:1;H311:1
99339,Di-p-tolylmercury,208-672-9,537-64-4,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H330:38;H410:38;H400:38;H373:38;H300:38;H310:38
99342,"(1Ó,4ß[E(trans)])-1-{4-[2-(4-vinylcyclohexyl)ethenyl]-cycloh exyl}-4-methoxy-benzen",605-706-8,174079-87-9,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
99343,"2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile",407-650-8,97460-76-9,Aquatic Chronic 4,Harmonised C&L,0,H413:0
99344,3-(4-hydroxy-3-methoxyphenyl)propionic acid,214-489-5,1135-23-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H302:38;H319:43
99345,tert-butyl N-[(E)-(4-pyridin-2-ylphenyl)methylideneamino]carbamate,918-454-1,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H335:1;H315:1;H319:1
99346,Pentadecanenitrile,242-184-7,18300-91-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H312:38;H332:38;H302:38;H311:1;H331:1;H301:1
99351,"calcium 3,5-dioxo-4-(1-oxopropyl)-cyclohexanecarboxylate",603-193-5,127277-53-6,Aquatic Chronic 3,Notified C&L,94,H412:89;Not classified:4;H411:1
99358,4'-Chloro-2'-hydroxyacetophenone,614-935-2,6921-66-0,,Notified C&L,5,H335:4;H315:5;H319:5
99359,Vitamin K2,234-264-5,11032-49-8,Not Classified,Notified C&L,1,Not classified:1
99360,Acetone-dimethyl acetal,201-056-0,77-76-9,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,198,H335:20;H225:193;H315:107;H319:192;Not classified:6;H371:2;H302:1;H332:1;H334:1
99362,2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one,420-580-2,151798-26-4,Aquatic Chronic 4;Repr. 1B,Harmonised C&L,0,H360:0;H413:0
99365,C.I. Acid Red 257,601-873-6,12217-36-6,Not Classified,Notified C&L,1,Not classified:1
99367,Disodium 6-hydroxy-5-[[4-[[4-(phenylamino)-3-sulphonatophenyl]azo]naphthyl]azo]naphthalene-2-sulphonate,228-412-8,6262-07-3,Aquatic Chronic 3,REACH registration C&L,74,H412:53;H319:4;Not classified:17;H411:4
99368,"1-amino-4-anilino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic acid, compound with 2,2',2''-nitrilotris[ethanol] (1:1)",263-705-4,62707-55-5,Not Classified,Notified C&L,1,Not classified:1
99374,"Chrysanthellum americanum, ext.",303-394-5,94166-95-7,Flam. Liq. 3,Notified C&L,2,H226:2
99381,5-methyl-2-pyridylamine,216-503-5,1603-41-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,59,H311:57;H315:58;H301:59;H319:58;H331:43;H335:50;H411:1
99390,4-hydroxyphenyl 4-pyridyl ketone,257-081-2,51246-77-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1;H319:1
99391,Terbium oxide,235-796-0,12738-76-0,Not Classified,Notified C&L,1,Not classified:1
99395,"L-Asparagine, N-(triphenylmethyl)-",603-577-2,132388-58-0,Not Classified,Notified C&L,1,Not classified:1
99396,2-chloroethyldiethylammonium chloride,212-786-4,869-24-9,Acute Tox. 2;Skin Corr. 1C;Muta. 2;Aquatic Chronic 3,REACH registration C&L,98,H341:51;H314:55;H412:35;H300:95;H330:54;H318:40;H315:43;H335:39;H310:58;H411:19;H319:5;H331:1;H301:3;H311:4;H410:1;Not classified:1;H351:1
99397,"2-methyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol",248-907-2,28219-60-5,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1590,H400:1335;H410:1325;H319:1335;H315:234;Not classified:32
99401,"Tetrahydro-N-methylthiophen-3-amine 1,1-dioxide",256-947-7,51070-55-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
99404,"3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)propyl(methyl)ammonium chloride",207-118-3,438-59-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H410:38;H400:38;H302:40;H312:1;H319:1;H315:1;H335:1
99405,"Hexasodium 4-amino-3,6-bis[[4-[[4-chloro-6-[(4-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulphonatophenyl]azo]-5-hydroxynaphthalene-2,7-disulphonate",277-434-4,73398-36-4,Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,2,H335:2;H334:2;H319:2
99408,5-chloro-2-nitrobenzaldehyde,229-614-9,6628-86-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H317:39;H315:40;H319:40
99409,"2,3-dihydrothieno[3,4-b][1,4]dioxine",415-450-7,126213-50-1,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 3,Notified C&L,4,H312:1;Not classified:1;H412:3;H302:4;H311:3;H319:2
99410,"3,3'-[sulphonylbis(4,1-phenyleneoxy)]dianiline",250-091-8,30203-11-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,37,H311:32;H315:37;H301:32;H319:37;H335:4;H302:4
99412,"Extracts (petroleum), light paraffinic distillate solvent, hydrotreated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",292-633-6,90641-09-1,Carc. 1B,Harmonised C&L,0,H350:0
99414,"BENZENE SULPHONIC ACID C15-C30 ALKYL DERIVITIVES, SODIUM SALT",616-605-3,78330-12-8,,Notified C&L,729,Not classified:446;H413:282;H319:253
99417,Sebacamide,217-103-3,1740-54-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H302:1;H319:1
99421,Isothipendyl,207-578-5,482-15-5,Acute Tox. 4,Notified C&L,38,H302:38
99422,"(2Z)-7-chloro-2-({[(1S)-2,2-dimethylcyclopropyl]carbonyl}amino)hept-2-enoic acid",618-065-4,877674-77-6,Skin Sens. 1,REACH registration C&L,1,H317:1
99424,Chloropentafluorobenzene,206-450-6,344-07-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:40;H315:40;H319:40;H332:1
99425,"Triisooctyl 2,2',2''-[(methylstannylidyne)tris(thio)]triacetate",259-374-0,54849-38-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,55,H335:55;H413:55;H315:55;H319:55
99426,Dilithium adipate,242-449-7,18621-94-8,Acute Tox. 4,REACH registration C&L,51,H302:9;H319:38;Not classified:4
99427,"Nonanedioic acid, 1,9-bis(2-octyldodecyl) ester",618-295-5,897626-46-9,Not Classified,REACH registration C&L,1,Not classified:1
99429,3-cyclopentylpropionic acid,205-433-0,140-77-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H226:48;H335:47;H315:48;H319:48
99430,"Tetrasodium 3,3'-[azoxybis[(2-methoxy-4,1-phenylene)azo]]bis[4,5-dihydroxynaphthalene-2,7-disulphonate]",281-545-3,83968-64-3,Not Classified,Notified C&L,2,Not classified:2
99432,3-methylpent-1-ene,212-076-4,760-20-3,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,65,H225:65;H304:43;H335:22;H315:22;H319:22
99437,Ethylcellulose,618-384-9,9004-57-3,Not Classified,Notified C&L,2520,Not classified:2511;H319:9;H412:6;H303:5;H313:5;H315:9;H335:9;H312:1;H302:1
99438,Disodium 1-icosyl 2-sulphonatosuccinate,287-298-8,85455-64-7,,Notified C&L,2,H318:1;Not classified:1
99440,"Solvent naphtha (coal), xylene-styrene cut;Light Oil Redistillate, intermediate boiling",287-502-5,85536-20-5,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
99441,"Dinaphtho[1',2'3':3,4;3'',2'',1'':9,10]perylo[1,12-efg][1,4]dioxocin-5,10-dione, dibromo-17,18-dihydro-",603-601-1,1324-70-5,Not Classified,Notified C&L,1,Not classified:1
99445,(2-{[Carboxy-(2-hydroxy-5-sulfo-phenyl)-methyl]-amino}-ethylamino)-(2-hydroxy-5-sulfo-phenyl)-acetic acid,611-514-5,57368-07-7,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,3,H318:3;H315:3
99448,4-(4-hydroxy-3-methoxyphenyl)-3-buten-2-one,214-096-9,1080-12-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H312:1;H302:1;H319:1;H315:1;H332:1
99449,"Indan-1,2,3-trione",213-340-1,938-24-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,90,H335:90;H315:90;H302:90;H319:90
99450,"Sodium metaborate, anhydrous",231-891-6,7775-19-1,Eye Irrit. 2;Repr. 2,REACH registration C&L,921,H361:730;H319:437;H315:149;H335:55;H360:25;H412:15;Not classified:2
99451,"Hydrogen 5-chloro-2-[3-[5-chloro-3-(3-sulphonatopropyl)-3H-benzoxazol-2-ylidene]-2-ethylprop-1-enyl]-3-(3-sulphonatopropyl)benzoxazolium, compound with triethylamine (1:1)",254-349-0,39201-42-8,,Notified C&L,1,Not classified:1
99458,PIGMENTGELB P-13456,424-630-4,,Not Classified,Notified C&L,31,Not classified:31
99462,"β-D-Glucopyranoside, 1H-indol-3-yl",610-433-2,487-60-5,Not Classified,Notified C&L,2,Not classified:2
99468,"Amines, tallow alkyl, ethoxylated, sulfates, ammonium salts",614-139-5,67785-16-4,Not Classified,Notified C&L,37,Not classified:36;H411:1;H319:1
99469,"(1’R, 2R)-2-(1’, 2’-Dihydroxyethyl)-6-fluorochromane",608-459-4,303176-45-6,Not Classified,REACH registration C&L,2,Not classified:1;H412:1
99475,"Senna, Cassia fistula, ext.",284-307-7,84848-75-9,Flam. Liq. 2;Skin Sens. 1,Notified C&L,1286,H225:1286;H317:1286
99476,Titanium tetrabutanolate,227-006-8,5593-70-4,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT SE 3,REACH registration C&L,1498,H335:461;H318:1200;H336:425;H315:1346;H226:1253;Not classified:102;H319:182;H228:26;H314:4;H261:1;H303:1
99479,"4,4'-methylenebis(2-ethylaniline);4,4'-methylenebis(2-ethylbenzeneamine)",243-420-1,19900-65-3,Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H351:0;H400:0;H302:0
99480,"Resin acids and Rosin acids, reaction products with formaldehyde, sodium salts",293-631-8,91081-28-6,Eye Irrit. 2,REACH registration C&L,1,H319:1
99481,"Hexanoic acid, 2-ethyl-, rare earth salts",262-971-9,61788-37-2,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,235,H412:220;H315:209;Not classified:11;H413:2
99482,(2-benzyl-acryloylamino)-acetic acid benzyl ester,921-619-0,,Not Classified,Notified C&L,1,Not classified:1
99487,Disodium peroxodisulphate,231-892-1,7775-27-1,Ox. Sol. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,3180,H302:3138;H319:2840;H272:2984;H334:3047;H315:2848;H317:3138;H335:2952;H270:176;H271:65;Not classified:42;H318:8;H412:1;H332:1
99488,"fluroxypyr (ISO);4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid",614-957-2,69377-81-7,Aquatic Chronic 3,Harmonised C&L,0,H412:0
99492,"Hafnium, [N-[2,6-bis(1-methylethyl)phenyl]-α-[2-(1-methylethyl)phenyl]-6-(1-naphthalenyl-κC2)-2-pyridinemethanaminato(2-)-κN1,κN2]dimethyl-",610-796-7,521964-95-4,Water-react. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H260:1;H315:1;H319:1
99493,1-[4-(methylsulphonyl)phenyl]ethan-1-one,233-672-0,10297-73-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
99497,"3,7-dimethyl-6-octenyl 2-butenoate",268-254-7,68039-38-3,Not Classified,Notified C&L,89,Not classified:89
99498,C.I. Reactive Red 3:1,618-834-4,92307-87-4,Eye Irrit. 2,Notified C&L,1,H319:1
99502,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with m-phenylenebis(methylamine) and trimethylhexane-1,6-diamine",500-614-3,161278-24-6,Not Classified,Notified C&L,10,Not classified:9;H302:1;H412:1;H314:1;H317:1;H331:1
99504,p-nitroaniline,202-810-1,100-01-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H373:0;H331:0;H301:0;H311:0
99507,"Benzenesulfonic acid, C10-16-alkyl derivs., compds. with N,N-dimethyl-1,3-propanediamine",618-067-5,877677-48-0,Acute Tox. 4;Skin Irrit. 2,Notified C&L,1,H315:1;H302:1
99513,"Hydrazine, (2-ethylphenyl)-, hydrochloride (1:1)",606-304-5,19398-06-2,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H302:42;H410:42;H318:42;H400:42;H372:42;H317:42;H351:42
99522,isooctyl acrylate,249-707-8,29590-42-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H319:0;H400:0;H315:0;H335:0
99523,2-amino-4-(S-methylsulphonimidoyl)butyric acid,217-845-8,1982-67-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
99527,"1,1,2-trimethoxyethane",246-175-9,24332-20-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H226:41;H335:41;H315:42;H319:42;H225:1
99530,2-butoxyethyl methacrylate,236-885-7,13532-94-0,Skin Irrit. 2;STOT SE 3,REACH registration C&L,40,H335:40;H315:40;H319:38
99535,"(1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride",220-384-5,2746-19-2,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H318:0;H317:0;H334:0
99540,Butyl nicotinate,230-064-7,6938-06-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H335:1;H315:2;H319:2
99541,(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-[(triphenylmethyl)carbamoyl]propanoic acid,603-578-8,132388-59-1,Aquatic Chronic 4,Notified C&L,47,H413:44;Not classified:2;H411:2;H335:2;H312:1;H332:2;H302:2;H319:1;H315:1
99542,2-nonylcrotonaldehyde,229-772-9,6720-16-7,Not Classified,Notified C&L,88,Not classified:88
99544,Ethyl phenylglyoxylate,216-504-0,1603-79-8,Not Classified,REACH registration C&L,35,Not classified:35
99545,Fluchloralin,251-426-0,33245-39-5,Aquatic Acute 1,Notified C&L,41,H400:38;H302:3
99546,"Trisodium 5-[[dihydroxy[(2-hydroxynitrosulfophenyl)azo]phenyl]azo]4-hydroxy-3-[(4-nitrophenyl)azo-2,7-naphthalenedisulfonate",405-071-5,,Not Classified,Notified C&L,2,Not classified:2
99549,"tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate",400-130-1,,Resp. Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H334:0
99550,Dimethyl phenylphosphonite,220-960-6,2946-61-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43,H318:39;H314:39;H335:4;H315:4;H319:4
99551,"Fatty acids, C8-24",275-164-1,71076-48-7,Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,1,H318:1;H314:1
99553,"Phenol, polymer with 2,6,6-trimethylbicyclo[3.1.1]hept-2-ene",607-707-9,25359-84-6,Not Classified,Notified C&L,208,Not classified:208
99554,"2,3,5,6,8,9,11,12,14,15-decahydro-4,13-(ethanoxyethanoxyethano)-4H,13H-1,7,10,16,4,13-benzotetraoxadiazacyclooctadecine",250-532-4,31250-18-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
99555,"Methanaminium, N-[4-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, tetracosa-μ-oxododecaoxo[μ12-[phosphato(3-)-O:O:O:O':O':O':O'':O'':O'':O''':O''':O''']]dodecamolybdate(3-) (3:1)",267-951-3,67953-39-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H400:83;H410:83
99557,"N-1,3-dimethylbutyl-N'-phenyl-p-phenylenediamine",212-344-0,793-24-8,Acute Tox. 4;Skin Sens. 1;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,264,H410:262;H302:132;H400:258;H317:262;H360:41;H315:5;H319:3;H373:1;H335:1;Not classified:1;H336:1
99558,Formic [2H]acid,213-129-4,925-94-0,Flam. Liq. 3;Skin Corr. 1A,Notified C&L,39,H226:39;H314:39
99560,4-nitroimidazole,221-224-7,3034-38-6,Acute Tox. 4,REACH registration C&L,145,H302:145;H312:42;H319:45;H315:45;H335:43;H332:42;H341:5
99565,"(Benzyloxycarbonyl)methyl 3-[5-acetamido-4-(2-chloro-4,6-dinitrophenylazo)-2-methoxyanilino]propionate",436-000-6,159010-67-0,Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,39,H317:39;H413:39
99566,"2,3,5,6-tetrafluorobenzenethiol",212-210-1,769-40-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H226:44;H335:43;H315:43;H319:43;H312:4;H302:4;H331:4
99568,Reaction mass of Sodium or ammonium [1-{(E)-[2-(hydroxy-kO)-4-nitrophenyl]diazenyl}naphthalen-2-olato(2-)-kO][3-{(E)-[2-(hydroxy-kO)-5-nitrophenyl]diazenyl}naphthalen-2-olato(2-)-kO]chromate(1-) and Sodium or ammonium [3-{(E)-[2-(hydroxy-kO)-5-(2-methylbutan-2-yl)-3-nitrophenyl]diazenyl}naphthalen-2-olato(2-)-kO][1-{(E)-[2-(hydroxy-kO)-5-nitrophenyl]diazenyl}naphthalen-2-olato(2-)-kO]chromate(1-) and Sodium or ammonium [3-{(E)-[2-(hydroxy-kO)-5-(2-methylbutan-2-yl)-3-nitrophenyl]diazenyl}naphthalen-2-olato(2-)-kO][1-{(E)-[2-(hydroxy-kO)-4-nitrophenyl]diazenyl}naphthalen-2-olato(2-)-kO]chromate(1-) and Sodium or ammonium [1-{(E)-[2-(hydroxy-kO)-5-nitrophenyl]diazenyl}naphthalen-2-olato(2-)-kO][3-{(E)-[2-(hydroxy-kO)-5-nitrophenyl]diazenyl}naphthalen-2-olato(2-)-kO]chromate(1-) and Sodium or ammonium [1-{(E)-[2-(hydroxy-kO)-4-nitrophenyl]diazenyl}naphthalen-2-olato(2-)-kO][3-{(E)-[2-(hydroxy-kO)-4-nitrophenyl]diazenyl}naphthalen-2-olato(2-)-kO]chromate(1-) and Sodium or ammonium [1-{(E)-[2-(hydroxy-kO)-5-(2-methylbutan-2-yl)-3-nitrophenyl]diazenyl}naphthalen-2-olato(2-)-kO][3-{(Z)-[2-(hydroxy-kO)-5-(2-methylbutan-2-yl)-3-nitrophenyl]diazenyl}naphthalen-2-olato(2-)-kO]chromate(1-),815-236-7,1029600-34-7,Aquatic Chronic 2,Notified C&L,1,H411:1
99572,4-(3-phenylpropyl)pyridine,218-159-1,2057-49-0,Acute Tox. 4;Aquatic Acute 1,REACH registration C&L,1474,H400:41;H302:149;H317:1286;H315:1425;H319:1425;H335:138;H412:35;H410:35;H413:2;H411:1
99579,Sepiolite,264-465-3,63800-37-3,Not Classified,Notified C&L,247,Not classified:247
99581,Polymercaptan 407,478-110-7,,Not Classified,Notified C&L,1,Not classified:1
99583,"Butanedioic acid, sulfo-, C-(2-C12-14-fatty amidoethyl) esters, disodium salts",286-261-3,85203-71-0,Not Classified,Notified C&L,22,Not classified:22
99584,Methyl phenylcarbamate,220-014-2,2603-10-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
99588,"9-Anthracenecarboxylic acid, (triethoxysilyl)methyl ester",608-605-7,313482-99-4,Not Classified,Notified C&L,1,Not classified:1
99590,reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate,406-240-6,,Flam. Liq. 3;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H226:0;H314:0;H411:0
99592,Calcium abietate,236-677-6,13463-98-4,Not Classified,Notified C&L,17,Not classified:17
99599,(triphenylphosphoranylidene)acetaldehyde,218-375-6,2136-75-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
99600,Barium phosphonate,248-126-7,26946-37-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
99607,Oct-2-ynoic acid,227-121-3,5663-96-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,42,H312:38;H314:42;H332:38;H302:38
99608,"7-azatridecane-1,13-diamine",205-593-1,143-23-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;STOT SE 3;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,269,H312:51;H302:269;H412:3;H318:146;H314:269;H335:23;H311:57;H310:9;H317:1
99610,"Octane-1,2-diol",214-254-7,1117-86-8,Eye Irrit. 2,REACH registration C&L,523,H319:396;H302:84;Not classified:65;H318:61;H311:10;H331:10
99615,"Rape oil, reaction products with diethanolamine",269-125-8,68187-80-4,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,18,H411:9;H315:13;H319:13;Not classified:5;H318:4
99617,"propanil (ISO);3',4'-dichloropropionanilide",211-914-6,709-98-8,Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H400:0;H302:0
99619,"3,7-diamino-5-phenylphenazinium chloride",201-387-0,81-93-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:39;H315:39;H319:39
99621,"Amides, from ethylenediamine, oleic acid, stearic acid and vegetable-oil fatty acids",305-744-2,95009-16-8,Not Classified,Notified C&L,29,Not classified:29
99622,"2,6-di-tert-butyl-4-methoxyphenol",207-693-0,489-01-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
99624,"2,2',2''-[(butylstannylidyne)tris(thio)]triethanol",274-833-5,70729-71-4,Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1;H315:1;H317:1;H373:1;H301:1;H332:1;H310:1
99628,N-(2-hydroxyethyl)undec-10-enamide,243-870-9,20545-92-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,39,H318:3;H411:1;H315:2;Not classified:36
99629,(Z)-o-methoxycinnamic acid,238-803-5,14737-91-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H302:39;H319:39
99632,Diarsenic triselenide,215-119-5,1303-36-2,Not Classified,REACH registration C&L,12,Not classified:6;H410:6;H400:6;H330:4;H373:2;H331:2;H301:2
99635,"Benzaldehyde, 2,5-difluoro-4-hydroxy-",618-795-3,918523-99-6,,Notified C&L,5,H335:5;H315:5;H319:5
99637,"Poly(oxy-1,2-ethanediyl), α-[3-[(carboxymethyl)methylamino]-2-hydroxypropyl]-ω-(4-nonylphenoxy)-, sodium salt (1:1)",616-248-3,75627-31-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H315:1;H319:1
99640,Calcium silicide,234-587-1,12013-55-7,Water-react. 2,Notified C&L,215,H261:181;Not classified:34
99641,"Proteinase, Bacillus subtilis",257-520-8,51931-23-8,Skin Irrit. 2;Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1;H315:1
99642,Silver,231-131-3,7440-22-4,Not Classified,REACH registration C&L,2086,Not classified:648;H400:1425;H410:1402;H319:34;H315:29;H372:35;H335:30;H351:26;H317:9;H370:9;H314:4;H332:1;H312:1;H411:1
99647,Sodium butane-1-sulphonate,219-201-1,2386-54-1,Not Classified,Notified C&L,3,Not classified:2;H335:1;H315:1;H319:1
99648,Bis(2-ethylhexyl)amine,203-372-4,106-20-7,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 1,REACH registration C&L,634,H302:632;H410:123;H318:561;H314:633;H331:146;H311:161;H312:472;H330:442;H411:469;H400:4;H301:1;Not classified:1
99651,(2-Hydroxyethyl)trimethylammonium toluene-4-sulphonate,611-261-0,55357-38-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:44;H319:44;Not classified:1
99652,2-chlorocyclopentan-one,211-769-9,694-28-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
99653,2'-ethoxyacetanilide,209-460-9,581-08-8,Acute Tox. 4,Notified C&L,1,H302:1
99656,"1-Pentanol, 2-propyl-",611-630-6,58175-57-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
99662,"Myristica fragans, ext.",616-921-1,8008-45-5,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,190,H410:97;H400:97;H317:102;H350:102;H226:152;H304:101;H335:51;H315:55;H319:53;Not classified:36;H341:8;H411:3;H302:1;H412:1
99665,Cornmint oil terpenes,614-655-0,68608-35-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,91,H410:91;H400:54;H315:91;H317:91;H226:91;H304:91;H319:1
99667,8-bromooct-1-ene,220-268-4,2695-48-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H335:40;H315:41;H319:41
99674,"Reaction mass of 12-hydroxy-N-[2-[(1-oxodecyl)amino]ethyl]octadecanamide, 12-hydroxy-N-[2-[(1-oxooctyl)amino]ethyl]octadecanamide and N,N'-1,2-ethanediylbis[12-hydroxyoctadecanamide]",484-050-2,,Not Classified,REACH registration C&L,60,Not classified:2;H400:58;H410:58
99676,"2,6-dimethylthiomorpholine",258-685-9,53651-62-0,Flam. Liq. 4;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H302:1;H314:1;H335:1;H332:1;H227:1
99680,3-Hydroxyglutaronitrile,604-095-5,13880-89-2,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,2,H319:2;H315:2;H331:1;H301:2;H311:1;H335:1
99681,2-methyl-1H-imidazole-4-carboxylic acid,215-943-5,1457-58-5,,Notified C&L,2,H335:2;H315:2;H319:2
99683,"Ethanol, 2-amino-, reaction products with ammonia, 1-piperazineethanamine fraction",296-543-8,92731-41-4,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Repr. 2;Lact.;Aquatic Chronic 3,Notified C&L,84,H361:83;H302:84;H412:84;H318:84;H314:84;H317:84;H362:83;H311:84;H360:1
99686,1-(2-hydroxymethylphenyl)-2-phenyl-4-methylpiperazine,925-588-4,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
99687,"Vanilla pompona, ext.",304-864-2,94280-16-7,Skin Sens. 1,Notified C&L,28,H317:28
99689,"1,2,3-Trifluor-5-[4-(trans-4-propylcyclohexyl)-1-cyclohexen-1-yl]-benzene",604-431-0,144675-91-2,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
99690,"Disodium 1-amino-4-[[4-[[[(2,3-dichloro-6-quinoxalinyl)carbonyl]methylamino]methyl]-2-sulphonatophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",280-400-1,83399-87-5,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,12,H412:12;H317:12
99696,"Phosphoramidothioic acid, N-(1-methylpropyl)-, O-ethyl O-(5-methyl-2-nitrophenyl) ester",609-231-7,36335-67-8,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,127,H410:127;H400:127;H302:127
99697,"tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate",411-540-5,130201-57-9,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H317:0;H411:0
99699,3-bromopyridine,210-952-0,626-55-1,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,58,H335:55;H302:50;H319:58;H315:57;H226:54;H311:11;H332:7;H312:3;H301:7;H331:3;H330:4
99700,Ethyl (R)-(-)-4-Cyano-3-hydroxybutyrate,604-264-3,141942-85-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:38;H315:38;H319:45
99701,6-ethyltetrahydro-2H-pyran-2-one,221-972-4,3301-90-4,Not Classified,Notified C&L,89,Not classified:89
99705,"2,4-dichloro-5-isopropoxyaniline",255-258-9,41200-96-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT SE 3,Notified C&L,42,H312:42;H302:42;H318:38;H315:42;H331:38;H335:42;H319:4;H332:4
99706,2-aminoethylmethylamine,203-707-4,109-81-9,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,47,H226:47;H314:47;H318:4;H312:1;H302:1;H332:1
99707,"α,3,3-trimethylbicyclo[2.2.1]heptane-2-methanol",266-095-8,66062-78-0,Eye Irrit. 2,Notified C&L,88,H319:88
99708,2-ethyl-4-hydroxy-5-methylfuran-3(2H)-one,248-514-6,27538-10-9,Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,548,H318:37;H314:37;H302:468;H317:37;H315:392;H319:392;Not classified:80;H412:35
99709,"Amines, polyethylenepoly-, reaction products with succinic anhydride polybutenyl derivs.",614-489-9,68439-80-5,Not Classified,Notified C&L,6,Not classified:6
99710,(-)-menthyl benzoate,228-505-3,6284-35-1,Not Classified,Notified C&L,25,Not classified:25
99713,"N,N-dimethylaniline",204-493-5,121-69-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H331:0;H301:0;H311:0;H351:0
99714,"Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;Kerosine - unspecified;[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C",285-508-2,85116-57-0,Asp. Tox. 1,Harmonised C&L,0,H304:0
99715,"Benzenesulfonic acid, 2-methyl-5-nitro-, alkaline condition products, reaction products with formaldehyde",215-394-1,1325-38-8,,Notified C&L,120,Not classified:120
99716,"Zinc, C4-10-fatty acid octanoate complexes",295-937-7,92201-09-7,Not Classified,Notified C&L,1,Not classified:1
99717,"2-Propenoic acid, 2-cyano-3-(3,4-dimethoxyphenyl)-, (2E)-",609-453-4,37630-52-7,,REACH registration C&L,1,H318:1
99719,(4-Fluorophenyl)acetaldehyde,605-686-0,1736-67-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H318:38;H302:39;H319:1;H315:1;H335:1;H332:1
99720,"2,3,4,5-tetrafluorobenzoyl chloride",619-058-9,94695-48-4,Skin Corr. 1B,REACH registration C&L,46,H314:45;Not classified:1;H318:1;H290:1
99722,Sulphurous acid,231-973-1,7782-99-2,Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,107,H318:83;H314:101;H332:106;H335:5;H315:5;H319:5;Not classified:1
99723,"4-bromo-1,1,2-trifluorobut-1-ene",234-019-2,10493-44-4,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H312:39;H302:39;H319:43;H335:42;H225:43;H332:39
99724,"L-Cysteine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-S-(triphenylmethyl)-",600-408-4,103213-32-7,Not Classified,Notified C&L,6,Not classified:4;H335:2;H315:2;H319:1;H332:1;H302:1
99729,P14511,434-860-7,,Not Classified,Notified C&L,44,Not classified:44
99731,"Molybdenum, bis(ditridecylcarbamodithioato-.kappa.S,.kappa.S')dioxodi-.mu.-thioxodi-, branched",607-719-4,253873-84-6,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H315:1
99732,2-(octadecyloxy)ethanol,218-374-0,2136-72-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
99733,"2,2-diphenylcyclopropanecarbonitrile",250-397-1,30932-41-3,Acute Tox. 4,Notified C&L,39,H302:39
99735,"1,5-pentanediyl bis[1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-1H-isoquinoline-2-propionate]",264-740-8,64228-77-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
99736,"Oxirane, mono[(C8-10-alkyloxy)methyl] derivs.",271-845-2,68609-96-1,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,241,H317:236;H411:67;H315:213;H319:123;H318:55;H334:38;H351:38;H335:18;Not classified:5
99737,5-tert-butyl-m-xylene,202-647-6,98-19-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H315:46;H319:46
99740,"26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-yl dihydrogen phosphate",266-231-6,66197-78-2,Not Classified,Notified C&L,1,Not classified:1
99743,Aziprotryne,225-101-9,4658-28-0,,Notified C&L,38,Not classified:38
99748,Oleandomycin phosphate,230-351-7,7060-74-4,Acute Tox. 2,Notified C&L,42,H300:41;H332:1;H315:1;H302:1;H319:1
99749,(3S)-pyrrolidin-3-ol,600-044-6,100243-39-8,,Notified C&L,8,H335:7;H315:8;H319:8
99755,"2'-methylspiro[bicyclo[2.2.1]heptane-2,5'-[1,3]dioxane]",289-330-6,87641-24-5,Acute Tox. 4,Notified C&L,88,H302:88
99756,"2-Dodecen-1-ol, (E)-",614-914-8,69064-37-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
99757,"3,4-dichlorobut-1-ene",212-079-0,760-23-6,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,43,H226:43;H314:39;H332:39;H302:40;H318:1;H331:1;H341:1;H411:1;H350:1
99759,Silicomanganese manufacturing fumes dedusting solid residues,930-776-4,,Not Classified,Notified C&L,1,Not classified:1
99765,"Methyl 3-amino-5,6-dichloropyrazine-2-carboxylate",215-947-7,1458-18-0,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,48,H411:4;H317:4;H400:4;H335:44;H332:39;H315:44;H319:44
99766,2-aminoethylammonium chloride,242-181-0,18299-54-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,69,H302:69;H319:69;H334:69;H315:69;H317:69;H335:69;H226:14
99767,"1,3-Benzenedisulfonic acid, 4-[[5-(aminocarbonyl)-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl]azo]-6-[[4-[[3-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-sulfophenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-",300-530-5,93941-80-1,Not Classified,REACH registration C&L,4,Not classified:4
99769,"Distillates (petroleum), hydrodesulfurized thermal cracked middle;Cracked gasoil;[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",285-505-6,85116-53-6,Carc. 1B,Harmonised C&L,0,H350:0
99772,Cyclobutylamine,219-736-0,2516-34-9,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,47,H225:46;H314:47;H312:2;H302:2;H318:2;H332:2;H226:1
99775,"2',5'-dihydroxypropiophenone",213-343-8,938-46-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H302:38;H319:42
99778,"Acacia mearnsi, ext., reaction products with ammonium chloride and formaldehyde",285-077-0,85029-52-3,Eye Irrit. 2,REACH registration C&L,12,H319:11;Not classified:1;H334:1
99782,6-hydroxy-2-naphthyl phenyl ketone,257-755-6,52222-87-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
99783,Methyl isovalerate,209-117-3,556-24-1,Flam. Liq. 3,Notified C&L,1644,H226:1571;H225:71;H332:4;H411:1;H224:1
99784,"1-[3,5-bis(trifluoromethyl)phenyl]ethan-1-one",250-023-7,30071-93-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
99785,"3,4-dihydro-2-methoxy-2H-pyran",224-698-3,4454-05-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2A,REACH registration C&L,128,H225:89;H315:89;H319:128;H226:39;H332:39;H302:44;H335:4
99790,"Hawthorn, Crataegus curvisepala, ext.",305-620-8,94891-21-1,Not Classified,Notified C&L,1,Not classified:1
99792,1-(4-methoxyphenyl)cyclopropane-1-carbonitrile,240-786-4,16728-00-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
99793,2-[(but-3-yn-2-yloxy)carbonyl]benzoic acid,610-090-9,42969-62-0,Acute Tox. 4,REACH registration C&L,4,H302:4;H312:2;H319:2;H315:2;H335:2;H332:2
99796,"Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",292-632-0,90641-08-0,Carc. 1B,Harmonised C&L,0,H350:0
99803,"N,N'-(dithiodiethylene)bisacetamide",211-338-5,638-44-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
99806,"Benzene-1,2,4-triyltriamine",210-443-3,615-71-4,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H317:1;H302:1;H319:1
99809,"1,1-dimethylguanidinium sulphate (2:1)",209-946-0,598-65-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,196,H315:196;H319:196;H335:39
99812,"reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-);trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-);trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-);trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-);disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate",406-870-1,115100-55-5,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
99814,"1,1'-isopropylidenebis(p-phenyleneoxy)dipropan-2-ol",204-137-9,116-37-0,Aquatic Chronic 2,REACH registration C&L,115,H411:49;H412:56;Not classified:9;H335:1;H315:1;H319:1
99819,"Prickly ash, ext.",290-207-4,90105-89-8,Not Classified,Notified C&L,11,Not classified:10;H319:1;H411:1;H315:1;H317:1;H226:1;H304:1
99820,"Isopropylmethylcyclohexane, tetradehydro derivative",215-532-0,1329-99-3,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1,Notified C&L,279,H226:279;H302:278;H304:279;H317:1;H411:1
99821,Butane-1-thiol,203-705-3,109-79-5,,REACH registration C&L,1628,H410:4;H225:1628;H317:44;H302:1606;H319:1615;H315:64;H335:64;H332:1599;H330:22;H300:22;H310:22;H360:4;H361:1;H371:1
99824,(2H10)ethylbenzene,247-292-8,25837-05-2,Flam. Liq. 2;Acute Tox. 4,Notified C&L,46,H225:43;H332:42;H224:3;H302:1
99825,"1,1,1,3,4,4,5,5,5-nonafluoro-2-(trifluoromethyl)pent-4-ene",216-436-1,1584-03-8,Flam. Liq. 2,Notified C&L,47,H225:46;H335:2;H315:2;H319:2;H312:1;H220:1;H332:1
99826,diarsenic pentaoxide;arsenic pentoxide;arsenic oxide,215-116-9,1303-28-2,Acute Tox. 3;Acute Tox. 3;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H350:0;H331:0;H301:0
99827,"(+)-R-2-(2,4-Dichlorophenoxy)propionic acid",604-810-0,15165-67-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,38,H318:38;H317:38;H315:38;H302:38
99830,3-methyl-9H-carbazole,225-048-1,4630-20-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
99832,"(1,5-dimethylhexyl)ammonium chloride",227-798-5,5984-59-8,,Notified C&L,1,H335:1;H315:1;H319:1
99838,reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-);pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-),407-570-3,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
99843,Sodium 2-thenoate,246-628-0,25112-68-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:41;H315:41;H319:41;H302:1
99846,Chloro(chloromethyl)methylphosphine oxide,247-626-2,26350-26-5,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H290:1;H314:1
99847,"1,2,3-propanetriyl triisooctadecanoate",248-122-5,26942-95-0,Not Classified,REACH registration C&L,65,Not classified:65
99850,Sodium 6-amino-5-[[2-[(ethylphenylamino)sulphonyl]phenyl]azo]-4-hydroxynaphthalene-2-sulphonate,274-958-5,70865-30-4,Eye Irrit. 2,REACH registration C&L,52,H319:5;Not classified:47
99851,Cefmetazole,260-384-2,56796-20-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,2,H319:1;H334:2;H315:1;H317:2;H335:1
99852,2-chloroethyl acetate,208-820-2,542-58-5,Flam. Liq. 3;Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,39,H226:39;H300:39;H330:38;H310:38
99854,Dimethyl phosphonate,212-783-8,868-85-9,Skin Sens. 1;Muta. 2;Carc. 2;Aquatic Chronic 3,REACH registration C&L,604,H341:127;H317:127;H412:127;H351:141;H226:450;H315:461;H319:477;H311:104;H335:4;H302:1
99864,"2-Propenoic acid, 2-methyl-, polymer with N1,N2-bis(2-aminoethyl)-1,2-ethanediamine, 2-(chloromethyl)oxirane, 4,4'-(1-methylethylidene)bis[phenol] and N1-(9Z)-9-octadecen-1-yl-1,3-propanediamine",614-152-6,67846-33-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,23,H317:23;H315:22;H319:22;H314:1;H411:1
99865,"9ß,11ßepoxy-17,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-acetate",608-267-0,2884-51-7,STOT RE 2,REACH registration C&L,2,H373:2
99871,"1,5-diamino-4,8-dihydroxy-2-(4-methoxyphenyl)anthraquinone",237-221-9,13698-89-0,Not Classified,Notified C&L,8,Not classified:8
99874,2-(N-methyl-p-toluidino)ethanol,220-638-5,2842-44-6,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,95,H317:6;H411:6;H319:43;Not classified:52;H335:37;H315:37;H302:37
99875,Dimethyl(1-naphthyl)amine,201-682-4,86-56-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:39;H315:40;H302:44;H319:40;H312:4;H332:4;H331:1;H301:1;H411:1
99876,2-nitro-4-(trifluoromethyl)benzonitrile,212-298-1,778-94-9,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,47,H410:4;H317:4;H400:4;H302:9;H335:38;H315:42;H319:42;H311:4;H332:5;H312:1
99877,(2-ethylhexanoato-O)(isononanoato-O)nickel,287-470-2,85508-45-8,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H341:0;H410:0;H334:0;H400:0;H372:0;H317:0;H350:0;H360:0
99879,Cinnamyl alcohol,203-212-3,104-54-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1906,H317:1866;H411:30;H302:189;H315:73;H319:80;Not classified:2;H335:1
99882,Undecanol,250-092-3,30207-98-8,Not Classified,Notified C&L,88,Not classified:88
99883,"3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-yl isobutyrate",268-255-2,68039-39-4,Not Classified,Notified C&L,263,Not classified:236;H400:25;H410:25;H319:27;H411:1
99885,p-tolylacetonitrile,220-963-2,2947-61-7,Eye Irrit. 2,Notified C&L,46,H319:45;H312:6;H302:6;H315:7;H335:6;H332:6;H331:2;H301:2;H311:2
99894,"Alcohols, C10-16, ethoxylated, sulfates, mono(hydroxyethyl)ammonium salts",500-343-0,157627-92-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,39,H412:2;H318:39;H315:39
99895,Doxylamine hydrogen succinate,209-228-7,562-10-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,81,H312:75;H332:75;H302:80;Not classified:1;H335:2;H315:2;H319:2;H412:1;H402:1
99899,"1,2,4,5-tetrabromobenzene",211-253-3,636-28-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,49,H335:48;H413:40;H315:49;H319:49
99900,2-methyl-5-vinylpyridine,205-432-5,140-76-1,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1,Notified C&L,12,H330:11;H302:11;H319:11;H315:11;H311:11;H226:1;H314:1;H301:1;H317:1
99901,Furan-2-acetyl chloride,220-381-9,2745-27-9,Flam. Liq. 4;Skin Corr. 1B,Notified C&L,1,H314:1;H227:1
99906,"2,5,6-triaminopyrimidin-4-ol sulphate",216-500-9,1603-02-7,,Notified C&L,12,H335:12;H315:12;H319:12
99908,"4,4,5,5,5-PENTAFLUOR-1-PENTANOL",604-621-3,148043-73-6,Eye Irrit. 2,Notified C&L,48,H319:39;H412:9;H302:9;H335:1;H315:1
99912,zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate,417-130-2,,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0
99915,Civet (secretion),272-826-1,68916-26-7,Not Classified,Notified C&L,115,Not classified:115
99920,"1-Propene, homopolymer, isotactic",607-534-9,25085-53-4,Not Classified,Notified C&L,22,Not classified:22
99923,"Disodium 4,4'-[(9,10-dihydro-9,10-dioxo-1,4-anthrylene)bis[imino(3-methylpropane-1,3-diyl)]]bis(benzenesulphonate)",277-431-8,73398-31-9,Aquatic Chronic 3,Notified C&L,8,H412:8
99928,8-isopropyl-8-azabicyclo[3.2.1]octan-3-one,222-315-4,3423-28-7,,Notified C&L,3,Not classified:1;H301:2;H335:1;H315:1;H319:1
99929,"Hexa-2,4-dienyl isobutyrate",240-551-6,16491-24-0,Not Classified,Notified C&L,126,Not classified:88;H400:38;H410:38
99931,N-[3-(trifluoromethyl)phenyl]formamide,211-520-4,657-78-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H302:39;H319:39;H312:1;H315:1;H335:1;H332:1
99936,"4-[[4-(dimethylamino)phenyl][4-(dimethyliminio)cyclohexa-2,5-dien-1-ylidene]methyl]-N,N,N-trimethylanilinium dichloride",201-447-6,82-94-0,Not Classified,Notified C&L,3,Not classified:1;H335:2;H413:2;H315:2;H319:2
99938,7-amino-4-methylcoumarin,247-454-8,26093-31-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H335:48;H315:49;H319:49;H312:2;H302:2;H332:1
99939,"2-Propenoic acid, 2-methyl-, eicosyl ester, polymer with 1-ethenyl-2-pyrrolidinone, hexadecyl 2-methyl-2-propenoate, isodecyl 2-methyl-2-propenoate, methyl 2-methyl-2-propenoate and octadecyl 2-methyl-2-propenoate",614-348-1,68171-46-0,Not Classified,Notified C&L,1,Not classified:1
99941,N-[3-(dimethylamino)propyl]dodecanamide monoacetate,245-307-2,22890-14-8,Aquatic Chronic 1,Notified C&L,5,H410:5
99942,"[1R-(1α,4aβ,10aα)]-1,2,3,4,4a,9,10,10a-octahydro-7-isopropyl-1,4a-dimethylphenanthren-1-carboxylic acid",217-102-8,1740-19-8,Acute Tox. 4,Notified C&L,702,H302:457;Not classified:205;H410:40;H400:41;H301:40;H312:1;H332:1;H319:1
99945,N-acetyl-L-tyrosine,208-671-3,537-55-3,Eye Dam. 1,Notified C&L,390,H318:329;Not classified:60;H319:1
99946,"2-Heptanol, 3,4,5,6,6-pentamethyl-",617-964-9,87118-95-4,Aquatic Chronic 2,Notified C&L,52,H411:52
99947,Thallium trifluoride,232-010-8,7783-57-5,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,39,H411:38;H373:38;H300:38;H330:38;H311:1;H331:1;H301:1
99960,methyl 3-bromo-4-fluorobenzoate,617-378-3,82702-31-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H335:1;H302:1
99963,p-(diethoxymethyl)anisole,219-288-6,2403-58-9,Not Classified,Notified C&L,89,Not classified:89
99966,"2,5-Furandione, polymer with 2,4,4-trimethylpentene, sodium salt",609-343-6,37199-81-8,Not Classified,Notified C&L,369,Not classified:257;H319:85;H332:20;H318:7;H315:1
99967,Bromoethylmagnesium,213-127-3,925-90-6,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,75,H225:32;H314:75;H318:5;H260:74;H302:4;H336:4;H224:4;H261:1
99970,Pent-2-yn-1-ol,228-411-2,6261-22-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H226:44;H335:44;H315:44;H319:44;H318:1;H314:1;H411:1
99972,"Sulfuric acid, mono-C12-15-alkyl esters, ammonium salts",272-385-5,68815-61-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:1;H315:1;Not classified:1
99974,"2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol",248-908-8,28219-61-6,Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,1777,H410:1761;H319:1734;H400:335;H315:295;H411:17;Not classified:1
99975,"Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides",287-089-1,85409-22-9,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,272,H314:272;H400:233;H302:272;H410:92;H318:85;H312:12;H330:6;H373:6
99976,"Distillates (petroleum), solvent-dewaxed light naphthenic;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C",265-168-1,64742-64-9,Carc. 1B,Harmonised C&L,0,H350:0
99979,Cellulose ethyl hydroxyethyl ether,618-385-4,9004-58-4,Not Classified,Notified C&L,46,Not classified:46
99981,"1,12-dibromododecane",222-096-5,3344-70-5,Not Classified,REACH registration C&L,7,Not classified:4;H302:3;H319:1;H301:1
99983,"1,2,4-triazolo[4,3-a]pyridin-3(2H)-one",230-191-8,6969-71-7,Aquatic Chronic 3,REACH registration C&L,79,H412:16;H335:55;H315:55;H319:55;Not classified:7;H302:1
99985,4-phenylcyclohexanone,225-517-0,4894-75-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:2;H315:2;H319:2;Not classified:1
99986,"1,1'-(1,4-dihydro-2,4,6-trimethylpyridine-3,5-diyl)bisethan-1-one",214-099-5,1081-09-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
99987,5-bromo-2-methoxybenzaldehyde,246-564-3,25016-01-7,Acute Tox. 4,Notified C&L,43,H302:38;H335:4;H315:5;H319:5
99988,Melaleuca viridiflora extract,310-217-5,132940-73-9,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1415,H319:1408;H411:1414;H315:1415;H317:1415;H226:1415;H304:1415;H410:1;H400:1
99990,"8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione",606-705-5,21098-11-3,Acute Tox. 4;Muta. 2,REACH registration C&L,5,H341:4;H302:5
99993,DL-valine,208-220-0,516-06-3,Not Classified,Notified C&L,116,Not classified:116
99997,4-(ethyl(2-hydroxyethyl)amino)benzenediazonium zinc chloride,236-886-2,13532-96-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;H312:1;H332:1;H228:1;H302:1
99999,"1,1'-(hexadecylimino)dipropan-2-ol",218-870-7,2269-21-8,Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,1,H314:1;H411:1
100005,"Tris(pentane-2,4-dionato-O,O')indium",238-378-6,14405-45-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,40,H312:40;H302:40;H319:39;H315:39;H335:40;H332:40;H351:39;H317:1
100006,Garlic extract,616-782-7,8000-78-0,Skin Sens. 1B,Notified C&L,271,H317:155;H226:156;H315:143;H302:156;H319:53;Not classified:1
100007,trisodium N-(3-propionato)-.sc.l.sc.-aspartate,422-090-4,172737-80-3,Eye Dam. 1,Harmonised C&L,0,H318:0
100008,"1,7-dicarbadodecaborane(12)",241-065-7,16986-24-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H302:39;H319:39;H228:1
100009,"(S)-7-[[2-O-6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one",236-216-9,13241-33-3,Not Classified,REACH registration C&L,6,Not classified:6
100010,"2,2-ethylmethylthiazolidine",404-500-3,694-64-4,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H317:0;H411:0;H302:0
100013,"Benzaldehyde, 4-[ethyl(phenylmethyl)amino]-",614-101-8,67676-47-5,Not Classified,Notified C&L,1,Not classified:1
100016,"tris(pentane-2,4-dionato)iron(III)",237-853-5,14024-18-1,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,207,H312:33;H318:44;H331:7;H302:192;H319:77;H332:26;Not classified:15;H315:39;H335:14
100027,"4-amino-3,6-bis[[4-[[4-chloro-6-[(3-sulphophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulphophenyl]azo]-5-hydroxynaphthalene-2,7-disulphonic acid",257-151-2,51357-74-5,Eye Irrit. 2,REACH registration C&L,4,H319:4;H335:2;H334:2
100038,1-methyl-5-nitro-1H-imidazole,221-225-2,3034-42-2,Acute Tox. 4,Notified C&L,38,H302:38
100042,p-anisic anhydride,212-345-6,794-94-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
100043,Guanosine 5'-(disodium hydrogen pyrophosphate),231-026-2,7415-69-2,Not Classified,Notified C&L,1,Not classified:1
100045,Ethyl [2]alcohol,213-128-9,925-93-9,Flam. Liq. 2,Notified C&L,42,H225:42;Not classified:1
100047,Sodium hydrogen DL-aspartate,254-507-9,39557-43-2,,Notified C&L,33,Not classified:33
100048,"N-[[3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]carbamoyl]-2,6-difluorobenzamide",601-779-5,121451-02-3,Repr. 2;Lact.;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,175,H361:174;H362:174;H400:19;H410:175
100050,"3,4,5-triethoxybenzoic acid",230-192-3,6970-19-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:42;H315:42;H319:42
100051,2-bromo-4-(trifluoromethyl)benzaldehyde,285-677-2,85118-24-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H312:1;H302:2;H319:2;H315:2;H335:2;H332:1
100057,"Gases (petroleum), oil refinery gas distn. off;Refinery gas;[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.]",271-258-1,68527-15-1,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
100060,2-(isopropyl)-5-methylcyclohexylamine,244-377-1,21411-81-4,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H335:1;H314:1;H302:1
100061,Tetrahydro-3-methyl-2H-pyran,247-455-3,26093-63-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H225:38;H315:38;H319:38
100062,"Ethanol, 2,2'-[(6-chloro-4,8-di-1-piperidinylpyrimido[5,4-d]pyrimidin-2-yl)imino]bis-",611-094-3,54093-92-4,,Notified C&L,1,H302:1
100064,3-Methyl-6-isopropenyl-9-decenyl acetate,613-572-7,64309-03-1,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H317:89;H400:89;H410:89
100065,"2,4-dimethylcyclohexanemethanol",270-892-6,68480-15-9,Not Classified,Notified C&L,88,Not classified:88
100067,"Fatty acids, C9-11-branched, glycidyl esters, polymers with castor oil, formaldehyde, 6-phenyl-1,3,5-triazine-2,4-diamine and phthalic anhydride",614-516-4,68459-31-4,Not Classified,Notified C&L,41,Not classified:41
100070,Tin telluride,234-914-8,12040-02-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H335:56;H315:56;H302:56;H319:56
100072,"9-fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17,21-di(propionate)",227-005-2,5593-20-4,Repr. 2,Notified C&L,108,H361:58;H410:46;H360:47;H330:35;H372:46;Not classified:2;H373:3;H332:1;H302:1;H319:1;H412:1;H315:1;H335:1;H362:1
100073,N-[2-(trifluoromethyl)phenyl]acetamide,206-453-2,344-62-7,Acute Tox. 4;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,42,H334:38;H302:42;H319:42;H335:4;H315:4
100074,Sodium phenylphosphinate,224-305-5,4297-95-4,Eye Dam. 1,REACH registration C&L,95,H318:85;H302:85;Not classified:8;H314:2
100078,"2,5-dihydrothiophene 1,1-dioxide",201-059-7,77-79-2,Eye Dam. 1,Notified C&L,53,H318:42;H319:11;H335:1
100080,2-hydrazino-δ-2-imidazoline hydrobromide,259-921-3,55959-84-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H319:43
100084,Methyl 2-bromo-5-methoxybenzoate,609-129-2,35450-36-3,Acute Tox. 3,Notified C&L,43,H301:39;H315:4;H319:4;H311:1;H331:1
100086,6-chloropyridine-2-carbonitrile,251-429-7,33252-29-8,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H335:44;H318:40;H315:44;H301:41;H302:4;H319:6;H311:5;H332:4;H331:1
100087,2-[N-(2-acetoxyethyl)-4-chloro-2-nitro-5-[2-(propionamido)anilino]anilino]ethyl acetate,248-050-4,26850-12-4,Not Classified,Notified C&L,33,Not classified:33
100090,Dibutyl [1-(butylamino)cyclohexyl]phosphonate,257-085-4,51249-05-9,,Notified C&L,38,Not classified:38
100094,"Methyl 1,2,2,6,6-pentamethyl-4-piperidyl sebacate",280-060-4,82919-37-7,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1300,H317:1201;H400:873;H410:875;Not classified:99;H411:5
100097,1-dimethylaminopropan-2-ol;dimepranol (INN),203-556-4,108-16-7,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Harmonised C&L,0,H226:0;H314:0;H302:0
100100,"2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium hydrogen sulphate",276-586-9,72319-18-7,Met. Corr. 1;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,90,H302:87;H318:87;H290:87;H411:87;H315:87;Not classified:3
100101,"Proteinase, Aspergillus acid",232-796-2,9025-49-4,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,1395,H335:108;H334:1395;H315:108;H319:108
100102,"Resin acids and Rosin acids, maleated, esters with glycerol",305-515-7,94581-16-5,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,18,H317:13;H413:6;H319:13;Not classified:5
100103,"Poly(oxy-1,2-ethanediyl), α,α',α''-1,2,3-propanetriyltris[ω-methoxy-",608-501-1,305812-16-2,Not Classified,Notified C&L,3,Not classified:3
100104,3-methylglutaric acid,210-951-5,626-51-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H335:44;H315:45;H319:45
100105,"Hexanedioic acid, polymer with 2,2-dimethyl-1,3-propanediol, 1,6-hexanediol and 2,2'-oxybis[ethanol]",608-201-0,28388-17-2,Not Classified,Notified C&L,1,Not classified:1
100107,Diammonium dimolybdate,248-517-2,27546-07-2,Not Classified,REACH registration C&L,86,Not classified:84;H332:1;H412:1
100108,Sodium 2-[2-[2-(tridecyloxy)ethoxy]ethoxy]ethyl sulphate,246-985-2,25446-78-0,Eye Irrit. 2,Notified C&L,810,H319:531;H412:213;H318:223;H315:223;Not classified:56
100109,DL-2-phenylbutyronitrile,212-213-8,769-68-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H312:42;H332:42;H302:42;H319:4;H315:4
100110,4'-nitroacetanilide,203-169-0,104-04-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:42;H315:43;H319:43;H312:1;H332:1;H302:1
100114,"sodium 3,6-dichloro-o-anisate",217-846-3,1982-69-0,Aquatic Chronic 3,Harmonised C&L,0,H412:0
100120,Meglumine,228-506-9,6284-40-8,Not Classified,REACH registration C&L,404,Not classified:343;H318:56;H362:24;H360:24;H351:24;H335:4;H315:4;H319:4;H311:1;H301:1
100126,"Biphenyl-2,2'-dicarboxylic acid",207-576-4,482-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
100130,Sodium N-methyl-N-(1-oxotetradecyl)aminoacetate,250-151-3,30364-51-3,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,61,H318:61;H315:59;H330:55
100134,"Terpenes and terpenoids, turpentine-oil, α-pinene fraction, oligomers",500-245-8,70750-57-1,Aquatic Chronic 4,REACH registration C&L,18,H413:15;Not classified:2;H315:1
100135,"L-Serine, O-(1,1-dimethylethyl)-",606-131-5,18822-58-7,Not Classified,Notified C&L,2,Not classified:2
100136,Tetraethylphosphorodiamidic chloride,217-262-9,1794-24-7,,Notified C&L,4,H314:4
100138,"4,4'-methylenebis(2,6-diisopropylaniline)",243-421-7,19900-69-7,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,68,H317:15;H413:15;H302:68;H312:38;H319:38;H315:38;H335:38;H332:38;H412:8
100143,"1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-C11-13-alkyl derivs.",291-473-4,90411-94-2,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H410:1;H302:1;H318:1;H400:1;H314:1
100144,2-[2-(2-butoxyethoxy)ethoxy]ethanol;TEGBE;triethylene glycol monobutyl ether;butoxytriethylene glycol,205-592-6,143-22-6,Eye Dam. 1,Harmonised C&L,0,H318:0
100146,"3(2H)-Benzofuranone, O-methyloxime, (3Z)-",606-662-2,208711-51-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,33,H412:33;H317:33;H315:33;H302:33
100156,"9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthylium acetate",264-859-5,64381-99-3,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,230,H411:7;H319:8;H314:2;H412:89;H318:176;H335:84;H315:84;Not classified:45;H302:4;H341:1;H312:1
100164,pencycuron (ISO);1-[(4-chlorophenyl)methyl]-1-cyclopentyl-3-phenylurea,266-096-3,66063-05-6,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
100166,4-(trifluoromethyl)benzylamine,221-971-9,3300-51-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:39;H315:38;H319:39;H314:9;H318:1
100171,"Propane-1,3-dithiol",203-706-9,109-80-8,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2,REACH registration C&L,141,H226:3;H315:128;H301:4;H335:126;H319:127;H302:26;Not classified:12;H300:4;H334:1;H317:1
100172,Lupinine,207-638-0,486-70-4,,Notified C&L,4,H312:4;H332:4;H302:4
100175,Magnesium bromide,603-827-0,13446-53-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:46;H315:46;H319:46
100176,Arprinocide,259-817-8,55779-18-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
100177,Dimethylammonium dimethyldithiocarbamate,209-945-5,598-64-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
100178,"o-fluoro-α,α,α-trichlorotoluene",207-692-5,488-98-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H315:40;H319:40
100179,"Resin acids and Rosin acids, esters with triethylene glycol",232-478-3,8050-25-7,Not Classified,REACH registration C&L,90,Not classified:65;H412:25
100181,N-(phenylmethyl)glycine,241-194-9,17136-36-6,Not Classified,Notified C&L,1,Not classified:1
100187,Sodium dodecylbenzenesulfonate,246-680-4,25155-30-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,2213,H318:1310;H315:1417;H302:2079;H312:686;H319:799;H412:180;H335:418;Not classified:77;H330:20;H411:19;H317:2;H334:1;H301:1
100188,"(2-endo,3-exo)-Ethyl 3-(1-methylethyl)bicyclo[2.2.1]hept-",639-060-3,116044-44-1,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,173,H317:173;H411:173
100192,"2,3,6-trichlorotoluene",218-202-4,2077-46-5,,Notified C&L,37,Not classified:36;H335:1;H315:1;H319:1
100197,(E)-oct-2-enyl butyrate,283-437-1,84642-60-4,Not Classified,Notified C&L,88,Not classified:88
100199,Dimethyl 5-bromoisophthalate,257-386-0,51760-21-5,Acute Tox. 3,Notified C&L,44,H301:38;H335:5;H315:6;H319:6
100200,2-methylbutyl propionate,219-449-0,2438-20-2,Flam. Liq. 3,Harmonised C&L,0,H226:0
100202,"1,4-dihydro-2H-isoquinolin-3-one",246-174-3,24331-94-0,,Notified C&L,2,H335:2;H315:2;H319:2
100204,Dipropyl adipate,203-371-9,106-19-4,Not Classified,Notified C&L,2,Not classified:2
100206,"3,5-bis(benzyloxy)acetophenone",249-315-7,28924-21-2,Not Classified,REACH registration C&L,2,Not classified:2
100207,nickel bis(2-ethylhexanoate),224-699-9,4454-16-4,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H341:0;H410:0;H334:0;H400:0;H372:0;H317:0;H350:0;H360:0
100211,4-aminobutyrate ethyl hydrochloride,230-063-1,6937-16-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:40;H315:40;H319:40
100215,"Estr-4-en-3-one, 17-(sulfooxy)-, sodium salt, (17β)-",262-368-0,60672-82-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1B,Notified C&L,16,H312:16;H302:16;H360:16;H332:16;H351:16
100222,Neryl isovalerate,223-478-4,3915-83-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:38;H319:38;Not classified:1
100225,"2,3,5,6-tetrachloro-p-xylene-α,α-diol",230-502-7,7154-26-9,Acute Tox. 4,Notified C&L,38,H302:38
100226,"1H-Pyrazole, 4,5-dihydro-1,3,5-triphenyl-",616-061-7,742-01-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
100228,1-[4-(trifluoromethyl)phenyl]ethan-1-one,211-913-0,709-63-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:44;H315:46;H319:46
100232,"Hydrogen bis[2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]cobaltate(1-), compound with cyclohexylamine (1:1)",275-628-3,71566-27-3,Not Classified,Notified C&L,2,Not classified:2
100248,sodium,231-132-9,7440-23-5,Water-react. 1;Skin Corr. 1B,Harmonised C&L,0,H260:0;H314:0
100250,"Poly(oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-(hexyloxy)- (3 EO)",600-651-6,105391-15-9,Eye Dam. 1,Notified C&L,498,H318:498;Not classified:33;H315:57
100265,2-(hexadecyloxy)ethanol,218-373-5,2136-71-2,Not Classified,Notified C&L,13,Not classified:13
100266,6-chloro-m-cresol,210-444-9,615-74-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,80,H335:43;H315:47;H319:40;H312:38;H302:39;H318:37;H400:37;H317:33;H332:4;H411:1
100267,"Pentamethylene bis[1-(3,4-dimethoxybenzyl)-3,4-dihydro-6,7-dimethoxy-1H-isoquinoline-2-propionate], dioxalate",264-741-3,64228-78-0,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2,Notified C&L,19,H300:16;H330:16;H310:16;H335:1;H315:1;H319:2;H312:1;H332:1;H302:1;H317:1;H400:1;H410:1
100269,2- cyclohexyl-2-cyclohexylidene acetonitrile,600-592-6,10461-98-0,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,122,H411:122;H302:122;H331:1
100271,"2,6-dichlorobenzoyl chloride",225-102-4,4659-45-4,Skin Corr. 1B,Notified C&L,82,H314:81;H412:4;H318:1;H290:1;Not classified:1
100272,"Guanidine, cyano-, reaction products with diethylenetriamine",287-353-6,85480-72-4,Not Classified,Notified C&L,2,Not classified:2
100273,Desoximetasone,206-845-3,382-67-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,43,H312:40;H302:42;H319:40;H315:41;H317:39;H335:40;H332:40;H351:39;H361:4;H373:1
100274,4-chloropyridine N-oxide,214-336-2,1121-76-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H335:41;H315:42;H319:42;H312:2;H302:2;H332:2
100275,"Quinoline, 5-chloro-2,6-dimethoxy-4-methyl-8-nitro-",606-189-1,189746-21-2,Skin Sens. 1,Notified C&L,1,H317:1
100276,Docosyl acrylate,242-182-6,18299-85-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,268,H335:264;H411:264;H315:265;H319:265;Not classified:3
100283,"2,4-Difluoroanisole",610-230-9,452-10-8,,Notified C&L,6,H226:6;H335:4;H315:6;H319:6
100285,7-amino-4-hydroxy-3-[[4-[(4-sulphophenyl)azo]phenyl]azo]naphthalene-2-sulphonic acid,263-926-6,63147-42-2,Not Classified,Notified C&L,1,Not classified:1
100287,"2,2,4-trimethylpentane",208-759-1,540-84-1,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H336:0;H400:0;H315:0;H225:0;H304:0
100290,Arsenic sulfide,215-117-4,1303-33-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46,H410:46;H400:46;H331:42;H301:46;H311:39;H330:4
100294,"Pentasodium 4-amino-6-[[5-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-2-sulphonatophenyl]azo]-3-[(2,5-disulphonatophenyl)azo]-5-hydroxynaphthalene-2,7-disulphonate",274-959-0,70865-31-5,Not Classified,Notified C&L,2,Not classified:1;H317:1;H334:1
100296,"2,3-diphenyl-1H-indole",222-432-0,3469-20-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H335:38;H318:38;H413:38;H315:38
100301,"Sorbitan, triisooctadecanoate",259-141-3,54392-27-7,Not Classified,Notified C&L,2,Not classified:2
100304,(E)-3-methyl-2-(pent-2-enyl)cyclopent-2-en-1-one,228-410-7,6261-18-3,Not Classified,Notified C&L,113,Not classified:113
100306,Polydimethylsiloxanes,613-156-5,63148-62-9,Not Classified,Notified C&L,1754,Not classified:1402;H319:219;H411:39;H361:25;H318:25;H314:25;H412:14;H315:13;H226:27;H300:2;H413:2;H373:1
100308,2-[ethyl[(heptadecafluorooctyl)sulphonyl]amino]ethyl acrylate,207-031-0,423-82-5,Not Classified,Notified C&L,6,Not classified:6
100318,1-(tert-Butoxycarbonyl)-4-(methanesulfonyloxy)piperidine,619-988-5,141699-59-4,Acute Tox. 3,Notified C&L,129,H301:127;H315:2;H319:2;H335:1;H302:1
100321,Sphingomyelinase C,232-869-9,9031-54-3,Resp. Sens. 1,Notified C&L,1,H334:1
100322,"N-[2-[(1-butyl-4,5-dicyano-1H-imidazol-2-yl)azo]-5-(dibutylamino)phenyl]",417-520-2,107689-03-2,Aquatic Chronic 4,Notified C&L,1,H413:1
100326,(2H5)glycine,225-518-6,4896-77-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H335:2;H315:2;H319:2
100329,"2,5-dihydro-2,5-dioxo-1H-pyrrole-1-carboxamide",222-097-0,3345-50-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H302:38;H319:42;H335:4;H315:4
100330,C.I. Reactive Red 31,602-664-2,12237-00-2,,Notified C&L,1,Not classified:1
100333,"Cuprate(4-), [2-[[[[2-hydroxy-3-sulfo-5-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]phenylmethyl]azo]-4-sulfobenzoato(6-)]-, sodium",291-103-1,90341-71-2,Skin Sens. 1B,REACH registration C&L,50,H317:42;Not classified:6;H412:2;H334:1
100335,"Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",292-631-5,90641-07-9,Carc. 1B,Harmonised C&L,0,H350:0
100337,"2H-1,3-Benzoxazine-2,4(3H)-dione, 7-methyl-",607-320-5,24088-77-5,,Notified C&L,1,H335:1;H315:1;H319:1
100339,"4-(benzyloxy)-α-[[tert-butylamino]methyl]-m-xylene-α,α'-diol",260-385-8,56796-66-8,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,4,H315:2;H302:3;H410:1
100341,"Trisodium 2-[(2-hydroxy-3,6-disulphonato-1-naphthyl)azo]benzoate",217-401-3,1836-22-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H335:38;H315:38;H319:38;Not classified:11
100343,"oxirane, mono[(C",271-846-8,68609-97-2,Skin Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H315:0
100345,2-methoxybenzonitrile,229-559-0,6609-56-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:40;H315:45;H319:45;H312:6;H302:6;H332:6;H331:2;H301:2;H311:2
100347,"Castor oil, oxidized",269-128-4,68187-84-8,Not Classified,REACH registration C&L,289,Not classified:289
100348,Ethyl loflazepate,249-489-4,29177-84-2,STOT SE 3,Notified C&L,1,H336:1
100351,"Acetaldehyde, polymers",618-341-4,9002-91-9,Flam. Sol. 2;Acute Tox. 3;Acute Tox. 2,Notified C&L,38,H228:38;H301:38;H330:38
100353,2-bromopropionic acid,209-947-6,598-72-1,Acute Tox. 3;Skin Corr. 1B,REACH registration C&L,57,H314:57;H301:10;H302:47;H318:3;H290:2;H312:1;H332:1
100356,"Pinane, didehydro derivative",215-533-6,1330-16-1,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,25,H410:25;H400:25;H315:13;H317:25;H304:25
100357,"Gases (petroleum), hydrogen absorber off;Refinery gas;[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.]",270-779-1,68477-96-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
100360,"Fatty acids, tallow, hydrogenated, distn. residues",276-611-3,72379-28-3,Not Classified,Notified C&L,10,Not classified:10
100364,"reaction mass of: Trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate;5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt",423-200-3,,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0;H317:0
100365,3-hydroxypropiononitrile,203-704-8,109-78-4,Not Classified,REACH registration C&L,165,Not classified:118;H335:46;H315:47;H319:47
100367,"[1R-(1α,7β,8α)]-1,2,3,5,6,7,8,8a-octahydro-1,8a-dimethyl-7-(1-methylvinyl)naphthalene",225-047-6,4630-07-3,Asp. Tox. 1,Notified C&L,1681,H304:1655;H226:27;H412:52;Not classified:1;H312:1;H302:1;H332:2;H319:1;H315:1
100368,"Dammar, sulfurized",272-825-6,68916-22-3,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Repr. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,2,H361:1;H412:1;H315:1;H373:1;H317:1;H226:1;Not classified:1
100369,"Sulfonic acids, C13-17-sec-alkane, sodium salts",288-330-3,85711-69-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,462,H318:425;H315:460;H302:230;H412:13
100374,"2,4,4,7-tetramethyl-6-octen-3-one",422-520-0,74338-72-0,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
100376,p-fluorophenethylamine,216-435-6,1583-88-6,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,43,H311:40;H314:43;H331:39;H301:40;H318:2
100382,Potassium oleate,205-590-5,143-18-0,Eye Irrit. 2,Notified C&L,814,H319:649;Not classified:163;H315:195;H335:56;H400:72;H318:1;H314:2;H412:1
100384,"Creosote oil, low-boiling distillate;Wash Oil;[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38°C (100°F).]",274-566-4,70321-80-1,Carc. 1B,Harmonised C&L,0,H350:0
100385,"Methyl 3,5-diamino-6-chloropyrazinecarboxylate",215-946-1,1458-01-1,Acute Tox. 3;Eye Irrit. 2;STOT SE 3;STOT RE 2,REACH registration C&L,50,H335:48;H373:5;H301:5;H319:49;H315:44;Not classified:1
100386,2-hydroxyethyl acetate,208-821-8,542-59-6,Eye Dam. 1,Notified C&L,41,H318:41
100388,Cycloheptanecarbonitrile,251-180-4,32730-85-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H312:43;H302:43;H319:43;H315:43;H335:43;H332:43
100390,Cyclopropylmethanol,219-735-5,2516-33-8,,REACH registration C&L,111,H226:110;H302:109;H319:58;H361:42;H373:43;H314:51;H332:5;H372:3;H335:1;H225:1;H315:1
100400,4-(diethylamino)butan-2-one,221-970-3,3299-38-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H226:39;H335:39;H315:39;H319:38;H302:1;H318:1
100401,"2,4-diamino-6-methylphenol dihydrochloride",279-664-0,81028-94-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
100403,"2,4-Dimethoxybenzenesulfonyl chloride",613-290-4,63624-28-2,Skin Corr. 1B;Skin Sens. 1,Notified C&L,42,H314:42;H317:38
100406,N-methyl-L-tyrosine,208-670-8,537-49-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H315:38;H319:38
100408,3-phenylpropionaldehyde,203-211-8,104-53-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1678,H315:1678;H319:1678;H317:25;H335:5;H225:1
100410,"3,6-dihydro-2,4-dimethyl-6-phenyl-2H-pyran",268-256-8,68039-40-7,Not Classified,Notified C&L,236,Not classified:235;H412:1;H319:1
100412,9-methylanthracene,212-299-7,779-02-2,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,48,H318:40;H410:45;H400:45;H302:39;Not classified:3
100414,"2,3,4,5,6-pentafluorobenzyl (1R-trans)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate",278-329-6,75867-00-4,Acute Tox. 3;Acute Tox. 4;Acute Tox. 2,Notified C&L,38,H312:38;H301:38;H330:38
100415,Barium diboron tetraoxide,237-222-4,13701-59-2,Acute Tox. 4;Repr. 1B,REACH registration C&L,390,H360:64;H302:211;Not classified:176;H332:147;H335:3;H315:2;H319:3;H412:1
100416,C.I. Acid Red 425,604-800-6,151499-54-6,,Notified C&L,33,Not classified:33
100418,Estragon oil,616-992-9,8016-88-4,Acute Tox. 4,Notified C&L,71,H302:43;H341:33;H371:28;H411:33;H317:33;H351:33;H304:33
100420,α-Bungarotoxin,234-266-6,11032-79-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,116,H312:116;H332:116;H302:116
100421,"Alcohols, C10-16, ethoxylated, sulfates, triethanolammonium salts",500-344-6,157627-94-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
100422,"Bis(pentane-2,4-dionato)calcium",243-001-3,19372-44-2,Acute Tox. 4;Skin Sens. 1A;Eye Dam. 1,REACH registration C&L,114,H318:62;H317:62;H302:105;H361:40;H319:45;H315:43;H335:42;Not classified:6;H331:3;H311:3;H312:3;H332:2
100425,dimethyl sulphate,201-058-1,77-78-1,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Muta. 2;Carc. 1B,Harmonised C&L,0,H341:0;H330:0;H314:0;H317:0;H350:0;H301:0
100427,(2S)-2-(Chloromethyl)oxirane,614-150-5,67843-74-7,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Carc. 1B,Notified C&L,61,H314:60;H317:60;H350:60;H301:61;H331:47;H226:60;H311:61;H330:9;H361:6
100428,"Silica gel, fluorinated",276-584-8,72319-09-6,Not Classified,Notified C&L,56,Not classified:56
100429,Chlorphenoxamine hydrochloride,209-227-1,562-09-4,Acute Tox. 4,Notified C&L,39,H302:39
100432,"2,4,5-trichloroaniline",211-254-9,636-30-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,203,H410:201;H373:201;H331:202;H301:202;H311:202;H400:164;Not classified:1;H411:1
100433,"2-(2,2-dicyclohexylethyl)piperidinium hydrogen maleate",229-775-5,6724-53-4,Not Classified,Notified C&L,1,Not classified:1
100436,"1,4-diamino-2-methoxyanthraquinone",220-703-8,2872-48-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,60,H335:38;H315:39;H302:39;H319:39;Not classified:17;H317:5
100437,3-methyl-2-pyridylamine,216-501-4,1603-40-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2,Notified C&L,47,H311:41;H373:38;H331:41;H301:46;H319:8;H315:8;H335:7;H310:5;Not classified:1
100443,5-amino-2-chlorotoluene-4-sulphonic acid,201-839-7,88-53-9,Not Classified,REACH registration C&L,158,Not classified:36;H319:84;H314:38;H315:1
100444,Magnesium diboride,234-501-2,12007-25-9,Water-react. 2;Acute Tox. 4,Notified C&L,1,H261:1;H302:1
100446,"1,3-bis(1,2-dibromoethyl)benzene",247-293-3,25850-49-1,Skin Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38
100449,6-methoxy-3-pyridylamine,229-612-8,6628-77-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H302:47;H319:47;H332:1
100451,Dimethylammonium iodide,256-945-6,51066-74-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1
100452,"Disodium 3,3'-[(9,10-dihydro-5,8-dihydroxy-9,10-dioxo-1,4-anthrylene)diimino]bis[6-butylbenzenesulphonate]",277-432-3,73398-32-0,Not Classified,Notified C&L,6,Not classified:4;H319:1;H412:1
100453,2-nitro-5-thiocyanatobenzoic acid,250-093-9,30211-77-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:39
100457,"Cheese, Blue, ext.",309-826-9,101227-04-7,Not Classified,Notified C&L,10,Not classified:10
100459,"1,2-dimethylimidazole",217-101-2,1739-84-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Harmonised C&L,0,H318:0;H315:0;H302:0
100462,PART OF FREKOTE (R) RANGE OF MOULD RELEASE AGENTS,481-810-5,,Not Classified,Notified C&L,1,Not classified:1
100463,"1-(2,6,6-trimethyl-2-cyclohexen-1-yl)pentan-3-one",270-894-7,68480-17-1,Not Classified,Notified C&L,233,Not classified:233
100467,(-)-trans-4-(4'-Fluorphenyl)-3-hydroxymethyl-N-methylpiperidin,600-679-9,105812-81-5,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,7,H318:6;H411:6;H302:7
100472,N-[3-(dimethylamino)propyl]decan-1-amide,245-306-7,22890-11-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,7,H410:7;H319:7;H318:7;H400:7;H315:7;H314:7
100477,N-butylbenzylamine,219-287-0,2403-22-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:38;H315:38;H319:38;H314:6;H318:1
100479,Sebacohydrazide,213-126-8,925-83-7,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,110,H412:2;H302:3;Not classified:107;H312:1;H319:1;H315:1;H335:1;H332:1
100481,"9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethylxanthylium tetrafluoroborate",259-376-1,54854-14-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
100486,"Ocotea pretiosa, ext.",285-383-4,85085-57-0,Acute Tox. 4;Muta. 2;Carc. 1B,Notified C&L,28,H341:28;H350:28;H302:28
100488,2-ethylbut-1-ene,212-078-5,760-21-4,Flam. Liq. 2;Skin Sens. 1,Notified C&L,90,H225:90;H317:38;H336:25;H304:26;H319:27;H335:4;H315:5;H411:1
100490,"Distillates (petroleum), solvent-dewaxed heavy paraffinic;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",265-169-7,64742-65-0,Carc. 1B,Harmonised C&L,0,H350:0
100492,ANTIHALOFARBSTOFF OXONOLROT 536 PINA,426-690-7,,Aquatic Chronic 3,Notified C&L,1,H412:1
100493,"Sodium 3-[2-(2-heptyl-4,5-dihydro-1H-imidazol-1-yl)ethoxy]propionate",272-563-2,68877-55-4,Skin Sens. 1,Notified C&L,50,H317:47;H315:3;H319:3
100501,"1,4-dichlorophthalazine",225-275-6,4752-10-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H315:1;H319:1
100502,2'-hydroxy-5'-methylpropiophenone,213-342-2,938-45-4,Acute Tox. 4,Notified C&L,39,H302:38;H335:1;H315:1;H319:1
100503,"Sodium [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]cobaltate(1-)",277-509-1,73507-66-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,85,H400:84;H410:84;Not classified:1
100505,"Oxirane, 2-methyl-, polymer with oxirane, monoacetate, 2-propen-1-yl ether",611-355-1,56090-69-8,Not Classified,Notified C&L,26,Not classified:22;H315:4;H319:4
100509,1-phenylethyl isobutyrate,231-894-2,7775-39-5,Not Classified,Notified C&L,90,Not classified:90
100514,4-[[(p-anisyl)methylhydrazono]methyl]-1-methylpyridinium methyl sulphate,272-798-0,68912-02-7,Not Classified,Notified C&L,1,Not classified:1
100523,Cyclohexadecenone,608-568-7,3100-36-5,Skin Irrit. 2,Notified C&L,50,H315:25;H400:25;H410:25
100526,1-methyl-2-oxopropyl butyrate,283-438-7,84642-61-5,Not Classified,Notified C&L,91,Not classified:91
100531,"Fusanus spicatus, ext.",296-618-5,92875-02-0,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1509,H317:205;H411:1353;H315:1442;H319:1388;Not classified:18;H226:6;H412:6
100534,4-chloro-3-nitroanisole,233-674-1,10298-80-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H335:43;H315:44;H319:44
100537,"Octanoic acid, reaction products with 2-[(2-aminoethyl)amino]ethanol, acrylic acid alkylated (1:2), disodium salts",272-383-4,68815-55-4,Not Classified,Notified C&L,13,Not classified:11;H318:1;H315:2;H319:1;H301:1;H331:1;H311:1;H225:1
100542,"Tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate",402-070-1,88122-99-0,Aquatic Chronic 4,REACH registration C&L,184,H413:183;Not classified:1
100545,"5-butoxy-2-[4-(4-butoxy-2-hydroxyphenyl)-6-(2,4-dibutoxyphenyl)-1,3,5-triazin-2-yl]phenol",434-080-7,,Not Classified,REACH registration C&L,87,Not classified:87
100547,Dichlorocyclohexylmethylsilane,226-956-0,5578-42-7,Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,45,H412:2;H318:3;H314:41;H335:38;Not classified:4;H290:1
100548,"Xylosidase, exo-1,4-β-",232-797-8,9025-53-0,Resp. Sens. 1,Notified C&L,5,H334:5
100550,ethyl 3-[[2-[[4-[(Z)-N'-hexoxycarbonylcarbamimidoyl]anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate,606-722-8,211915-06-9,Not Classified,REACH registration C&L,3,Not classified:2;H413:1
100553,"4-[[4-(dimethylamino)phenyl][4-(dimethyliminio)cyclohexa-2,5-dien-1-ylidene]methyl]-N-ethyl-N,N-dimethylanilinium bromidechloride",238-920-1,14855-76-6,Not Classified,Notified C&L,9,Not classified:7;H335:2;H315:2;H319:2
100554,2-Bromo-5-fluorophenol,604-585-9,147460-41-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47;H302:6;H312:2;H332:2
100557,Disodium dihydrogen (1-hydroxyethylidene)bisphosphonate,231-025-7,7414-83-7,Not Classified,Notified C&L,301,Not classified:122;H302:115;H413:55;H411:6;H315:4;H319:5;H373:1;H335:1
100560,1-Diphenylmethyl-3-azetidinyl methanesulfonate,608-857-8,33301-41-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
100562,Benzyl 2-methoxy-4-prop-1-enylphenyl ether,204-370-6,120-11-6,Not Classified,REACH registration C&L,1619,Not classified:1580;H410:38;H318:38;H400:38;H315:39;H317:38;H335:38;H319:1
100565,"2-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthryl)oxy]ethyl ethyl carbonate",254-959-7,40530-60-7,Not Classified,REACH registration C&L,2,Not classified:2
100568,Bis(2-hydroxyethyl)[2-(stearoyloxy)ethyl]ammonium acetate,241-350-6,17329-61-2,Not Classified,Notified C&L,1,Not classified:1
100570,"Cashew, nutshell liq., polymer with sulfuric acid",614-899-8,69012-00-6,Skin Sens. 1,Notified C&L,3,H317:2;Not classified:1
100572,Tributyltin fluoride,217-847-9,1983-10-4,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H312:42;H410:42;H319:42;H400:42;H315:42;H372:42;H301:42
100575,Benzyl carbazate,226-230-3,5331-43-1,Eye Dam. 1,Notified C&L,79,H318:46;H372:33;H302:34;H319:33;H335:4;H315:5;H312:1;H332:1
100577,"1,3,4,6,7,8-hexahydro-1-methyl-2H-pyrimido[1,2-a]pyrimidine",281-791-1,84030-20-6,Skin Corr. 1B,Notified C&L,41,H314:41;H318:1
100579,"Hydrocarbons, C1-3;Petroleum gas;[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 °C to minus 42 °C (– 263 °F to – 44 °F).]",271-259-7,68527-16-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;Not classified:0;H350:0;H340:0
100580,"Protein hydrolyzates, wheat, reaction products with lauroyl chloride, sodium salts",604-652-2,148812-64-0,,Notified C&L,2,Not classified:2
100581,Strontium,231-133-4,7440-24-6,Water-react. 1;Skin Corr. 1A,REACH registration C&L,177,H260:123;H314:38;H315:43;Not classified:48;H261:6;H335:1;H319:1
100582,Cinnamaldehyde oxime,236-449-6,13372-81-1,Acute Tox. 3,Notified C&L,38,H301:38
100583,Piperidolate,201-449-7,82-98-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H311:38;H331:38;H301:38
100585,"Alcohols, C12-14-secondary",603-174-1,126950-60-5,Not Classified,Notified C&L,159,Not classified:146;H400:13;H410:13
100587,N-[3-(dimethylamino)propyl]octanamide,245-305-1,22890-10-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,7,H410:7;H319:7;H318:7;H400:7;H315:7;H314:7
100590,Pentazirconium trisilicide,234-913-2,12039-97-3,Not Classified,Notified C&L,1,Not classified:1
100593,Partially saponified Fischer-Tropsch wax,921-287-7,,Not Classified,Notified C&L,37,Not classified:37
100594,"1,4-dichloro-2-(chloromethyl)benzene",220-382-4,2745-49-5,,Notified C&L,6,H314:6
100595,Sodium N-methyl-N-(1-oxo-9-octadecenyl)aminoacetate,222-829-9,3624-77-9,Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,108,H412:41;H318:68;H400:108;H315:108;H332:42;H410:71;H319:40
100597,Bis[(dimethylamino)methyl]phenol,275-162-0,71074-89-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,542,H312:178;H302:254;H318:318;H314:515;H335:178;H317:33;H315:21;H319:21;Not classified:6
100598,Dilanthanum trisulphide,234-752-8,12031-49-1,,Notified C&L,120,Not classified:116;H335:4;H261:4;H315:4;H319:4
100601,"1-(2,3-dichlorophenyl)piperazine",609-896-3,41202-77-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H335:2;H315:2;H302:1;H319:2;Not classified:1
100602,2-(2-hydroxyethoxy)ethyl acrylate,236-887-8,13533-05-6,Acute Tox. 4;Acute Tox. 2;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,Notified C&L,442,H302:442;H318:442;H317:442;H314:442;H310:441;H312:1;H400:1;H411:1;H335:1
100603,D-(+)-proline,206-452-7,344-25-2,Not Classified,REACH registration C&L,14,Not classified:12;H335:2;H315:2;H319:2
100604,"1,4-bis[(2-ethyl-6-methylphenyl)amino]anthraquinone",255-460-7,41611-76-1,Not Classified,REACH registration C&L,82,Not classified:44;H335:38;H315:38;H319:38
100605,1-naphthoic acid,201-681-9,86-55-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,138,H335:137;H315:138;H319:138;H320:1;H303:1
100606,"N,N''-(isobutylidene)diurea",228-055-8,6104-30-9,Not Classified,REACH registration C&L,86,Not classified:86
100607,"1-[diphenyl[3-(trifluoromethyl)phenyl]methyl]-1H-1,2,4-triazole",250-534-5,31251-03-3,Aquatic Chronic 4,Notified C&L,1,H413:1
100608,m-methylphenylacetonitrile,220-962-7,2947-60-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H312:44;H302:44;H319:44;H315:44;H335:43;H332:44;H331:1;H301:1;H311:1
100610,Isohexadecyl isooctadecanoate,257-598-3,52006-45-8,Not Classified,Notified C&L,8,Not classified:8
100612,Hafnium diboride,234-500-7,12007-23-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,210,H335:208;H315:208;H319:208;Not classified:2
100613,"1,5-Dimethylpyrazole",614-969-8,694-31-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H226:2;H315:2;H319:2
100615,"2-[[3-[(mercaptoacetyl)oxy]-2,2-bis[[(mercaptoacetyl)oxy]methyl]propoxy]methyl]-2-[[(mercaptoacetyl)oxy]methyl]-1,3-propanediyl bis(mercaptoacetate)",251-428-1,33250-21-4,Acute Tox. 4,Notified C&L,2,H302:2;H317:1;H315:1
100616,"Boric acid, reaction products with diethanolamine",273-238-8,68954-07-4,Not Classified,Notified C&L,16,Not classified:15;H318:1;H317:1
100617,5-Bromo-2-methoxypyridine,603-856-9,13472-85-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H335:43;H315:48;H319:49;H312:2;H302:2;H332:1
100619,"(1R,11aS)-1-hydroxy-11a-methyl-2,3,3a,5,6,8,9,11-octahydrospiro[cyclopenta[a]phenanthrene-7,2'-[1,3]dioxolane]-1-carbonitrile",608-856-2,33300-19-5,Not Classified,REACH registration C&L,2,Not classified:2
100620,Sodium 2-[2-[2-(tetradecyloxy)ethoxy]ethoxy]ethyl sulphate,246-986-8,25446-80-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,454,H318:441;H315:454;H412:13;H319:13
100621,1-Amino-1-deoxy-β-D-galactose,616-151-6,74867-91-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
100622,"N1,N1-dimethylpropane-1,2-diamine",203-555-9,108-15-6,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H226:38;H314:38;H302:38
100625,"2-bromo-5-nitro-1,3-thiazole",221-226-8,3034-48-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H335:45;H315:46;H319:46
100626,Diammonium hexakis(thiocyanato)platinate,243-002-9,19372-45-3,,Notified C&L,4,H312:4;H332:4;H412:4;H302:4
100630,"2,3-dihydroxypropyl 12-hydroxyoctadecanoate",228-507-4,6284-43-1,Not Classified,REACH registration C&L,3,Not classified:3
100631,(3-chloropropyl)benzene,203-210-2,104-52-9,Not Classified,REACH registration C&L,50,Not classified:3;H315:46;H335:5;H319:6;H411:1;H302:1
100637,tris(2-octyldodecyl) citrate,603-121-2,126121-35-5,Aquatic Chronic 4,REACH registration C&L,473,H413:6;H317:442;Not classified:25
100639,"21-hydroxypregna-4,9(11),16-triene-3,20-dione 21-acetate",245-674-9,23460-76-6,Not Classified,REACH registration C&L,2,Not classified:2
100640,3-phenylbutan-2-one,212-212-2,769-59-5,Acute Tox. 4;Skin Sens. 1,Notified C&L,39,H317:39;H302:39;H319:1;H335:1;H227:1
100641,"Solvent naphtha (coal), coumarone-styrene contg.;Light Oil Redistillate, intermediate boiling",287-500-4,85536-19-2,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
100647,"1H-Indene, 2,3,3a,4,5,6-hexahydro-1,1,2,3,3-pentamethyl-7-[(2-methyl-2-propen-1-yl)oxy]-",613-928-1,663623-54-9,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,10,H410:10;H400:10;H315:10;H319:10
100657,"tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate];C.I. Direct Blue 6",220-012-1,2602-46-2,Carc. 1B;Repr. 2,Harmonised C&L,0,H361:0;H350:0
100658,"1,1'-[isobutylidenebis(oxy)]bis[2-ethylhexane]",243-422-2,19900-85-7,Not Classified,Notified C&L,1,Not classified:1
100661,titanium dioxide; [in powder form containing 1 % or more of particles with aerodynamic diameter ≤ 10 μm],236-675-5,13463-67-7,Carc. 2,Harmonised C&L,0,H351:0
100662,Sodium oleate,205-591-0,143-19-1,Not Classified,Notified C&L,522,Not classified:522
100669,"Sodium [2,4-diamino-5-[(2-hydroxy-5-nitrophenyl)azo]benzene-1-sulphonato(3-)]ferrate(1-)",306-068-0,95873-76-0,Not Classified,Notified C&L,1,Not classified:1
100670,iso(C,404-800-4,118832-72-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
100674,"(1R)-1,7,7-trimethyl-3-(trifluoroacetyl)bicyclo[2.2.1]heptan-2-one",257-429-3,51800-98-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H319:38
100675,"(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate",604-433-1,144689-63-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,97,H312:56;H332:56;H302:92;H360:37;H319:36;H361:4;H373:2;H315:1;H335:1
100682,"Quaternized ethoxylated oleyl amine, chloride",603-715-1,133189-76-1,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,31,H318:31;H410:31;H400:31;H302:31
100685,Disodium C-isodecyl sulphonatosuccinate,253-452-8,37294-49-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,103,H412:66;H315:65;H302:81;H319:96;H410:14;Not classified:5;H318:2
100686,"Artemisia afra, ext.",294-744-5,91745-71-0,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,3,H412:3;H302:3
100688,Isoquinoline-1-carboxylic acid,207-639-6,486-73-7,,Notified C&L,6,H335:5;H315:6;H319:6
100690,Rhodium trinitrate,233-397-6,10139-58-9,Ox. Sol. 1;Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,134,H271:89;H341:89;H302:91;H410:91;H318:91;H290:91;H400:90;H314:134;H317:91;H272:40
100694,"Resin acids and Rosin acids, esters with pentaerythritol",232-479-9,8050-26-8,Not Classified,REACH registration C&L,336,Not classified:333;H319:2;H317:1
100695,"α-n-butyl-α-(4-chlorophenyl)-1H-1,2,4-triazole-1-propanenitrile",410-400-0,88671-89-0,Acute Tox. 4;Eye Irrit. 2;Repr. 2;Aquatic Chronic 2,Notified C&L,140,H361:140;H411:140;H302:140;H319:140;H373:55
100696,"Resin acids and Rosin acids, fumarated, esters with pentaerythritol",305-514-1,94581-15-4,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,122,H317:115;H413:42;H319:115;Not classified:7
100701,"Oils, fish, bisulfited",269-127-9,68187-82-6,Skin Irrit. 2,Notified C&L,30,H315:30
100704,Prednisolone steaglate,225-763-9,5060-55-9,Acute Tox. 4;Repr. 1A,Notified C&L,31,H360:30;H302:30;H361:1;Not classified:1
100709,4'-fluoro-4-(4-fluorophenyl)butyrophenone,241-193-3,17135-49-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H301:1;H302:1
100713,Diethoxymethane,207-330-6,462-95-3,Flam. Liq. 2,REACH registration C&L,206,H225:206;H335:55;H315:45;H319:45;H336:11;H311:4
100715,Disodium 1-[1-methyl-2-[(1-oxooctadec-9-enyl)amino]ethyl] 2-sulphonatosuccinate,256-120-0,43154-85-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,10,H318:5;H315:5;Not classified:5
100716,"Phosphoric acid, mixed Bu and stearyl esters, compds. with diethanolamine",291-928-7,90506-64-2,Not Classified,Notified C&L,1,Not classified:1
100719,3-hydroxypyridine-2-carboxylic acid,212-859-0,874-24-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H335:46;H315:47;H319:47;H302:1;H332:1
100720,Calcium ascorbate,611-529-7,5743-28-2,Not Classified,Notified C&L,2,Not classified:2
100722,2-[bis(2-hydroxyethyl)amino]ethyl laurate,217-261-3,1793-68-6,Not Classified,Notified C&L,1,Not classified:1
100724,6-methoxynicotinic acid methylester,607-886-3,26218-80-4,,Notified C&L,7,H335:7;H315:7;H319:7
100725,"2,4-diamino-6-vinyl-s-triazine",424-800-8,3194-70-5,Not Classified,Notified C&L,26,Not classified:25;H312:1;H302:1;H319:1;H315:1;H332:1
100726,(N-methylcarboxamido)propenoic acid,230-062-6,6936-48-7,,Notified C&L,5,H335:4;H315:5;H319:5
100727,"2,4,6-triisopropylbenzenesulphonyl chloride",229-479-6,6553-96-4,,REACH registration C&L,50,H314:50;H318:2;H290:2;H312:1;H332:1;H302:1
100728,"Acetamide, N-(4-amino-2-chlorophenyl)-",611-558-5,57556-49-7,,Notified C&L,4,H335:4;H315:4;H302:4;H319:4
100730,Butyl laurate,203-370-3,106-18-3,Not Classified,Notified C&L,90,Not classified:90
